Background  ||| S:24 E:43 ||| NNP
Myosin-1c  ||| S:43 E:53 ||| NNP
( ||| S:53 E:54 ||| -LRB-
Myo1c ||| S:54 E:59 ||| NNP
) ||| S:59 E:60 ||| -RRB-
,  ||| S:60 E:62 ||| ,
the  ||| S:62 E:66 ||| DT
myosin  ||| S:66 E:73 ||| NN
previously  ||| S:73 E:84 ||| RB
called  ||| S:84 E:99 ||| VBN
myosin-Iβ ||| S:99 E:108 ||| JJ
,  ||| S:108 E:110 ||| ,
myr  ||| S:110 E:114 ||| CD
2 ||| S:114 E:115 ||| CD
,  ||| S:115 E:117 ||| ,
or  ||| S:117 E:120 ||| CC
MI-110K  ||| S:120 E:128 ||| NNP
[  ||| S:128 E:130 ||| -LRB-
1  ||| S:130 E:132 ||| LS
]  ||| S:132 E:134 ||| -RRB-
,  ||| S:134 E:136 ||| ,
is  ||| S:136 E:139 ||| VBZ
an  ||| S:139 E:142 ||| DT
unconventional  ||| S:142 E:165 ||| JJ
myosin  ||| S:165 E:172 ||| NNS
isozyme  ||| S:172 E:180 ||| VBP
implicated  ||| S:180 E:191 ||| VBN
in  ||| S:191 E:194 ||| IN
nuclear  ||| S:194 E:202 ||| JJ
transcription  ||| S:202 E:216 ||| NNS
[  ||| S:216 E:218 ||| -LRB-
2  ||| S:218 E:220 ||| LS
]  ||| S:220 E:222 ||| -RRB-
,  ||| S:222 E:232 ||| ,
lamellopodia  ||| S:232 E:245 ||| JJ
dynamics  ||| S:245 E:254 ||| NNS
of  ||| S:254 E:257 ||| IN
motile  ||| S:257 E:264 ||| JJ
cells  ||| S:264 E:270 ||| NNS
[  ||| S:270 E:272 ||| -LRB-
3  ||| S:272 E:274 ||| CD
4  ||| S:274 E:276 ||| CD
]  ||| S:276 E:278 ||| -RRB-
,  ||| S:278 E:288 ||| ,
brush-border  ||| S:288 E:301 ||| JJ
dynamics  ||| S:301 E:310 ||| NNS
of  ||| S:310 E:313 ||| IN
proximal-tubule  ||| S:313 E:329 ||| JJ
cells  ||| S:329 E:335 ||| NNS
of  ||| S:335 E:338 ||| IN
the  ||| S:338 E:350 ||| DT
kidney  ||| S:350 E:357 ||| NN
[  ||| S:357 E:359 ||| -LRB-
5  ||| S:359 E:361 ||| CD
6  ||| S:361 E:363 ||| CD
]  ||| S:363 E:365 ||| -RRB-
,  ||| S:365 E:367 ||| ,
and  ||| S:367 E:371 ||| CC
adaptation  ||| S:371 E:382 ||| NN
of  ||| S:382 E:385 ||| IN
mechanoelectrical  ||| S:385 E:411 ||| JJ
transduction  ||| S:411 E:424 ||| NN
in  ||| S:424 E:427 ||| IN
hair  ||| S:427 E:432 ||| NN
cells ||| S:432 E:437 ||| NNS
,  ||| S:437 E:439 ||| ,
the  ||| S:439 E:443 ||| DT
sensory  ||| S:443 E:451 ||| JJ
cells  ||| S:451 E:457 ||| NNS
of  ||| S:457 E:460 ||| IN
the  ||| S:460 E:464 ||| DT
inner  ||| S:464 E:478 ||| JJ
ear  ||| S:478 E:482 ||| NN
[  ||| S:482 E:484 ||| -LRB-
7  ||| S:484 E:486 ||| CD
]  ||| S:486 E:488 ||| -RRB-
.  ||| S:488 E:490 ||| .
Myo1c  ||| S:490 E:496 ||| NNP
belongs  ||| S:496 E:504 ||| VBZ
to  ||| S:504 E:507 ||| TO
the  ||| S:507 E:511 ||| DT
myosin-I  ||| S:511 E:520 ||| JJ
class ||| S:520 E:525 ||| NN
,  ||| S:525 E:527 ||| ,
which  ||| S:527 E:541 ||| WDT
contains  ||| S:541 E:550 ||| VBZ
eight  ||| S:550 E:556 ||| CD
members  ||| S:556 E:564 ||| NNS
in  ||| S:564 E:567 ||| IN
humans  ||| S:567 E:574 ||| NNS
[  ||| S:574 E:576 ||| -LRB-
8  ||| S:576 E:578 ||| CD
]  ||| S:578 E:580 ||| -RRB-
and  ||| S:580 E:584 ||| CC
mice  ||| S:584 E:589 ||| NNS
[  ||| S:589 E:591 ||| -LRB-
9  ||| S:591 E:593 ||| CD
]  ||| S:593 E:595 ||| -RRB-
;  ||| S:595 E:597 ||| :
the  ||| S:597 E:609 ||| DT
bullfrog  ||| S:609 E:618 ||| JJ
genome  ||| S:618 E:625 ||| NN
possesses  ||| S:625 E:635 ||| VBZ
at  ||| S:635 E:638 ||| IN
least  ||| S:638 E:644 ||| JJS
two  ||| S:644 E:648 ||| CD
members  ||| S:648 E:656 ||| NNS
[  ||| S:656 E:658 ||| -LRB-
10  ||| S:658 E:661 ||| CD
]  ||| S:661 E:663 ||| -RRB-
.  ||| S:663 E:673 ||| .
Members  ||| S:673 E:681 ||| NNS
of  ||| S:681 E:684 ||| IN
the  ||| S:684 E:688 ||| DT
myosin-I  ||| S:688 E:697 ||| JJ
class  ||| S:697 E:703 ||| NN
have  ||| S:703 E:708 ||| VBP
a  ||| S:708 E:710 ||| DT
single  ||| S:710 E:717 ||| JJ
globular  ||| S:717 E:726 ||| JJ
motor  ||| S:726 E:740 ||| NN
domain ||| S:740 E:746 ||| NN
,  ||| S:746 E:748 ||| ,
followed  ||| S:748 E:757 ||| VBN
by  ||| S:757 E:760 ||| IN
a  ||| S:760 E:762 ||| DT
neck  ||| S:762 E:767 ||| NN
region  ||| S:767 E:774 ||| NN
and  ||| S:774 E:778 ||| CC
a  ||| S:778 E:780 ||| DT
relatively  ||| S:780 E:791 ||| RB
short  ||| S:791 E:805 ||| JJ
( ||| S:805 E:806 ||| -LRB-
30-40  ||| S:806 E:812 ||| NNP
kD ||| S:812 E:814 ||| NNP
)  ||| S:814 E:816 ||| -RRB-
tail  ||| S:816 E:821 ||| NN
domain  ||| S:821 E:828 ||| NN
( ||| S:828 E:829 ||| -LRB-
Fig.  ||| S:829 E:834 ||| NNP
1A ||| S:834 E:836 ||| NNP
) ||| S:836 E:837 ||| -RRB-
.  ||| S:837 E:839 ||| .
This  ||| S:839 E:844 ||| DT
latter  ||| S:844 E:851 ||| JJ
domain  ||| S:851 E:858 ||| NN
is  ||| S:858 E:869 ||| VBZ
highly  ||| S:869 E:876 ||| RB
basic  ||| S:876 E:882 ||| JJ
and  ||| S:882 E:886 ||| CC
binds  ||| S:886 E:892 ||| JJ
to  ||| S:892 E:895 ||| TO
acidic  ||| S:895 E:902 ||| VB
phospholipids  ||| S:902 E:916 ||| NNS
[  ||| S:916 E:918 ||| -LRB-
11  ||| S:918 E:921 ||| CD
]  ||| S:921 E:923 ||| -RRB-
.  ||| S:923 E:933 ||| .
Like  ||| S:933 E:938 ||| IN
all  ||| S:938 E:942 ||| DT
biochemically  ||| S:942 E:956 ||| NN
characterized  ||| S:956 E:970 ||| VBD
unconventional  ||| S:970 E:993 ||| JJ
myosins ||| S:993 E:1000 ||| NN
,  ||| S:1000 E:1002 ||| ,
Myo1c  ||| S:1002 E:1008 ||| FW
binds  ||| S:1008 E:1014 ||| FW
calmodulin  ||| S:1014 E:1025 ||| FW
light  ||| S:1025 E:1031 ||| JJ
chains  ||| S:1031 E:1038 ||| NNS
in  ||| S:1038 E:1041 ||| IN
its  ||| S:1041 E:1045 ||| PRP$
neck  ||| S:1045 E:1058 ||| NN
region  ||| S:1058 E:1065 ||| NN
[  ||| S:1065 E:1067 ||| -LRB-
12  ||| S:1067 E:1070 ||| CD
]  ||| S:1070 E:1072 ||| -RRB-
;  ||| S:1072 E:1074 ||| :
this  ||| S:1074 E:1079 ||| DT
region  ||| S:1079 E:1086 ||| NN
also  ||| S:1086 E:1091 ||| RB
interacts  ||| S:1091 E:1101 ||| VBN
with  ||| S:1101 E:1114 ||| IN
non-calmodulin  ||| S:1114 E:1129 ||| JJ
receptors  ||| S:1129 E:1139 ||| NNS
in  ||| S:1139 E:1142 ||| IN
hair  ||| S:1142 E:1147 ||| NN
cells  ||| S:1147 E:1153 ||| NNS
[  ||| S:1153 E:1155 ||| -LRB-
13  ||| S:1155 E:1158 ||| CD
]  ||| S:1158 E:1160 ||| -RRB-
.  ||| S:1160 E:1170 ||| .
Unconventional  ||| S:1170 E:1185 ||| JJ
myosins  ||| S:1185 E:1193 ||| NNS
contain  ||| S:1193 E:1201 ||| VBP
from  ||| S:1201 E:1206 ||| IN
one  ||| S:1206 E:1210 ||| CD
to  ||| S:1210 E:1213 ||| TO
several  ||| S:1213 E:1221 ||| JJ
IQ  ||| S:1221 E:1232 ||| NNP
domains ||| S:1232 E:1239 ||| NN
,  ||| S:1239 E:1241 ||| ,
which  ||| S:1241 E:1247 ||| WDT
are  ||| S:1247 E:1251 ||| VBP
calmodulin-binding  ||| S:1251 E:1270 ||| JJ
motifs  ||| S:1270 E:1277 ||| NNS
that  ||| S:1277 E:1282 ||| WDT
adhere  ||| S:1282 E:1289 ||| VBZ
to  ||| S:1289 E:1300 ||| TO
the  ||| S:1300 E:1304 ||| DT
general  ||| S:1304 E:1312 ||| JJ
consensus  ||| S:1312 E:1322 ||| NN
sequence  ||| S:1322 E:1331 ||| NN
IQX  ||| S:1331 E:1344 ||| NNP
3  ||| S:1344 E:1346 ||| CD
RGX  ||| S:1346 E:1359 ||| CD
3  ||| S:1359 E:1361 ||| CD
R  ||| S:1361 E:1363 ||| NN
[  ||| S:1363 E:1365 ||| -LRB-
14  ||| S:1365 E:1368 ||| CD
]  ||| S:1368 E:1370 ||| -RRB-
.  ||| S:1370 E:1372 ||| .
Calmodulin ||| S:1372 E:1382 ||| NNP
,  ||| S:1382 E:1384 ||| ,
which  ||| S:1384 E:1390 ||| WDT
can  ||| S:1390 E:1394 ||| MD
bind  ||| S:1394 E:1407 ||| VB
up  ||| S:1407 E:1410 ||| RP
to  ||| S:1410 E:1413 ||| TO
four  ||| S:1413 E:1418 ||| CD
Ca  ||| S:1418 E:1421 ||| NNP
2+ions ||| S:1421 E:1427 ||| NNP
,  ||| S:1427 E:1429 ||| ,
generally  ||| S:1429 E:1439 ||| RB
binds  ||| S:1439 E:1445 ||| JJ
IQ  ||| S:1445 E:1448 ||| NNP
domains  ||| S:1448 E:1456 ||| NN
in  ||| S:1456 E:1459 ||| IN
the  ||| S:1459 E:1463 ||| DT
Ca  ||| S:1463 E:1474 ||| NNP
2+-free  ||| S:1474 E:1482 ||| NNP
conformation ||| S:1482 E:1494 ||| NN
;  ||| S:1494 E:1496 ||| :
interaction  ||| S:1496 E:1508 ||| NN
of  ||| S:1508 E:1511 ||| IN
Ca  ||| S:1511 E:1514 ||| NNP
2+-bound  ||| S:1514 E:1523 ||| NNP
calmodulin  ||| S:1523 E:1542 ||| VBD
to  ||| S:1542 E:1545 ||| TO
other  ||| S:1545 E:1551 ||| JJ
proteins  ||| S:1551 E:1560 ||| NNS
occurs  ||| S:1560 E:1567 ||| VBZ
through  ||| S:1567 E:1575 ||| IN
alternative  ||| S:1575 E:1587 ||| JJ
binding  ||| S:1587 E:1595 ||| JJ
motifs  ||| S:1595 E:1610 ||| NNS
[  ||| S:1610 E:1612 ||| -LRB-
14  ||| S:1612 E:1615 ||| CD
]  ||| S:1615 E:1617 ||| -RRB-
.  ||| S:1617 E:1627 ||| .
Myo1c  ||| S:1627 E:1633 ||| NNP
contains  ||| S:1633 E:1642 ||| VBZ
three  ||| S:1642 E:1648 ||| CD
readily  ||| S:1648 E:1656 ||| RB
recognized  ||| S:1656 E:1667 ||| VBN
IQ  ||| S:1667 E:1670 ||| NNP
motifs  ||| S:1670 E:1677 ||| NNS
of  ||| S:1677 E:1680 ||| IN
23  ||| S:1680 E:1691 ||| CD
amino  ||| S:1691 E:1697 ||| NNS
acids  ||| S:1697 E:1703 ||| VBP
each  ||| S:1703 E:1708 ||| DT
( ||| S:1708 E:1709 ||| -LRB-
Fig.  ||| S:1709 E:1714 ||| NNP
1C ||| S:1714 E:1716 ||| NNP
;  ||| S:1716 E:1718 ||| :
refs.  ||| S:1718 E:1724 ||| CD
[  ||| S:1724 E:1726 ||| -LRB-
10  ||| S:1726 E:1729 ||| CD
15  ||| S:1729 E:1732 ||| CD
16  ||| S:1732 E:1735 ||| CD
17  ||| S:1735 E:1738 ||| CD
18  ||| S:1738 E:1741 ||| CD
]  ||| S:1741 E:1743 ||| CD
) ||| S:1743 E:1744 ||| -RRB-
.  ||| S:1744 E:1754 ||| .
Purified  ||| S:1754 E:1763 ||| NNP
Myo1c  ||| S:1763 E:1769 ||| NNP
apparently  ||| S:1769 E:1780 ||| RB
includes  ||| S:1780 E:1789 ||| VBZ
2-3  ||| S:1789 E:1793 ||| CD
calmodulins  ||| S:1793 E:1805 ||| NN
per  ||| S:1805 E:1817 ||| IN
Myo1c  ||| S:1817 E:1823 ||| CD
heavy  ||| S:1823 E:1829 ||| JJ
chain  ||| S:1829 E:1835 ||| NN
[  ||| S:1835 E:1837 ||| -LRB-
19  ||| S:1837 E:1840 ||| CD
20  ||| S:1840 E:1843 ||| CD
21  ||| S:1843 E:1846 ||| CD
]  ||| S:1846 E:1848 ||| -RRB-
;  ||| S:1848 E:1850 ||| :
calmodulin  ||| S:1850 E:1861 ||| JJ
supplementation  ||| S:1861 E:1885 ||| NN
can  ||| S:1885 E:1889 ||| MD
increase  ||| S:1889 E:1898 ||| VB
the  ||| S:1898 E:1902 ||| DT
stoichiometry  ||| S:1902 E:1916 ||| NN
to  ||| S:1916 E:1919 ||| TO
as  ||| S:1919 E:1922 ||| RB
many  ||| S:1922 E:1927 ||| JJ
as  ||| S:1927 E:1930 ||| IN
4  ||| S:1930 E:1932 ||| CD
calmodulins  ||| S:1932 E:1952 ||| NN
per  ||| S:1952 E:1956 ||| IN
Myo1c  ||| S:1956 E:1962 ||| NNP
[  ||| S:1962 E:1964 ||| -LRB-
21  ||| S:1964 E:1967 ||| CD
]  ||| S:1967 E:1969 ||| -RRB-
.  ||| S:1969 E:1971 ||| .
Unfortunately ||| S:1971 E:1984 ||| RB
,  ||| S:1984 E:1986 ||| ,
the  ||| S:1986 E:1990 ||| DT
lack  ||| S:1990 E:1995 ||| NN
of  ||| S:1995 E:1998 ||| IN
appropriate  ||| S:1998 E:2018 ||| JJ
quantitation  ||| S:2018 E:2031 ||| JJ
standards  ||| S:2031 E:2041 ||| NNS
for  ||| S:2041 E:2045 ||| IN
the  ||| S:2045 E:2049 ||| DT
Myo1c  ||| S:2049 E:2055 ||| JJ
heavy  ||| S:2055 E:2061 ||| JJ
chain  ||| S:2061 E:2067 ||| NN
in  ||| S:2067 E:2070 ||| IN
those  ||| S:2070 E:2084 ||| DT
experiments  ||| S:2084 E:2096 ||| NNS
limits  ||| S:2096 E:2103 ||| VBZ
the  ||| S:2103 E:2107 ||| DT
reliability  ||| S:2107 E:2119 ||| NN
of  ||| S:2119 E:2122 ||| IN
these  ||| S:2122 E:2128 ||| DT
values ||| S:2128 E:2134 ||| NNS
.  ||| S:2134 E:2144 ||| .
How  ||| S:2144 E:2148 ||| WRB
Ca  ||| S:2148 E:2151 ||| NNP
2+and  ||| S:2151 E:2157 ||| FW
calmodulin  ||| S:2157 E:2168 ||| FW
regulate  ||| S:2168 E:2177 ||| FW
Myo1c  ||| S:2177 E:2183 ||| FW
or  ||| S:2183 E:2186 ||| CC
indeed  ||| S:2186 E:2193 ||| RB
any  ||| S:2193 E:2205 ||| DT
myosin-I  ||| S:2205 E:2214 ||| NN
is  ||| S:2214 E:2217 ||| VBZ
unclear ||| S:2217 E:2224 ||| JJ
.  ||| S:2224 E:2226 ||| .
Although  ||| S:2226 E:2235 ||| IN
Ca  ||| S:2235 E:2238 ||| NNP
2+increases  ||| S:2238 E:2250 ||| NNP
ATPase  ||| S:2250 E:2265 ||| JJ
activity  ||| S:2265 E:2274 ||| NN
of  ||| S:2274 E:2277 ||| IN
most  ||| S:2277 E:2282 ||| RBS
myosin-I  ||| S:2282 E:2291 ||| JJ
isozymes ||| S:2291 E:2299 ||| NN
,  ||| S:2299 E:2310 ||| ,
in  ||| S:2310 E:2313 ||| IN
vitro  ||| S:2313 E:2319 ||| JJ
motility  ||| S:2319 E:2328 ||| NN
is  ||| S:2328 E:2331 ||| VBZ
usually  ||| S:2331 E:2339 ||| RB
blocked  ||| S:2339 E:2355 ||| VBN
under  ||| S:2355 E:2361 ||| IN
identical  ||| S:2361 E:2371 ||| JJ
conditions  ||| S:2371 E:2382 ||| NNS
[  ||| S:2382 E:2384 ||| -LRB-
11  ||| S:2384 E:2387 ||| CD
]  ||| S:2387 E:2389 ||| -RRB-
.  ||| S:2389 E:2391 ||| .
Ca  ||| S:2391 E:2394 ||| NNP
2+dissociates  ||| S:2394 E:2408 ||| CD
one  ||| S:2408 E:2412 ||| CD
or  ||| S:2412 E:2423 ||| CC
more  ||| S:2423 E:2428 ||| JJR
calmodulins  ||| S:2428 E:2440 ||| NN
from  ||| S:2440 E:2445 ||| IN
the  ||| S:2445 E:2449 ||| DT
myosin-calmodulin  ||| S:2449 E:2467 ||| JJ
complex ||| S:2467 E:2474 ||| NN
,  ||| S:2474 E:2476 ||| ,
which  ||| S:2476 E:2490 ||| WDT
apparently  ||| S:2490 E:2501 ||| RB
elevates  ||| S:2501 E:2510 ||| VBZ
ATPase  ||| S:2510 E:2517 ||| JJ
activity  ||| S:2517 E:2526 ||| NN
and  ||| S:2526 E:2530 ||| CC
inhibits  ||| S:2530 E:2539 ||| JJ
motility  ||| S:2539 E:2548 ||| NNS
[  ||| S:2548 E:2558 ||| -LRB-
11  ||| S:2558 E:2561 ||| CD
]  ||| S:2561 E:2563 ||| -RRB-
.  ||| S:2563 E:2565 ||| .
In  ||| S:2565 E:2568 ||| IN
conventional  ||| S:2568 E:2581 ||| JJ
myosin ||| S:2581 E:2587 ||| NN
,  ||| S:2587 E:2589 ||| ,
light  ||| S:2589 E:2595 ||| JJ
chains  ||| S:2595 E:2602 ||| NNS
related  ||| S:2602 E:2610 ||| VBN
to  ||| S:2610 E:2621 ||| TO
calmodulin  ||| S:2621 E:2632 ||| NNS
appear  ||| S:2632 E:2639 ||| VBP
to  ||| S:2639 E:2642 ||| TO
be  ||| S:2642 E:2645 ||| VB
essential  ||| S:2645 E:2655 ||| JJ
for  ||| S:2655 E:2659 ||| IN
stabilization  ||| S:2659 E:2673 ||| NN
of  ||| S:2673 E:2676 ||| IN
the  ||| S:2676 E:2688 ||| DT
myosin  ||| S:2688 E:2695 ||| JJ
lever  ||| S:2695 E:2701 ||| JJ
arm  ||| S:2701 E:2705 ||| NN
[  ||| S:2705 E:2707 ||| -LRB-
22  ||| S:2707 E:2710 ||| CD
]  ||| S:2710 E:2712 ||| -RRB-
,  ||| S:2712 E:2714 ||| ,
a  ||| S:2714 E:2716 ||| DT
domain  ||| S:2716 E:2723 ||| NN
that  ||| S:2723 E:2728 ||| WDT
is  ||| S:2728 E:2731 ||| VBZ
vital  ||| S:2731 E:2737 ||| JJ
for  ||| S:2737 E:2749 ||| IN
efficient  ||| S:2749 E:2759 ||| JJ
conversion  ||| S:2759 E:2770 ||| NN
of  ||| S:2770 E:2773 ||| IN
chemical  ||| S:2773 E:2782 ||| JJ
energy  ||| S:2782 E:2789 ||| NN
into  ||| S:2789 E:2794 ||| IN
mechanical  ||| S:2794 E:2813 ||| JJ
work  ||| S:2813 E:2818 ||| NN
[  ||| S:2818 E:2820 ||| -LRB-
23  ||| S:2820 E:2823 ||| CD
]  ||| S:2823 E:2825 ||| -RRB-
.  ||| S:2825 E:2827 ||| .
Calmodulin  ||| S:2827 E:2838 ||| NNP
probably  ||| S:2838 E:2847 ||| RB
plays  ||| S:2847 E:2853 ||| VBZ
a  ||| S:2853 E:2855 ||| DT
similar  ||| S:2855 E:2863 ||| JJ
lever-arm  ||| S:2863 E:2881 ||| JJ
stabilizing  ||| S:2881 E:2893 ||| JJ
role  ||| S:2893 E:2898 ||| NN
for  ||| S:2898 E:2902 ||| IN
Myo1c ||| S:2902 E:2907 ||| CD
;  ||| S:2907 E:2909 ||| :
Ca  ||| S:2909 E:2912 ||| NNP
2+-induced  ||| S:2912 E:2923 ||| NNP
calmodulin  ||| S:2923 E:2942 ||| JJ
release  ||| S:2942 E:2950 ||| NN
would  ||| S:2950 E:2956 ||| MD
reverse  ||| S:2956 E:2964 ||| VB
the  ||| S:2964 E:2968 ||| DT
stabilization  ||| S:2968 E:2982 ||| NN
and  ||| S:2982 E:2986 ||| CC
inhibit  ||| S:2986 E:3002 ||| JJ
motility ||| S:3002 E:3010 ||| NN
.  ||| S:3010 E:3020 ||| .
To  ||| S:3020 E:3023 ||| TO
better  ||| S:3023 E:3030 ||| RB
understand  ||| S:3030 E:3041 ||| VB
the  ||| S:3041 E:3045 ||| DT
regulation  ||| S:3045 E:3056 ||| NN
of  ||| S:3056 E:3059 ||| IN
Myo1c  ||| S:3059 E:3065 ||| CD
activity  ||| S:3065 E:3074 ||| NN
by  ||| S:3074 E:3085 ||| IN
calmodulin ||| S:3085 E:3095 ||| NN
,  ||| S:3095 E:3097 ||| ,
we  ||| S:3097 E:3100 ||| PRP
sought  ||| S:3100 E:3107 ||| VBD
to  ||| S:3107 E:3110 ||| TO
more  ||| S:3110 E:3115 ||| RBR
accurately  ||| S:3115 E:3126 ||| RB
determine  ||| S:3126 E:3136 ||| VB
how  ||| S:3136 E:3148 ||| WRB
calmodulin  ||| S:3148 E:3159 ||| JJ
binds  ||| S:3159 E:3165 ||| NN
to  ||| S:3165 E:3168 ||| TO
Myo1c  ||| S:3168 E:3174 ||| CD
by  ||| S:3174 E:3177 ||| IN
measuring  ||| S:3177 E:3187 ||| VBG
the  ||| S:3187 E:3191 ||| DT
Ca  ||| S:3191 E:3194 ||| JJ
2+-dependence  ||| S:3194 E:3216 ||| NN
of  ||| S:3216 E:3219 ||| IN
calmodulin  ||| S:3219 E:3230 ||| JJ
binding  ||| S:3230 E:3238 ||| NN
to  ||| S:3238 E:3241 ||| TO
individual  ||| S:3241 E:3252 ||| JJ
Myo1c  ||| S:3252 E:3258 ||| NNP
IQ  ||| S:3258 E:3261 ||| NNP
peptides ||| S:3261 E:3269 ||| NN
.  ||| S:3269 E:3271 ||| .
In  ||| S:3271 E:3282 ||| IN
addition ||| S:3282 E:3290 ||| NN
,  ||| S:3290 E:3292 ||| ,
to  ||| S:3292 E:3295 ||| TO
examine  ||| S:3295 E:3303 ||| VB
the  ||| S:3303 E:3307 ||| DT
consequences  ||| S:3307 E:3320 ||| NNS
of  ||| S:3320 E:3323 ||| IN
calmodulin  ||| S:3323 E:3334 ||| JJ
binding  ||| S:3334 E:3350 ||| NN
to  ||| S:3350 E:3353 ||| TO
adjacent  ||| S:3353 E:3362 ||| JJ
IQ  ||| S:3362 E:3365 ||| NNP
domains ||| S:3365 E:3372 ||| NN
,  ||| S:3372 E:3374 ||| ,
we  ||| S:3374 E:3377 ||| PRP
measured  ||| S:3377 E:3386 ||| VBD
hydrodynamic  ||| S:3386 E:3399 ||| JJ
properties  ||| S:3399 E:3418 ||| NNS
of  ||| S:3418 E:3421 ||| IN
recombinant  ||| S:3421 E:3433 ||| JJ
Myo1c-calmodulin  ||| S:3433 E:3450 ||| CD
complexes ||| S:3450 E:3459 ||| NNS
,  ||| S:3459 E:3461 ||| ,
under  ||| S:3461 E:3467 ||| IN
differing  ||| S:3467 E:3485 ||| VBG
conditions  ||| S:3485 E:3496 ||| NNS
of  ||| S:3496 E:3499 ||| IN
Ca  ||| S:3499 E:3502 ||| NNP
2+ ||| S:3502 E:3504 ||| NNP
,  ||| S:3504 E:3506 ||| ,
calmodulin ||| S:3506 E:3516 ||| NN
,  ||| S:3516 E:3518 ||| ,
and  ||| S:3518 E:3522 ||| CC
temperature ||| S:3522 E:3533 ||| NN
.  ||| S:3533 E:3535 ||| .
These  ||| S:3535 E:3549 ||| DT
measurements  ||| S:3549 E:3562 ||| NNS
allowed  ||| S:3562 E:3570 ||| VBD
us  ||| S:3570 E:3573 ||| PRP
to  ||| S:3573 E:3576 ||| TO
determine  ||| S:3576 E:3586 ||| VB
the  ||| S:3586 E:3590 ||| DT
molecular  ||| S:3590 E:3600 ||| JJ
mass  ||| S:3600 E:3605 ||| NN
and  ||| S:3605 E:3617 ||| CC
hence  ||| S:3617 E:3623 ||| RB
stoichiometry  ||| S:3623 E:3637 ||| VBN
of  ||| S:3637 E:3640 ||| IN
the  ||| S:3640 E:3644 ||| DT
Myo1c  ||| S:3644 E:3650 ||| JJ
complex ||| S:3650 E:3657 ||| NN
.  ||| S:3657 E:3659 ||| .
Our  ||| S:3659 E:3663 ||| PRP$
results  ||| S:3663 E:3679 ||| NNS
indicate  ||| S:3679 E:3688 ||| VBP
that  ||| S:3688 E:3693 ||| IN
IQ1 ||| S:3693 E:3696 ||| NNP
,  ||| S:3696 E:3698 ||| ,
IQ2 ||| S:3698 E:3701 ||| NNP
,  ||| S:3701 E:3703 ||| ,
and  ||| S:3703 E:3707 ||| CC
IQ3  ||| S:3707 E:3711 ||| NNP
have  ||| S:3711 E:3716 ||| VBP
calmodulin  ||| S:3716 E:3727 ||| VBN
bound  ||| S:3727 E:3733 ||| VBN
when  ||| S:3733 E:3746 ||| WRB
the  ||| S:3746 E:3750 ||| DT
concentration  ||| S:3750 E:3764 ||| NN
of  ||| S:3764 E:3767 ||| IN
Ca  ||| S:3767 E:3770 ||| NNP
2+is  ||| S:3770 E:3775 ||| NNP
low ||| S:3775 E:3778 ||| JJ
,  ||| S:3778 E:3780 ||| ,
and  ||| S:3780 E:3784 ||| CC
that  ||| S:3784 E:3789 ||| WDT
increased  ||| S:3789 E:3799 ||| VBD
Ca  ||| S:3799 E:3810 ||| NNP
2+induces  ||| S:3810 E:3820 ||| NNP
release  ||| S:3820 E:3828 ||| NN
of  ||| S:3828 E:3831 ||| IN
calmodulin  ||| S:3831 E:3842 ||| NN
from  ||| S:3842 E:3847 ||| IN
IQ1  ||| S:3847 E:3851 ||| NNP
and  ||| S:3851 E:3855 ||| CC
IQ2 ||| S:3855 E:3858 ||| NNP
.  ||| S:3858 E:3882 ||| .
Results  ||| S:3882 E:3909 ||| NNS
Sequence  ||| S:3909 E:3918 ||| JJ
analysis  ||| S:3918 E:3927 ||| NN
of  ||| S:3927 E:3930 ||| IN
IQ  ||| S:3930 E:3933 ||| NNP
domains  ||| S:3933 E:3951 ||| VBD
Examination  ||| S:3951 E:3963 ||| NNP
of  ||| S:3963 E:3966 ||| IN
the  ||| S:3966 E:3970 ||| DT
primary  ||| S:3970 E:3978 ||| JJ
sequence  ||| S:3978 E:3987 ||| NN
of  ||| S:3987 E:3990 ||| IN
the  ||| S:3990 E:3994 ||| DT
bullfrog  ||| S:3994 E:4013 ||| JJ
Myo1c  ||| S:4013 E:4019 ||| CD
neck  ||| S:4019 E:4024 ||| NN
region  ||| S:4024 E:4031 ||| NN
reveals  ||| S:4031 E:4039 ||| VBZ
an  ||| S:4039 E:4042 ||| DT
exact  ||| S:4042 E:4048 ||| JJ
repeat  ||| S:4048 E:4055 ||| NN
of  ||| S:4055 E:4058 ||| IN
five  ||| S:4058 E:4063 ||| CD
amino  ||| S:4063 E:4079 ||| NNS
acids  ||| S:4079 E:4085 ||| VBP
located  ||| S:4085 E:4093 ||| VBN
both  ||| S:4093 E:4098 ||| DT
in  ||| S:4098 E:4101 ||| IN
the  ||| S:4101 E:4105 ||| DT
IQ3  ||| S:4105 E:4109 ||| JJ
region  ||| S:4109 E:4116 ||| NN
( ||| S:4116 E:4117 ||| -LRB-
YRNQP ||| S:4117 E:4122 ||| NNP
;  ||| S:4122 E:4124 ||| :
residues  ||| S:4124 E:4143 ||| CD
761-765 ||| S:4143 E:4150 ||| CD
)  ||| S:4150 E:4152 ||| -RRB-
and  ||| S:4152 E:4156 ||| CC
at  ||| S:4156 E:4159 ||| IN
residues  ||| S:4159 E:4168 ||| CD
786-790 ||| S:4168 E:4175 ||| CD
.  ||| S:4175 E:4177 ||| .
Alignment  ||| S:4177 E:4187 ||| NNP
of  ||| S:4187 E:4190 ||| IN
the  ||| S:4190 E:4204 ||| DT
residues  ||| S:4204 E:4213 ||| NN
surrounding  ||| S:4213 E:4225 ||| VBG
the  ||| S:4225 E:4229 ||| DT
repeat  ||| S:4229 E:4236 ||| NN
revealed  ||| S:4236 E:4245 ||| VBD
reasonable  ||| S:4245 E:4266 ||| JJ
homology  ||| S:4266 E:4275 ||| NN
with  ||| S:4275 E:4280 ||| IN
the  ||| S:4280 E:4284 ||| DT
three  ||| S:4284 E:4290 ||| CD
known  ||| S:4290 E:4296 ||| VBN
IQ  ||| S:4296 E:4299 ||| NNP
domains ||| S:4299 E:4306 ||| NN
,  ||| S:4306 E:4308 ||| ,
with  ||| S:4308 E:4313 ||| IN
particular  ||| S:4313 E:4334 ||| JJ
similarity  ||| S:4334 E:4345 ||| NN
to  ||| S:4345 E:4348 ||| TO
IQ3 ||| S:4348 E:4351 ||| CD
,  ||| S:4351 E:4353 ||| ,
suggesting  ||| S:4353 E:4364 ||| VBG
that  ||| S:4364 E:4369 ||| IN
this  ||| S:4369 E:4374 ||| DT
region  ||| S:4374 E:4381 ||| NN
may  ||| S:4381 E:4385 ||| MD
be  ||| S:4385 E:4388 ||| VB
a  ||| S:4388 E:4400 ||| DT
fourth  ||| S:4400 E:4407 ||| JJ
IQ  ||| S:4407 E:4410 ||| NNP
domain  ||| S:4410 E:4417 ||| NN
( ||| S:4417 E:4418 ||| -LRB-
Fig.  ||| S:4418 E:4423 ||| NNP
1C ||| S:4423 E:4425 ||| NNP
) ||| S:4425 E:4426 ||| -RRB-
.  ||| S:4426 E:4428 ||| .
Although  ||| S:4428 E:4437 ||| IN
the  ||| S:4437 E:4441 ||| DT
pair  ||| S:4441 E:4446 ||| NN
of  ||| S:4446 E:4449 ||| IN
amino  ||| S:4449 E:4465 ||| JJ
acids  ||| S:4465 E:4471 ||| NNS
( ||| S:4471 E:4472 ||| -LRB-
LM ||| S:4472 E:4474 ||| NNP
;  ||| S:4474 E:4476 ||| :
residues  ||| S:4476 E:4485 ||| CD
782  ||| S:4485 E:4489 ||| CD
and  ||| S:4489 E:4493 ||| CC
783 ||| S:4493 E:4496 ||| CD
)  ||| S:4496 E:4498 ||| -RRB-
that  ||| S:4498 E:4503 ||| WDT
align  ||| S:4503 E:4509 ||| VBP
with  ||| S:4509 E:4514 ||| IN
the  ||| S:4514 E:4518 ||| DT
RG  ||| S:4518 E:4531 ||| NNP
of  ||| S:4531 E:4534 ||| IN
the  ||| S:4534 E:4538 ||| DT
IQ  ||| S:4538 E:4541 ||| NNP
consensus  ||| S:4541 E:4551 ||| NN
motif  ||| S:4551 E:4557 ||| NNS
are  ||| S:4557 E:4561 ||| VBP
not  ||| S:4561 E:4565 ||| RB
conserved ||| S:4565 E:4574 ||| JJ
,  ||| S:4574 E:4576 ||| ,
the  ||| S:4576 E:4580 ||| DT
first  ||| S:4580 E:4596 ||| JJ
pair  ||| S:4596 E:4601 ||| NN
of  ||| S:4601 E:4604 ||| IN
amino  ||| S:4604 E:4610 ||| JJ
acids  ||| S:4610 E:4616 ||| NNS
( ||| S:4616 E:4617 ||| -LRB-
IR ||| S:4617 E:4619 ||| NNP
;  ||| S:4619 E:4621 ||| :
residues  ||| S:4621 E:4630 ||| CD
777  ||| S:4630 E:4634 ||| CD
and  ||| S:4634 E:4638 ||| CC
778 ||| S:4638 E:4641 ||| CD
)  ||| S:4641 E:4643 ||| -RRB-
that  ||| S:4643 E:4648 ||| WDT
align  ||| S:4648 E:4664 ||| VBP
with  ||| S:4664 E:4669 ||| IN
the  ||| S:4669 E:4673 ||| DT
consensus  ||| S:4673 E:4683 ||| NN
IQ  ||| S:4683 E:4686 ||| NNP
adhere  ||| S:4686 E:4693 ||| VBD
to  ||| S:4693 E:4696 ||| TO
the  ||| S:4696 E:4700 ||| DT
consensus  ||| S:4700 E:4710 ||| NN
better  ||| S:4710 E:4717 ||| RBR
than  ||| S:4717 E:4732 ||| IN
those  ||| S:4732 E:4738 ||| DT
of  ||| S:4738 E:4741 ||| IN
IQ3 ||| S:4741 E:4744 ||| CD
.  ||| S:4744 E:4746 ||| .
Because  ||| S:4746 E:4754 ||| IN
of  ||| S:4754 E:4757 ||| IN
the  ||| S:4757 E:4761 ||| DT
sequence  ||| S:4761 E:4770 ||| JJ
similarity  ||| S:4770 E:4781 ||| NN
to  ||| S:4781 E:4784 ||| TO
IQ3  ||| S:4784 E:4798 ||| CD
and  ||| S:4798 E:4802 ||| CC
because  ||| S:4802 E:4810 ||| IN
this  ||| S:4810 E:4815 ||| DT
peptide  ||| S:4815 E:4823 ||| FW
binds  ||| S:4823 E:4829 ||| FW
calmodulin  ||| S:4829 E:4840 ||| FW
( ||| S:4840 E:4841 ||| -LRB-
albeit  ||| S:4841 E:4848 ||| IN
weakly ||| S:4848 E:4854 ||| NNS
;  ||| S:4854 E:4866 ||| :
see  ||| S:4866 E:4870 ||| VBP
below ||| S:4870 E:4875 ||| RB
) ||| S:4875 E:4876 ||| -RRB-
,  ||| S:4876 E:4878 ||| ,
we  ||| S:4878 E:4881 ||| PRP
refer  ||| S:4881 E:4887 ||| VBP
to  ||| S:4887 E:4890 ||| TO
this  ||| S:4890 E:4895 ||| DT
domain  ||| S:4895 E:4902 ||| NN
as  ||| S:4902 E:4905 ||| IN
IQ4 ||| S:4905 E:4908 ||| CD
.  ||| S:4908 E:4938 ||| .
IQ  ||| S:4938 E:4941 ||| NNP
-  ||| S:4941 E:4943 ||| :
Alexa-calmodulin  ||| S:4943 E:4960 ||| JJ
interaction  ||| S:4960 E:4972 ||| NN
on  ||| S:4972 E:4975 ||| IN
plastic  ||| S:4975 E:4993 ||| JJ
plates  ||| S:4993 E:5010 ||| NN
To  ||| S:5010 E:5013 ||| TO
investigate  ||| S:5013 E:5025 ||| VB
the  ||| S:5025 E:5029 ||| DT
calmodulin-binding  ||| S:5029 E:5048 ||| JJ
properties  ||| S:5048 E:5059 ||| NNS
of  ||| S:5059 E:5072 ||| IN
each  ||| S:5072 E:5077 ||| DT
Myo1c  ||| S:5077 E:5083 ||| NNP
IQ  ||| S:5083 E:5086 ||| NNP
domain ||| S:5086 E:5092 ||| NN
,  ||| S:5092 E:5094 ||| ,
we  ||| S:5094 E:5097 ||| PRP
measured  ||| S:5097 E:5106 ||| VBD
interaction  ||| S:5106 E:5118 ||| VBN
of  ||| S:5118 E:5121 ||| IN
a  ||| S:5121 E:5133 ||| DT
fluorescently  ||| S:5133 E:5147 ||| FW
labeled  ||| S:5147 E:5155 ||| FW
calmodulin  ||| S:5155 E:5166 ||| FW
( ||| S:5166 E:5167 ||| -LRB-
Alexa-calmodulin ||| S:5167 E:5183 ||| NNP
)  ||| S:5183 E:5185 ||| -RRB-
with  ||| S:5185 E:5200 ||| IN
individual  ||| S:5200 E:5211 ||| JJ
Myo1c  ||| S:5211 E:5217 ||| NNP
IQ  ||| S:5217 E:5220 ||| NNP
peptides  ||| S:5220 E:5229 ||| NN
that  ||| S:5229 E:5234 ||| WDT
had  ||| S:5234 E:5238 ||| VBD
been  ||| S:5238 E:5243 ||| VBN
conjugated  ||| S:5243 E:5254 ||| VBN
to  ||| S:5254 E:5267 ||| TO
wells  ||| S:5267 E:5273 ||| NNS
of  ||| S:5273 E:5276 ||| IN
a  ||| S:5276 E:5278 ||| DT
plastic  ||| S:5278 E:5286 ||| JJ
plate ||| S:5286 E:5291 ||| NN
.  ||| S:5291 E:5293 ||| .
We  ||| S:5293 E:5296 ||| PRP
used  ||| S:5296 E:5301 ||| VBD
an  ||| S:5301 E:5304 ||| DT
IQ  ||| S:5304 E:5307 ||| NNP
peptide  ||| S:5307 E:5315 ||| NN
from  ||| S:5315 E:5330 ||| IN
neuromodulin  ||| S:5330 E:5343 ||| NNS
[  ||| S:5343 E:5345 ||| -LRB-
24  ||| S:5345 E:5348 ||| CD
]  ||| S:5348 E:5350 ||| -RRB-
as  ||| S:5350 E:5353 ||| IN
a  ||| S:5353 E:5355 ||| DT
positive  ||| S:5355 E:5364 ||| JJ
control ||| S:5364 E:5371 ||| NN
;  ||| S:5371 E:5373 ||| :
calmodulin  ||| S:5373 E:5394 ||| JJ
binds  ||| S:5394 E:5400 ||| NN
to  ||| S:5400 E:5403 ||| TO
this  ||| S:5403 E:5408 ||| DT
site ||| S:5408 E:5412 ||| NN
,  ||| S:5412 E:5414 ||| ,
with  ||| S:5414 E:5419 ||| IN
its  ||| S:5419 E:5423 ||| PRP$
interaction  ||| S:5423 E:5435 ||| NNS
reduced  ||| S:5435 E:5443 ||| VBN
by  ||| S:5443 E:5446 ||| IN
high  ||| S:5446 E:5461 ||| JJ
ionic  ||| S:5461 E:5467 ||| JJ
strength  ||| S:5467 E:5476 ||| NN
[  ||| S:5476 E:5478 ||| -LRB-
24  ||| S:5478 E:5481 ||| CD
25  ||| S:5481 E:5484 ||| CD
]  ||| S:5484 E:5486 ||| -RRB-
.  ||| S:5486 E:5488 ||| .
As  ||| S:5488 E:5491 ||| IN
a  ||| S:5491 E:5493 ||| DT
negative  ||| S:5493 E:5502 ||| JJ
control ||| S:5502 E:5509 ||| NN
,  ||| S:5509 E:5511 ||| ,
we  ||| S:5511 E:5514 ||| PRP
used  ||| S:5514 E:5529 ||| VBD
a  ||| S:5529 E:5531 ||| DT
peptide  ||| S:5531 E:5539 ||| NN
( ||| S:5539 E:5540 ||| -LRB-
PVP ||| S:5540 E:5543 ||| NNP
) ||| S:5543 E:5544 ||| -RRB-
,  ||| S:5544 E:5546 ||| ,
corresponding  ||| S:5546 E:5560 ||| JJ
to  ||| S:5560 E:5563 ||| TO
the  ||| S:5563 E:5567 ||| DT
25  ||| S:5567 E:5570 ||| CD
amino  ||| S:5570 E:5576 ||| CD
acids  ||| S:5576 E:5582 ||| NNS
of  ||| S:5582 E:5595 ||| IN
Myo1c  ||| S:5595 E:5601 ||| NNP
immediately  ||| S:5601 E:5613 ||| RB
following  ||| S:5613 E:5623 ||| VBG
IQ4 ||| S:5623 E:5626 ||| CD
.  ||| S:5626 E:5628 ||| .
Indeed ||| S:5628 E:5634 ||| RB
,  ||| S:5634 E:5636 ||| ,
Alexa-calmodulin  ||| S:5636 E:5663 ||| JJ
bound  ||| S:5663 E:5669 ||| NN
to  ||| S:5669 E:5672 ||| TO
wells  ||| S:5672 E:5678 ||| VB
derivatized  ||| S:5678 E:5690 ||| VBN
with  ||| S:5690 E:5695 ||| IN
the  ||| S:5695 E:5699 ||| DT
neuromodulin  ||| S:5699 E:5712 ||| JJ
IQ  ||| S:5712 E:5725 ||| NNP
peptide  ||| S:5725 E:5733 ||| NN
and  ||| S:5733 E:5737 ||| CC
did  ||| S:5737 E:5741 ||| VBD
not  ||| S:5741 E:5745 ||| RB
bind  ||| S:5745 E:5750 ||| VBN
to  ||| S:5750 E:5753 ||| TO
the  ||| S:5753 E:5757 ||| DT
PVP  ||| S:5757 E:5761 ||| NNP
peptide  ||| S:5761 E:5769 ||| NNS
( ||| S:5769 E:5770 ||| -LRB-
Fig.  ||| S:5770 E:5785 ||| NNP
2A ||| S:5785 E:5787 ||| NNP
) ||| S:5787 E:5788 ||| -RRB-
.  ||| S:5788 E:5800 ||| .
Substantial  ||| S:5800 E:5812 ||| JJ
amounts  ||| S:5812 E:5820 ||| NNS
of  ||| S:5820 E:5823 ||| IN
Alexa-calmodulin  ||| S:5823 E:5840 ||| JJ
bound  ||| S:5840 E:5846 ||| NN
to  ||| S:5846 E:5849 ||| TO
wells  ||| S:5849 E:5865 ||| VB
derivatized  ||| S:5865 E:5877 ||| VBN
with  ||| S:5877 E:5882 ||| IN
IQ1 ||| S:5882 E:5885 ||| NNP
,  ||| S:5885 E:5887 ||| ,
IQ2 ||| S:5887 E:5890 ||| NNP
,  ||| S:5890 E:5892 ||| ,
and  ||| S:5892 E:5896 ||| CC
IQ3 ||| S:5896 E:5899 ||| NNP
;  ||| S:5899 E:5901 ||| :
by  ||| S:5901 E:5904 ||| IN
contrast ||| S:5904 E:5912 ||| NN
,  ||| S:5912 E:5924 ||| ,
relatively  ||| S:5924 E:5935 ||| RB
little  ||| S:5935 E:5942 ||| RB
bound  ||| S:5942 E:5948 ||| VBN
to  ||| S:5948 E:5951 ||| TO
IQ4-coated  ||| S:5951 E:5962 ||| CD
wells  ||| S:5962 E:5968 ||| NNS
under  ||| S:5968 E:5974 ||| IN
these  ||| S:5974 E:5990 ||| DT
conditions  ||| S:5990 E:6001 ||| NNS
( ||| S:6001 E:6002 ||| -LRB-
Fig.  ||| S:6002 E:6007 ||| NNP
2A ||| S:6007 E:6009 ||| NNP
) ||| S:6009 E:6010 ||| -RRB-
.  ||| S:6010 E:6012 ||| .
As  ||| S:6012 E:6015 ||| RB
has  ||| S:6015 E:6019 ||| VBZ
been  ||| S:6019 E:6024 ||| VBN
noted  ||| S:6024 E:6030 ||| VBN
for  ||| S:6030 E:6034 ||| IN
the  ||| S:6034 E:6048 ||| DT
neuromodulin  ||| S:6048 E:6061 ||| JJ
IQ  ||| S:6061 E:6064 ||| NNP
domain  ||| S:6064 E:6071 ||| NN
[  ||| S:6071 E:6073 ||| -LRB-
25  ||| S:6073 E:6076 ||| CD
]  ||| S:6076 E:6078 ||| -RRB-
,  ||| S:6078 E:6080 ||| ,
increasing  ||| S:6080 E:6091 ||| VBG
the  ||| S:6091 E:6095 ||| DT
KCl  ||| S:6095 E:6109 ||| JJ
concentration  ||| S:6109 E:6123 ||| NN
reduced  ||| S:6123 E:6131 ||| VBD
binding  ||| S:6131 E:6139 ||| VBG
to  ||| S:6139 E:6142 ||| TO
each  ||| S:6142 E:6147 ||| DT
IQ  ||| S:6147 E:6150 ||| NNP
peptide ||| S:6150 E:6157 ||| NN
.  ||| S:6157 E:6169 ||| .
Although  ||| S:6169 E:6178 ||| IN
the  ||| S:6178 E:6182 ||| DT
data  ||| S:6182 E:6187 ||| NNS
shown  ||| S:6187 E:6193 ||| VBN
in  ||| S:6193 E:6196 ||| IN
Fig.  ||| S:6196 E:6201 ||| NNP
2Awere  ||| S:6201 E:6208 ||| NNP
obtained  ||| S:6208 E:6217 ||| VBD
at  ||| S:6217 E:6220 ||| IN
room  ||| S:6220 E:6235 ||| NN
temperature ||| S:6235 E:6246 ||| NN
,  ||| S:6246 E:6248 ||| ,
we  ||| S:6248 E:6251 ||| PRP
saw  ||| S:6251 E:6255 ||| VBD
a  ||| S:6255 E:6257 ||| DT
similar  ||| S:6257 E:6265 ||| JJ
rank  ||| S:6265 E:6270 ||| NN
order  ||| S:6270 E:6276 ||| NN
of  ||| S:6276 E:6279 ||| IN
binding  ||| S:6279 E:6287 ||| JJ
-  ||| S:6287 E:6299 ||| :
albeit  ||| S:6299 E:6306 ||| NN
with  ||| S:6306 E:6311 ||| IN
lower  ||| S:6311 E:6317 ||| JJR
total  ||| S:6317 E:6323 ||| JJ
Alexa-calmodulin  ||| S:6323 E:6340 ||| JJ
bound  ||| S:6340 E:6346 ||| NN
-  ||| S:6346 E:6348 ||| :
at  ||| S:6348 E:6351 ||| IN
4°C  ||| S:6351 E:6365 ||| NNP
( ||| S:6365 E:6366 ||| -LRB-
data  ||| S:6366 E:6371 ||| NNS
not  ||| S:6371 E:6375 ||| RB
shown ||| S:6375 E:6380 ||| VBN
) ||| S:6380 E:6381 ||| -RRB-
.  ||| S:6381 E:6393 ||| .
To  ||| S:6393 E:6396 ||| TO
confirm  ||| S:6396 E:6404 ||| VB
the  ||| S:6404 E:6408 ||| DT
approximate  ||| S:6408 E:6420 ||| JJ
binding  ||| S:6420 E:6428 ||| JJ
strength  ||| S:6428 E:6437 ||| NN
reported  ||| S:6437 E:6456 ||| VBD
by  ||| S:6456 E:6459 ||| IN
this  ||| S:6459 E:6464 ||| DT
assay ||| S:6464 E:6469 ||| NN
,  ||| S:6469 E:6471 ||| ,
we  ||| S:6471 E:6474 ||| PRP
used  ||| S:6474 E:6479 ||| VBD
free  ||| S:6479 E:6484 ||| JJ
IQ  ||| S:6484 E:6487 ||| NNP
peptides  ||| S:6487 E:6496 ||| VBD
to  ||| S:6496 E:6499 ||| TO
prevent  ||| S:6499 E:6517 ||| VB
Alexa-calmodulin  ||| S:6517 E:6534 ||| JJ
binding  ||| S:6534 E:6542 ||| NN
to  ||| S:6542 E:6545 ||| TO
an  ||| S:6545 E:6548 ||| DT
IQ3-derivatized  ||| S:6548 E:6564 ||| JJ
plate ||| S:6564 E:6569 ||| NN
.  ||| S:6569 E:6581 ||| .
Because  ||| S:6581 E:6589 ||| IN
the  ||| S:6589 E:6593 ||| DT
IQ  ||| S:6593 E:6596 ||| NNP
peptides  ||| S:6596 E:6605 ||| VBD
strongly  ||| S:6605 E:6614 ||| RB
quenched  ||| S:6614 E:6633 ||| JJ
Alexa-calmodulin  ||| S:6633 E:6650 ||| JJ
fluorescence  ||| S:6650 E:6663 ||| NN
when  ||| S:6663 E:6668 ||| WRB
bound ||| S:6668 E:6673 ||| VBN
,  ||| S:6673 E:6675 ||| ,
we  ||| S:6675 E:6678 ||| PRP
corrected  ||| S:6678 E:6698 ||| VBD
fluorescence  ||| S:6698 E:6711 ||| JJ
measurements  ||| S:6711 E:6724 ||| NNS
using  ||| S:6724 E:6730 ||| VBG
an  ||| S:6730 E:6733 ||| DT
identical  ||| S:6733 E:6743 ||| JJ
assay  ||| S:6743 E:6749 ||| NN
in  ||| S:6749 E:6752 ||| IN
an  ||| S:6752 E:6765 ||| DT
underivatized  ||| S:6765 E:6779 ||| JJ
plate ||| S:6779 E:6784 ||| NN
.  ||| S:6784 E:6786 ||| .
Although  ||| S:6786 E:6795 ||| IN
this  ||| S:6795 E:6800 ||| DT
quenching  ||| S:6800 E:6810 ||| JJ
correction  ||| S:6810 E:6831 ||| NN
introduced  ||| S:6831 E:6842 ||| VBD
substantial  ||| S:6842 E:6854 ||| JJ
scatter  ||| S:6854 E:6862 ||| NN
into  ||| S:6862 E:6867 ||| IN
the  ||| S:6867 E:6871 ||| DT
data ||| S:6871 E:6875 ||| NNS
,  ||| S:6875 E:6877 ||| ,
we  ||| S:6877 E:6880 ||| PRP
found  ||| S:6880 E:6896 ||| VBD
that  ||| S:6896 E:6901 ||| IN
the  ||| S:6901 E:6905 ||| DT
apparent  ||| S:6905 E:6914 ||| JJ
affinities  ||| S:6914 E:6925 ||| NNS
for  ||| S:6925 E:6929 ||| IN
binding  ||| S:6929 E:6937 ||| VBG
of  ||| S:6937 E:6940 ||| IN
peptides  ||| S:6940 E:6949 ||| VBG
to  ||| S:6949 E:6962 ||| TO
Alexa-calmodulin  ||| S:6962 E:6979 ||| NNP
followed  ||| S:6979 E:6988 ||| VBD
the  ||| S:6988 E:6992 ||| DT
order  ||| S:6992 E:6998 ||| NN
IQ3  ||| S:6998 E:7002 ||| FW
>  ||| S:7002 E:7004 ||| FW
IQ1  ||| S:7004 E:7008 ||| FW
≈  ||| S:7008 E:7010 ||| FW
IQ2  ||| S:7010 E:7024 ||| FW
>  ||| S:7024 E:7026 ||| FW
IQ4  ||| S:7026 E:7030 ||| FW
( ||| S:7030 E:7031 ||| -LRB-
Fig.  ||| S:7031 E:7036 ||| NNP
2B ||| S:7036 E:7038 ||| NNP
) ||| S:7038 E:7039 ||| -RRB-
.  ||| S:7039 E:7069 ||| .
IQ  ||| S:7069 E:7072 ||| NNP
-  ||| S:7072 E:7074 ||| :
calmodulin  ||| S:7074 E:7085 ||| JJ
interaction  ||| S:7085 E:7097 ||| NN
by  ||| S:7097 E:7100 ||| IN
quenching  ||| S:7100 E:7110 ||| NN
of  ||| S:7110 E:7123 ||| IN
Alexa-calmodulin  ||| S:7123 E:7140 ||| JJ
fluorescence  ||| S:7140 E:7163 ||| NNS
As  ||| S:7163 E:7166 ||| RB
noted  ||| S:7166 E:7172 ||| VBD
above ||| S:7172 E:7177 ||| RB
,  ||| S:7177 E:7179 ||| ,
Alexa-calmodulin  ||| S:7179 E:7196 ||| JJ
fluorescence  ||| S:7196 E:7209 ||| NN
was  ||| S:7209 E:7223 ||| VBD
quenched  ||| S:7223 E:7232 ||| VBN
upon  ||| S:7232 E:7237 ||| IN
binding  ||| S:7237 E:7245 ||| VBG
to  ||| S:7245 E:7248 ||| TO
an  ||| S:7248 E:7251 ||| DT
IQ  ||| S:7251 E:7254 ||| NNP
peptide  ||| S:7254 E:7262 ||| NNS
( ||| S:7262 E:7263 ||| -LRB-
Fig.  ||| S:7263 E:7268 ||| NNP
3A ||| S:7268 E:7270 ||| NNP
) ||| S:7270 E:7271 ||| -RRB-
.  ||| S:7271 E:7273 ||| .
Because  ||| S:7273 E:7291 ||| IN
an  ||| S:7291 E:7294 ||| DT
excess  ||| S:7294 E:7301 ||| NN
of  ||| S:7301 E:7304 ||| IN
unlabeled  ||| S:7304 E:7314 ||| JJ
calmodulin  ||| S:7314 E:7325 ||| NN
was  ||| S:7325 E:7329 ||| VBD
able  ||| S:7329 E:7334 ||| JJ
to  ||| S:7334 E:7337 ||| TO
reverse  ||| S:7337 E:7355 ||| VB
70-95 ||| S:7355 E:7360 ||| CD
%  ||| S:7360 E:7362 ||| NN
of  ||| S:7362 E:7365 ||| IN
the  ||| S:7365 E:7369 ||| DT
quench  ||| S:7369 E:7376 ||| NN
( ||| S:7376 E:7377 ||| -LRB-
Fig.  ||| S:7377 E:7382 ||| NNP
3A ||| S:7382 E:7384 ||| NNP
) ||| S:7384 E:7385 ||| -RRB-
,  ||| S:7385 E:7387 ||| ,
we  ||| S:7387 E:7390 ||| PRP
inferred  ||| S:7390 E:7399 ||| VBD
that  ||| S:7399 E:7404 ||| DT
most  ||| S:7404 E:7419 ||| RBS
Alexa-calmodulin  ||| S:7419 E:7436 ||| JJ
bound  ||| S:7436 E:7442 ||| NN
to  ||| S:7442 E:7445 ||| TO
the  ||| S:7445 E:7449 ||| DT
same  ||| S:7449 E:7454 ||| JJ
site  ||| S:7454 E:7459 ||| NN
as  ||| S:7459 E:7462 ||| IN
unlabeled  ||| S:7462 E:7482 ||| JJ
calmodulin ||| S:7482 E:7492 ||| NN
.  ||| S:7492 E:7494 ||| .
We  ||| S:7494 E:7497 ||| PRP
used  ||| S:7497 E:7502 ||| VBD
this  ||| S:7502 E:7507 ||| DT
fluorescence-intensity  ||| S:7507 E:7530 ||| JJ
quench  ||| S:7530 E:7547 ||| JJ
empirically  ||| S:7547 E:7559 ||| NN
to  ||| S:7559 E:7562 ||| TO
measure  ||| S:7562 E:7570 ||| VB
the  ||| S:7570 E:7574 ||| DT
affinity  ||| S:7574 E:7583 ||| NN
of  ||| S:7583 E:7586 ||| IN
each  ||| S:7586 E:7591 ||| DT
IQ  ||| S:7591 E:7594 ||| NNP
peptide  ||| S:7594 E:7612 ||| NN
for  ||| S:7612 E:7616 ||| IN
Alexa-calmodulin  ||| S:7616 E:7633 ||| NNP
( ||| S:7633 E:7634 ||| -LRB-
Fig.  ||| S:7634 E:7639 ||| NNP
3B ||| S:7639 E:7641 ||| NNP
) ||| S:7641 E:7642 ||| -RRB-
.  ||| S:7642 E:7644 ||| .
In  ||| S:7644 E:7647 ||| IN
some  ||| S:7647 E:7652 ||| DT
experiments ||| S:7652 E:7663 ||| NNS
,  ||| S:7663 E:7665 ||| ,
Ca  ||| S:7665 E:7678 ||| NNP
2+was  ||| S:7678 E:7684 ||| NNP
held  ||| S:7684 E:7689 ||| VBD
at  ||| S:7689 E:7692 ||| IN
< ||| S:7692 E:7693 ||| SYM
30  ||| S:7693 E:7696 ||| CD
nM  ||| S:7696 E:7699 ||| NN
by  ||| S:7699 E:7702 ||| IN
chelation  ||| S:7702 E:7712 ||| NN
with  ||| S:7712 E:7717 ||| IN
100  ||| S:7717 E:7721 ||| CD
μM  ||| S:7721 E:7724 ||| JJ
EGTA ||| S:7724 E:7728 ||| NNP
;  ||| S:7728 E:7730 ||| :
in  ||| S:7730 E:7743 ||| IN
other  ||| S:7743 E:7749 ||| JJ
experiments ||| S:7749 E:7760 ||| NNS
,  ||| S:7760 E:7762 ||| ,
we  ||| S:7762 E:7765 ||| PRP
added  ||| S:7765 E:7771 ||| VBD
25  ||| S:7771 E:7774 ||| CD
μM  ||| S:7774 E:7777 ||| JJ
exogenous  ||| S:7777 E:7787 ||| JJ
CaCl  ||| S:7787 E:7803 ||| JJ
2  ||| S:7803 E:7805 ||| CD
in  ||| S:7805 E:7808 ||| IN
the  ||| S:7808 E:7812 ||| DT
absence  ||| S:7812 E:7820 ||| NN
of  ||| S:7820 E:7823 ||| IN
EGTA ||| S:7823 E:7827 ||| NNP
.  ||| S:7827 E:7829 ||| .
These  ||| S:7829 E:7835 ||| DT
two  ||| S:7835 E:7849 ||| CD
concentrations  ||| S:7849 E:7864 ||| NNS
mimic  ||| S:7864 E:7870 ||| VBP
the  ||| S:7870 E:7874 ||| DT
low-  ||| S:7874 E:7879 ||| JJ
and  ||| S:7879 E:7883 ||| CC
high-Ca  ||| S:7883 E:7891 ||| JJ
2+conditions  ||| S:7891 E:7914 ||| NN
that  ||| S:7914 E:7919 ||| IN
Myo1c  ||| S:7919 E:7925 ||| NNP
may  ||| S:7925 E:7929 ||| MD
encounter  ||| S:7929 E:7939 ||| VB
in  ||| S:7939 E:7942 ||| IN
hair  ||| S:7942 E:7947 ||| NN
cells  ||| S:7947 E:7953 ||| NNS
when  ||| S:7953 E:7958 ||| WRB
the  ||| S:7958 E:7972 ||| DT
transduction  ||| S:7972 E:7985 ||| JJ
channel  ||| S:7985 E:7993 ||| NN
is  ||| S:7993 E:7996 ||| VBZ
closed  ||| S:7996 E:8003 ||| VBN
or  ||| S:8003 E:8006 ||| CC
open  ||| S:8006 E:8011 ||| JJ
[  ||| S:8011 E:8013 ||| -LRB-
26  ||| S:8013 E:8016 ||| CD
]  ||| S:8016 E:8018 ||| -RRB-
.  ||| S:8018 E:8020 ||| .
In  ||| S:8020 E:8023 ||| IN
the  ||| S:8023 E:8037 ||| DT
presence  ||| S:8037 E:8046 ||| NN
of  ||| S:8046 E:8049 ||| IN
100  ||| S:8049 E:8053 ||| CD
μM  ||| S:8053 E:8056 ||| JJ
EGTA ||| S:8056 E:8060 ||| NNP
,  ||| S:8060 E:8062 ||| ,
K  ||| S:8062 E:8075 ||| NNP
d  ||| S:8075 E:8077 ||| SYM
values  ||| S:8077 E:8084 ||| VBZ
followed  ||| S:8084 E:8093 ||| VBN
the  ||| S:8093 E:8097 ||| DT
order  ||| S:8097 E:8103 ||| NN
IQ3  ||| S:8103 E:8107 ||| CD
< ||| S:8107 E:8108 ||| SYM
IQ1  ||| S:8119 E:8123 ||| CD
≈  ||| S:8123 E:8125 ||| CD
IQ2  ||| S:8125 E:8129 ||| CD
< ||| S:8129 E:8130 ||| SYM
< ||| S:8130 E:8132 ||| SYM
IQ4 ||| S:8132 E:8135 ||| CD
.  ||| S:8135 E:8137 ||| .
Although  ||| S:8137 E:8146 ||| IN
the  ||| S:8146 E:8150 ||| DT
data  ||| S:8150 E:8155 ||| NNS
were  ||| S:8155 E:8160 ||| VBD
fit  ||| S:8160 E:8174 ||| VBN
somewhat  ||| S:8174 E:8183 ||| RB
better  ||| S:8183 E:8190 ||| JJR
with  ||| S:8190 E:8195 ||| IN
a  ||| S:8195 E:8197 ||| DT
modified  ||| S:8197 E:8206 ||| JJ
Hill  ||| S:8206 E:8211 ||| NNP
equation  ||| S:8211 E:8220 ||| NN
that  ||| S:8220 E:8225 ||| IN
with  ||| S:8225 E:8230 ||| IN
a  ||| S:8230 E:8242 ||| DT
standard  ||| S:8242 E:8251 ||| JJ
bimolecular-binding  ||| S:8251 E:8271 ||| JJ
isotherm  ||| S:8271 E:8280 ||| NNS
( ||| S:8280 E:8281 ||| -LRB-
Fig.  ||| S:8281 E:8286 ||| NNP
3B ||| S:8286 E:8288 ||| NNP
) ||| S:8288 E:8289 ||| -RRB-
,  ||| S:8289 E:8291 ||| ,
the  ||| S:8291 E:8305 ||| DT
physiological  ||| S:8305 E:8319 ||| JJ
significance  ||| S:8319 E:8332 ||| NN
of  ||| S:8332 E:8335 ||| IN
Hill  ||| S:8335 E:8340 ||| NNP
coefficients  ||| S:8340 E:8353 ||| VBD
> ||| S:8353 E:8354 ||| CD
1  ||| S:8354 E:8356 ||| CD
is  ||| S:8356 E:8369 ||| VBZ
uncertain ||| S:8369 E:8378 ||| JJ
,  ||| S:8378 E:8380 ||| ,
particularly  ||| S:8380 E:8393 ||| RB
given  ||| S:8393 E:8399 ||| VBN
the  ||| S:8399 E:8403 ||| DT
1 ||| S:8403 E:8404 ||| CD
: ||| S:8404 E:8405 ||| :
1  ||| S:8405 E:8407 ||| CD
peptide ||| S:8407 E:8414 ||| NNS
: ||| S:8414 E:8415 ||| :
calmodulin  ||| S:8415 E:8436 ||| FW
stoichiometry  ||| S:8436 E:8450 ||| FW
( ||| S:8450 E:8451 ||| -LRB-
see  ||| S:8451 E:8455 ||| VB
below ||| S:8455 E:8460 ||| IN
) ||| S:8460 E:8461 ||| -RRB-
.  ||| S:8461 E:8463 ||| .
Ca  ||| S:8463 E:8466 ||| MD
2+had  ||| S:8466 E:8472 ||| RB
only  ||| S:8472 E:8477 ||| RB
modest  ||| S:8477 E:8484 ||| JJ
effects  ||| S:8484 E:8502 ||| NNS
on  ||| S:8502 E:8505 ||| IN
the  ||| S:8505 E:8509 ||| DT
affinity  ||| S:8509 E:8518 ||| NN
of  ||| S:8518 E:8521 ||| IN
the  ||| S:8521 E:8525 ||| DT
Myo1c  ||| S:8525 E:8531 ||| NNP
IQ  ||| S:8531 E:8534 ||| NNP
peptides  ||| S:8534 E:8543 ||| NN
for  ||| S:8543 E:8557 ||| IN
Alexa-calmodulin  ||| S:8557 E:8574 ||| NNP
( ||| S:8574 E:8575 ||| -LRB-
Table  ||| S:8575 E:8581 ||| NNP
1 ||| S:8581 E:8582 ||| CD
) ||| S:8582 E:8583 ||| -RRB-
.  ||| S:8583 E:8595 ||| .
Despite  ||| S:8595 E:8603 ||| IN
only  ||| S:8603 E:8608 ||| RB
minor  ||| S:8608 E:8614 ||| JJ
effects  ||| S:8614 E:8622 ||| NNS
on  ||| S:8622 E:8625 ||| IN
binding  ||| S:8625 E:8633 ||| JJ
affinity ||| S:8633 E:8641 ||| NN
,  ||| S:8641 E:8643 ||| ,
Ca  ||| S:8643 E:8656 ||| MD
2+did  ||| S:8656 E:8662 ||| RB
influence  ||| S:8662 E:8672 ||| VB
the  ||| S:8672 E:8676 ||| DT
calmodulin-peptide  ||| S:8676 E:8695 ||| JJ
complex ||| S:8695 E:8702 ||| NN
,  ||| S:8702 E:8704 ||| ,
as  ||| S:8704 E:8717 ||| RB
signaled  ||| S:8717 E:8726 ||| VBN
by  ||| S:8726 E:8729 ||| IN
changes  ||| S:8729 E:8737 ||| NNS
in  ||| S:8737 E:8740 ||| IN
Alexa-calmodulin  ||| S:8740 E:8757 ||| JJ
fluorescence ||| S:8757 E:8769 ||| NN
.  ||| S:8769 E:8781 ||| .
Changes  ||| S:8781 E:8789 ||| NNS
in  ||| S:8789 E:8792 ||| IN
fluorescence  ||| S:8792 E:8805 ||| JJ
intensity  ||| S:8805 E:8815 ||| NN
during  ||| S:8815 E:8822 ||| IN
manipulation  ||| S:8822 E:8835 ||| NN
of  ||| S:8835 E:8848 ||| IN
a  ||| S:8848 E:8850 ||| DT
single  ||| S:8850 E:8857 ||| JJ
parameter ||| S:8857 E:8866 ||| NN
,  ||| S:8866 E:8868 ||| ,
like  ||| S:8868 E:8873 ||| IN
Ca  ||| S:8873 E:8876 ||| NNP
2+concentration ||| S:8876 E:8891 ||| NNP
,  ||| S:8891 E:8893 ||| ,
should  ||| S:8893 E:8910 ||| MD
report  ||| S:8910 E:8917 ||| VB
conformational  ||| S:8917 E:8932 ||| JJ
changes  ||| S:8932 E:8940 ||| NNS
in  ||| S:8940 E:8943 ||| IN
Alexa-calmodulin ||| S:8943 E:8959 ||| JJ
.  ||| S:8959 E:8961 ||| .
For  ||| S:8961 E:8975 ||| IN
example ||| S:8975 E:8982 ||| NN
,  ||| S:8982 E:8984 ||| ,
the  ||| S:8984 E:8988 ||| DT
fluorescence  ||| S:8988 E:9001 ||| JJ
intensity  ||| S:9001 E:9011 ||| NN
of  ||| S:9011 E:9014 ||| IN
free  ||| S:9014 E:9029 ||| JJ
Alexa-calmodulin  ||| S:9029 E:9046 ||| NN
in  ||| S:9046 E:9049 ||| IN
solution  ||| S:9049 E:9058 ||| NN
was  ||| S:9058 E:9062 ||| VBD
~15 ||| S:9062 E:9065 ||| CD
%  ||| S:9065 E:9067 ||| NN
lower  ||| S:9067 E:9073 ||| JJR
in  ||| S:9073 E:9076 ||| IN
25  ||| S:9076 E:9079 ||| CD
μM  ||| S:9079 E:9082 ||| JJ
CaCl  ||| S:9082 E:9108 ||| JJ
2  ||| S:9108 E:9110 ||| CD
than  ||| S:9110 E:9115 ||| IN
in  ||| S:9115 E:9118 ||| IN
100  ||| S:9118 E:9122 ||| CD
μM  ||| S:9122 E:9125 ||| JJ
EGTA  ||| S:9125 E:9130 ||| NNP
( ||| S:9130 E:9131 ||| -LRB-
left-hand  ||| S:9131 E:9151 ||| JJ
limits  ||| S:9151 E:9158 ||| NNS
in  ||| S:9158 E:9161 ||| IN
Fig.  ||| S:9161 E:9166 ||| CD
4 ||| S:9166 E:9167 ||| CD
) ||| S:9167 E:9168 ||| -RRB-
.  ||| S:9168 E:9170 ||| .
Because  ||| S:9170 E:9178 ||| IN
the  ||| S:9178 E:9182 ||| DT
dye  ||| S:9182 E:9186 ||| NN
moiety  ||| S:9186 E:9193 ||| VBD
itself  ||| S:9193 E:9200 ||| PRP
is  ||| S:9200 E:9203 ||| VBZ
not  ||| S:9203 E:9217 ||| RB
Ca  ||| S:9217 E:9220 ||| JJ
2+sensitive  ||| S:9220 E:9232 ||| NNP
[  ||| S:9232 E:9234 ||| -LRB-
27  ||| S:9234 E:9237 ||| CD
]  ||| S:9237 E:9239 ||| -RRB-
,  ||| S:9239 E:9241 ||| ,
the  ||| S:9241 E:9245 ||| DT
Ca  ||| S:9245 E:9248 ||| NNP
2+-dependent  ||| S:9248 E:9261 ||| NNP
fluorescent  ||| S:9261 E:9283 ||| JJ
change  ||| S:9283 E:9290 ||| NN
reflects  ||| S:9290 E:9299 ||| VBZ
changes  ||| S:9299 E:9307 ||| NNS
in  ||| S:9307 E:9310 ||| IN
the  ||| S:9310 E:9314 ||| DT
dye ||| S:9314 E:9317 ||| NN
's  ||| S:9317 E:9320 ||| POS
surrounding  ||| S:9320 E:9342 ||| VBG
environment ||| S:9342 E:9353 ||| NN
,  ||| S:9353 E:9355 ||| ,
probably  ||| S:9355 E:9364 ||| RB
signaling  ||| S:9364 E:9374 ||| VBG
the  ||| S:9374 E:9378 ||| DT
compact-to-open  ||| S:9378 E:9404 ||| JJ
structural  ||| S:9404 E:9415 ||| JJ
change  ||| S:9415 E:9422 ||| NN
seen  ||| S:9422 E:9427 ||| VBN
when  ||| S:9427 E:9432 ||| WRB
Ca  ||| S:9432 E:9435 ||| NNP
2+binds  ||| S:9435 E:9443 ||| NNP
to  ||| S:9443 E:9446 ||| TO
calmodulin  ||| S:9446 E:9457 ||| VB
[  ||| S:9457 E:9459 ||| -LRB-
28  ||| S:9459 E:9472 ||| CD
]  ||| S:9472 E:9474 ||| -RRB-
.  ||| S:9474 E:9476 ||| .
In  ||| S:9476 E:9479 ||| IN
contrast  ||| S:9479 E:9488 ||| NN
to  ||| S:9488 E:9491 ||| TO
the  ||| S:9491 E:9495 ||| DT
reduction  ||| S:9495 E:9505 ||| NN
of  ||| S:9505 E:9508 ||| IN
free  ||| S:9508 E:9513 ||| JJ
Alexa-calmodulin  ||| S:9513 E:9540 ||| JJ
fluorescence  ||| S:9540 E:9553 ||| NN
by  ||| S:9553 E:9556 ||| IN
Ca  ||| S:9556 E:9559 ||| NNP
2+ ||| S:9559 E:9561 ||| NNP
,  ||| S:9561 E:9563 ||| ,
fluorescence  ||| S:9563 E:9576 ||| VBG
of  ||| S:9576 E:9579 ||| IN
Alexa-calmodulin  ||| S:9579 E:9606 ||| JJ
when  ||| S:9606 E:9611 ||| WRB
saturated  ||| S:9611 E:9621 ||| VBN
by  ||| S:9621 E:9624 ||| IN
IQ  ||| S:9624 E:9627 ||| NNP
peptides  ||| S:9627 E:9636 ||| NN
was  ||| S:9636 E:9640 ||| VBD
1.5-  ||| S:9640 E:9645 ||| CD
to  ||| S:9645 E:9648 ||| TO
2-fold  ||| S:9648 E:9666 ||| CD
greater  ||| S:9666 E:9674 ||| JJR
in  ||| S:9674 E:9677 ||| IN
25  ||| S:9677 E:9680 ||| CD
μM  ||| S:9680 E:9683 ||| JJ
CaCl  ||| S:9683 E:9699 ||| JJ
2  ||| S:9699 E:9701 ||| CD
than  ||| S:9701 E:9706 ||| IN
in  ||| S:9706 E:9709 ||| IN
100  ||| S:9709 E:9713 ||| CD
μM  ||| S:9713 E:9716 ||| JJ
EGTA  ||| S:9716 E:9721 ||| NNP
( ||| S:9721 E:9722 ||| -LRB-
Fig.  ||| S:9722 E:9727 ||| CD
4 ||| S:9727 E:9728 ||| CD
;  ||| S:9728 E:9730 ||| :
Table  ||| S:9730 E:9746 ||| NNP
1 ||| S:9746 E:9747 ||| CD
) ||| S:9747 E:9748 ||| -RRB-
.  ||| S:9748 E:9750 ||| .
Thus ||| S:9750 E:9754 ||| RB
,  ||| S:9754 E:9756 ||| ,
when  ||| S:9756 E:9761 ||| WRB
Alexa-calmodulin  ||| S:9761 E:9778 ||| NNP
was  ||| S:9778 E:9782 ||| VBD
bound  ||| S:9782 E:9788 ||| VBN
to  ||| S:9788 E:9791 ||| TO
IQ  ||| S:9791 E:9794 ||| NNP
peptides ||| S:9794 E:9802 ||| NN
,  ||| S:9802 E:9814 ||| ,
Ca  ||| S:9814 E:9817 ||| NNP
2+induced  ||| S:9817 E:9827 ||| CD
a  ||| S:9827 E:9829 ||| DT
conformational  ||| S:9829 E:9844 ||| JJ
change  ||| S:9844 E:9851 ||| NN
that  ||| S:9851 E:9856 ||| WDT
was  ||| S:9856 E:9870 ||| VBD
substantially  ||| S:9870 E:9884 ||| RB
different  ||| S:9884 E:9894 ||| JJ
from  ||| S:9894 E:9899 ||| IN
that  ||| S:9899 E:9904 ||| DT
seen  ||| S:9904 E:9909 ||| VBN
in  ||| S:9909 E:9912 ||| IN
the  ||| S:9912 E:9926 ||| DT
peptide-free  ||| S:9926 E:9939 ||| JJ
state ||| S:9939 E:9944 ||| NN
.  ||| S:9944 E:9974 ||| .
IQ  ||| S:9974 E:9977 ||| NNP
-  ||| S:9977 E:9979 ||| :
calmodulin  ||| S:9979 E:9990 ||| JJ
interaction  ||| S:9990 E:10002 ||| NN
under  ||| S:10002 E:10018 ||| IN
stoichiometric-titration  ||| S:10018 E:10043 ||| JJ
conditions  ||| S:10043 E:10064 ||| NNS
To  ||| S:10064 E:10067 ||| TO
determine  ||| S:10067 E:10077 ||| VB
the  ||| S:10077 E:10081 ||| DT
affinities  ||| S:10081 E:10092 ||| NN
of  ||| S:10092 E:10095 ||| IN
the  ||| S:10095 E:10099 ||| DT
Myo1c  ||| S:10099 E:10105 ||| NNP
IQ  ||| S:10105 E:10108 ||| NNP
peptides  ||| S:10108 E:10127 ||| NN
for  ||| S:10127 E:10131 ||| IN
unlabeled  ||| S:10131 E:10141 ||| JJ
calmodulin ||| S:10141 E:10151 ||| NN
,  ||| S:10151 E:10153 ||| ,
we  ||| S:10153 E:10156 ||| PRP
used  ||| S:10156 E:10161 ||| VBD
Alexa-calmodulin  ||| S:10161 E:10178 ||| JJ
as  ||| S:10178 E:10181 ||| IN
a  ||| S:10181 E:10193 ||| DT
reporter  ||| S:10193 E:10202 ||| NN
( ||| S:10202 E:10203 ||| -LRB-
Alexa-calmodulin  ||| S:10203 E:10220 ||| NNP
:  ||| S:10220 E:10222 ||| :
unlabeled  ||| S:10222 E:10232 ||| JJ
calmodulin  ||| S:10232 E:10243 ||| JJ
ratio  ||| S:10243 E:10259 ||| NN
of  ||| S:10259 E:10262 ||| IN
1 ||| S:10262 E:10263 ||| CD
: ||| S:10263 E:10264 ||| :
100 ||| S:10264 E:10267 ||| CD
)  ||| S:10267 E:10269 ||| -RRB-
in  ||| S:10269 E:10272 ||| IN
our  ||| S:10272 E:10276 ||| PRP$
binding  ||| S:10276 E:10284 ||| JJ
studies ||| S:10284 E:10291 ||| NNS
.  ||| S:10291 E:10293 ||| .
This  ||| S:10293 E:10298 ||| DT
approach  ||| S:10298 E:10307 ||| NN
assumes  ||| S:10307 E:10325 ||| VBZ
that  ||| S:10325 E:10330 ||| IN
Alexa-calmodulin  ||| S:10330 E:10347 ||| NNP
is  ||| S:10347 E:10350 ||| VBZ
functionally  ||| S:10350 E:10363 ||| JJ
equivalent  ||| S:10363 E:10374 ||| NN
to  ||| S:10374 E:10387 ||| TO
unlabeled  ||| S:10387 E:10397 ||| VB
calmodulin ||| S:10397 E:10407 ||| NNS
.  ||| S:10407 E:10419 ||| .
We  ||| S:10419 E:10422 ||| PRP
determined  ||| S:10422 E:10433 ||| VBD
affinities  ||| S:10433 E:10444 ||| VBN
by  ||| S:10444 E:10447 ||| IN
fitting  ||| S:10447 E:10455 ||| VBG
the  ||| S:10455 E:10459 ||| DT
IQ-peptide  ||| S:10459 E:10480 ||| JJ
concentration  ||| S:10480 E:10494 ||| FW
vs.  ||| S:10494 E:10498 ||| FW
fluorescence  ||| S:10498 E:10511 ||| FW
quench  ||| S:10511 E:10518 ||| FW
data  ||| S:10518 E:10523 ||| NNS
with  ||| S:10523 E:10528 ||| IN
an  ||| S:10528 E:10541 ||| DT
appropriate  ||| S:10541 E:10553 ||| JJ
model ||| S:10553 E:10558 ||| NN
.  ||| S:10558 E:10560 ||| .
If  ||| S:10560 E:10563 ||| IN
the  ||| S:10563 E:10567 ||| DT
IQ  ||| S:10567 E:10570 ||| NNP
peptides  ||| S:10570 E:10579 ||| VBD
bound  ||| S:10579 E:10585 ||| VBN
only  ||| S:10585 E:10600 ||| RB
Alexa-calmodulin  ||| S:10600 E:10617 ||| JJ
and  ||| S:10617 E:10621 ||| CC
not  ||| S:10621 E:10625 ||| RB
unlabeled  ||| S:10625 E:10635 ||| JJ
calmodulin ||| S:10635 E:10645 ||| NN
,  ||| S:10645 E:10647 ||| ,
the  ||| S:10647 E:10651 ||| DT
K  ||| S:10651 E:10664 ||| NNP
d  ||| S:10664 E:10666 ||| NN
and  ||| S:10666 E:10670 ||| CC
F  ||| S:10670 E:10683 ||| NNP
IQ  ||| S:10683 E:10686 ||| NNP
/ ||| S:10686 E:10687 ||| NNP
F  ||| S:10687 E:10689 ||| NN
values  ||| S:10689 E:10696 ||| NNS
of  ||| S:10696 E:10699 ||| IN
Table  ||| S:10699 E:10705 ||| NNP
1would  ||| S:10705 E:10712 ||| NNP
have  ||| S:10712 E:10727 ||| VBP
described  ||| S:10727 E:10737 ||| VBN
the  ||| S:10737 E:10741 ||| DT
fit  ||| S:10741 E:10745 ||| NN
to  ||| S:10745 E:10748 ||| TO
the  ||| S:10748 E:10752 ||| DT
concentration-quench  ||| S:10752 E:10773 ||| JJ
plots ||| S:10773 E:10778 ||| NNS
.  ||| S:10778 E:10780 ||| .
The  ||| S:10780 E:10794 ||| DT
line  ||| S:10794 E:10799 ||| NN
derived  ||| S:10799 E:10807 ||| VBN
from  ||| S:10807 E:10812 ||| IN
these  ||| S:10812 E:10818 ||| DT
values  ||| S:10818 E:10825 ||| NNS
did  ||| S:10825 E:10829 ||| VBD
not  ||| S:10829 E:10833 ||| RB
fit  ||| S:10833 E:10837 ||| VB
the  ||| S:10837 E:10841 ||| DT
data  ||| S:10841 E:10846 ||| NNS
( ||| S:10846 E:10847 ||| -LRB-
Fig.  ||| S:10847 E:10862 ||| CD
5 ||| S:10862 E:10863 ||| CD
) ||| S:10863 E:10864 ||| -RRB-
,  ||| S:10864 E:10866 ||| ,
indicating  ||| S:10866 E:10877 ||| VBG
that ||| S:10877 E:10881 ||| IN
,  ||| S:10881 E:10883 ||| ,
as  ||| S:10883 E:10886 ||| RB
expected ||| S:10886 E:10894 ||| VBN
,  ||| S:10894 E:10896 ||| ,
unlabeled  ||| S:10896 E:10906 ||| JJ
calmodulin  ||| S:10906 E:10927 ||| JJ
binds  ||| S:10927 E:10933 ||| NN
to  ||| S:10933 E:10936 ||| TO
the  ||| S:10936 E:10940 ||| DT
Myo1c  ||| S:10940 E:10946 ||| NNP
IQ  ||| S:10946 E:10949 ||| NNP
peptides ||| S:10949 E:10957 ||| NN
.  ||| S:10957 E:10969 ||| .
These  ||| S:10969 E:10975 ||| DT
experimental  ||| S:10975 E:10988 ||| JJ
conditions  ||| S:10988 E:10999 ||| NNS
resembled  ||| S:10999 E:11009 ||| VBP
a  ||| S:11009 E:11021 ||| DT
stoichiometric  ||| S:11021 E:11036 ||| JJ
titration ||| S:11036 E:11045 ||| NN
,  ||| S:11045 E:11047 ||| ,
where  ||| S:11047 E:11053 ||| WRB
the  ||| S:11053 E:11057 ||| DT
total  ||| S:11057 E:11063 ||| JJ
concentration  ||| S:11063 E:11087 ||| NN
of  ||| S:11087 E:11090 ||| IN
calmodulin  ||| S:11090 E:11101 ||| NN
was  ||| S:11101 E:11105 ||| VBD
higher  ||| S:11105 E:11112 ||| JJR
than  ||| S:11112 E:11117 ||| IN
the  ||| S:11117 E:11121 ||| DT
K  ||| S:11121 E:11134 ||| NNP
d  ||| S:11134 E:11136 ||| NN
values  ||| S:11136 E:11143 ||| NNS
for  ||| S:11143 E:11147 ||| IN
IQ1 ||| S:11147 E:11150 ||| NNP
,  ||| S:11150 E:11152 ||| ,
IQ2 ||| S:11152 E:11155 ||| NNP
,  ||| S:11155 E:11157 ||| ,
and  ||| S:11157 E:11161 ||| CC
IQ3 ||| S:11161 E:11164 ||| NNP
.  ||| S:11164 E:11166 ||| .
Under  ||| S:11166 E:11182 ||| IN
true  ||| S:11182 E:11187 ||| JJ
stoichiometric-titration  ||| S:11187 E:11212 ||| JJ
conditions  ||| S:11212 E:11223 ||| NNS
( ||| S:11223 E:11224 ||| -LRB-
fixed  ||| S:11224 E:11240 ||| JJ
concentration  ||| S:11240 E:11254 ||| NN
of  ||| S:11254 E:11257 ||| IN
receptor  ||| S:11257 E:11266 ||| NN
at  ||| S:11266 E:11269 ||| IN
100-fold  ||| S:11269 E:11278 ||| NNP
or  ||| S:11278 E:11281 ||| CC
more  ||| S:11281 E:11286 ||| JJR
than  ||| S:11286 E:11291 ||| IN
the  ||| S:11291 E:11295 ||| DT
K  ||| S:11295 E:11308 ||| NNP
d  ||| S:11308 E:11310 ||| NN
,  ||| S:11310 E:11312 ||| ,
varying  ||| S:11312 E:11320 ||| VBG
the  ||| S:11320 E:11324 ||| DT
ligand  ||| S:11324 E:11331 ||| JJ
concentration  ||| S:11331 E:11355 ||| NN
up  ||| S:11355 E:11358 ||| RP
to  ||| S:11358 E:11361 ||| TO
and  ||| S:11361 E:11365 ||| CC
beyond  ||| S:11365 E:11372 ||| IN
the  ||| S:11372 E:11376 ||| DT
receptor  ||| S:11376 E:11385 ||| NN
concentration ||| S:11385 E:11398 ||| NN
) ||| S:11398 E:11399 ||| -RRB-
,  ||| S:11399 E:11401 ||| ,
almost  ||| S:11401 E:11408 ||| RB
all  ||| S:11408 E:11422 ||| RB
of  ||| S:11422 E:11425 ||| IN
the  ||| S:11425 E:11429 ||| DT
added  ||| S:11429 E:11435 ||| VBD
IQ  ||| S:11435 E:11438 ||| NNP
peptide  ||| S:11438 E:11446 ||| NN
would  ||| S:11446 E:11452 ||| MD
bind  ||| S:11452 E:11457 ||| VB
tightly  ||| S:11457 E:11465 ||| RB
to  ||| S:11465 E:11468 ||| TO
calmodulin  ||| S:11468 E:11489 ||| VB
and  ||| S:11489 E:11493 ||| CC
linearly  ||| S:11493 E:11502 ||| RB
decrease  ||| S:11502 E:11511 ||| VB
the  ||| S:11511 E:11515 ||| DT
fluorescence ||| S:11515 E:11527 ||| NN
;  ||| S:11527 E:11529 ||| :
at  ||| S:11529 E:11532 ||| IN
the  ||| S:11532 E:11536 ||| DT
point  ||| S:11536 E:11552 ||| NN
where  ||| S:11552 E:11558 ||| WRB
the  ||| S:11558 E:11562 ||| DT
IQ-peptide  ||| S:11562 E:11573 ||| JJ
concentration  ||| S:11573 E:11587 ||| NN
exceeds  ||| S:11587 E:11595 ||| VBZ
the  ||| S:11595 E:11599 ||| DT
calmodulin  ||| S:11599 E:11620 ||| JJ
concentration  ||| S:11620 E:11634 ||| NN
multiplied  ||| S:11634 E:11645 ||| NN
by  ||| S:11645 E:11648 ||| IN
the  ||| S:11648 E:11652 ||| DT
peptide ||| S:11652 E:11659 ||| NN
: ||| S:11659 E:11660 ||| :
calmodulin  ||| S:11660 E:11681 ||| FW
stoichiometry  ||| S:11681 E:11695 ||| FW
(  ||| S:11695 E:11708 ||| -LRB-
m  ||| S:11708 E:11710 ||| LS
) ||| S:11710 E:11711 ||| -RRB-
,  ||| S:11711 E:11713 ||| ,
a  ||| S:11713 E:11715 ||| DT
plateau  ||| S:11715 E:11723 ||| NN
in  ||| S:11723 E:11726 ||| IN
the  ||| S:11726 E:11730 ||| DT
fluorescence  ||| S:11730 E:11753 ||| JJ
intensity  ||| S:11753 E:11763 ||| NN
would  ||| S:11763 E:11769 ||| MD
be  ||| S:11769 E:11772 ||| VB
reached ||| S:11772 E:11779 ||| VBN
.  ||| S:11779 E:11781 ||| .
Because  ||| S:11781 E:11789 ||| IN
the  ||| S:11789 E:11793 ||| DT
relatively  ||| S:11793 E:11804 ||| RB
weak  ||| S:11804 E:11819 ||| JJ
affinities  ||| S:11819 E:11830 ||| NNS
observed  ||| S:11830 E:11839 ||| VBD
here  ||| S:11839 E:11844 ||| RB
make  ||| S:11844 E:11849 ||| VB
such  ||| S:11849 E:11854 ||| JJ
true  ||| S:11854 E:11859 ||| JJ
stoichiometric  ||| S:11859 E:11884 ||| JJ
titration  ||| S:11884 E:11894 ||| JJ
impractical ||| S:11894 E:11905 ||| NN
,  ||| S:11905 E:11907 ||| ,
we  ||| S:11907 E:11910 ||| PRP
used  ||| S:11910 E:11915 ||| VBD
an  ||| S:11915 E:11918 ||| DT
intermediate  ||| S:11918 E:11941 ||| JJ
concentration  ||| S:11941 E:11955 ||| NN
of  ||| S:11955 E:11958 ||| IN
calmodulin  ||| S:11958 E:11969 ||| NNS
( ||| S:11969 E:11970 ||| -LRB-
50  ||| S:11970 E:11973 ||| CD
μM ||| S:11973 E:11975 ||| NN
,  ||| S:11975 E:11977 ||| ,
~10-fold  ||| S:11977 E:11986 ||| RB
larger  ||| S:11986 E:11993 ||| JJR
than  ||| S:11993 E:12008 ||| IN
K  ||| S:12008 E:12021 ||| NN
d  ||| S:12021 E:12023 ||| LS
)  ||| S:12023 E:12025 ||| -RRB-
and  ||| S:12025 E:12029 ||| CC
used  ||| S:12029 E:12034 ||| VBN
equation  ||| S:12034 E:12043 ||| NN
( ||| S:12043 E:12044 ||| -LRB-
7 ||| S:12044 E:12045 ||| CD
)  ||| S:12045 E:12047 ||| -RRB-
to  ||| S:12047 E:12050 ||| TO
describe  ||| S:12050 E:12069 ||| VB
the  ||| S:12069 E:12073 ||| DT
equilibrium  ||| S:12073 E:12085 ||| NN
precisely ||| S:12085 E:12094 ||| RB
.  ||| S:12094 E:12096 ||| .
This  ||| S:12096 E:12101 ||| DT
approach  ||| S:12101 E:12110 ||| NN
allowed  ||| S:12110 E:12118 ||| VBD
us  ||| S:12118 E:12121 ||| PRP
to  ||| S:12121 E:12134 ||| TO
determine  ||| S:12134 E:12144 ||| VB
both  ||| S:12144 E:12160 ||| DT
m  ||| S:12160 E:12162 ||| NN
and  ||| S:12162 E:12166 ||| CC
K  ||| S:12166 E:12179 ||| NNP
d  ||| S:12179 E:12181 ||| NN
in  ||| S:12181 E:12184 ||| IN
the  ||| S:12184 E:12188 ||| DT
same  ||| S:12188 E:12193 ||| JJ
experiment ||| S:12193 E:12203 ||| NN
.  ||| S:12203 E:12215 ||| .
In  ||| S:12215 E:12218 ||| IN
the  ||| S:12218 E:12222 ||| DT
presence  ||| S:12222 E:12231 ||| NN
of  ||| S:12231 E:12234 ||| IN
EGTA ||| S:12234 E:12238 ||| NNP
,  ||| S:12238 E:12240 ||| ,
the  ||| S:12240 E:12244 ||| DT
IQ1 ||| S:12244 E:12247 ||| NNP
,  ||| S:12247 E:12249 ||| ,
IQ2 ||| S:12249 E:12252 ||| NNP
,  ||| S:12252 E:12254 ||| ,
and  ||| S:12254 E:12258 ||| CC
IQ3  ||| S:12258 E:12262 ||| CD
binding  ||| S:12262 E:12280 ||| JJ
data  ||| S:12280 E:12285 ||| NNS
were  ||| S:12285 E:12290 ||| VBD
much  ||| S:12290 E:12295 ||| RB
better  ||| S:12295 E:12302 ||| JJR
fit  ||| S:12302 E:12306 ||| NN
by  ||| S:12306 E:12320 ||| IN
m  ||| S:12320 E:12322 ||| CD
=  ||| S:12322 E:12324 ||| SYM
1  ||| S:12324 E:12326 ||| CD
than  ||| S:12326 E:12331 ||| IN
they  ||| S:12331 E:12336 ||| PRP
were  ||| S:12336 E:12341 ||| VBD
to  ||| S:12341 E:12355 ||| TO
m  ||| S:12355 E:12357 ||| CD
=  ||| S:12357 E:12359 ||| SYM
2 ||| S:12359 E:12360 ||| CD
,  ||| S:12360 E:12362 ||| ,
indicating  ||| S:12362 E:12373 ||| VBG
that  ||| S:12373 E:12378 ||| IN
the  ||| S:12378 E:12382 ||| DT
binding  ||| S:12382 E:12400 ||| JJ
stoichiometry  ||| S:12400 E:12414 ||| NN
of  ||| S:12414 E:12417 ||| IN
peptide  ||| S:12417 E:12425 ||| VBG
to  ||| S:12425 E:12428 ||| TO
calmodulin  ||| S:12428 E:12439 ||| NNS
was  ||| S:12439 E:12443 ||| VBD
1 ||| S:12443 E:12444 ||| CD
: ||| S:12444 E:12445 ||| :
1  ||| S:12445 E:12447 ||| CD
( ||| S:12447 E:12448 ||| -LRB-
Fig.  ||| S:12448 E:12453 ||| CD
5 ||| S:12453 E:12454 ||| CD
) ||| S:12454 E:12455 ||| -RRB-
.  ||| S:12455 E:12467 ||| .
The  ||| S:12467 E:12471 ||| DT
K  ||| S:12471 E:12484 ||| NNP
d  ||| S:12484 E:12486 ||| SYM
values  ||| S:12486 E:12493 ||| VBZ
determined  ||| S:12493 E:12504 ||| VBN
with  ||| S:12504 E:12509 ||| IN
equation  ||| S:12509 E:12518 ||| NN
( ||| S:12518 E:12519 ||| -LRB-
7 ||| S:12519 E:12520 ||| CD
)  ||| S:12520 E:12532 ||| -RRB-
were  ||| S:12532 E:12537 ||| VBD
very  ||| S:12537 E:12542 ||| RB
similar  ||| S:12542 E:12550 ||| JJ
to  ||| S:12550 E:12553 ||| TO
those  ||| S:12553 E:12559 ||| DT
determined  ||| S:12559 E:12570 ||| VBN
for  ||| S:12570 E:12574 ||| IN
binding  ||| S:12574 E:12582 ||| VBG
to  ||| S:12582 E:12595 ||| TO
Alexa-calmodulin  ||| S:12595 E:12612 ||| JJ
alone  ||| S:12612 E:12618 ||| NNS
( ||| S:12618 E:12619 ||| -LRB-
Tables  ||| S:12619 E:12626 ||| NNP
1and  ||| S:12626 E:12631 ||| CD
2 ||| S:12631 E:12632 ||| CD
) ||| S:12632 E:12633 ||| -RRB-
,  ||| S:12633 E:12635 ||| ,
confirming  ||| S:12635 E:12646 ||| VBG
that  ||| S:12646 E:12661 ||| IN
under  ||| S:12661 E:12667 ||| IN
these  ||| S:12667 E:12673 ||| DT
conditions ||| S:12673 E:12683 ||| NNS
,  ||| S:12683 E:12685 ||| ,
the  ||| S:12685 E:12689 ||| DT
IQ  ||| S:12689 E:12692 ||| NNP
peptides  ||| S:12692 E:12701 ||| JJ
bind  ||| S:12701 E:12706 ||| NN
to  ||| S:12706 E:12709 ||| TO
unlabeled  ||| S:12709 E:12729 ||| VB
calmodulin  ||| S:12729 E:12740 ||| NNS
and  ||| S:12740 E:12744 ||| CC
Alexa-calmodulin  ||| S:12744 E:12761 ||| JJ
similarly ||| S:12761 E:12770 ||| NN
.  ||| S:12770 E:12782 ||| .
In  ||| S:12782 E:12785 ||| IN
the  ||| S:12785 E:12789 ||| DT
presence  ||| S:12789 E:12798 ||| NN
of  ||| S:12798 E:12801 ||| IN
Ca  ||| S:12801 E:12804 ||| NNP
2+ ||| S:12804 E:12806 ||| NNP
,  ||| S:12806 E:12808 ||| ,
IQ3  ||| S:12808 E:12812 ||| NNP
also  ||| S:12812 E:12817 ||| RB
bound  ||| S:12817 E:12823 ||| VBN
to  ||| S:12823 E:12826 ||| TO
calmodulin  ||| S:12826 E:12847 ||| VB
with  ||| S:12847 E:12852 ||| IN
a  ||| S:12852 E:12854 ||| DT
stoichiometry  ||| S:12854 E:12868 ||| NN
of  ||| S:12868 E:12871 ||| IN
1 ||| S:12871 E:12872 ||| CD
: ||| S:12872 E:12873 ||| :
1  ||| S:12873 E:12875 ||| CD
( ||| S:12875 E:12876 ||| -LRB-
Fig.  ||| S:12876 E:12881 ||| CD
5 ||| S:12881 E:12882 ||| CD
) ||| S:12882 E:12883 ||| -RRB-
.  ||| S:12883 E:12885 ||| .
The  ||| S:12885 E:12889 ||| DT
fits  ||| S:12889 E:12894 ||| VBZ
to  ||| S:12894 E:12908 ||| TO
m  ||| S:12908 E:12910 ||| CD
=  ||| S:12910 E:12912 ||| SYM
1  ||| S:12912 E:12914 ||| CD
and  ||| S:12914 E:12918 ||| CC
2  ||| S:12918 E:12920 ||| CD
were  ||| S:12920 E:12925 ||| VBD
equally  ||| S:12925 E:12933 ||| RB
good  ||| S:12933 E:12938 ||| JJ
for  ||| S:12938 E:12952 ||| IN
IQ1  ||| S:12952 E:12956 ||| NNP
and  ||| S:12956 E:12960 ||| CC
IQ2  ||| S:12960 E:12964 ||| CD
in  ||| S:12964 E:12967 ||| IN
the  ||| S:12967 E:12971 ||| DT
presence  ||| S:12971 E:12980 ||| NN
of  ||| S:12980 E:12983 ||| IN
Ca  ||| S:12983 E:12986 ||| NNP
2+ ||| S:12986 E:12988 ||| NNP
,  ||| S:12988 E:12990 ||| ,
signifying  ||| S:12990 E:13001 ||| VBG
the  ||| S:13001 E:13015 ||| DT
inability  ||| S:13015 E:13025 ||| NN
for  ||| S:13025 E:13029 ||| IN
this  ||| S:13029 E:13034 ||| DT
analysis  ||| S:13034 E:13043 ||| NN
to  ||| S:13043 E:13046 ||| TO
determine  ||| S:13046 E:13056 ||| VB
precise  ||| S:13056 E:13064 ||| JJ
binding  ||| S:13064 E:13082 ||| JJ
stoichiometry  ||| S:13082 E:13096 ||| NN
of  ||| S:13096 E:13099 ||| IN
IQ1  ||| S:13099 E:13103 ||| NNP
and  ||| S:13103 E:13107 ||| CC
IQ2  ||| S:13107 E:13111 ||| CD
under  ||| S:13111 E:13117 ||| IN
these  ||| S:13117 E:13123 ||| DT
conditions ||| S:13123 E:13133 ||| NNS
.  ||| S:13133 E:13135 ||| .
In  ||| S:13135 E:13148 ||| IN
addition ||| S:13148 E:13156 ||| NN
,  ||| S:13156 E:13158 ||| ,
these  ||| S:13158 E:13164 ||| DT
data  ||| S:13164 E:13169 ||| NNS
indicate  ||| S:13169 E:13178 ||| VBP
that  ||| S:13178 E:13183 ||| IN
the  ||| S:13183 E:13187 ||| DT
apparent  ||| S:13187 E:13206 ||| JJ
affinities  ||| S:13206 E:13217 ||| NNS
of  ||| S:13217 E:13220 ||| IN
IQ1  ||| S:13220 E:13224 ||| NNP
and  ||| S:13224 E:13228 ||| CC
IQ2  ||| S:13228 E:13232 ||| CD
for  ||| S:13232 E:13236 ||| IN
unlabeled  ||| S:13236 E:13246 ||| JJ
calmodulin  ||| S:13246 E:13257 ||| NN
were  ||| S:13257 E:13272 ||| VBD
substantially  ||| S:13272 E:13286 ||| RB
weakened  ||| S:13286 E:13295 ||| VBN
by  ||| S:13295 E:13298 ||| IN
Ca  ||| S:13298 E:13301 ||| NNP
2+ ||| S:13301 E:13303 ||| NNP
( ||| S:13303 E:13304 ||| -LRB-
Table  ||| S:13304 E:13310 ||| NNP
2 ||| S:13310 E:13311 ||| CD
) ||| S:13311 E:13312 ||| -RRB-
,  ||| S:13312 E:13314 ||| ,
unlike  ||| S:13314 E:13321 ||| IN
results  ||| S:13321 E:13339 ||| NNS
with  ||| S:13339 E:13344 ||| IN
Alexa-calmodulin  ||| S:13344 E:13361 ||| JJ
alone  ||| S:13361 E:13367 ||| NNS
( ||| S:13367 E:13368 ||| -LRB-
Table  ||| S:13368 E:13374 ||| NNP
1 ||| S:13374 E:13375 ||| CD
) ||| S:13375 E:13376 ||| -RRB-
.  ||| S:13376 E:13378 ||| .
Because  ||| S:13378 E:13386 ||| IN
the  ||| S:13386 E:13400 ||| DT
assumption  ||| S:13400 E:13411 ||| NN
that  ||| S:13411 E:13416 ||| IN
affinities  ||| S:13416 E:13427 ||| NNS
of  ||| S:13427 E:13430 ||| IN
Alexa-calmodulin  ||| S:13430 E:13447 ||| JJ
and  ||| S:13447 E:13461 ||| CC
unlabeled  ||| S:13461 E:13471 ||| JJ
calmodulin  ||| S:13471 E:13482 ||| NN
for  ||| S:13482 E:13486 ||| IN
IQ  ||| S:13486 E:13489 ||| NNP
peptides  ||| S:13489 E:13498 ||| NNS
are  ||| S:13498 E:13502 ||| VBP
identical  ||| S:13502 E:13512 ||| RB
was  ||| S:13512 E:13526 ||| VBD
violated  ||| S:13526 E:13535 ||| VBN
for  ||| S:13535 E:13539 ||| IN
IQ1  ||| S:13539 E:13543 ||| NNP
and  ||| S:13543 E:13547 ||| CC
IQ2 ||| S:13547 E:13550 ||| NNP
,  ||| S:13550 E:13552 ||| ,
the  ||| S:13552 E:13556 ||| DT
actual  ||| S:13556 E:13563 ||| JJ
affinities  ||| S:13563 E:13574 ||| NNS
of  ||| S:13574 E:13577 ||| IN
these  ||| S:13577 E:13593 ||| DT
IQ  ||| S:13593 E:13596 ||| NNP
peptides  ||| S:13596 E:13605 ||| NN
for  ||| S:13605 E:13609 ||| IN
unlabeled  ||| S:13609 E:13619 ||| JJ
calmodulin  ||| S:13619 E:13630 ||| NN
may  ||| S:13630 E:13634 ||| MD
be  ||| S:13634 E:13637 ||| VB
even  ||| S:13637 E:13642 ||| RB
weaker  ||| S:13642 E:13659 ||| JJR
than  ||| S:13659 E:13664 ||| IN
those  ||| S:13664 E:13670 ||| DT
reported  ||| S:13670 E:13679 ||| VBN
in  ||| S:13679 E:13682 ||| IN
Table  ||| S:13682 E:13688 ||| NNP
2 ||| S:13688 E:13689 ||| CD
.  ||| S:13689 E:13691 ||| .
By  ||| S:13691 E:13694 ||| IN
contrast ||| S:13694 E:13702 ||| NN
,  ||| S:13702 E:13704 ||| ,
Ca  ||| S:13704 E:13707 ||| NNP
2+had  ||| S:13707 E:13723 ||| NNP
only  ||| S:13723 E:13728 ||| RB
a  ||| S:13728 E:13730 ||| DT
very  ||| S:13730 E:13735 ||| RB
modest  ||| S:13735 E:13742 ||| JJ
effect  ||| S:13742 E:13749 ||| NN
on  ||| S:13749 E:13752 ||| IN
IQ3  ||| S:13752 E:13756 ||| CD
affinity  ||| S:13756 E:13765 ||| NN
for  ||| S:13765 E:13769 ||| IN
unlabeled  ||| S:13769 E:13789 ||| JJ
calmodulin ||| S:13789 E:13799 ||| NN
.  ||| S:13799 E:13811 ||| .
Binding  ||| S:13811 E:13819 ||| VBG
of  ||| S:13819 E:13822 ||| IN
IQ4  ||| S:13822 E:13826 ||| CD
to  ||| S:13826 E:13829 ||| TO
unlabeled  ||| S:13829 E:13839 ||| VB
calmodulin  ||| S:13839 E:13850 ||| NNS
was  ||| S:13850 E:13854 ||| VBD
distinct  ||| S:13854 E:13873 ||| JJ
from  ||| S:13873 E:13878 ||| IN
that  ||| S:13878 E:13883 ||| DT
of  ||| S:13883 E:13886 ||| IN
the  ||| S:13886 E:13890 ||| DT
other  ||| S:13890 E:13896 ||| JJ
IQ  ||| S:13896 E:13899 ||| NNP
peptides ||| S:13899 E:13907 ||| NN
.  ||| S:13907 E:13909 ||| .
The  ||| S:13909 E:13913 ||| DT
data  ||| S:13913 E:13918 ||| NNS
with  ||| S:13918 E:13923 ||| IN
IQ4  ||| S:13923 E:13937 ||| NNP
were  ||| S:13937 E:13942 ||| VBD
best  ||| S:13942 E:13947 ||| JJS
fit  ||| S:13947 E:13951 ||| NN
with  ||| S:13951 E:13956 ||| IN
a  ||| S:13956 E:13958 ||| DT
Hill  ||| S:13958 E:13963 ||| NNP
equation  ||| S:13963 E:13972 ||| NN
( ||| S:13972 E:13973 ||| -LRB-
equation  ||| S:13973 E:13982 ||| CD
4 ||| S:13982 E:13983 ||| CD
) ||| S:13983 E:13984 ||| -RRB-
,  ||| S:13984 E:13986 ||| ,
with  ||| S:13986 E:13991 ||| IN
a  ||| S:13991 E:14003 ||| DT
Hill  ||| S:14003 E:14008 ||| NNP
coefficient  ||| S:14008 E:14020 ||| NN
of  ||| S:14020 E:14023 ||| IN
greater  ||| S:14023 E:14031 ||| JJR
than  ||| S:14031 E:14036 ||| IN
2  ||| S:14036 E:14038 ||| CD
( ||| S:14038 E:14039 ||| -LRB-
Fig.  ||| S:14039 E:14044 ||| CD
5 ||| S:14044 E:14045 ||| CD
,  ||| S:14045 E:14047 ||| ,
thick  ||| S:14047 E:14053 ||| JJ
solid  ||| S:14053 E:14069 ||| JJ
lines ||| S:14069 E:14074 ||| NNS
) ||| S:14074 E:14075 ||| -RRB-
,  ||| S:14075 E:14077 ||| ,
suggesting  ||| S:14077 E:14088 ||| VBG
that  ||| S:14088 E:14093 ||| IN
binding  ||| S:14093 E:14101 ||| VBG
of  ||| S:14101 E:14104 ||| IN
two  ||| S:14104 E:14108 ||| CD
peptides  ||| S:14108 E:14117 ||| NN
per  ||| S:14117 E:14131 ||| IN
calmodulin  ||| S:14131 E:14142 ||| NNS
may  ||| S:14142 E:14146 ||| MD
be  ||| S:14146 E:14149 ||| VB
required  ||| S:14149 E:14158 ||| VBN
for  ||| S:14158 E:14162 ||| IN
the  ||| S:14162 E:14166 ||| DT
fluorescence  ||| S:14166 E:14179 ||| JJ
change ||| S:14179 E:14185 ||| NN
.  ||| S:14185 E:14197 ||| .
The  ||| S:14197 E:14201 ||| DT
apparent  ||| S:14201 E:14210 ||| JJ
affinities  ||| S:14210 E:14221 ||| NNS
( ||| S:14221 E:14222 ||| -LRB-
~100  ||| S:14222 E:14227 ||| NNP
μM ||| S:14227 E:14229 ||| NNP
)  ||| S:14229 E:14231 ||| -RRB-
were  ||| S:14231 E:14236 ||| VBD
similar  ||| S:14236 E:14244 ||| JJ
to  ||| S:14244 E:14247 ||| TO
the  ||| S:14247 E:14261 ||| DT
concentration  ||| S:14261 E:14275 ||| NN
of  ||| S:14275 E:14278 ||| IN
calmodulin  ||| S:14278 E:14289 ||| NNS
( ||| S:14289 E:14290 ||| -LRB-
50  ||| S:14290 E:14293 ||| CD
μM ||| S:14293 E:14295 ||| NN
) ||| S:14295 E:14296 ||| -RRB-
,  ||| S:14296 E:14298 ||| ,
however ||| S:14298 E:14305 ||| RB
,  ||| S:14305 E:14307 ||| ,
indicating  ||| S:14307 E:14328 ||| VBG
that  ||| S:14328 E:14333 ||| IN
the  ||| S:14333 E:14337 ||| DT
apparent  ||| S:14337 E:14346 ||| JJ
affinities  ||| S:14346 E:14357 ||| NNS
did  ||| S:14357 E:14361 ||| VBD
not  ||| S:14361 E:14365 ||| RB
accurately  ||| S:14365 E:14376 ||| RB
reflect  ||| S:14376 E:14384 ||| VB
K  ||| S:14384 E:14407 ||| NNP
d  ||| S:14407 E:14409 ||| NN
values ||| S:14409 E:14415 ||| NNS
.  ||| S:14415 E:14417 ||| .
These  ||| S:14417 E:14423 ||| DT
results  ||| S:14423 E:14431 ||| NNS
with  ||| S:14431 E:14436 ||| IN
a  ||| S:14436 E:14438 ||| DT
mixture  ||| S:14438 E:14456 ||| NN
of  ||| S:14456 E:14459 ||| IN
unlabeled  ||| S:14459 E:14469 ||| NN
and  ||| S:14469 E:14473 ||| CC
Alexa-calmodulin  ||| S:14473 E:14490 ||| NNP
were  ||| S:14490 E:14495 ||| VBD
different  ||| S:14495 E:14505 ||| JJ
from  ||| S:14505 E:14520 ||| IN
those  ||| S:14520 E:14526 ||| DT
with  ||| S:14526 E:14531 ||| IN
Alexa-calmodulin  ||| S:14531 E:14548 ||| JJ
alone ||| S:14548 E:14553 ||| RB
,  ||| S:14553 E:14555 ||| ,
where  ||| S:14555 E:14561 ||| WRB
IQ4  ||| S:14561 E:14565 ||| NNP
Hill  ||| S:14565 E:14580 ||| NNP
coefficients  ||| S:14580 E:14593 ||| NN
were  ||| S:14593 E:14598 ||| VBD
close  ||| S:14598 E:14604 ||| RB
to  ||| S:14604 E:14607 ||| TO
1  ||| S:14607 E:14609 ||| CD
( ||| S:14609 E:14610 ||| -LRB-
data  ||| S:14610 E:14615 ||| NNS
not  ||| S:14615 E:14619 ||| RB
shown ||| S:14619 E:14624 ||| VBN
) ||| S:14624 E:14625 ||| -RRB-
.  ||| S:14625 E:14637 ||| .
Nevertheless ||| S:14637 E:14649 ||| RB
,  ||| S:14649 E:14651 ||| ,
these  ||| S:14651 E:14657 ||| DT
data  ||| S:14657 E:14662 ||| NNS
show  ||| S:14662 E:14667 ||| VBP
that  ||| S:14667 E:14672 ||| IN
unlabeled  ||| S:14672 E:14682 ||| JJ
calmodulin  ||| S:14682 E:14703 ||| NN
can  ||| S:14703 E:14707 ||| MD
bind  ||| S:14707 E:14712 ||| VB
to  ||| S:14712 E:14715 ||| TO
IQ4 ||| S:14715 E:14718 ||| CD
,  ||| S:14718 E:14720 ||| ,
albeit  ||| S:14720 E:14727 ||| VBG
with  ||| S:14727 E:14732 ||| IN
weak  ||| S:14732 E:14737 ||| JJ
affinity  ||| S:14737 E:14746 ||| NN
and  ||| S:14746 E:14750 ||| CC
uncertain  ||| S:14750 E:14770 ||| JJ
stoichiometry ||| S:14770 E:14783 ||| NN
.  ||| S:14783 E:14813 ||| .
Hydrodynamic  ||| S:14813 E:14826 ||| JJ
analysis  ||| S:14826 E:14835 ||| NN
of  ||| S:14835 E:14838 ||| IN
full-length  ||| S:14838 E:14850 ||| JJ
Myo1c  ||| S:14850 E:14866 ||| NN
To  ||| S:14866 E:14869 ||| TO
determine  ||| S:14869 E:14879 ||| VB
the  ||| S:14879 E:14883 ||| DT
stoichiometry  ||| S:14883 E:14897 ||| NN
and  ||| S:14897 E:14901 ||| CC
Ca  ||| S:14901 E:14904 ||| NNP
2+-dependent  ||| S:14904 E:14927 ||| NNP
regulation  ||| S:14927 E:14938 ||| NN
of  ||| S:14938 E:14941 ||| IN
calmodulin  ||| S:14941 E:14952 ||| JJ
binding  ||| S:14952 E:14960 ||| NN
to  ||| S:14960 E:14963 ||| TO
Myo1c  ||| S:14963 E:14969 ||| CD
with  ||| S:14969 E:14974 ||| IN
all  ||| S:14974 E:14978 ||| DT
four  ||| S:14978 E:14993 ||| CD
IQ  ||| S:14993 E:14996 ||| NNP
motifs ||| S:14996 E:15002 ||| NNS
,  ||| S:15002 E:15004 ||| ,
we  ||| S:15004 E:15007 ||| PRP
co-expressed  ||| S:15007 E:15020 ||| JJ
calmodulin  ||| S:15020 E:15031 ||| NN
and  ||| S:15031 E:15035 ||| CC
full-length  ||| S:15035 E:15057 ||| JJ
bullfrog  ||| S:15057 E:15066 ||| JJ
Myo1c  ||| S:15066 E:15072 ||| NN
in  ||| S:15072 E:15075 ||| IN
insect  ||| S:15075 E:15082 ||| JJ
cells  ||| S:15082 E:15088 ||| NNS
using  ||| S:15088 E:15094 ||| VBG
baculoviruses  ||| S:15094 E:15108 ||| NNS
and  ||| S:15108 E:15122 ||| CC
subjected  ||| S:15122 E:15132 ||| VBN
the  ||| S:15132 E:15136 ||| DT
purified  ||| S:15136 E:15145 ||| JJ
Myo1c-calmodulin  ||| S:15145 E:15162 ||| CD
complexes  ||| S:15162 E:15172 ||| NNS
( ||| S:15172 E:15173 ||| -LRB-
Fig.  ||| S:15173 E:15188 ||| NNP
1B ||| S:15188 E:15190 ||| NNP
)  ||| S:15190 E:15192 ||| -RRB-
to  ||| S:15192 E:15195 ||| TO
hydrodynamic  ||| S:15195 E:15208 ||| VB
analysis  ||| S:15208 E:15217 ||| NN
( ||| S:15217 E:15218 ||| -LRB-
Table  ||| S:15218 E:15224 ||| NNP
3 ||| S:15224 E:15225 ||| CD
) ||| S:15225 E:15226 ||| -RRB-
.  ||| S:15226 E:15228 ||| .
We  ||| S:15228 E:15231 ||| PRP
carried  ||| S:15231 E:15239 ||| VBD
out  ||| S:15239 E:15253 ||| RP
velocity  ||| S:15253 E:15262 ||| JJ
sedimentation  ||| S:15262 E:15276 ||| NN
of  ||| S:15276 E:15279 ||| IN
Myo1c-calmodulin  ||| S:15279 E:15296 ||| CD
complexes  ||| S:15296 E:15306 ||| NNS
on  ||| S:15306 E:15319 ||| IN
5-20 ||| S:15319 E:15323 ||| CD
%  ||| S:15323 E:15325 ||| NN
sucrose  ||| S:15325 E:15333 ||| VBZ
gradients  ||| S:15333 E:15343 ||| VBN
to  ||| S:15343 E:15346 ||| TO
determine  ||| S:15346 E:15356 ||| VB
sedimentation  ||| S:15356 E:15380 ||| JJ
coefficients ||| S:15380 E:15392 ||| NN
.  ||| S:15392 E:15394 ||| .
We  ||| S:15394 E:15397 ||| PRP
measured  ||| S:15397 E:15406 ||| VBD
the  ||| S:15406 E:15410 ||| DT
Stokes  ||| S:15410 E:15417 ||| JJ
radius  ||| S:15417 E:15424 ||| NN
of  ||| S:15424 E:15437 ||| IN
Myo1c-calmodulin  ||| S:15437 E:15454 ||| CD
complexes  ||| S:15454 E:15464 ||| NNS
using  ||| S:15464 E:15470 ||| VBG
gel  ||| S:15470 E:15474 ||| JJ
filtration  ||| S:15474 E:15485 ||| NN
on  ||| S:15485 E:15498 ||| IN
Superdex  ||| S:15498 E:15507 ||| NNP
200  ||| S:15507 E:15511 ||| CD
under  ||| S:15511 E:15517 ||| IN
temperature  ||| S:15517 E:15529 ||| NN
and  ||| S:15529 E:15533 ||| CC
buffer  ||| S:15533 E:15540 ||| JJ
conditions  ||| S:15540 E:15561 ||| NNS
identical  ||| S:15561 E:15571 ||| JJ
to  ||| S:15571 E:15574 ||| TO
those  ||| S:15574 E:15580 ||| DT
of  ||| S:15580 E:15583 ||| IN
the  ||| S:15583 E:15587 ||| DT
velocity-sedimentation  ||| S:15587 E:15620 ||| JJ
experiments  ||| S:15620 E:15632 ||| NNS
( ||| S:15632 E:15633 ||| -LRB-
Table  ||| S:15633 E:15639 ||| NNP
3 ||| S:15639 E:15640 ||| CD
) ||| S:15640 E:15641 ||| -RRB-
.  ||| S:15641 E:15643 ||| .
Although  ||| S:15643 E:15652 ||| IN
most  ||| S:15652 E:15657 ||| JJS
experiments  ||| S:15657 E:15669 ||| NNS
used  ||| S:15669 E:15674 ||| VBD
400  ||| S:15674 E:15688 ||| CD
mM  ||| S:15688 E:15691 ||| JJ
KCl  ||| S:15691 E:15695 ||| NN
( ||| S:15695 E:15696 ||| -LRB-
which  ||| S:15696 E:15702 ||| WDT
prevented  ||| S:15702 E:15712 ||| VBD
adsorption  ||| S:15712 E:15723 ||| VBN
to  ||| S:15723 E:15726 ||| TO
the  ||| S:15726 E:15730 ||| DT
gel-filtration  ||| S:15730 E:15755 ||| JJ
matrix ||| S:15755 E:15761 ||| NN
) ||| S:15761 E:15762 ||| -RRB-
,  ||| S:15762 E:15764 ||| ,
we  ||| S:15764 E:15767 ||| PRP
obtained  ||| S:15767 E:15776 ||| VBD
identical  ||| S:15776 E:15786 ||| JJ
sedimentation  ||| S:15786 E:15800 ||| JJ
coefficients  ||| S:15800 E:15823 ||| NN
in  ||| S:15823 E:15826 ||| IN
the  ||| S:15826 E:15830 ||| DT
presence  ||| S:15830 E:15839 ||| NN
of  ||| S:15839 E:15842 ||| IN
150  ||| S:15842 E:15846 ||| CD
or  ||| S:15846 E:15849 ||| CC
250  ||| S:15849 E:15853 ||| CD
mM  ||| S:15853 E:15856 ||| JJ
KCl  ||| S:15856 E:15860 ||| NN
( ||| S:15860 E:15861 ||| -LRB-
not  ||| S:15861 E:15865 ||| RB
shown ||| S:15865 E:15870 ||| VBN
) ||| S:15870 E:15871 ||| -RRB-
.  ||| S:15871 E:15883 ||| .
Velocity-sedimentation  ||| S:15883 E:15906 ||| NNP
and  ||| S:15906 E:15910 ||| CC
gel-filtration  ||| S:15910 E:15925 ||| JJ
experiments  ||| S:15925 E:15947 ||| NNS
were  ||| S:15947 E:15952 ||| VBD
carried  ||| S:15952 E:15960 ||| VBN
out  ||| S:15960 E:15964 ||| RP
at  ||| S:15964 E:15967 ||| IN
4°C ||| S:15967 E:15970 ||| NNP
,  ||| S:15970 E:15972 ||| ,
the  ||| S:15972 E:15976 ||| DT
temperature  ||| S:15976 E:15988 ||| NN
used  ||| S:15988 E:15993 ||| VBN
for  ||| S:15993 E:15997 ||| IN
Myo1c  ||| S:15997 E:16013 ||| CD
purification ||| S:16013 E:16025 ||| NN
,  ||| S:16025 E:16027 ||| ,
as  ||| S:16027 E:16030 ||| RB
well  ||| S:16030 E:16035 ||| RB
as  ||| S:16035 E:16038 ||| RB
at  ||| S:16038 E:16041 ||| IN
25°C ||| S:16041 E:16045 ||| NNP
,  ||| S:16045 E:16047 ||| ,
a  ||| S:16047 E:16049 ||| DT
physiologically  ||| S:16049 E:16075 ||| JJ
relevant  ||| S:16075 E:16084 ||| JJ
temperature  ||| S:16084 E:16096 ||| NN
for  ||| S:16096 E:16100 ||| IN
a  ||| S:16100 E:16102 ||| DT
bullfrog ||| S:16102 E:16110 ||| NN
.  ||| S:16110 E:16122 ||| .
To  ||| S:16122 E:16125 ||| TO
calculate  ||| S:16125 E:16135 ||| VB
the  ||| S:16135 E:16139 ||| DT
molecular  ||| S:16139 E:16149 ||| JJ
mass  ||| S:16149 E:16154 ||| NN
of  ||| S:16154 E:16157 ||| IN
Myo1c-calmodulin  ||| S:16157 E:16184 ||| CD
complexes ||| S:16184 E:16193 ||| NNS
,  ||| S:16193 E:16195 ||| ,
we  ||| S:16195 E:16198 ||| PRP
applied  ||| S:16198 E:16206 ||| VBD
the  ||| S:16206 E:16210 ||| DT
modified  ||| S:16210 E:16219 ||| JJ
Svedberg  ||| S:16219 E:16228 ||| JJ
equation ||| S:16228 E:16236 ||| NN
,  ||| S:16236 E:16248 ||| ,
which  ||| S:16248 E:16254 ||| WDT
relates  ||| S:16254 E:16262 ||| VBZ
mass  ||| S:16262 E:16267 ||| VBN
to  ||| S:16267 E:16270 ||| TO
the  ||| S:16270 E:16274 ||| DT
diffusion  ||| S:16274 E:16284 ||| JJ
constant  ||| S:16284 E:16293 ||| JJ
( ||| S:16293 E:16294 ||| -LRB-
calculated  ||| S:16294 E:16315 ||| VBN
here  ||| S:16315 E:16320 ||| RB
from  ||| S:16320 E:16325 ||| IN
Stokes  ||| S:16325 E:16332 ||| NNP
radius ||| S:16332 E:16338 ||| CD
)  ||| S:16338 E:16340 ||| -RRB-
and  ||| S:16340 E:16344 ||| CC
the  ||| S:16344 E:16348 ||| DT
sedimentation  ||| S:16348 E:16372 ||| JJ
coefficient  ||| S:16372 E:16384 ||| NNS
[  ||| S:16384 E:16386 ||| -LRB-
29  ||| S:16386 E:16389 ||| CD
]  ||| S:16389 E:16391 ||| -RRB-
.  ||| S:16391 E:16393 ||| .
The  ||| S:16393 E:16397 ||| DT
partial  ||| S:16397 E:16405 ||| JJ
specific  ||| S:16405 E:16414 ||| JJ
volume  ||| S:16414 E:16421 ||| NN
of  ||| S:16421 E:16424 ||| IN
each  ||| S:16424 E:16439 ||| DT
protein  ||| S:16439 E:16447 ||| NN
complex  ||| S:16447 E:16455 ||| NN
was  ||| S:16455 E:16459 ||| VBD
determined  ||| S:16459 E:16470 ||| VBN
using  ||| S:16470 E:16476 ||| VBG
the  ||| S:16476 E:16480 ||| DT
amino-acid  ||| S:16480 E:16501 ||| JJ
composition  ||| S:16501 E:16513 ||| NN
of  ||| S:16513 E:16516 ||| IN
the  ||| S:16516 E:16520 ||| DT
constituent  ||| S:16520 E:16532 ||| NN
proteins  ||| S:16532 E:16541 ||| NNS
( ||| S:16541 E:16542 ||| -LRB-
Table  ||| S:16542 E:16548 ||| NNP
3 ||| S:16548 E:16549 ||| CD
;  ||| S:16549 E:16551 ||| :
ref.  ||| S:16551 E:16556 ||| CD
[  ||| S:16556 E:16568 ||| -LRB-
30  ||| S:16568 E:16571 ||| CD
]  ||| S:16571 E:16573 ||| CD
) ||| S:16573 E:16574 ||| -RRB-
.  ||| S:16574 E:16576 ||| .
Although  ||| S:16576 E:16585 ||| IN
the  ||| S:16585 E:16589 ||| DT
uncertainty  ||| S:16589 E:16601 ||| NN
in  ||| S:16601 E:16604 ||| IN
calmodulin  ||| S:16604 E:16625 ||| JJ
stoichiometry  ||| S:16625 E:16639 ||| NN
leads  ||| S:16639 E:16645 ||| VBZ
to  ||| S:16645 E:16648 ||| TO
ambiguity  ||| S:16648 E:16658 ||| VB
in  ||| S:16658 E:16661 ||| IN
this  ||| S:16661 E:16666 ||| DT
calculation ||| S:16666 E:16677 ||| NN
,  ||| S:16677 E:16679 ||| ,
the  ||| S:16679 E:16693 ||| DT
calculated  ||| S:16693 E:16704 ||| JJ
partial  ||| S:16704 E:16712 ||| JJ
specific  ||| S:16712 E:16721 ||| JJ
volumes  ||| S:16721 E:16729 ||| NNS
were  ||| S:16729 E:16734 ||| VBD
so  ||| S:16734 E:16737 ||| RB
close  ||| S:16737 E:16743 ||| VB
(  ||| S:16743 E:16756 ||| -LRB-
e.g.  ||| S:16756 E:16761 ||| NNP
,  ||| S:16761 E:16763 ||| ,
0.734  ||| S:16763 E:16769 ||| NNP
for  ||| S:16769 E:16773 ||| IN
one  ||| S:16773 E:16777 ||| CD
and  ||| S:16777 E:16781 ||| CC
0.731  ||| S:16781 E:16787 ||| CD
for  ||| S:16787 E:16801 ||| IN
three  ||| S:16801 E:16807 ||| CD
calmodulins  ||| S:16807 E:16819 ||| NN
per  ||| S:16819 E:16823 ||| IN
Myo1c  ||| S:16823 E:16829 ||| CD
complex ||| S:16829 E:16836 ||| NN
)  ||| S:16836 E:16838 ||| -RRB-
that  ||| S:16838 E:16843 ||| IN
the  ||| S:16843 E:16847 ||| DT
precise  ||| S:16847 E:16865 ||| JJ
value  ||| S:16865 E:16871 ||| NN
did  ||| S:16871 E:16875 ||| VBD
not  ||| S:16875 E:16879 ||| RB
significantly  ||| S:16879 E:16893 ||| RB
affect  ||| S:16893 E:16900 ||| VB
the  ||| S:16900 E:16904 ||| DT
final  ||| S:16904 E:16920 ||| JJ
molecular-mass  ||| S:16920 E:16935 ||| JJ
value ||| S:16935 E:16940 ||| NN
.  ||| S:16940 E:16952 ||| .
Full-length  ||| S:16952 E:16964 ||| JJ
Myo1c  ||| S:16964 E:16970 ||| FW
bound  ||| S:16970 E:16976 ||| FW
~3  ||| S:16976 E:16979 ||| FW
calmodulins  ||| S:16979 E:16991 ||| FW
per  ||| S:16991 E:16995 ||| FW
Myo1c  ||| S:16995 E:17001 ||| FW
at  ||| S:17001 E:17014 ||| IN
4°C  ||| S:17014 E:17018 ||| CD
in  ||| S:17018 E:17021 ||| IN
the  ||| S:17021 E:17025 ||| DT
presence  ||| S:17025 E:17034 ||| NN
of  ||| S:17034 E:17037 ||| IN
EGTA  ||| S:17037 E:17042 ||| NNP
or  ||| S:17042 E:17045 ||| CC
CaCl  ||| S:17045 E:17061 ||| JJ
2  ||| S:17061 E:17063 ||| CD
( ||| S:17063 E:17064 ||| -LRB-
Table  ||| S:17064 E:17070 ||| NNP
3 ||| S:17070 E:17071 ||| CD
) ||| S:17071 E:17072 ||| -RRB-
.  ||| S:17072 E:17074 ||| .
One  ||| S:17074 E:17078 ||| CD
of  ||| S:17078 E:17081 ||| IN
the  ||| S:17081 E:17085 ||| DT
bound  ||| S:17085 E:17101 ||| JJ
calmodulins  ||| S:17101 E:17113 ||| NN
was  ||| S:17113 E:17117 ||| VBD
only  ||| S:17117 E:17122 ||| RB
weakly  ||| S:17122 E:17129 ||| VB
associated ||| S:17129 E:17139 ||| VBN
,  ||| S:17139 E:17141 ||| ,
as  ||| S:17141 E:17144 ||| IN
elevation  ||| S:17144 E:17154 ||| NN
of  ||| S:17154 E:17167 ||| IN
the  ||| S:17167 E:17171 ||| DT
temperature  ||| S:17171 E:17183 ||| NN
to  ||| S:17183 E:17186 ||| TO
25°C  ||| S:17186 E:17191 ||| CD
induced  ||| S:17191 E:17199 ||| CD
the  ||| S:17199 E:17203 ||| DT
release  ||| S:17203 E:17211 ||| NN
of  ||| S:17211 E:17214 ||| IN
1  ||| S:17214 E:17216 ||| CD
mole  ||| S:17216 E:17221 ||| NN
of  ||| S:17221 E:17234 ||| IN
calmodulin  ||| S:17234 E:17245 ||| NN
in  ||| S:17245 E:17248 ||| IN
the  ||| S:17248 E:17252 ||| DT
presence  ||| S:17252 E:17261 ||| NN
of  ||| S:17261 E:17264 ||| IN
EGTA ||| S:17264 E:17268 ||| NNP
.  ||| S:17268 E:17270 ||| .
When  ||| S:17270 E:17275 ||| WRB
Ca  ||| S:17275 E:17278 ||| NNP
2+was  ||| S:17278 E:17294 ||| NNP
elevated  ||| S:17294 E:17303 ||| VBD
to  ||| S:17303 E:17306 ||| TO
25  ||| S:17306 E:17309 ||| CD
μM  ||| S:17309 E:17312 ||| NN
at  ||| S:17312 E:17315 ||| IN
25°C ||| S:17315 E:17319 ||| NNP
,  ||| S:17319 E:17321 ||| ,
however ||| S:17321 E:17328 ||| RB
,  ||| S:17328 E:17330 ||| ,
we  ||| S:17330 E:17333 ||| PRP
could  ||| S:17333 E:17339 ||| MD
not  ||| S:17339 E:17343 ||| RB
detect  ||| S:17343 E:17360 ||| VB
substantial  ||| S:17360 E:17372 ||| JJ
full-length  ||| S:17372 E:17384 ||| JJ
Myo1c  ||| S:17384 E:17390 ||| NN
in  ||| S:17390 E:17393 ||| IN
solution  ||| S:17393 E:17402 ||| NN
after  ||| S:17402 E:17418 ||| IN
sucrose-gradient  ||| S:17418 E:17435 ||| JJ
centrifugation  ||| S:17435 E:17450 ||| NN
or  ||| S:17450 E:17453 ||| CC
gel  ||| S:17453 E:17457 ||| JJ
filtration ||| S:17457 E:17467 ||| NN
,  ||| S:17467 E:17479 ||| ,
suggesting  ||| S:17479 E:17490 ||| VBG
that  ||| S:17490 E:17495 ||| IN
the  ||| S:17495 E:17499 ||| DT
protein  ||| S:17499 E:17507 ||| NN
had  ||| S:17507 E:17511 ||| VBD
aggregated ||| S:17511 E:17521 ||| VBN
.  ||| S:17521 E:17551 ||| .
Hydrodynamic  ||| S:17551 E:17564 ||| JJ
analysis  ||| S:17564 E:17573 ||| NN
of  ||| S:17573 E:17576 ||| IN
T701-Myo1c  ||| S:17576 E:17597 ||| CD
Because  ||| S:17597 E:17605 ||| IN
the  ||| S:17605 E:17609 ||| DT
size  ||| S:17609 E:17614 ||| NN
of  ||| S:17614 E:17617 ||| IN
full-length  ||| S:17617 E:17629 ||| JJ
Myo1c  ||| S:17629 E:17635 ||| NNP
( ||| S:17635 E:17636 ||| -LRB-
125  ||| S:17636 E:17640 ||| CD
kD ||| S:17640 E:17642 ||| NN
,  ||| S:17642 E:17654 ||| ,
including  ||| S:17654 E:17664 ||| VBG
purification  ||| S:17664 E:17677 ||| NNS
and  ||| S:17677 E:17681 ||| CC
detection  ||| S:17681 E:17691 ||| JJ
tags ||| S:17691 E:17695 ||| NNS
)  ||| S:17695 E:17697 ||| -RRB-
is  ||| S:17697 E:17700 ||| VBZ
much  ||| S:17700 E:17705 ||| RB
larger  ||| S:17705 E:17722 ||| JJR
than  ||| S:17722 E:17727 ||| IN
calmodulin  ||| S:17727 E:17738 ||| NNS
( ||| S:17738 E:17739 ||| -LRB-
16.7  ||| S:17739 E:17744 ||| NNP
kD ||| S:17744 E:17746 ||| NNP
) ||| S:17746 E:17747 ||| -RRB-
,  ||| S:17747 E:17749 ||| ,
we  ||| S:17749 E:17752 ||| PRP
improved  ||| S:17752 E:17761 ||| VBD
our  ||| S:17761 E:17765 ||| PRP$
ability  ||| S:17765 E:17773 ||| NN
to  ||| S:17773 E:17786 ||| TO
determine  ||| S:17786 E:17796 ||| VB
stoichiometry  ||| S:17796 E:17810 ||| VBN
from  ||| S:17810 E:17815 ||| IN
molecular  ||| S:17815 E:17825 ||| JJ
mass  ||| S:17825 E:17830 ||| NN
by  ||| S:17830 E:17833 ||| IN
examining  ||| S:17833 E:17853 ||| VBG
a  ||| S:17853 E:17855 ||| DT
smaller  ||| S:17855 E:17863 ||| JJR
( ||| S:17863 E:17864 ||| -LRB-
45  ||| S:17864 E:17867 ||| CD
kD ||| S:17867 E:17869 ||| NN
)  ||| S:17869 E:17871 ||| -RRB-
neck-tail  ||| S:17871 E:17881 ||| JJ
recombinant  ||| S:17881 E:17893 ||| JJ
fragment  ||| S:17893 E:17902 ||| NN
of  ||| S:17902 E:17915 ||| IN
Myo1c ||| S:17915 E:17920 ||| CD
.  ||| S:17920 E:17922 ||| .
This  ||| S:17922 E:17927 ||| DT
construct ||| S:17927 E:17936 ||| NN
,  ||| S:17936 E:17938 ||| ,
T701-Myo1c ||| S:17938 E:17948 ||| NNP
,  ||| S:17948 E:17950 ||| ,
contained  ||| S:17950 E:17960 ||| VBD
amino  ||| S:17960 E:17966 ||| CD
acids  ||| S:17966 E:17982 ||| CD
701-1028  ||| S:17982 E:17991 ||| CD
of  ||| S:17991 E:17994 ||| IN
bullfrog  ||| S:17994 E:18003 ||| CD
Myo1c ||| S:18003 E:18008 ||| CD
,  ||| S:18008 E:18010 ||| ,
including  ||| S:18010 E:18020 ||| VBG
all  ||| S:18020 E:18024 ||| DT
four  ||| S:18024 E:18029 ||| CD
IQ  ||| S:18029 E:18042 ||| NNP
domains ||| S:18042 E:18049 ||| NN
,  ||| S:18049 E:18051 ||| ,
the  ||| S:18051 E:18055 ||| DT
entire  ||| S:18055 E:18062 ||| JJ
C-terminal  ||| S:18062 E:18073 ||| JJ
tail ||| S:18073 E:18077 ||| NN
,  ||| S:18077 E:18079 ||| ,
and  ||| S:18079 E:18083 ||| CC
N-terminal  ||| S:18083 E:18104 ||| JJ
purification  ||| S:18104 E:18117 ||| NN
and  ||| S:18117 E:18121 ||| CC
epitope  ||| S:18121 E:18129 ||| JJ
tags  ||| S:18129 E:18134 ||| NNS
( ||| S:18134 E:18135 ||| -LRB-
Fig.  ||| S:18135 E:18140 ||| NNP
1A ||| S:18140 E:18142 ||| NNP
, ||| S:18142 E:18143 ||| ,
1B ||| S:18143 E:18145 ||| CD
) ||| S:18145 E:18146 ||| -RRB-
.  ||| S:18146 E:18158 ||| .
T701-Myo1c  ||| S:18158 E:18169 ||| CD
bound  ||| S:18169 E:18175 ||| CD
2.5  ||| S:18175 E:18179 ||| CD
moles  ||| S:18179 E:18185 ||| NN
of  ||| S:18185 E:18188 ||| IN
calmodulin  ||| S:18188 E:18199 ||| NN
per  ||| S:18199 E:18203 ||| IN
mole  ||| S:18203 E:18208 ||| NN
of  ||| S:18208 E:18221 ||| IN
heavy  ||| S:18221 E:18227 ||| JJ
chain  ||| S:18227 E:18233 ||| NN
at  ||| S:18233 E:18236 ||| IN
4°C  ||| S:18236 E:18240 ||| CD
in  ||| S:18240 E:18243 ||| IN
the  ||| S:18243 E:18247 ||| DT
presence  ||| S:18247 E:18256 ||| NN
of  ||| S:18256 E:18259 ||| IN
100  ||| S:18259 E:18263 ||| CD
μM  ||| S:18263 E:18266 ||| JJ
EGTA  ||| S:18266 E:18271 ||| NNP
( ||| S:18271 E:18272 ||| -LRB-
Fig.  ||| S:18272 E:18287 ||| CD
6 ||| S:18287 E:18288 ||| CD
;  ||| S:18288 E:18290 ||| :
Table  ||| S:18290 E:18296 ||| NNP
4 ||| S:18296 E:18297 ||| CD
) ||| S:18297 E:18298 ||| -RRB-
.  ||| S:18298 E:18300 ||| .
As  ||| S:18300 E:18303 ||| RB
with  ||| S:18303 E:18308 ||| IN
full-length  ||| S:18308 E:18320 ||| JJ
Myo1c ||| S:18320 E:18325 ||| NN
,  ||| S:18325 E:18327 ||| ,
elevation  ||| S:18327 E:18337 ||| VBG
of  ||| S:18337 E:18340 ||| IN
the  ||| S:18340 E:18354 ||| DT
analysis  ||| S:18354 E:18363 ||| NN
temperature  ||| S:18363 E:18375 ||| NN
to  ||| S:18375 E:18378 ||| TO
25°C  ||| S:18378 E:18383 ||| CD
induced  ||| S:18383 E:18391 ||| CD
the  ||| S:18391 E:18395 ||| DT
release  ||| S:18395 E:18403 ||| NN
of  ||| S:18403 E:18406 ||| IN
~0.7  ||| S:18406 E:18421 ||| CD
mole  ||| S:18421 E:18426 ||| NN
of  ||| S:18426 E:18429 ||| IN
calmodulin ||| S:18429 E:18439 ||| NN
.  ||| S:18439 E:18441 ||| .
In  ||| S:18441 E:18444 ||| IN
contrast  ||| S:18444 E:18453 ||| NN
to  ||| S:18453 E:18456 ||| TO
the  ||| S:18456 E:18460 ||| DT
results  ||| S:18460 E:18468 ||| NNS
seen  ||| S:18468 E:18473 ||| VBN
with  ||| S:18473 E:18488 ||| IN
full-length  ||| S:18488 E:18500 ||| JJ
Myo1c ||| S:18500 E:18505 ||| NN
,  ||| S:18505 E:18507 ||| ,
elevation  ||| S:18507 E:18517 ||| VBG
of  ||| S:18517 E:18520 ||| IN
the  ||| S:18520 E:18524 ||| DT
CaCl  ||| S:18524 E:18540 ||| JJ
2  ||| S:18540 E:18542 ||| CD
concentration  ||| S:18542 E:18556 ||| NN
to  ||| S:18556 E:18559 ||| TO
25  ||| S:18559 E:18562 ||| CD
μM  ||| S:18562 E:18565 ||| NN
at  ||| S:18565 E:18568 ||| IN
4°C  ||| S:18568 E:18572 ||| NNP
also  ||| S:18572 E:18587 ||| RB
induced  ||| S:18587 E:18595 ||| VBN
the  ||| S:18595 E:18599 ||| DT
release  ||| S:18599 E:18607 ||| NN
of  ||| S:18607 E:18610 ||| IN
~0.7  ||| S:18610 E:18615 ||| CD
mole  ||| S:18615 E:18620 ||| NN
of  ||| S:18620 E:18623 ||| IN
calmodulin ||| S:18623 E:18633 ||| NN
.  ||| S:18633 E:18635 ||| .
The  ||| S:18635 E:18649 ||| DT
amount  ||| S:18649 E:18656 ||| NN
of  ||| S:18656 E:18659 ||| IN
T701-calmodulin  ||| S:18659 E:18675 ||| CD
complex  ||| S:18675 E:18683 ||| NN
recovered  ||| S:18683 E:18693 ||| VBD
on  ||| S:18693 E:18696 ||| IN
sucrose  ||| S:18696 E:18714 ||| JJ
gradients  ||| S:18714 E:18724 ||| NN
or  ||| S:18724 E:18727 ||| CC
by  ||| S:18727 E:18730 ||| IN
gel  ||| S:18730 E:18734 ||| JJ
filtration  ||| S:18734 E:18745 ||| NN
decreased  ||| S:18745 E:18755 ||| VBD
substantially  ||| S:18755 E:18779 ||| RB
when  ||| S:18779 E:18784 ||| WRB
the  ||| S:18784 E:18788 ||| DT
CaCl  ||| S:18788 E:18804 ||| JJ
2  ||| S:18804 E:18806 ||| CD
concentration  ||| S:18806 E:18820 ||| NN
was  ||| S:18820 E:18824 ||| VBD
elevated  ||| S:18824 E:18833 ||| VBN
to  ||| S:18833 E:18836 ||| TO
25  ||| S:18836 E:18839 ||| CD
μM  ||| S:18839 E:18852 ||| NN
at  ||| S:18852 E:18855 ||| IN
25°C ||| S:18855 E:18859 ||| NNP
,  ||| S:18859 E:18861 ||| ,
signaling  ||| S:18861 E:18871 ||| VBG
the  ||| S:18871 E:18875 ||| DT
formation  ||| S:18875 E:18885 ||| NN
of  ||| S:18885 E:18888 ||| IN
aggregates ||| S:18888 E:18898 ||| NNS
,  ||| S:18898 E:18900 ||| ,
as  ||| S:18900 E:18903 ||| RB
seen  ||| S:18903 E:18918 ||| VBN
with  ||| S:18918 E:18923 ||| IN
the  ||| S:18923 E:18927 ||| DT
full-length  ||| S:18927 E:18939 ||| JJ
complex ||| S:18939 E:18946 ||| NN
.  ||| S:18946 E:18948 ||| .
Furthermore ||| S:18948 E:18959 ||| RB
,  ||| S:18959 E:18961 ||| ,
the  ||| S:18961 E:18965 ||| DT
calculated  ||| S:18965 E:18986 ||| JJ
calmodulin  ||| S:18986 E:18997 ||| JJ
stoichiometry  ||| S:18997 E:19011 ||| NN
of  ||| S:19011 E:19014 ||| IN
the  ||| S:19014 E:19018 ||| DT
observed  ||| S:19018 E:19027 ||| JJ
T701-calmodulin  ||| S:19027 E:19053 ||| CD
complex  ||| S:19053 E:19061 ||| NN
under  ||| S:19061 E:19067 ||| IN
these  ||| S:19067 E:19073 ||| DT
conditions  ||| S:19073 E:19084 ||| NNS
was  ||| S:19084 E:19088 ||| VBD
only  ||| S:19088 E:19093 ||| RB
~0.3  ||| S:19093 E:19098 ||| CD
mole  ||| S:19098 E:19103 ||| NN
of  ||| S:19103 E:19116 ||| IN
calmodulin  ||| S:19116 E:19127 ||| NN
per  ||| S:19127 E:19131 ||| IN
mole  ||| S:19131 E:19136 ||| NN
of  ||| S:19136 E:19139 ||| IN
Myo1c ||| S:19139 E:19144 ||| NNP
,  ||| S:19144 E:19146 ||| ,
reinforcing  ||| S:19146 E:19158 ||| VBG
the  ||| S:19158 E:19162 ||| DT
suggestion  ||| S:19162 E:19183 ||| NN
that  ||| S:19183 E:19188 ||| WDT
Ca  ||| S:19188 E:19191 ||| MD
2+induced  ||| S:19191 E:19201 ||| RB
the  ||| S:19201 E:19205 ||| DT
dissociation  ||| S:19205 E:19218 ||| NN
of  ||| S:19218 E:19221 ||| IN
most  ||| S:19221 E:19226 ||| JJS
calmodulins  ||| S:19226 E:19238 ||| NN
at  ||| S:19238 E:19251 ||| IN
25°C  ||| S:19251 E:19256 ||| NNP
and  ||| S:19256 E:19260 ||| CC
that  ||| S:19260 E:19265 ||| IN
this  ||| S:19265 E:19270 ||| DT
loss  ||| S:19270 E:19275 ||| NN
of  ||| S:19275 E:19278 ||| IN
light  ||| S:19278 E:19284 ||| JJ
chains  ||| S:19284 E:19291 ||| NNS
resulted  ||| S:19291 E:19300 ||| VBD
in  ||| S:19300 E:19313 ||| IN
aggregation ||| S:19313 E:19324 ||| NN
.  ||| S:19324 E:19336 ||| .
We  ||| S:19336 E:19339 ||| PRP
could  ||| S:19339 E:19345 ||| MD
not  ||| S:19345 E:19349 ||| RB
prevent  ||| S:19349 E:19357 ||| VB
the  ||| S:19357 E:19361 ||| DT
release  ||| S:19361 E:19369 ||| NN
of  ||| S:19369 E:19372 ||| IN
calmodulin  ||| S:19372 E:19383 ||| NN
at  ||| S:19383 E:19386 ||| IN
25°C  ||| S:19386 E:19401 ||| CD
by  ||| S:19401 E:19404 ||| IN
saturating  ||| S:19404 E:19415 ||| JJ
T701-Myo1c  ||| S:19415 E:19426 ||| NN
with  ||| S:19426 E:19431 ||| IN
excess  ||| S:19431 E:19438 ||| JJ
calmodulin  ||| S:19438 E:19459 ||| NNS
immediately  ||| S:19459 E:19471 ||| RB
prior  ||| S:19471 E:19477 ||| RB
to  ||| S:19477 E:19480 ||| TO
centrifugation  ||| S:19480 E:19495 ||| VB
( ||| S:19495 E:19496 ||| -LRB-
preloading ||| S:19496 E:19506 ||| LS
) ||| S:19506 E:19507 ||| -RRB-
.  ||| S:19507 E:19509 ||| .
In  ||| S:19509 E:19522 ||| IN
EGTA ||| S:19522 E:19526 ||| NNP
,  ||| S:19526 E:19528 ||| ,
the  ||| S:19528 E:19532 ||| DT
sedimentation  ||| S:19532 E:19546 ||| JJ
coefficient  ||| S:19546 E:19558 ||| NN
of  ||| S:19558 E:19571 ||| IN
calmodulin-preloaded  ||| S:19571 E:19592 ||| JJ
T701-Myo1c  ||| S:19592 E:19603 ||| NN
measured  ||| S:19603 E:19612 ||| VBN
at  ||| S:19612 E:19615 ||| IN
25°C  ||| S:19615 E:19620 ||| NNP
( ||| S:19620 E:19621 ||| -LRB-
3.85  ||| S:19621 E:19626 ||| CD
±  ||| S:19626 E:19638 ||| CD
0.07  ||| S:19638 E:19643 ||| CD
S ||| S:19643 E:19644 ||| NNP
;  ||| S:19644 E:19646 ||| :
n  ||| S:19646 E:19648 ||| CD
=  ||| S:19648 E:19650 ||| SYM
2 ||| S:19650 E:19651 ||| LS
)  ||| S:19651 E:19653 ||| -RRB-
was  ||| S:19653 E:19657 ||| VBD
nearly  ||| S:19657 E:19664 ||| RB
identical  ||| S:19664 E:19674 ||| JJ
to  ||| S:19674 E:19677 ||| TO
that  ||| S:19677 E:19682 ||| DT
measured  ||| S:19682 E:19701 ||| VBN
without  ||| S:19701 E:19709 ||| IN
preloading  ||| S:19709 E:19720 ||| NNS
( ||| S:19720 E:19721 ||| -LRB-
3.83  ||| S:19721 E:19726 ||| NNP
S ||| S:19726 E:19727 ||| NNP
;  ||| S:19727 E:19729 ||| :
Table  ||| S:19729 E:19735 ||| NNP
4 ||| S:19735 E:19736 ||| CD
) ||| S:19736 E:19737 ||| -RRB-
.  ||| S:19737 E:19739 ||| .
Likewise ||| S:19739 E:19747 ||| RB
,  ||| S:19747 E:19749 ||| ,
the  ||| S:19749 E:19763 ||| DT
sedimentation  ||| S:19763 E:19777 ||| JJ
coefficient  ||| S:19777 E:19789 ||| NN
of  ||| S:19789 E:19792 ||| IN
calmodulin-preloaded  ||| S:19792 E:19823 ||| JJ
T701-Myo1c  ||| S:19823 E:19834 ||| NN
measured  ||| S:19834 E:19843 ||| VBN
at  ||| S:19843 E:19846 ||| IN
25°C  ||| S:19846 E:19851 ||| NNP
and  ||| S:19851 E:19855 ||| CC
in  ||| S:19855 E:19858 ||| IN
25  ||| S:19858 E:19861 ||| CD
μM  ||| S:19861 E:19864 ||| JJ
CaCl  ||| S:19864 E:19880 ||| JJ
2  ||| S:19880 E:19882 ||| CD
( ||| S:19882 E:19883 ||| -LRB-
2.80  ||| S:19883 E:19888 ||| NNP
±  ||| S:19888 E:19890 ||| NNP
0.42  ||| S:19890 E:19895 ||| NNP
S ||| S:19895 E:19896 ||| NNP
;  ||| S:19896 E:19898 ||| :
n  ||| S:19898 E:19900 ||| CD
=  ||| S:19900 E:19902 ||| SYM
2 ||| S:19902 E:19903 ||| LS
)  ||| S:19903 E:19905 ||| -RRB-
was  ||| S:19905 E:19909 ||| VBD
similar  ||| S:19909 E:19927 ||| JJ
to  ||| S:19927 E:19930 ||| TO
that  ||| S:19930 E:19935 ||| DT
measured  ||| S:19935 E:19944 ||| VBN
without  ||| S:19944 E:19952 ||| IN
preloading  ||| S:19952 E:19963 ||| NNS
( ||| S:19963 E:19964 ||| -LRB-
3.13  ||| S:19964 E:19969 ||| NNP
S ||| S:19969 E:19970 ||| NNP
;  ||| S:19970 E:19972 ||| :
Table  ||| S:19972 E:19988 ||| NNP
4 ||| S:19988 E:19989 ||| CD
) ||| S:19989 E:19990 ||| -RRB-
.  ||| S:19990 E:20002 ||| .
By  ||| S:20002 E:20005 ||| IN
contrast ||| S:20005 E:20013 ||| NN
,  ||| S:20013 E:20015 ||| ,
we  ||| S:20015 E:20018 ||| PRP
could  ||| S:20018 E:20024 ||| MD
prevent  ||| S:20024 E:20032 ||| VB
the  ||| S:20032 E:20046 ||| DT
temperature-dependent  ||| S:20046 E:20068 ||| JJ
loss  ||| S:20068 E:20073 ||| NN
of  ||| S:20073 E:20076 ||| IN
calmodulin  ||| S:20076 E:20087 ||| NN
by  ||| S:20087 E:20090 ||| IN
carrying  ||| S:20090 E:20099 ||| VBG
out  ||| S:20099 E:20113 ||| RP
sedimentation  ||| S:20113 E:20127 ||| NNS
in  ||| S:20127 E:20130 ||| IN
the  ||| S:20130 E:20134 ||| DT
continuous  ||| S:20134 E:20145 ||| JJ
presence  ||| S:20145 E:20154 ||| NN
of  ||| S:20154 E:20157 ||| IN
5  ||| S:20157 E:20159 ||| CD
μM  ||| S:20159 E:20172 ||| JJ
calmodulin  ||| S:20172 E:20183 ||| NNS
( ||| S:20183 E:20184 ||| -LRB-
Fig.  ||| S:20184 E:20189 ||| NNP
6C ||| S:20189 E:20191 ||| NNP
, ||| S:20191 E:20192 ||| ,
6D ||| S:20192 E:20194 ||| NNP
;  ||| S:20194 E:20196 ||| :
Table  ||| S:20196 E:20202 ||| NNP
5 ||| S:20202 E:20203 ||| CD
) ||| S:20203 E:20204 ||| -RRB-
.  ||| S:20204 E:20206 ||| .
Although  ||| S:20206 E:20215 ||| IN
gel-filtration  ||| S:20215 E:20240 ||| JJ
analysis  ||| S:20240 E:20249 ||| NN
was  ||| S:20249 E:20253 ||| VBD
impractical  ||| S:20253 E:20265 ||| VBN
with  ||| S:20265 E:20270 ||| IN
this  ||| S:20270 E:20275 ||| DT
high  ||| S:20275 E:20280 ||| JJ
calmodulin  ||| S:20280 E:20301 ||| JJ
concentration ||| S:20301 E:20314 ||| NN
,  ||| S:20314 E:20316 ||| ,
we  ||| S:20316 E:20319 ||| PRP
assumed  ||| S:20319 E:20327 ||| VBD
that  ||| S:20327 E:20332 ||| IN
the  ||| S:20332 E:20336 ||| DT
Stokes  ||| S:20336 E:20343 ||| JJ
radius  ||| S:20343 E:20350 ||| NN
of  ||| S:20350 E:20363 ||| IN
T701-Myo1c  ||| S:20363 E:20374 ||| CD
in  ||| S:20374 E:20377 ||| IN
the  ||| S:20377 E:20381 ||| DT
presence  ||| S:20381 E:20390 ||| NN
of  ||| S:20390 E:20393 ||| IN
calmodulin  ||| S:20393 E:20404 ||| NN
was  ||| S:20404 E:20408 ||| VBD
identical  ||| S:20408 E:20418 ||| JJ
to  ||| S:20418 E:20431 ||| TO
the  ||| S:20431 E:20435 ||| DT
value  ||| S:20435 E:20441 ||| NN
obtained  ||| S:20441 E:20450 ||| VBN
in  ||| S:20450 E:20453 ||| IN
the  ||| S:20453 E:20457 ||| DT
absence ||| S:20457 E:20464 ||| NN
.  ||| S:20464 E:20466 ||| .
Sedimentation  ||| S:20466 E:20480 ||| NNP
at  ||| S:20480 E:20483 ||| IN
25°C  ||| S:20483 E:20498 ||| CD
in  ||| S:20498 E:20501 ||| IN
EGTA  ||| S:20501 E:20506 ||| NNP
gradients  ||| S:20506 E:20516 ||| VBD
supplemented  ||| S:20516 E:20529 ||| VBN
with  ||| S:20529 E:20534 ||| IN
5  ||| S:20534 E:20536 ||| CD
μM  ||| S:20536 E:20539 ||| JJ
calmodulin  ||| S:20539 E:20560 ||| NN
resulted  ||| S:20560 E:20569 ||| VBD
in  ||| S:20569 E:20572 ||| IN
the  ||| S:20572 E:20576 ||| DT
retention  ||| S:20576 E:20586 ||| NN
of  ||| S:20586 E:20589 ||| IN
~3  ||| S:20589 E:20592 ||| FW
calmodulins  ||| S:20592 E:20604 ||| FW
per  ||| S:20604 E:20618 ||| FW
T701-Myo1c ||| S:20618 E:20628 ||| FW
.  ||| S:20628 E:20630 ||| .
In  ||| S:20630 E:20633 ||| IN
25  ||| S:20633 E:20636 ||| CD
μM  ||| S:20636 E:20639 ||| JJ
CaCl  ||| S:20639 E:20655 ||| JJ
2  ||| S:20655 E:20657 ||| CD
,  ||| S:20657 E:20659 ||| ,
supplementation  ||| S:20659 E:20675 ||| VBG
with  ||| S:20675 E:20680 ||| IN
5  ||| S:20680 E:20682 ||| CD
μM  ||| S:20682 E:20695 ||| JJ
calmodulin  ||| S:20695 E:20706 ||| NN
resulted  ||| S:20706 E:20715 ||| VBD
in  ||| S:20715 E:20718 ||| IN
~1  ||| S:20718 E:20721 ||| FW
calmodulin  ||| S:20721 E:20732 ||| FW
bound  ||| S:20732 E:20738 ||| FW
per  ||| S:20738 E:20752 ||| FW
T701-Myo1c ||| S:20752 E:20762 ||| FW
.  ||| S:20762 E:20764 ||| .
In  ||| S:20764 E:20767 ||| IN
addition ||| S:20767 E:20775 ||| NN
,  ||| S:20775 E:20777 ||| ,
protein  ||| S:20777 E:20785 ||| NN
loss  ||| S:20785 E:20790 ||| NN
due  ||| S:20790 E:20794 ||| JJ
to  ||| S:20794 E:20797 ||| TO
aggregation  ||| S:20797 E:20819 ||| NNS
was  ||| S:20819 E:20823 ||| VBD
minimal  ||| S:20823 E:20831 ||| JJ
under  ||| S:20831 E:20837 ||| IN
these  ||| S:20837 E:20843 ||| DT
conditions ||| S:20843 E:20853 ||| NNS
.  ||| S:20853 E:20883 ||| .
Myo1c-calmodulin  ||| S:20883 E:20900 ||| NNP
stoichiometry  ||| S:20900 E:20914 ||| NN
by  ||| S:20914 E:20917 ||| IN
gel  ||| S:20917 E:20931 ||| JJ
scanning  ||| S:20931 E:20950 ||| NN
To  ||| S:20950 E:20953 ||| TO
measure  ||| S:20953 E:20961 ||| VB
Myo1c-calmodulin  ||| S:20961 E:20978 ||| CD
stoichiometry  ||| S:20978 E:20992 ||| NN
by  ||| S:20992 E:20995 ||| IN
an  ||| S:20995 E:21008 ||| DT
independent  ||| S:21008 E:21020 ||| JJ
method ||| S:21020 E:21026 ||| NN
,  ||| S:21026 E:21028 ||| ,
we  ||| S:21028 E:21031 ||| PRP
separated  ||| S:21031 E:21041 ||| VBP
calmodulin  ||| S:21041 E:21052 ||| JJ
standards  ||| S:21052 E:21062 ||| NNS
and  ||| S:21062 E:21076 ||| CC
T701-Myo1c  ||| S:21076 E:21087 ||| CD
by  ||| S:21087 E:21090 ||| IN
SDS-PAGE  ||| S:21090 E:21099 ||| NNP
( ||| S:21099 E:21100 ||| -LRB-
Fig.  ||| S:21100 E:21105 ||| NNP
7A ||| S:21105 E:21107 ||| NNP
) ||| S:21107 E:21108 ||| -RRB-
.  ||| S:21108 E:21110 ||| .
Using  ||| S:21110 E:21116 ||| VBG
densitometry ||| S:21116 E:21128 ||| NN
,  ||| S:21128 E:21130 ||| ,
we  ||| S:21130 E:21143 ||| PRP
quantified  ||| S:21143 E:21154 ||| VBD
the  ||| S:21154 E:21158 ||| DT
staining  ||| S:21158 E:21167 ||| JJ
intensity  ||| S:21167 E:21177 ||| NN
of  ||| S:21177 E:21180 ||| IN
the  ||| S:21180 E:21184 ||| DT
calmodulin  ||| S:21184 E:21205 ||| JJ
standards  ||| S:21205 E:21215 ||| NNS
to  ||| S:21215 E:21218 ||| TO
generate  ||| S:21218 E:21227 ||| VB
a  ||| S:21227 E:21229 ||| DT
standard  ||| S:21229 E:21238 ||| JJ
curve  ||| S:21238 E:21244 ||| NN
( ||| S:21244 E:21245 ||| -LRB-
Fig.  ||| S:21245 E:21250 ||| NNP
7B ||| S:21250 E:21252 ||| NNP
)  ||| S:21252 E:21254 ||| -RRB-
and  ||| S:21254 E:21268 ||| CC
determined  ||| S:21268 E:21279 ||| VBN
the  ||| S:21279 E:21283 ||| DT
amount  ||| S:21283 E:21290 ||| NN
of  ||| S:21290 E:21293 ||| IN
calmodulin  ||| S:21293 E:21304 ||| JJ
present  ||| S:21304 E:21312 ||| NN
in  ||| S:21312 E:21315 ||| IN
each  ||| S:21315 E:21330 ||| DT
T701-Myo1c  ||| S:21330 E:21341 ||| JJ
sample ||| S:21341 E:21347 ||| NN
.  ||| S:21347 E:21349 ||| .
Applying  ||| S:21349 E:21358 ||| VBG
the  ||| S:21358 E:21362 ||| DT
analysis  ||| S:21362 E:21371 ||| NN
described  ||| S:21371 E:21381 ||| VBD
in  ||| S:21381 E:21394 ||| IN
Experimental  ||| S:21394 E:21407 ||| NNP
Procedures  ||| S:21407 E:21418 ||| NNP
and  ||| S:21418 E:21422 ||| CC
equation  ||| S:21422 E:21431 ||| NN
( ||| S:21431 E:21432 ||| -LRB-
13 ||| S:21432 E:21434 ||| CD
) ||| S:21434 E:21435 ||| -RRB-
,  ||| S:21435 E:21437 ||| ,
we  ||| S:21437 E:21440 ||| PRP
found  ||| S:21440 E:21446 ||| VBD
an  ||| S:21446 E:21459 ||| DT
average  ||| S:21459 E:21467 ||| NN
of  ||| S:21467 E:21470 ||| IN
2.6  ||| S:21470 E:21474 ||| CD
±  ||| S:21474 E:21476 ||| CD
0.2  ||| S:21476 E:21480 ||| CD
calmodulins  ||| S:21480 E:21492 ||| NN
per  ||| S:21492 E:21496 ||| IN
T701-Myo1c  ||| S:21496 E:21507 ||| NNP
( ||| S:21507 E:21508 ||| -LRB-
mean  ||| S:21508 E:21513 ||| VB
±  ||| S:21513 E:21525 ||| CD
standard  ||| S:21525 E:21534 ||| JJ
error ||| S:21534 E:21539 ||| NN
)  ||| S:21539 E:21541 ||| -RRB-
in  ||| S:21541 E:21544 ||| IN
six  ||| S:21544 E:21548 ||| CD
experiments ||| S:21548 E:21559 ||| NNS
,  ||| S:21559 E:21561 ||| ,
three  ||| S:21561 E:21567 ||| CD
separate  ||| S:21567 E:21586 ||| JJ
preparations  ||| S:21586 E:21599 ||| NNS
analyzed  ||| S:21599 E:21608 ||| VBD
in  ||| S:21608 E:21611 ||| IN
duplicate ||| S:21611 E:21620 ||| NN
.  ||| S:21620 E:21622 ||| .
This  ||| S:21622 E:21627 ||| DT
value  ||| S:21627 E:21633 ||| NN
was  ||| S:21633 E:21637 ||| VBD
very  ||| S:21637 E:21652 ||| RB
close  ||| S:21652 E:21658 ||| VB
to  ||| S:21658 E:21661 ||| TO
the  ||| S:21661 E:21665 ||| DT
value  ||| S:21665 E:21671 ||| NN
of  ||| S:21671 E:21674 ||| IN
2.5  ||| S:21674 E:21678 ||| CD
±  ||| S:21678 E:21680 ||| CD
0.1  ||| S:21680 E:21684 ||| CD
bound  ||| S:21684 E:21690 ||| NNS
calmodulins  ||| S:21690 E:21712 ||| VBP
determined  ||| S:21712 E:21723 ||| VBN
independently  ||| S:21723 E:21737 ||| RB
by  ||| S:21737 E:21740 ||| IN
hydrodynamic  ||| S:21740 E:21753 ||| JJ
analysis  ||| S:21753 E:21762 ||| NN
( ||| S:21762 E:21763 ||| -LRB-
Table  ||| S:21763 E:21779 ||| NNP
4 ||| S:21779 E:21780 ||| CD
) ||| S:21780 E:21781 ||| -RRB-
.  ||| S:21781 E:21814 ||| .
Discussion  ||| S:21814 E:21844 ||| NNP
Calmodulin  ||| S:21844 E:21855 ||| NNP
interaction  ||| S:21855 E:21867 ||| NN
with  ||| S:21867 E:21872 ||| IN
individual  ||| S:21872 E:21883 ||| JJ
Myo1c  ||| S:21883 E:21889 ||| NNP
IQ  ||| S:21889 E:21902 ||| NNP
domains  ||| S:21902 E:21920 ||| VBD
To  ||| S:21920 E:21923 ||| TO
examine  ||| S:21923 E:21931 ||| VB
how  ||| S:21931 E:21935 ||| WRB
calmodulin  ||| S:21935 E:21946 ||| JJ
binds  ||| S:21946 E:21952 ||| NN
to  ||| S:21952 E:21955 ||| TO
the  ||| S:21955 E:21959 ||| DT
Myo1c  ||| S:21959 E:21965 ||| NNP
IQ  ||| S:21965 E:21968 ||| NNP
sites ||| S:21968 E:21973 ||| NNS
,  ||| S:21973 E:21985 ||| ,
we  ||| S:21985 E:21988 ||| PRP
developed  ||| S:21988 E:21998 ||| VBD
two  ||| S:21998 E:22002 ||| CD
binding  ||| S:22002 E:22010 ||| NNS
assays  ||| S:22010 E:22017 ||| VBP
using  ||| S:22017 E:22023 ||| VBG
a  ||| S:22023 E:22025 ||| DT
commercially  ||| S:22025 E:22048 ||| JJ
available  ||| S:22048 E:22058 ||| JJ
fluorescent  ||| S:22058 E:22070 ||| JJ
calmodulin  ||| S:22070 E:22081 ||| NN
and  ||| S:22081 E:22085 ||| CC
individual  ||| S:22085 E:22096 ||| JJ
IQ  ||| S:22096 E:22109 ||| NNP
peptides ||| S:22109 E:22117 ||| NN
.  ||| S:22117 E:22119 ||| .
In  ||| S:22119 E:22122 ||| IN
one  ||| S:22122 E:22126 ||| CD
assay ||| S:22126 E:22131 ||| NN
,  ||| S:22131 E:22133 ||| ,
we  ||| S:22133 E:22136 ||| PRP
covalently  ||| S:22136 E:22147 ||| VBP
attached  ||| S:22147 E:22156 ||| VBN
peptides  ||| S:22156 E:22175 ||| VBN
to  ||| S:22175 E:22178 ||| TO
plastic  ||| S:22178 E:22186 ||| JJ
plates ||| S:22186 E:22192 ||| NN
,  ||| S:22192 E:22194 ||| ,
then  ||| S:22194 E:22199 ||| RB
measured  ||| S:22199 E:22208 ||| VBN
the  ||| S:22208 E:22212 ||| DT
amount  ||| S:22212 E:22219 ||| NN
of  ||| S:22219 E:22232 ||| IN
fluorescent  ||| S:22232 E:22244 ||| JJ
calmodulin  ||| S:22244 E:22255 ||| NN
that  ||| S:22255 E:22260 ||| WDT
remained  ||| S:22260 E:22269 ||| VBD
unbound  ||| S:22269 E:22277 ||| VBN
after  ||| S:22277 E:22293 ||| IN
incubation  ||| S:22293 E:22304 ||| NN
with  ||| S:22304 E:22309 ||| IN
the  ||| S:22309 E:22313 ||| DT
peptide-derivatized  ||| S:22313 E:22333 ||| JJ
plate ||| S:22333 E:22338 ||| NN
.  ||| S:22338 E:22340 ||| .
This  ||| S:22340 E:22345 ||| DT
assay  ||| S:22345 E:22361 ||| NN
was  ||| S:22361 E:22365 ||| VBD
simple  ||| S:22365 E:22372 ||| JJ
and  ||| S:22372 E:22376 ||| CC
fast ||| S:22376 E:22380 ||| RB
,  ||| S:22380 E:22382 ||| ,
and  ||| S:22382 E:22386 ||| CC
allowed  ||| S:22386 E:22394 ||| VBD
us  ||| S:22394 E:22397 ||| PRP
to  ||| S:22397 E:22400 ||| TO
measure  ||| S:22400 E:22408 ||| VB
binding  ||| S:22408 E:22426 ||| VBN
under  ||| S:22426 E:22432 ||| IN
a  ||| S:22432 E:22434 ||| DT
wide  ||| S:22434 E:22439 ||| JJ
variety  ||| S:22439 E:22447 ||| NN
of  ||| S:22447 E:22450 ||| IN
conditions ||| S:22450 E:22460 ||| NNS
.  ||| S:22460 E:22462 ||| .
In  ||| S:22462 E:22465 ||| IN
our  ||| S:22465 E:22469 ||| PRP$
second  ||| S:22469 E:22476 ||| JJ
assay ||| S:22476 E:22481 ||| NN
,  ||| S:22481 E:22493 ||| ,
we  ||| S:22493 E:22496 ||| PRP
exploited  ||| S:22496 E:22506 ||| VBD
the  ||| S:22506 E:22510 ||| DT
empirical  ||| S:22510 E:22520 ||| JJ
observation  ||| S:22520 E:22532 ||| NN
that  ||| S:22532 E:22537 ||| IN
the  ||| S:22537 E:22551 ||| DT
Alexa-calmodulin  ||| S:22551 E:22568 ||| JJ
fluorescence  ||| S:22568 E:22581 ||| JJ
intensity  ||| S:22581 E:22591 ||| NN
is  ||| S:22591 E:22594 ||| VBZ
quenched  ||| S:22594 E:22603 ||| VBN
by  ||| S:22603 E:22616 ||| IN
binding  ||| S:22616 E:22624 ||| VBG
of  ||| S:22624 E:22627 ||| IN
IQ  ||| S:22627 E:22630 ||| NNP
peptides ||| S:22630 E:22638 ||| NN
.  ||| S:22638 E:22640 ||| .
As  ||| S:22640 E:22643 ||| RB
in  ||| S:22643 E:22646 ||| IN
other  ||| S:22646 E:22652 ||| JJ
assays  ||| S:22652 E:22659 ||| NN
with  ||| S:22659 E:22674 ||| IN
fluorescently  ||| S:22674 E:22688 ||| FW
labeled  ||| S:22688 E:22696 ||| FW
calmodulins  ||| S:22696 E:22708 ||| FW
( ||| S:22708 E:22709 ||| -LRB-
e.g. ||| S:22709 E:22713 ||| NNP
,  ||| S:22713 E:22715 ||| ,
ref.  ||| S:22715 E:22720 ||| NNP
[  ||| S:22720 E:22722 ||| -LRB-
31  ||| S:22722 E:22725 ||| CD
]  ||| S:22725 E:22727 ||| CD
) ||| S:22727 E:22728 ||| -RRB-
,  ||| S:22728 E:22740 ||| ,
binding  ||| S:22740 E:22748 ||| VBG
of  ||| S:22748 E:22751 ||| IN
the  ||| S:22751 E:22755 ||| DT
peptides  ||| S:22755 E:22764 ||| NN
to  ||| S:22764 E:22767 ||| TO
Alexa-calmodulin  ||| S:22767 E:22784 ||| NNP
did  ||| S:22784 E:22788 ||| VBD
not  ||| S:22788 E:22802 ||| RB
perfectly  ||| S:22802 E:22812 ||| RB
mimic  ||| S:22812 E:22818 ||| VBP
binding  ||| S:22818 E:22826 ||| VBG
to  ||| S:22826 E:22829 ||| TO
unlabeled  ||| S:22829 E:22839 ||| VB
calmodulin ||| S:22839 E:22849 ||| NNS
.  ||| S:22849 E:22851 ||| .
For  ||| S:22851 E:22865 ||| IN
example ||| S:22865 E:22872 ||| NN
,  ||| S:22872 E:22874 ||| ,
Alexa-calmodulin  ||| S:22874 E:22891 ||| JJ
bound  ||| S:22891 E:22897 ||| JJ
IQ  ||| S:22897 E:22900 ||| NNP
peptides  ||| S:22900 E:22909 ||| VBD
more  ||| S:22909 E:22914 ||| RBR
strongly  ||| S:22914 E:22933 ||| RB
in  ||| S:22933 E:22936 ||| IN
the  ||| S:22936 E:22940 ||| DT
presence  ||| S:22940 E:22949 ||| NN
of  ||| S:22949 E:22952 ||| IN
Ca  ||| S:22952 E:22955 ||| NNP
2+than  ||| S:22955 E:22962 ||| NNP
did  ||| S:22962 E:22966 ||| VBD
unlabeled  ||| S:22966 E:22976 ||| JJ
calmodulin ||| S:22976 E:22986 ||| NN
.  ||| S:22986 E:22998 ||| .
Moreover ||| S:22998 E:23006 ||| RB
,  ||| S:23006 E:23008 ||| ,
excess  ||| S:23008 E:23015 ||| JJ
unlabeled  ||| S:23015 E:23025 ||| JJ
calmodulin  ||| S:23025 E:23036 ||| NN
could  ||| S:23036 E:23042 ||| MD
not  ||| S:23042 E:23046 ||| RB
fully  ||| S:23046 E:23062 ||| RB
reverse  ||| S:23062 E:23070 ||| VB
the  ||| S:23070 E:23074 ||| DT
quenching  ||| S:23074 E:23084 ||| NN
of  ||| S:23084 E:23087 ||| IN
Alexa-calmodulin  ||| S:23087 E:23104 ||| JJ
fluorescence  ||| S:23104 E:23127 ||| JJ
induced  ||| S:23127 E:23135 ||| NN
by  ||| S:23135 E:23138 ||| IN
IQ  ||| S:23138 E:23141 ||| NNP
peptides ||| S:23141 E:23149 ||| NN
,  ||| S:23149 E:23151 ||| ,
suggesting  ||| S:23151 E:23162 ||| VBG
that  ||| S:23162 E:23167 ||| IN
IQ  ||| S:23167 E:23170 ||| NNP
peptides  ||| S:23170 E:23179 ||| NN
could  ||| S:23179 E:23195 ||| MD
bind  ||| S:23195 E:23200 ||| VB
to  ||| S:23200 E:23203 ||| TO
Alexa-calmodulin  ||| S:23203 E:23220 ||| JJ
at  ||| S:23220 E:23223 ||| IN
two  ||| S:23223 E:23227 ||| CD
sites ||| S:23227 E:23232 ||| NNS
,  ||| S:23232 E:23234 ||| ,
including  ||| S:23234 E:23244 ||| VBG
one  ||| S:23244 E:23258 ||| CD
where  ||| S:23258 E:23264 ||| WRB
unlabeled  ||| S:23264 E:23274 ||| JJ
calmodulin  ||| S:23274 E:23285 ||| NN
could  ||| S:23285 E:23291 ||| MD
not  ||| S:23291 E:23295 ||| RB
bind ||| S:23295 E:23299 ||| NN
.  ||| S:23299 E:23301 ||| .
Indeed ||| S:23301 E:23307 ||| RB
,  ||| S:23307 E:23319 ||| ,
binding  ||| S:23319 E:23327 ||| VBG
of  ||| S:23327 E:23330 ||| IN
IQ  ||| S:23330 E:23333 ||| NNP
peptides  ||| S:23333 E:23342 ||| VBD
to  ||| S:23342 E:23345 ||| TO
both  ||| S:23345 E:23350 ||| DT
sites  ||| S:23350 E:23356 ||| NNS
on  ||| S:23356 E:23359 ||| IN
a  ||| S:23359 E:23361 ||| DT
single  ||| S:23361 E:23378 ||| JJ
fluorescent  ||| S:23378 E:23390 ||| JJ
calmodulin  ||| S:23390 E:23401 ||| NN
could  ||| S:23401 E:23407 ||| MD
account  ||| S:23407 E:23415 ||| VB
for  ||| S:23415 E:23419 ||| IN
Hill  ||| S:23419 E:23434 ||| NNP
coefficients  ||| S:23434 E:23447 ||| NN
of  ||| S:23447 E:23450 ||| IN
> ||| S:23450 E:23451 ||| CD
1  ||| S:23451 E:23453 ||| CD
seen  ||| S:23453 E:23458 ||| VBN
in  ||| S:23458 E:23461 ||| IN
some  ||| S:23461 E:23466 ||| DT
experiments  ||| S:23466 E:23478 ||| NNS
( ||| S:23478 E:23479 ||| -LRB-
e.g. ||| S:23479 E:23483 ||| NNP
,  ||| S:23483 E:23495 ||| ,
Figs.  ||| S:23495 E:23501 ||| CD
3Band  ||| S:23501 E:23507 ||| CD
4 ||| S:23507 E:23508 ||| CD
) ||| S:23508 E:23509 ||| -RRB-
.  ||| S:23509 E:23511 ||| .
Nevertheless ||| S:23511 E:23523 ||| RB
,  ||| S:23523 E:23525 ||| ,
these  ||| S:23525 E:23531 ||| DT
discrepancies  ||| S:23531 E:23545 ||| NNS
should  ||| S:23545 E:23562 ||| MD
not  ||| S:23562 E:23566 ||| RB
prevent  ||| S:23566 E:23574 ||| VB
use  ||| S:23574 E:23578 ||| NN
of  ||| S:23578 E:23581 ||| IN
Alexa-calmodulin  ||| S:23581 E:23598 ||| JJ
for  ||| S:23598 E:23602 ||| IN
measuring  ||| S:23602 E:23622 ||| VBG
interaction  ||| S:23622 E:23634 ||| NN
with  ||| S:23634 E:23639 ||| IN
calmodulin ||| S:23639 E:23649 ||| NN
's  ||| S:23649 E:23652 ||| POS
targets ||| S:23652 E:23659 ||| NNS
,  ||| S:23659 E:23661 ||| ,
particularly  ||| S:23661 E:23674 ||| RB
if  ||| S:23674 E:23687 ||| IN
the  ||| S:23687 E:23691 ||| DT
interaction  ||| S:23691 E:23703 ||| NN
with  ||| S:23703 E:23708 ||| IN
unlabeled  ||| S:23708 E:23718 ||| JJ
calmodulin  ||| S:23718 E:23729 ||| NN
is  ||| S:23729 E:23732 ||| VBZ
compared  ||| S:23732 E:23741 ||| VBN
to  ||| S:23741 E:23754 ||| TO
the  ||| S:23754 E:23758 ||| DT
interaction  ||| S:23758 E:23770 ||| NN
with  ||| S:23770 E:23775 ||| IN
Alexa-calmodulin ||| S:23775 E:23791 ||| JJ
.  ||| S:23791 E:23803 ||| .
Calmodulin  ||| S:23803 E:23814 ||| RB
bound  ||| S:23814 E:23820 ||| VBN
to  ||| S:23820 E:23823 ||| TO
peptides  ||| S:23823 E:23832 ||| VB
corresponding  ||| S:23832 E:23846 ||| JJ
to  ||| S:23846 E:23849 ||| TO
each  ||| S:23849 E:23854 ||| DT
of  ||| S:23854 E:23867 ||| IN
the  ||| S:23867 E:23871 ||| DT
four  ||| S:23871 E:23876 ||| CD
Myo1c  ||| S:23876 E:23882 ||| CD
IQ  ||| S:23882 E:23885 ||| NNP
domains ||| S:23885 E:23892 ||| NN
,  ||| S:23892 E:23894 ||| ,
although  ||| S:23894 E:23903 ||| IN
with  ||| S:23903 E:23908 ||| IN
differing  ||| S:23908 E:23928 ||| VBG
affinity  ||| S:23928 E:23937 ||| NNS
and  ||| S:23937 E:23941 ||| CC
Ca  ||| S:23941 E:23944 ||| NNP
2+sensitivity ||| S:23944 E:23957 ||| NNP
.  ||| S:23957 E:23959 ||| .
Affinities  ||| S:23959 E:23970 ||| NNS
for  ||| S:23970 E:23974 ||| IN
calmodulin  ||| S:23974 E:23995 ||| JJ
binding  ||| S:23995 E:24003 ||| NN
to  ||| S:24003 E:24006 ||| TO
IQ1  ||| S:24006 E:24010 ||| CD
and  ||| S:24010 E:24014 ||| CC
IQ2  ||| S:24014 E:24018 ||| NNP
were  ||| S:24018 E:24023 ||| VBD
relatively  ||| S:24023 E:24034 ||| RB
modest  ||| S:24034 E:24041 ||| JJ
( ||| S:24041 E:24042 ||| -LRB-
K  ||| S:24042 E:24055 ||| NNP
d  ||| S:24055 E:24057 ||| NN
values  ||| S:24057 E:24064 ||| NNS
of  ||| S:24064 E:24067 ||| IN
~5  ||| S:24067 E:24070 ||| NNP
μM ||| S:24070 E:24072 ||| NNP
) ||| S:24072 E:24073 ||| -RRB-
.  ||| S:24073 E:24075 ||| .
As  ||| S:24075 E:24078 ||| RB
with  ||| S:24078 E:24083 ||| IN
other  ||| S:24083 E:24089 ||| JJ
IQ  ||| S:24089 E:24102 ||| NNP
domains  ||| S:24102 E:24110 ||| NNS
[  ||| S:24110 E:24112 ||| -LRB-
14  ||| S:24112 E:24115 ||| CD
]  ||| S:24115 E:24117 ||| -RRB-
,  ||| S:24117 E:24119 ||| ,
Ca  ||| S:24119 E:24122 ||| NNP
2+weakened  ||| S:24122 E:24133 ||| CD
the  ||| S:24133 E:24137 ||| DT
affinity  ||| S:24137 E:24146 ||| NN
of  ||| S:24146 E:24149 ||| IN
calmodulin  ||| S:24149 E:24170 ||| NN
for  ||| S:24170 E:24174 ||| IN
IQ1  ||| S:24174 E:24178 ||| NNP
and  ||| S:24178 E:24182 ||| CC
IQ2  ||| S:24182 E:24186 ||| CD
by  ||| S:24186 E:24189 ||| IN
more  ||| S:24189 E:24194 ||| JJR
than  ||| S:24194 E:24199 ||| IN
10-fold ||| S:24199 E:24206 ||| JJ
.  ||| S:24206 E:24218 ||| .
By  ||| S:24218 E:24221 ||| IN
contrast ||| S:24221 E:24229 ||| NN
,  ||| S:24229 E:24231 ||| ,
calmodulin  ||| S:24231 E:24242 ||| JJ
binding  ||| S:24242 E:24250 ||| NN
to  ||| S:24250 E:24253 ||| TO
IQ3  ||| S:24253 E:24257 ||| NNP
was  ||| S:24257 E:24261 ||| VBD
slightly  ||| S:24261 E:24280 ||| RB
stronger  ||| S:24280 E:24289 ||| JJR
and  ||| S:24289 E:24293 ||| CC
was  ||| S:24293 E:24297 ||| VBD
affected  ||| S:24297 E:24306 ||| VBN
much  ||| S:24306 E:24311 ||| RB
less  ||| S:24311 E:24316 ||| JJR
by  ||| S:24316 E:24319 ||| IN
Ca  ||| S:24319 E:24322 ||| NNP
2+ ||| S:24322 E:24324 ||| NNP
.  ||| S:24324 E:24326 ||| .
Because  ||| S:24326 E:24344 ||| IN
calmodulin  ||| S:24344 E:24355 ||| JJ
binds  ||| S:24355 E:24361 ||| NNS
strongly  ||| S:24361 E:24370 ||| RB
to  ||| S:24370 E:24373 ||| TO
classic  ||| S:24373 E:24381 ||| JJ
IQ  ||| S:24381 E:24384 ||| NNP
domains  ||| S:24384 E:24392 ||| VBD
only  ||| S:24392 E:24397 ||| RB
in  ||| S:24397 E:24410 ||| IN
the  ||| S:24410 E:24414 ||| DT
absence  ||| S:24414 E:24422 ||| NN
of  ||| S:24422 E:24425 ||| IN
Ca  ||| S:24425 E:24428 ||| NNP
2+  ||| S:24428 E:24431 ||| NNP
[  ||| S:24431 E:24433 ||| -LRB-
14  ||| S:24433 E:24436 ||| CD
32  ||| S:24436 E:24439 ||| CD
]  ||| S:24439 E:24441 ||| -RRB-
,  ||| S:24441 E:24443 ||| ,
its  ||| S:24443 E:24447 ||| PRP$
strong  ||| S:24447 E:24454 ||| JJ
binding  ||| S:24454 E:24462 ||| NN
to  ||| S:24462 E:24475 ||| TO
IQ3  ||| S:24475 E:24479 ||| CD
in  ||| S:24479 E:24482 ||| IN
the  ||| S:24482 E:24486 ||| DT
presence  ||| S:24486 E:24495 ||| NN
of  ||| S:24495 E:24498 ||| IN
Ca  ||| S:24498 E:24501 ||| NNP
2+suggests  ||| S:24501 E:24512 ||| CD
the  ||| S:24512 E:24516 ||| DT
participation  ||| S:24516 E:24530 ||| NN
of  ||| S:24530 E:24543 ||| IN
an  ||| S:24543 E:24546 ||| DT
additional  ||| S:24546 E:24557 ||| JJ
Ca  ||| S:24557 E:24560 ||| NNP
2+-requiring  ||| S:24560 E:24573 ||| NNP
binding  ||| S:24573 E:24581 ||| JJ
motif ||| S:24581 E:24586 ||| NN
.  ||| S:24586 E:24588 ||| .
Two  ||| S:24588 E:24592 ||| CD
common  ||| S:24592 E:24609 ||| JJ
calmodulin-binding  ||| S:24609 E:24628 ||| JJ
motifs ||| S:24628 E:24634 ||| NNS
,  ||| S:24634 E:24636 ||| ,
called  ||| S:24636 E:24643 ||| VBD
1-8-14  ||| S:24643 E:24650 ||| CD
and  ||| S:24650 E:24654 ||| CC
1-5-10  ||| S:24654 E:24661 ||| CD
for  ||| S:24661 E:24675 ||| IN
the  ||| S:24675 E:24679 ||| DT
pattern  ||| S:24679 E:24687 ||| NN
of  ||| S:24687 E:24690 ||| IN
hydrophobic  ||| S:24690 E:24702 ||| JJ
amino-acid  ||| S:24702 E:24713 ||| JJ
residues ||| S:24713 E:24721 ||| NNS
,  ||| S:24721 E:24723 ||| ,
require  ||| S:24723 E:24741 ||| FW
Ca  ||| S:24741 E:24744 ||| FW
2+for  ||| S:24744 E:24750 ||| FW
calmodulin  ||| S:24750 E:24761 ||| FW
binding  ||| S:24761 E:24769 ||| FW
[  ||| S:24769 E:24771 ||| -LRB-
14  ||| S:24771 E:24774 ||| CD
]  ||| S:24774 E:24776 ||| -RRB-
.  ||| S:24776 E:24778 ||| .
IQ3  ||| S:24778 E:24782 ||| NNP
has  ||| S:24782 E:24786 ||| VBZ
two  ||| S:24786 E:24790 ||| CD
nearly  ||| S:24790 E:24807 ||| RB
perfect  ||| S:24807 E:24815 ||| JJ
1-5-10  ||| S:24815 E:24822 ||| CD
domains  ||| S:24822 E:24830 ||| NNS
that  ||| S:24830 E:24835 ||| WDT
are  ||| S:24835 E:24839 ||| VBP
at  ||| S:24839 E:24842 ||| IN
+2  ||| S:24842 E:24845 ||| CD
net  ||| S:24845 E:24849 ||| JJ
charge  ||| S:24849 E:24856 ||| NN
instead  ||| S:24856 E:24874 ||| RB
of  ||| S:24874 E:24877 ||| IN
the  ||| S:24877 E:24881 ||| DT
minimum  ||| S:24881 E:24889 ||| JJ
+3  ||| S:24889 E:24892 ||| NN
in  ||| S:24892 E:24895 ||| IN
the  ||| S:24895 E:24899 ||| DT
consensus  ||| S:24899 E:24909 ||| NN
[  ||| S:24909 E:24911 ||| -LRB-
14  ||| S:24911 E:24914 ||| CD
]  ||| S:24914 E:24916 ||| -RRB-
.  ||| S:24916 E:24918 ||| .
In  ||| S:24918 E:24921 ||| IN
addition ||| S:24921 E:24929 ||| NN
,  ||| S:24929 E:24941 ||| ,
IQ3  ||| S:24941 E:24945 ||| NNP
has  ||| S:24945 E:24949 ||| VBZ
a  ||| S:24949 E:24951 ||| DT
1-8-14  ||| S:24951 E:24958 ||| JJ
motif  ||| S:24958 E:24964 ||| NN
with  ||| S:24964 E:24969 ||| IN
a  ||| S:24969 E:24971 ||| DT
proline  ||| S:24971 E:24979 ||| JJ
residue  ||| S:24979 E:24987 ||| NN
at  ||| S:24987 E:24990 ||| IN
position  ||| S:24990 E:25009 ||| NN
14  ||| S:25009 E:25012 ||| CD
instead  ||| S:25012 E:25020 ||| RB
of  ||| S:25020 E:25023 ||| IN
phenylalanine ||| S:25023 E:25036 ||| NN
,  ||| S:25036 E:25038 ||| ,
isoleucine ||| S:25038 E:25048 ||| NN
,  ||| S:25048 E:25050 ||| ,
leucine ||| S:25050 E:25057 ||| NN
,  ||| S:25057 E:25059 ||| ,
valine ||| S:25059 E:25065 ||| NN
,  ||| S:25065 E:25077 ||| ,
or  ||| S:25077 E:25080 ||| CC
tryptophan ||| S:25080 E:25090 ||| NN
.  ||| S:25090 E:25092 ||| .
Because  ||| S:25092 E:25100 ||| IN
most  ||| S:25100 E:25105 ||| JJS
proteins  ||| S:25105 E:25114 ||| NNS
that  ||| S:25114 E:25119 ||| IN
bind  ||| S:25119 E:25124 ||| JJ
calmodulin  ||| S:25124 E:25145 ||| NN
through  ||| S:25145 E:25153 ||| IN
the  ||| S:25153 E:25157 ||| DT
1-8-14  ||| S:25157 E:25164 ||| NNP
and  ||| S:25164 E:25168 ||| CC
1-5-10  ||| S:25168 E:25175 ||| CD
motifs  ||| S:25175 E:25182 ||| NNS
do  ||| S:25182 E:25185 ||| VBP
so  ||| S:25185 E:25188 ||| RB
strongly ||| S:25188 E:25196 ||| RB
,  ||| S:25196 E:25198 ||| ,
the  ||| S:25198 E:25212 ||| DT
relatively  ||| S:25212 E:25223 ||| RB
modest  ||| S:25223 E:25230 ||| JJ
affinity  ||| S:25230 E:25239 ||| NN
of  ||| S:25239 E:25242 ||| IN
IQ3  ||| S:25242 E:25246 ||| CD
for  ||| S:25246 E:25250 ||| IN
calmodulin  ||| S:25250 E:25261 ||| NN
in  ||| S:25261 E:25264 ||| IN
the  ||| S:25264 E:25278 ||| DT
presence  ||| S:25278 E:25287 ||| NN
of  ||| S:25287 E:25290 ||| IN
Ca  ||| S:25290 E:25293 ||| NNP
2+suggests  ||| S:25293 E:25304 ||| NNP
that  ||| S:25304 E:25309 ||| IN
calmodulin  ||| S:25309 E:25320 ||| JJ
binds  ||| S:25320 E:25326 ||| NN
through  ||| S:25326 E:25344 ||| IN
one  ||| S:25344 E:25348 ||| CD
of  ||| S:25348 E:25351 ||| IN
these  ||| S:25351 E:25357 ||| DT
imperfect  ||| S:25357 E:25367 ||| JJ
motifs  ||| S:25367 E:25374 ||| NNS
located  ||| S:25374 E:25382 ||| VBN
within  ||| S:25382 E:25389 ||| IN
this  ||| S:25389 E:25394 ||| DT
IQ  ||| S:25394 E:25407 ||| NNP
domain ||| S:25407 E:25413 ||| NN
.  ||| S:25413 E:25415 ||| .
To  ||| S:25415 E:25418 ||| TO
interact  ||| S:25418 E:25427 ||| VB
with  ||| S:25427 E:25432 ||| IN
an  ||| S:25432 E:25435 ||| DT
alternate  ||| S:25435 E:25445 ||| JJ
set  ||| S:25445 E:25449 ||| NN
of  ||| S:25449 E:25452 ||| IN
residues ||| S:25452 E:25460 ||| NNS
,  ||| S:25460 E:25462 ||| ,
Ca  ||| S:25462 E:25475 ||| NNP
2+-calmodulin  ||| S:25475 E:25489 ||| NNP
must  ||| S:25489 E:25494 ||| MD
adopt  ||| S:25494 E:25500 ||| VB
a  ||| S:25500 E:25502 ||| DT
new  ||| S:25502 E:25506 ||| JJ
conformation ||| S:25506 E:25518 ||| NN
.  ||| S:25518 E:25520 ||| .
A  ||| S:25520 E:25522 ||| DT
similar  ||| S:25522 E:25530 ||| JJ
Ca  ||| S:25530 E:25543 ||| NNP
2+-dependent  ||| S:25543 E:25556 ||| NNP
rearrangement  ||| S:25556 E:25570 ||| NN
was  ||| S:25570 E:25574 ||| VBD
predicted  ||| S:25574 E:25584 ||| VBN
for  ||| S:25584 E:25588 ||| IN
the  ||| S:25588 E:25592 ||| DT
complex  ||| S:25592 E:25610 ||| NN
of  ||| S:25610 E:25613 ||| IN
calmodulin  ||| S:25613 E:25624 ||| NN
and  ||| S:25624 E:25628 ||| CC
the  ||| S:25628 E:25632 ||| DT
first  ||| S:25632 E:25638 ||| JJ
IQ  ||| S:25638 E:25641 ||| NNP
domain  ||| S:25641 E:25648 ||| NN
of  ||| S:25648 E:25651 ||| IN
myosin-1a  ||| S:25651 E:25671 ||| NNP
( ||| S:25671 E:25672 ||| -LRB-
brush-border  ||| S:25672 E:25685 ||| NNP
myosin  ||| S:25685 E:25692 ||| VBD
I ||| S:25692 E:25693 ||| PRP
)  ||| S:25693 E:25695 ||| -RRB-
[  ||| S:25695 E:25697 ||| -LRB-
32  ||| S:25697 E:25700 ||| CD
]  ||| S:25700 E:25702 ||| -RRB-
.  ||| S:25702 E:25714 ||| .
In  ||| S:25714 E:25717 ||| IN
support  ||| S:25717 E:25725 ||| NN
of  ||| S:25725 E:25728 ||| IN
this  ||| S:25728 E:25733 ||| DT
view ||| S:25733 E:25737 ||| NN
,  ||| S:25737 E:25739 ||| ,
we  ||| S:25739 E:25742 ||| PRP
observed  ||| S:25742 E:25751 ||| VBD
evidence  ||| S:25751 E:25760 ||| NN
for  ||| S:25760 E:25764 ||| IN
Ca  ||| S:25764 E:25777 ||| NNP
2+-dependent  ||| S:25777 E:25790 ||| NNP
conformational  ||| S:25790 E:25805 ||| NN
changes  ||| S:25805 E:25813 ||| NNS
in  ||| S:25813 E:25816 ||| IN
calmodulin  ||| S:25816 E:25827 ||| NN
while  ||| S:25827 E:25843 ||| IN
bound  ||| S:25843 E:25849 ||| VBN
to  ||| S:25849 E:25852 ||| TO
IQ  ||| S:25852 E:25855 ||| NNP
peptides ||| S:25855 E:25863 ||| NN
.  ||| S:25863 E:25865 ||| .
When  ||| S:25865 E:25870 ||| WRB
Alexa-calmodulin  ||| S:25870 E:25887 ||| NNP
was  ||| S:25887 E:25891 ||| VBD
bound  ||| S:25891 E:25897 ||| VBN
to  ||| S:25897 E:25910 ||| TO
Myo1c  ||| S:25910 E:25916 ||| NNP
IQ  ||| S:25916 E:25919 ||| NNP
peptides ||| S:25919 E:25927 ||| NN
,  ||| S:25927 E:25929 ||| ,
its  ||| S:25929 E:25933 ||| PRP$
fluorescence  ||| S:25933 E:25946 ||| NN
was  ||| S:25946 E:25950 ||| VBD
higher  ||| S:25950 E:25957 ||| JJR
in  ||| S:25957 E:25960 ||| IN
the  ||| S:25960 E:25974 ||| DT
presence  ||| S:25974 E:25983 ||| NN
of  ||| S:25983 E:25986 ||| IN
Ca  ||| S:25986 E:25989 ||| NNP
2+than  ||| S:25989 E:25996 ||| NNP
in  ||| S:25996 E:25999 ||| IN
its  ||| S:25999 E:26003 ||| PRP$
absence ||| S:26003 E:26010 ||| NN
,  ||| S:26010 E:26012 ||| ,
suggesting  ||| S:26012 E:26023 ||| VBG
that  ||| S:26023 E:26038 ||| IN
that  ||| S:26038 E:26043 ||| WDT
Ca  ||| S:26043 E:26046 ||| MD
2+-bound  ||| S:26046 E:26055 ||| RB
Alexa-calmodulin  ||| S:26055 E:26072 ||| JJ
binds  ||| S:26072 E:26078 ||| NN
to  ||| S:26078 E:26081 ||| TO
the  ||| S:26081 E:26085 ||| DT
IQ  ||| S:26085 E:26098 ||| NNP
peptides  ||| S:26098 E:26107 ||| NN
in  ||| S:26107 E:26110 ||| IN
a  ||| S:26110 E:26112 ||| DT
different  ||| S:26112 E:26122 ||| JJ
conformation  ||| S:26122 E:26135 ||| NN
than  ||| S:26135 E:26140 ||| IN
does  ||| S:26140 E:26145 ||| VBZ
Ca  ||| S:26145 E:26148 ||| NNP
2+-free  ||| S:26148 E:26166 ||| NNP
Alexa-calmodulin ||| S:26166 E:26182 ||| NNP
.  ||| S:26182 E:26184 ||| .
For  ||| S:26184 E:26188 ||| IN
example ||| S:26188 E:26195 ||| NN
,  ||| S:26195 E:26197 ||| ,
in  ||| S:26197 E:26200 ||| IN
the  ||| S:26200 E:26204 ||| DT
absence  ||| S:26204 E:26212 ||| NN
of  ||| S:26212 E:26215 ||| IN
Ca  ||| S:26215 E:26218 ||| NNP
2+ ||| S:26218 E:26220 ||| NNP
,  ||| S:26220 E:26232 ||| ,
Alexa-calmodulin  ||| S:26232 E:26249 ||| NNP
may  ||| S:26249 E:26253 ||| MD
bind  ||| S:26253 E:26258 ||| VB
to  ||| S:26258 E:26261 ||| TO
IQ  ||| S:26261 E:26264 ||| NNP
peptides  ||| S:26264 E:26273 ||| NN
in  ||| S:26273 E:26276 ||| IN
a  ||| S:26276 E:26278 ||| DT
more  ||| S:26278 E:26293 ||| RBR
compact  ||| S:26293 E:26301 ||| JJ
conformation ||| S:26301 E:26313 ||| NN
,  ||| S:26313 E:26315 ||| ,
quenching  ||| S:26315 E:26325 ||| JJ
fluorescence  ||| S:26325 E:26338 ||| NN
by  ||| S:26338 E:26341 ||| IN
burying  ||| S:26341 E:26359 ||| VBG
dye  ||| S:26359 E:26363 ||| JJ
moieties  ||| S:26363 E:26372 ||| NN
in  ||| S:26372 E:26375 ||| IN
a  ||| S:26375 E:26377 ||| DT
less  ||| S:26377 E:26382 ||| RBR
polar  ||| S:26382 E:26388 ||| JJ
environment ||| S:26388 E:26399 ||| NN
.  ||| S:26399 E:26401 ||| .
Although  ||| S:26401 E:26410 ||| IN
the  ||| S:26410 E:26414 ||| DT
Ca  ||| S:26414 E:26427 ||| NNP
2+-induced  ||| S:26427 E:26438 ||| NNP
conformational  ||| S:26438 E:26453 ||| JJ
change  ||| S:26453 E:26460 ||| NN
could  ||| S:26460 E:26466 ||| MD
be  ||| S:26466 E:26469 ||| VB
a  ||| S:26469 E:26471 ||| DT
property  ||| S:26471 E:26480 ||| NN
of  ||| S:26480 E:26493 ||| IN
Alexa-calmodulin  ||| S:26493 E:26510 ||| JJ
rather  ||| S:26510 E:26517 ||| RB
than  ||| S:26517 E:26522 ||| IN
calmodulin  ||| S:26522 E:26533 ||| VBG
itself ||| S:26533 E:26539 ||| PRP
,  ||| S:26539 E:26541 ||| ,
the  ||| S:26541 E:26545 ||| DT
Ca  ||| S:26545 E:26558 ||| JJ
2+-dependent  ||| S:26558 E:26571 ||| CD
changes  ||| S:26571 E:26579 ||| NNS
in  ||| S:26579 E:26582 ||| IN
affinity  ||| S:26582 E:26591 ||| NN
of  ||| S:26591 E:26594 ||| IN
calmodulin  ||| S:26594 E:26605 ||| NN
for  ||| S:26605 E:26609 ||| IN
IQ1  ||| S:26609 E:26623 ||| NNP
and  ||| S:26623 E:26627 ||| CC
IQ2  ||| S:26627 E:26631 ||| NNP
( ||| S:26631 E:26632 ||| -LRB-
Table  ||| S:26632 E:26638 ||| NNP
2 ||| S:26638 E:26639 ||| CD
)  ||| S:26639 E:26641 ||| -RRB-
and  ||| S:26641 E:26645 ||| CC
calmodulin ||| S:26645 E:26655 ||| NN
's  ||| S:26655 E:26658 ||| POS
likely  ||| S:26658 E:26665 ||| JJ
shift  ||| S:26665 E:26671 ||| NN
to  ||| S:26671 E:26674 ||| TO
a  ||| S:26674 E:26676 ||| DT
new  ||| S:26676 E:26690 ||| JJ
binding  ||| S:26690 E:26698 ||| JJ
site  ||| S:26698 E:26703 ||| NN
on  ||| S:26703 E:26706 ||| IN
IQ3  ||| S:26706 E:26710 ||| NNP
suggests  ||| S:26710 E:26719 ||| VBZ
that  ||| S:26719 E:26724 ||| IN
the  ||| S:26724 E:26728 ||| DT
conformational  ||| S:26728 E:26753 ||| JJ
change  ||| S:26753 E:26760 ||| NN
is  ||| S:26760 E:26763 ||| VBZ
probably  ||| S:26763 E:26772 ||| RB
also  ||| S:26772 E:26777 ||| RB
a  ||| S:26777 E:26779 ||| DT
property  ||| S:26779 E:26788 ||| NN
of  ||| S:26788 E:26791 ||| IN
authentic  ||| S:26791 E:26811 ||| JJ
calmodulin ||| S:26811 E:26821 ||| NN
.  ||| S:26821 E:26833 ||| .
Calmodulin  ||| S:26833 E:26844 ||| NNP
also  ||| S:26844 E:26849 ||| RB
bound  ||| S:26849 E:26855 ||| VBN
to  ||| S:26855 E:26858 ||| TO
a  ||| S:26858 E:26860 ||| DT
newly  ||| S:26860 E:26866 ||| RB
identified  ||| S:26866 E:26877 ||| VBN
domain ||| S:26877 E:26883 ||| NN
,  ||| S:26883 E:26895 ||| ,
IQ4 ||| S:26895 E:26898 ||| NNP
.  ||| S:26898 E:26900 ||| .
Because  ||| S:26900 E:26908 ||| IN
the  ||| S:26908 E:26912 ||| DT
affinity  ||| S:26912 E:26921 ||| NN
of  ||| S:26921 E:26924 ||| IN
calmodulin  ||| S:26924 E:26935 ||| NN
for  ||| S:26935 E:26939 ||| IN
IQ4  ||| S:26939 E:26943 ||| NNP
is  ||| S:26943 E:26946 ||| VBZ
very  ||| S:26946 E:26961 ||| RB
weak ||| S:26961 E:26965 ||| JJ
,  ||| S:26965 E:26967 ||| ,
calmodulin  ||| S:26967 E:26978 ||| NNS
should  ||| S:26978 E:26985 ||| MD
only  ||| S:26985 E:26990 ||| RB
occupy  ||| S:26990 E:26997 ||| VB
IQ4  ||| S:26997 E:27001 ||| CD
in  ||| S:27001 E:27004 ||| IN
subcellular  ||| S:27004 E:27026 ||| JJ
locations  ||| S:27026 E:27036 ||| NNS
with  ||| S:27036 E:27041 ||| IN
a  ||| S:27041 E:27043 ||| DT
low  ||| S:27043 E:27047 ||| JJ
Ca  ||| S:27047 E:27050 ||| NNP
2+concentration  ||| S:27050 E:27066 ||| NNP
and  ||| S:27066 E:27070 ||| CC
a  ||| S:27070 E:27072 ||| DT
high  ||| S:27072 E:27077 ||| JJ
level  ||| S:27077 E:27093 ||| NN
of  ||| S:27093 E:27096 ||| IN
free  ||| S:27096 E:27101 ||| JJ
calmodulin ||| S:27101 E:27111 ||| NN
.  ||| S:27111 E:27113 ||| .
For  ||| S:27113 E:27117 ||| IN
example ||| S:27117 E:27124 ||| NN
,  ||| S:27124 E:27126 ||| ,
a  ||| S:27126 E:27128 ||| DT
small  ||| S:27128 E:27134 ||| JJ
population  ||| S:27134 E:27145 ||| NN
of  ||| S:27145 E:27158 ||| IN
Myo1c  ||| S:27158 E:27164 ||| CD
molecules  ||| S:27164 E:27174 ||| NNS
with  ||| S:27174 E:27179 ||| IN
calmodulin  ||| S:27179 E:27190 ||| VBG
bound  ||| S:27190 E:27196 ||| VBN
to  ||| S:27196 E:27199 ||| TO
IQ4  ||| S:27199 E:27203 ||| NNP
should  ||| S:27203 E:27210 ||| MD
be  ||| S:27210 E:27223 ||| VB
present  ||| S:27223 E:27231 ||| JJ
in  ||| S:27231 E:27234 ||| IN
the  ||| S:27234 E:27238 ||| DT
stereocilia  ||| S:27238 E:27250 ||| NN
of  ||| S:27250 E:27253 ||| IN
inner-ear  ||| S:27253 E:27263 ||| JJ
hair  ||| S:27263 E:27268 ||| NN
cells ||| S:27268 E:27273 ||| NNS
,  ||| S:27273 E:27275 ||| ,
which  ||| S:27275 E:27291 ||| WDT
contain  ||| S:27291 E:27299 ||| VBP
~35  ||| S:27299 E:27303 ||| RB
μM  ||| S:27303 E:27306 ||| JJ
free  ||| S:27306 E:27311 ||| JJ
calmodulin  ||| S:27311 E:27322 ||| NNS
[  ||| S:27322 E:27324 ||| -LRB-
33  ||| S:27324 E:27327 ||| CD
]  ||| S:27327 E:27329 ||| -RRB-
.  ||| S:27329 E:27331 ||| .
Although  ||| S:27331 E:27340 ||| IN
most  ||| S:27340 E:27355 ||| JJS
tissues  ||| S:27355 E:27363 ||| NNS
contain  ||| S:27363 E:27371 ||| VBP
less  ||| S:27371 E:27376 ||| RBR
free  ||| S:27376 E:27381 ||| JJ
calmodulin  ||| S:27381 E:27392 ||| NNS
[  ||| S:27392 E:27394 ||| -LRB-
34  ||| S:27394 E:27397 ||| CD
]  ||| S:27397 E:27399 ||| -RRB-
,  ||| S:27399 E:27411 ||| ,
concentrations  ||| S:27411 E:27426 ||| NNS
in  ||| S:27426 E:27429 ||| IN
other  ||| S:27429 E:27435 ||| JJ
individual  ||| S:27435 E:27446 ||| JJ
organelles  ||| S:27446 E:27457 ||| NN
can  ||| S:27457 E:27461 ||| MD
reach  ||| S:27461 E:27477 ||| VB
the  ||| S:27477 E:27481 ||| DT
millimolar  ||| S:27481 E:27492 ||| JJ
range  ||| S:27492 E:27498 ||| NN
[  ||| S:27498 E:27500 ||| -LRB-
35  ||| S:27500 E:27503 ||| CD
]  ||| S:27503 E:27505 ||| -RRB-
.  ||| S:27505 E:27507 ||| .
On  ||| S:27507 E:27510 ||| IN
the  ||| S:27510 E:27514 ||| DT
other  ||| S:27514 E:27520 ||| JJ
hand ||| S:27520 E:27524 ||| NN
,  ||| S:27524 E:27526 ||| ,
the  ||| S:27526 E:27530 ||| DT
weak  ||| S:27530 E:27545 ||| JJ
affinity  ||| S:27545 E:27554 ||| NN
of  ||| S:27554 E:27557 ||| IN
this  ||| S:27557 E:27562 ||| DT
IQ  ||| S:27562 E:27565 ||| NNP
domain  ||| S:27565 E:27572 ||| NN
for  ||| S:27572 E:27576 ||| IN
calmodulin  ||| S:27576 E:27587 ||| NN
suggests  ||| S:27587 E:27596 ||| VBZ
that  ||| S:27596 E:27611 ||| IN
IQ4  ||| S:27611 E:27615 ||| NNP
may  ||| S:27615 E:27619 ||| MD
play  ||| S:27619 E:27624 ||| VB
another  ||| S:27624 E:27632 ||| DT
role ||| S:27632 E:27636 ||| NN
,  ||| S:27636 E:27638 ||| ,
such  ||| S:27638 E:27643 ||| JJ
as  ||| S:27643 E:27646 ||| IN
interacting  ||| S:27646 E:27658 ||| NN
with  ||| S:27658 E:27673 ||| IN
another  ||| S:27673 E:27681 ||| DT
protein ||| S:27681 E:27688 ||| NN
.  ||| S:27688 E:27718 ||| .
Calmodulin  ||| S:27718 E:27729 ||| JJ
interaction  ||| S:27729 E:27741 ||| NN
with  ||| S:27741 E:27746 ||| IN
Myo1c  ||| S:27746 E:27762 ||| CD
The  ||| S:27762 E:27766 ||| DT
binding  ||| S:27766 E:27774 ||| JJ
affinities  ||| S:27774 E:27785 ||| NNS
of  ||| S:27785 E:27788 ||| IN
calmodulin  ||| S:27788 E:27799 ||| NN
for  ||| S:27799 E:27803 ||| IN
the  ||| S:27803 E:27817 ||| DT
individual  ||| S:27817 E:27828 ||| JJ
IQ  ||| S:27828 E:27831 ||| NNP
peptides  ||| S:27831 E:27840 ||| NNS
do  ||| S:27840 E:27843 ||| VBP
not  ||| S:27843 E:27847 ||| RB
reflect  ||| S:27847 E:27855 ||| VBP
exactly  ||| S:27855 E:27863 ||| RB
the  ||| S:27863 E:27877 ||| DT
affinities  ||| S:27877 E:27888 ||| NN
of  ||| S:27888 E:27891 ||| IN
calmodulin  ||| S:27891 E:27902 ||| NN
for  ||| S:27902 E:27906 ||| IN
the  ||| S:27906 E:27910 ||| DT
IQ  ||| S:27910 E:27913 ||| NNP
domains  ||| S:27913 E:27921 ||| NN
within  ||| S:27921 E:27928 ||| IN
Myo1c ||| S:27928 E:27933 ||| CD
.  ||| S:27933 E:27945 ||| .
For  ||| S:27945 E:27949 ||| IN
example ||| S:27949 E:27956 ||| NN
,  ||| S:27956 E:27958 ||| ,
despite  ||| S:27958 E:27966 ||| IN
micromolar  ||| S:27966 E:27977 ||| JJ
K  ||| S:27977 E:27990 ||| NNP
d  ||| S:27990 E:27992 ||| NN
values  ||| S:27992 E:27999 ||| NNS
for  ||| S:27999 E:28003 ||| IN
calmodulin-IQ  ||| S:28003 E:28017 ||| JJ
peptide  ||| S:28017 E:28035 ||| JJ
interactions ||| S:28035 E:28047 ||| NNS
,  ||| S:28047 E:28049 ||| ,
calmodulin  ||| S:28049 E:28060 ||| NN
remains  ||| S:28060 E:28068 ||| VBZ
bound  ||| S:28068 E:28074 ||| VBN
to  ||| S:28074 E:28077 ||| TO
Myo1c  ||| S:28077 E:28083 ||| CD
during  ||| S:28083 E:28100 ||| IN
long  ||| S:28100 E:28105 ||| JJ
gel-filtration  ||| S:28105 E:28120 ||| JJ
or  ||| S:28120 E:28123 ||| CC
centrifugation  ||| S:28123 E:28138 ||| JJ
experiments ||| S:28138 E:28149 ||| NNS
,  ||| S:28149 E:28151 ||| ,
even  ||| S:28151 E:28166 ||| RB
at  ||| S:28166 E:28169 ||| IN
nanomolar  ||| S:28169 E:28179 ||| CD
Myo1c  ||| S:28179 E:28185 ||| CD
concentrations  ||| S:28185 E:28200 ||| NNS
( ||| S:28200 E:28201 ||| -LRB-
Fig.  ||| S:28201 E:28206 ||| CD
6 ||| S:28206 E:28207 ||| CD
) ||| S:28207 E:28208 ||| -RRB-
.  ||| S:28208 E:28210 ||| .
This  ||| S:28210 E:28215 ||| DT
result  ||| S:28215 E:28232 ||| NN
suggests  ||| S:28232 E:28241 ||| VBZ
that  ||| S:28241 E:28246 ||| DT
calmodulin  ||| S:28246 E:28257 ||| JJ
binds  ||| S:28257 E:28263 ||| NN
to  ||| S:28263 E:28266 ||| TO
some  ||| S:28266 E:28271 ||| DT
of  ||| S:28271 E:28274 ||| IN
Myo1c ||| S:28274 E:28279 ||| NNP
's  ||| S:28279 E:28282 ||| POS
four  ||| S:28282 E:28297 ||| CD
tandem  ||| S:28297 E:28304 ||| JJ
IQ  ||| S:28304 E:28307 ||| NNP
domains  ||| S:28307 E:28315 ||| VBD
substantially  ||| S:28315 E:28329 ||| RB
more  ||| S:28329 E:28334 ||| RBR
strongly  ||| S:28334 E:28343 ||| RB
than  ||| S:28343 E:28348 ||| IN
to  ||| S:28348 E:28351 ||| TO
the  ||| S:28351 E:28365 ||| DT
individual  ||| S:28365 E:28376 ||| JJ
peptides ||| S:28376 E:28384 ||| NN
.  ||| S:28384 E:28386 ||| .
For  ||| S:28386 E:28390 ||| IN
example ||| S:28390 E:28397 ||| NN
,  ||| S:28397 E:28399 ||| ,
other  ||| S:28399 E:28405 ||| JJ
regions  ||| S:28405 E:28413 ||| NNS
of  ||| S:28413 E:28416 ||| IN
Myo1c  ||| S:28416 E:28432 ||| NNP
could  ||| S:28432 E:28438 ||| MD
constrain  ||| S:28438 E:28448 ||| VB
the  ||| S:28448 E:28452 ||| DT
IQ  ||| S:28452 E:28455 ||| NNP
domains  ||| S:28455 E:28463 ||| NN
in  ||| S:28463 E:28466 ||| IN
conformations  ||| S:28466 E:28480 ||| NNS
that  ||| S:28480 E:28485 ||| WDT
are  ||| S:28485 E:28499 ||| VBP
substantially  ||| S:28499 E:28513 ||| RB
more  ||| S:28513 E:28518 ||| RBR
( ||| S:28518 E:28519 ||| -LRB-
or  ||| S:28519 E:28522 ||| CC
less ||| S:28522 E:28526 ||| JJR
)  ||| S:28526 E:28528 ||| -RRB-
favorable  ||| S:28528 E:28538 ||| JJ
for  ||| S:28538 E:28542 ||| IN
calmodulin  ||| S:28542 E:28563 ||| JJ
binding  ||| S:28563 E:28571 ||| NN
than  ||| S:28571 E:28576 ||| IN
the  ||| S:28576 E:28580 ||| DT
population  ||| S:28580 E:28591 ||| NN
of  ||| S:28591 E:28594 ||| IN
conformations  ||| S:28594 E:28608 ||| VBG
adopted  ||| S:28608 E:28616 ||| VBN
by  ||| S:28616 E:28619 ||| IN
a  ||| S:28619 E:28631 ||| DT
soluble  ||| S:28631 E:28639 ||| JJ
IQ  ||| S:28639 E:28642 ||| NNP
peptide ||| S:28642 E:28649 ||| NN
.  ||| S:28649 E:28651 ||| .
Moreover ||| S:28651 E:28659 ||| RB
,  ||| S:28659 E:28661 ||| ,
calmodulin  ||| S:28661 E:28672 ||| JJ
binding  ||| S:28672 E:28680 ||| NN
to  ||| S:28680 E:28683 ||| TO
Myo1c  ||| S:28683 E:28699 ||| NNP
could  ||| S:28699 E:28705 ||| MD
be  ||| S:28705 E:28708 ||| VB
influenced  ||| S:28708 E:28719 ||| VBN
by  ||| S:28719 E:28722 ||| IN
interactions  ||| S:28722 E:28735 ||| NNS
with  ||| S:28735 E:28740 ||| IN
adjacent  ||| S:28740 E:28759 ||| JJ
calmodulin  ||| S:28759 E:28770 ||| JJ
molecules  ||| S:28770 E:28780 ||| NNS
or  ||| S:28780 E:28783 ||| CC
to  ||| S:28783 E:28786 ||| TO
the  ||| S:28786 E:28790 ||| DT
Myo1c  ||| S:28790 E:28796 ||| JJ
head  ||| S:28796 E:28801 ||| NN
or  ||| S:28801 E:28804 ||| CC
tail  ||| S:28804 E:28819 ||| JJ
domains ||| S:28819 E:28826 ||| NN
.  ||| S:28826 E:28838 ||| .
To  ||| S:28838 E:28841 ||| TO
examine  ||| S:28841 E:28849 ||| VB
calmodulin  ||| S:28849 E:28860 ||| JJ
binding  ||| S:28860 E:28868 ||| NN
to  ||| S:28868 E:28871 ||| TO
IQ  ||| S:28871 E:28874 ||| NNP
domains  ||| S:28874 E:28882 ||| NN
in  ||| S:28882 E:28885 ||| IN
Myo1c ||| S:28885 E:28890 ||| NNP
,  ||| S:28890 E:28902 ||| ,
we  ||| S:28902 E:28905 ||| PRP
determined  ||| S:28905 E:28916 ||| VBD
the  ||| S:28916 E:28920 ||| DT
molecular  ||| S:28920 E:28930 ||| JJ
mass  ||| S:28930 E:28935 ||| NN
( ||| S:28935 E:28936 ||| -LRB-
and  ||| S:28936 E:28940 ||| CC
hence  ||| S:28940 E:28956 ||| RB
calmodulin ||| S:28956 E:28966 ||| JJ
: ||| S:28966 E:28967 ||| :
Myo1c  ||| S:28967 E:28973 ||| CD
stoichiometry ||| S:28973 E:28986 ||| CD
)  ||| S:28986 E:28988 ||| -RRB-
and  ||| S:28988 E:28992 ||| CC
shape  ||| S:28992 E:28998 ||| NN
of  ||| S:28998 E:29001 ||| IN
Myo1c  ||| S:29001 E:29007 ||| CD
under  ||| S:29007 E:29023 ||| IN
the  ||| S:29023 E:29027 ||| DT
appropriate  ||| S:29027 E:29039 ||| JJ
conditions  ||| S:29039 E:29050 ||| NNS
of  ||| S:29050 E:29053 ||| IN
temperature  ||| S:29053 E:29065 ||| NN
and  ||| S:29065 E:29069 ||| CC
Ca  ||| S:29069 E:29072 ||| NNP
2+ ||| S:29072 E:29074 ||| NNP
.  ||| S:29074 E:29086 ||| .
Although  ||| S:29086 E:29095 ||| IN
analytical  ||| S:29095 E:29106 ||| JJ
ultracentrifugation  ||| S:29106 E:29126 ||| NN
is  ||| S:29126 E:29129 ||| VBZ
more  ||| S:29129 E:29134 ||| RBR
commonly  ||| S:29134 E:29153 ||| RB
used  ||| S:29153 E:29158 ||| VBN
to  ||| S:29158 E:29161 ||| TO
measure  ||| S:29161 E:29169 ||| VB
molecular  ||| S:29169 E:29179 ||| JJ
size  ||| S:29179 E:29184 ||| NN
of  ||| S:29184 E:29187 ||| IN
protein-protein  ||| S:29187 E:29213 ||| JJ
complexes  ||| S:29213 E:29223 ||| NNS
[  ||| S:29223 E:29225 ||| -LRB-
36  ||| S:29225 E:29228 ||| CD
]  ||| S:29228 E:29230 ||| -RRB-
,  ||| S:29230 E:29232 ||| ,
we  ||| S:29232 E:29235 ||| PRP
instead  ||| S:29235 E:29243 ||| RB
used  ||| S:29243 E:29248 ||| VBN
classic  ||| S:29248 E:29256 ||| JJ
hydrodynamic  ||| S:29256 E:29279 ||| JJ
methods  ||| S:29279 E:29287 ||| NNS
of  ||| S:29287 E:29290 ||| IN
velocity  ||| S:29290 E:29299 ||| JJ
sedimentation  ||| S:29299 E:29313 ||| NN
on  ||| S:29313 E:29316 ||| IN
sucrose  ||| S:29316 E:29324 ||| JJ
gradients  ||| S:29324 E:29334 ||| NN
to  ||| S:29334 E:29347 ||| TO
obtain  ||| S:29347 E:29354 ||| VB
sedimentation  ||| S:29354 E:29368 ||| JJ
coefficients  ||| S:29368 E:29381 ||| NN
and  ||| S:29381 E:29385 ||| CC
gel  ||| S:29385 E:29389 ||| JJ
filtration  ||| S:29389 E:29400 ||| NN
to  ||| S:29400 E:29413 ||| TO
obtain  ||| S:29413 E:29420 ||| VB
Stokes ||| S:29420 E:29426 ||| NNP
'  ||| S:29426 E:29428 ||| POS
radius ||| S:29428 E:29434 ||| NN
.  ||| S:29434 E:29436 ||| .
One  ||| S:29436 E:29440 ||| CD
advantage  ||| S:29440 E:29450 ||| NN
of  ||| S:29450 E:29453 ||| IN
this  ||| S:29453 E:29458 ||| DT
approach  ||| S:29458 E:29467 ||| NN
was  ||| S:29467 E:29481 ||| VBD
that  ||| S:29481 E:29486 ||| IN
by  ||| S:29486 E:29489 ||| IN
detecting  ||| S:29489 E:29499 ||| NNS
Myo1c  ||| S:29499 E:29505 ||| VBP
using  ||| S:29505 E:29511 ||| VBG
a  ||| S:29511 E:29513 ||| DT
sensitive  ||| S:29513 E:29523 ||| JJ
ELISA  ||| S:29523 E:29529 ||| NNP
method ||| S:29529 E:29535 ||| NN
,  ||| S:29535 E:29547 ||| ,
we  ||| S:29547 E:29550 ||| PRP
were  ||| S:29550 E:29555 ||| VBD
able  ||| S:29555 E:29560 ||| JJ
to  ||| S:29560 E:29563 ||| TO
use  ||| S:29563 E:29567 ||| VB
very  ||| S:29567 E:29572 ||| RB
low  ||| S:29572 E:29576 ||| JJ
concentrations  ||| S:29576 E:29591 ||| NNS
of  ||| S:29591 E:29594 ||| IN
Myo1c ||| S:29594 E:29599 ||| CD
.  ||| S:29599 E:29611 ||| .
Furthermore ||| S:29611 E:29622 ||| RB
,  ||| S:29622 E:29624 ||| ,
we  ||| S:29624 E:29627 ||| PRP
were  ||| S:29627 E:29632 ||| VBD
able  ||| S:29632 E:29637 ||| JJ
to  ||| S:29637 E:29640 ||| TO
carry  ||| S:29640 E:29646 ||| VB
out  ||| S:29646 E:29650 ||| RP
sedimentation  ||| S:29650 E:29664 ||| NNS
in  ||| S:29664 E:29677 ||| IN
the  ||| S:29677 E:29681 ||| DT
presence  ||| S:29681 E:29690 ||| NN
of  ||| S:29690 E:29693 ||| IN
a  ||| S:29693 E:29695 ||| DT
high  ||| S:29695 E:29700 ||| JJ
concentration  ||| S:29700 E:29714 ||| NN
of  ||| S:29714 E:29717 ||| IN
calmodulin ||| S:29717 E:29727 ||| NN
,  ||| S:29727 E:29729 ||| ,
a  ||| S:29729 E:29741 ||| DT
manipulation  ||| S:29741 E:29754 ||| NN
that  ||| S:29754 E:29759 ||| WDT
prevents  ||| S:29759 E:29768 ||| VBZ
Myo1c  ||| S:29768 E:29774 ||| CD
detection  ||| S:29774 E:29784 ||| NN
in  ||| S:29784 E:29787 ||| IN
a  ||| S:29787 E:29789 ||| DT
standard  ||| S:29789 E:29808 ||| JJ
analytical  ||| S:29808 E:29819 ||| JJ
ultracentrifugation  ||| S:29819 E:29839 ||| JJ
experiment ||| S:29839 E:29849 ||| NN
.  ||| S:29849 E:29851 ||| .
A  ||| S:29851 E:29853 ||| DT
disadvantage  ||| S:29853 E:29876 ||| NN
of  ||| S:29876 E:29879 ||| IN
this  ||| S:29879 E:29884 ||| DT
approach  ||| S:29884 E:29893 ||| NN
was  ||| S:29893 E:29897 ||| VBD
the  ||| S:29897 E:29901 ||| DT
need  ||| S:29901 E:29906 ||| NN
for  ||| S:29906 E:29910 ||| IN
high  ||| S:29910 E:29915 ||| JJ
concentrations  ||| S:29915 E:29930 ||| NNS
of  ||| S:29930 E:29943 ||| IN
sucrose ||| S:29943 E:29950 ||| NN
,  ||| S:29950 E:29952 ||| ,
which  ||| S:29952 E:29958 ||| WDT
in  ||| S:29958 E:29961 ||| IN
rare  ||| S:29961 E:29966 ||| JJ
conditions  ||| S:29966 E:29977 ||| NNS
can  ||| S:29977 E:29981 ||| MD
substantially  ||| S:29981 E:30005 ||| RB
affect  ||| S:30005 E:30012 ||| VB
the  ||| S:30012 E:30016 ||| DT
hydrodynamic  ||| S:30016 E:30029 ||| JJ
properties  ||| S:30029 E:30040 ||| NNS
of  ||| S:30040 E:30043 ||| IN
a  ||| S:30043 E:30045 ||| DT
protein  ||| S:30045 E:30053 ||| NN
[  ||| S:30053 E:30055 ||| -LRB-
37  ||| S:30055 E:30058 ||| CD
]  ||| S:30058 E:30060 ||| -RRB-
;  ||| S:30060 E:30072 ||| :
nevertheless ||| S:30072 E:30084 ||| RB
,  ||| S:30084 E:30086 ||| ,
changes  ||| S:30086 E:30094 ||| NNS
in  ||| S:30094 E:30097 ||| IN
Myo1c  ||| S:30097 E:30103 ||| CD
size  ||| S:30103 E:30108 ||| NN
were  ||| S:30108 E:30113 ||| VBD
observed  ||| S:30113 E:30122 ||| VBN
both  ||| S:30122 E:30127 ||| DT
in  ||| S:30127 E:30140 ||| IN
velocity  ||| S:30140 E:30149 ||| JJ
sedimentation  ||| S:30149 E:30163 ||| NNS
( ||| S:30163 E:30164 ||| -LRB-
in  ||| S:30164 E:30167 ||| IN
the  ||| S:30167 E:30171 ||| DT
presence  ||| S:30171 E:30180 ||| NN
of  ||| S:30180 E:30183 ||| IN
sucrose ||| S:30183 E:30190 ||| CD
)  ||| S:30190 E:30192 ||| -RRB-
and  ||| S:30192 E:30206 ||| CC
in  ||| S:30206 E:30209 ||| IN
gel  ||| S:30209 E:30213 ||| JJ
filtration  ||| S:30213 E:30224 ||| NNS
( ||| S:30224 E:30225 ||| -LRB-
in  ||| S:30225 E:30228 ||| IN
its  ||| S:30228 E:30232 ||| PRP$
absence ||| S:30232 E:30239 ||| NN
) ||| S:30239 E:30240 ||| -RRB-
.  ||| S:30240 E:30242 ||| .
Another  ||| S:30242 E:30250 ||| DT
disadvantage  ||| S:30250 E:30273 ||| NN
of  ||| S:30273 E:30276 ||| IN
our  ||| S:30276 E:30280 ||| PRP$
classic  ||| S:30280 E:30288 ||| JJ
approach  ||| S:30288 E:30297 ||| NN
to  ||| S:30297 E:30300 ||| TO
molecular-mass  ||| S:30300 E:30315 ||| JJ
determination  ||| S:30315 E:30339 ||| NN
was  ||| S:30339 E:30343 ||| VBD
that  ||| S:30343 E:30348 ||| IN
the  ||| S:30348 E:30352 ||| DT
gel  ||| S:30352 E:30356 ||| JJ
filtration  ||| S:30356 E:30367 ||| NN
and  ||| S:30367 E:30371 ||| CC
velocity  ||| S:30371 E:30380 ||| JJ
sedimentations  ||| S:30380 E:30405 ||| NN
were  ||| S:30405 E:30410 ||| VBD
done  ||| S:30410 E:30415 ||| VBN
on  ||| S:30415 E:30418 ||| IN
different  ||| S:30418 E:30428 ||| JJ
time  ||| S:30428 E:30433 ||| NN
scales  ||| S:30433 E:30440 ||| NNS
( ||| S:30440 E:30441 ||| -LRB-
~1  ||| S:30441 E:30444 ||| FW
hour  ||| S:30444 E:30449 ||| FW
vs.  ||| S:30449 E:30453 ||| FW
15-18  ||| S:30453 E:30469 ||| FW
hours ||| S:30469 E:30474 ||| NNS
) ||| S:30474 E:30475 ||| -RRB-
.  ||| S:30475 E:30477 ||| .
If  ||| S:30477 E:30480 ||| IN
calmodulin  ||| S:30480 E:30491 ||| VBG
slowly  ||| S:30491 E:30498 ||| RB
dissociated  ||| S:30498 E:30510 ||| VBN
during  ||| S:30510 E:30517 ||| IN
the  ||| S:30517 E:30531 ||| DT
analysis  ||| S:30531 E:30540 ||| NN
( ||| S:30540 E:30541 ||| -LRB-
which  ||| S:30541 E:30547 ||| WDT
in  ||| S:30547 E:30550 ||| IN
both  ||| S:30550 E:30555 ||| DT
assays  ||| S:30555 E:30562 ||| NN
diluted  ||| S:30562 E:30570 ||| VBN
Myo1c  ||| S:30570 E:30576 ||| RB
well  ||| S:30576 E:30581 ||| RB
below  ||| S:30581 E:30587 ||| IN
1  ||| S:30587 E:30599 ||| CD
μM ||| S:30599 E:30601 ||| NN
) ||| S:30601 E:30602 ||| -RRB-
,  ||| S:30602 E:30604 ||| ,
the  ||| S:30604 E:30608 ||| DT
degree  ||| S:30608 E:30615 ||| NN
of  ||| S:30615 E:30618 ||| IN
dissociation  ||| S:30618 E:30631 ||| NNS
would  ||| S:30631 E:30637 ||| MD
be  ||| S:30637 E:30640 ||| VB
larger  ||| S:30640 E:30647 ||| JJR
in  ||| S:30647 E:30650 ||| IN
the  ||| S:30650 E:30664 ||| DT
velocity  ||| S:30664 E:30673 ||| JJ
sedimentation  ||| S:30673 E:30687 ||| JJ
experiments  ||| S:30687 E:30699 ||| NNS
than  ||| S:30699 E:30704 ||| IN
in  ||| S:30704 E:30707 ||| IN
the  ||| S:30707 E:30711 ||| DT
gel  ||| S:30711 E:30725 ||| JJ
filtration  ||| S:30725 E:30736 ||| NN
experiments ||| S:30736 E:30747 ||| NNS
.  ||| S:30747 E:30749 ||| .
Nevertheless ||| S:30749 E:30761 ||| RB
,  ||| S:30761 E:30763 ||| ,
our  ||| S:30763 E:30767 ||| PRP$
approach  ||| S:30767 E:30776 ||| NN
was  ||| S:30776 E:30790 ||| VBD
validated  ||| S:30790 E:30800 ||| VBN
by  ||| S:30800 E:30803 ||| IN
the  ||| S:30803 E:30807 ||| DT
demonstration  ||| S:30807 E:30821 ||| NN
that  ||| S:30821 E:30826 ||| IN
the  ||| S:30826 E:30830 ||| DT
number  ||| S:30830 E:30837 ||| NN
of  ||| S:30837 E:30850 ||| IN
calmodulins  ||| S:30850 E:30862 ||| NN
per  ||| S:30862 E:30866 ||| IN
T701-Myo1c  ||| S:30866 E:30877 ||| NNP
was  ||| S:30877 E:30881 ||| VBD
identical  ||| S:30881 E:30891 ||| JJ
in  ||| S:30891 E:30894 ||| IN
hydrodynamic  ||| S:30894 E:30917 ||| NN
and  ||| S:30917 E:30921 ||| CC
gel-scanning  ||| S:30921 E:30934 ||| JJ
experiments ||| S:30934 E:30945 ||| NNS
,  ||| S:30945 E:30947 ||| ,
at  ||| S:30947 E:30950 ||| IN
least  ||| S:30950 E:30956 ||| JJS
in  ||| S:30956 E:30959 ||| IN
EGTA  ||| S:30959 E:30964 ||| NNP
at  ||| S:30964 E:30977 ||| IN
4°C ||| S:30977 E:30980 ||| CD
.  ||| S:30980 E:30992 ||| .
Because  ||| S:30992 E:31000 ||| IN
T701-Myo1c  ||| S:31000 E:31011 ||| CD
mimicked  ||| S:31011 E:31020 ||| CD
properties  ||| S:31020 E:31031 ||| NNS
of  ||| S:31031 E:31034 ||| IN
the  ||| S:31034 E:31048 ||| DT
full-length  ||| S:31048 E:31060 ||| JJ
protein  ||| S:31060 E:31068 ||| NN
( ||| S:31068 E:31069 ||| -LRB-
except  ||| S:31069 E:31076 ||| IN
under  ||| S:31076 E:31082 ||| IN
low-temperature ||| S:31082 E:31097 ||| NNP
,  ||| S:31097 E:31109 ||| ,
high-Ca  ||| S:31109 E:31117 ||| NNP
2+conditions ||| S:31117 E:31129 ||| NNP
) ||| S:31129 E:31130 ||| -RRB-
,  ||| S:31130 E:31132 ||| ,
we  ||| S:31132 E:31135 ||| PRP
exploited  ||| S:31135 E:31145 ||| VBD
the  ||| S:31145 E:31149 ||| DT
neck-tail  ||| S:31149 E:31169 ||| JJ
construct  ||| S:31169 E:31179 ||| NN
for  ||| S:31179 E:31183 ||| IN
a  ||| S:31183 E:31185 ||| DT
more  ||| S:31185 E:31190 ||| RBR
detailed  ||| S:31190 E:31199 ||| JJ
analysis  ||| S:31199 E:31208 ||| NN
of  ||| S:31208 E:31211 ||| IN
calmodulin  ||| S:31211 E:31232 ||| JJ
binding ||| S:31232 E:31239 ||| NN
.  ||| S:31239 E:31241 ||| .
As  ||| S:31241 E:31244 ||| RB
expected  ||| S:31244 E:31253 ||| VBN
from  ||| S:31253 E:31258 ||| IN
the  ||| S:31258 E:31262 ||| DT
large  ||| S:31262 E:31268 ||| JJ
Ca  ||| S:31268 E:31271 ||| NNP
2+-dependent  ||| S:31271 E:31294 ||| NNP
weakening  ||| S:31294 E:31304 ||| NN
of  ||| S:31304 E:31307 ||| IN
calmodulin  ||| S:31307 E:31318 ||| JJ
affinity  ||| S:31318 E:31327 ||| NN
for  ||| S:31327 E:31331 ||| IN
IQ1  ||| S:31331 E:31335 ||| NNP
and  ||| S:31335 E:31339 ||| CC
IQ2  ||| S:31339 E:31343 ||| NNP
( ||| S:31343 E:31344 ||| -LRB-
Fig.  ||| S:31344 E:31349 ||| CD
5 ||| S:31349 E:31350 ||| CD
;  ||| S:31350 E:31362 ||| :
Table  ||| S:31362 E:31368 ||| NNP
2 ||| S:31368 E:31369 ||| CD
) ||| S:31369 E:31370 ||| -RRB-
,  ||| S:31370 E:31372 ||| ,
Ca  ||| S:31372 E:31375 ||| NNP
2+decreased  ||| S:31375 E:31387 ||| CD
the  ||| S:31387 E:31391 ||| DT
number  ||| S:31391 E:31398 ||| NN
of  ||| S:31398 E:31401 ||| IN
calmodulins  ||| S:31401 E:31413 ||| VBG
bound  ||| S:31413 E:31429 ||| VBN
to  ||| S:31429 E:31432 ||| TO
T701-Myo1c  ||| S:31432 E:31443 ||| CD
at  ||| S:31443 E:31446 ||| IN
high  ||| S:31446 E:31451 ||| JJ
ionic  ||| S:31451 E:31457 ||| JJ
strength ||| S:31457 E:31465 ||| NN
.  ||| S:31465 E:31467 ||| .
When  ||| S:31467 E:31472 ||| WRB
Ca  ||| S:31472 E:31475 ||| MD
2+was  ||| S:31475 E:31481 ||| RB
low  ||| S:31481 E:31495 ||| JJ
at  ||| S:31495 E:31498 ||| IN
25°C ||| S:31498 E:31502 ||| NNP
,  ||| S:31502 E:31504 ||| ,
each  ||| S:31504 E:31509 ||| DT
T701-Myo1c  ||| S:31509 E:31520 ||| NNP
had  ||| S:31520 E:31524 ||| VBD
about  ||| S:31524 E:31530 ||| IN
two  ||| S:31530 E:31534 ||| CD
bound  ||| S:31534 E:31540 ||| JJ
calmodulins ||| S:31540 E:31551 ||| NN
,  ||| S:31551 E:31563 ||| ,
with  ||| S:31563 E:31568 ||| IN
a  ||| S:31568 E:31570 ||| DT
third  ||| S:31570 E:31576 ||| JJ
bound  ||| S:31576 E:31582 ||| NN
if  ||| S:31582 E:31585 ||| IN
the  ||| S:31585 E:31589 ||| DT
calmodulin  ||| S:31589 E:31600 ||| JJ
concentration  ||| S:31600 E:31624 ||| NN
reached  ||| S:31624 E:31632 ||| VBD
5  ||| S:31632 E:31634 ||| CD
μM ||| S:31634 E:31636 ||| NN
.  ||| S:31636 E:31638 ||| .
At  ||| S:31638 E:31641 ||| IN
this  ||| S:31641 E:31646 ||| DT
calmodulin  ||| S:31646 E:31657 ||| JJ
concentration ||| S:31657 E:31670 ||| NN
,  ||| S:31670 E:31672 ||| ,
IQ  ||| S:31672 E:31685 ||| NNP
domains  ||| S:31685 E:31693 ||| VBD
1 ||| S:31693 E:31694 ||| CD
,  ||| S:31694 E:31696 ||| ,
2 ||| S:31696 E:31697 ||| CD
,  ||| S:31697 E:31699 ||| ,
and  ||| S:31699 E:31703 ||| CC
3  ||| S:31703 E:31705 ||| CD
are  ||| S:31705 E:31709 ||| VBP
likely  ||| S:31709 E:31716 ||| RB
occupied  ||| S:31716 E:31725 ||| VBN
by  ||| S:31725 E:31728 ||| IN
calmodulin ||| S:31728 E:31738 ||| NN
.  ||| S:31738 E:31750 ||| .
When  ||| S:31750 E:31755 ||| WRB
Ca  ||| S:31755 E:31758 ||| MD
2+is  ||| S:31758 E:31763 ||| RB
high  ||| S:31763 E:31768 ||| JJ
at  ||| S:31768 E:31771 ||| IN
25°C ||| S:31771 E:31775 ||| NNP
,  ||| S:31775 E:31777 ||| ,
all  ||| S:31777 E:31781 ||| DT
but  ||| S:31781 E:31785 ||| CC
one  ||| S:31785 E:31789 ||| CD
calmodulin  ||| S:31789 E:31810 ||| JJ
dissociated  ||| S:31810 E:31822 ||| NN
from  ||| S:31822 E:31827 ||| IN
T701-Myo1c  ||| S:31827 E:31838 ||| CD
in  ||| S:31838 E:31841 ||| IN
the  ||| S:31841 E:31845 ||| DT
presence  ||| S:31845 E:31854 ||| NN
of  ||| S:31854 E:31857 ||| IN
5  ||| S:31857 E:31859 ||| CD
μM  ||| S:31859 E:31862 ||| JJ
free  ||| S:31862 E:31877 ||| JJ
calmodulin ||| S:31877 E:31887 ||| NN
.  ||| S:31887 E:31889 ||| .
The  ||| S:31889 E:31893 ||| DT
strong  ||| S:31893 E:31900 ||| JJ
affinity  ||| S:31900 E:31909 ||| NN
of  ||| S:31909 E:31912 ||| IN
IQ3  ||| S:31912 E:31916 ||| CD
for  ||| S:31916 E:31920 ||| IN
Ca  ||| S:31920 E:31933 ||| NNP
2+-calmodulin  ||| S:31933 E:31947 ||| NNP
suggests  ||| S:31947 E:31956 ||| VBZ
that  ||| S:31956 E:31961 ||| IN
the  ||| S:31961 E:31965 ||| DT
remaining  ||| S:31965 E:31975 ||| JJ
calmodulin  ||| S:31975 E:31986 ||| NN
was  ||| S:31986 E:32000 ||| VBD
bound  ||| S:32000 E:32006 ||| VBN
to  ||| S:32006 E:32009 ||| TO
this  ||| S:32009 E:32014 ||| DT
IQ  ||| S:32014 E:32017 ||| NNP
domain ||| S:32017 E:32023 ||| NN
.  ||| S:32023 E:32035 ||| .
How  ||| S:32035 E:32039 ||| WRB
many  ||| S:32039 E:32044 ||| JJ
calmodulins  ||| S:32044 E:32056 ||| NNS
are  ||| S:32056 E:32060 ||| VBP
bound  ||| S:32060 E:32066 ||| VBN
to  ||| S:32066 E:32069 ||| TO
Myo1c  ||| S:32069 E:32075 ||| CD
in  ||| S:32075 E:32078 ||| IN
the  ||| S:32078 E:32082 ||| DT
cell  ||| S:32082 E:32087 ||| NN
at  ||| S:32087 E:32100 ||| IN
increased  ||| S:32100 E:32110 ||| JJ
Ca  ||| S:32110 E:32113 ||| NNP
2+concentrations ||| S:32113 E:32129 ||| NNP
?  ||| S:32129 E:32131 ||| .
The  ||| S:32131 E:32135 ||| DT
elevated  ||| S:32135 E:32144 ||| JJ
ionic  ||| S:32144 E:32160 ||| JJ
strength  ||| S:32160 E:32169 ||| NN
used  ||| S:32169 E:32174 ||| VBN
for  ||| S:32174 E:32178 ||| IN
the  ||| S:32178 E:32182 ||| DT
hydrodynamic  ||| S:32182 E:32195 ||| JJ
analysis  ||| S:32195 E:32204 ||| NN
probably  ||| S:32204 E:32223 ||| RB
weakened  ||| S:32223 E:32232 ||| VBN
the  ||| S:32232 E:32236 ||| DT
affinity  ||| S:32236 E:32245 ||| NN
of  ||| S:32245 E:32248 ||| IN
the  ||| S:32248 E:32252 ||| DT
calmodulin  ||| S:32252 E:32263 ||| NN
for  ||| S:32263 E:32267 ||| IN
IQ3  ||| S:32267 E:32271 ||| NNP
( ||| S:32271 E:32272 ||| -LRB-
Fig.  ||| S:32272 E:32287 ||| NNP
2A ||| S:32287 E:32289 ||| NNP
) ||| S:32289 E:32290 ||| -RRB-
,  ||| S:32290 E:32292 ||| ,
requiring  ||| S:32292 E:32302 ||| VBG
5  ||| S:32302 E:32304 ||| CD
μM  ||| S:32304 E:32307 ||| JJ
free  ||| S:32307 E:32312 ||| JJ
calmodulin  ||| S:32312 E:32323 ||| NN
to  ||| S:32323 E:32326 ||| TO
maintain  ||| S:32326 E:32335 ||| VB
occupancy  ||| S:32335 E:32355 ||| NN
of  ||| S:32355 E:32358 ||| IN
that  ||| S:32358 E:32363 ||| DT
site ||| S:32363 E:32367 ||| NN
.  ||| S:32367 E:32369 ||| .
We  ||| S:32369 E:32372 ||| PRP
therefore  ||| S:32372 E:32382 ||| RB
infer  ||| S:32382 E:32388 ||| VBN
that  ||| S:32388 E:32393 ||| IN
at  ||| S:32393 E:32396 ||| IN
a  ||| S:32396 E:32408 ||| DT
physiologically  ||| S:32408 E:32424 ||| JJ
significant  ||| S:32424 E:32436 ||| JJ
temperature  ||| S:32436 E:32448 ||| NN
and  ||| S:32448 E:32452 ||| CC
at  ||| S:32452 E:32455 ||| IN
a  ||| S:32455 E:32457 ||| DT
cellular  ||| S:32457 E:32476 ||| JJ
ionic  ||| S:32476 E:32482 ||| JJ
strength ||| S:32482 E:32490 ||| NN
,  ||| S:32490 E:32492 ||| ,
Ca  ||| S:32492 E:32495 ||| NNP
2+triggers  ||| S:32495 E:32506 ||| NNP
release  ||| S:32506 E:32514 ||| NN
of  ||| S:32514 E:32517 ||| IN
calmodulins  ||| S:32517 E:32529 ||| NN
from  ||| S:32529 E:32544 ||| IN
IQ1  ||| S:32544 E:32548 ||| NNP
and  ||| S:32548 E:32552 ||| CC
IQ2  ||| S:32552 E:32556 ||| CD
from  ||| S:32556 E:32561 ||| IN
T701-Myo1c ||| S:32561 E:32571 ||| NNP
,  ||| S:32571 E:32573 ||| ,
leaving  ||| S:32573 E:32581 ||| VBG
only  ||| S:32581 E:32586 ||| RB
IQ3  ||| S:32586 E:32590 ||| CD
occupied ||| S:32590 E:32598 ||| NNS
.  ||| S:32598 E:32610 ||| .
Although  ||| S:32610 E:32619 ||| IN
these  ||| S:32619 E:32625 ||| DT
results  ||| S:32625 E:32633 ||| NNS
contrast  ||| S:32633 E:32642 ||| NN
with  ||| S:32642 E:32647 ||| IN
those  ||| S:32647 E:32653 ||| DT
reported  ||| S:32653 E:32662 ||| VBN
for  ||| S:32662 E:32676 ||| IN
mammalian  ||| S:32676 E:32686 ||| CD
Myo1c ||| S:32686 E:32691 ||| CD
,  ||| S:32691 E:32693 ||| ,
where  ||| S:32693 E:32699 ||| WRB
only  ||| S:32699 E:32704 ||| RB
one  ||| S:32704 E:32708 ||| CD
of  ||| S:32708 E:32711 ||| IN
three  ||| S:32711 E:32717 ||| CD
calmodulins  ||| S:32717 E:32729 ||| NN
is  ||| S:32729 E:32742 ||| VBZ
released  ||| S:32742 E:32751 ||| VBN
by  ||| S:32751 E:32754 ||| IN
Ca  ||| S:32754 E:32757 ||| NNP
2+  ||| S:32757 E:32760 ||| NNP
[  ||| S:32760 E:32762 ||| -LRB-
19  ||| S:32762 E:32765 ||| CD
38  ||| S:32765 E:32768 ||| CD
]  ||| S:32768 E:32770 ||| -RRB-
,  ||| S:32770 E:32772 ||| ,
our  ||| S:32772 E:32776 ||| PRP$
T701  ||| S:32776 E:32781 ||| JJ
construct  ||| S:32781 E:32791 ||| NN
lacks  ||| S:32791 E:32807 ||| VBZ
Myo1c ||| S:32807 E:32812 ||| NNP
's  ||| S:32812 E:32815 ||| POS
motor  ||| S:32815 E:32821 ||| NN
domain ||| S:32821 E:32827 ||| NN
.  ||| S:32827 E:32829 ||| .
It  ||| S:32829 E:32832 ||| PRP
is  ||| S:32832 E:32835 ||| VBZ
entirely  ||| S:32835 E:32844 ||| RB
plausible  ||| S:32844 E:32854 ||| JJ
that  ||| S:32854 E:32859 ||| IN
even  ||| S:32859 E:32874 ||| RB
in  ||| S:32874 E:32877 ||| IN
the  ||| S:32877 E:32881 ||| DT
presence  ||| S:32881 E:32890 ||| NN
of  ||| S:32890 E:32893 ||| IN
Ca  ||| S:32893 E:32896 ||| NNP
2+ ||| S:32896 E:32898 ||| NNP
,  ||| S:32898 E:32900 ||| ,
calmodulin  ||| S:32900 E:32911 ||| NN
remains  ||| S:32911 E:32919 ||| VBZ
bound  ||| S:32919 E:32925 ||| VBN
to  ||| S:32925 E:32938 ||| TO
IQ1 ||| S:32938 E:32941 ||| CD
,  ||| S:32941 E:32943 ||| ,
albeit  ||| S:32943 E:32950 ||| VBG
in  ||| S:32950 E:32953 ||| IN
a  ||| S:32953 E:32955 ||| DT
different  ||| S:32955 E:32965 ||| JJ
conformation  ||| S:32965 E:32978 ||| NN
and  ||| S:32978 E:32982 ||| CC
dependent  ||| S:32982 E:32992 ||| JJ
on  ||| S:32992 E:33005 ||| IN
interactions  ||| S:33005 E:33018 ||| NNS
with  ||| S:33018 E:33023 ||| IN
the  ||| S:33023 E:33027 ||| DT
myosin  ||| S:33027 E:33034 ||| JJ
head ||| S:33034 E:33038 ||| NN
.  ||| S:33038 E:33040 ||| .
Our  ||| S:33040 E:33044 ||| PRP$
results  ||| S:33044 E:33052 ||| NNS
therefore  ||| S:33052 E:33072 ||| RB
suggest  ||| S:33072 E:33080 ||| VB
that  ||| S:33080 E:33085 ||| IN
Ca  ||| S:33085 E:33088 ||| NNP
2+either  ||| S:33088 E:33097 ||| NNP
induces  ||| S:33097 E:33105 ||| VBZ
the  ||| S:33105 E:33109 ||| DT
release  ||| S:33109 E:33117 ||| NN
of  ||| S:33117 E:33130 ||| IN
calmodulin  ||| S:33130 E:33141 ||| NN
from  ||| S:33141 E:33146 ||| IN
IQ1  ||| S:33146 E:33150 ||| NNP
or  ||| S:33150 E:33153 ||| CC
causes  ||| S:33153 E:33160 ||| VBZ
it  ||| S:33160 E:33163 ||| PRP
to  ||| S:33163 E:33166 ||| TO
change  ||| S:33166 E:33173 ||| VB
its  ||| S:33173 E:33187 ||| PRP$
interaction  ||| S:33187 E:33199 ||| NN
with  ||| S:33199 E:33204 ||| IN
Myo1c  ||| S:33204 E:33210 ||| NNP
substantially ||| S:33210 E:33223 ||| RB
.  ||| S:33223 E:33235 ||| .
Of  ||| S:33235 E:33238 ||| IN
the  ||| S:33238 E:33242 ||| DT
three  ||| S:33242 E:33248 ||| CD
calmodulins  ||| S:33248 E:33260 ||| NNS
bound  ||| S:33260 E:33266 ||| VBN
to  ||| S:33266 E:33269 ||| TO
Myo1c ||| S:33269 E:33274 ||| CD
,  ||| S:33274 E:33276 ||| ,
one  ||| S:33276 E:33280 ||| CD
of  ||| S:33280 E:33283 ||| IN
these  ||| S:33283 E:33299 ||| DT
binds  ||| S:33299 E:33305 ||| NN
relatively  ||| S:33305 E:33316 ||| RB
weakly  ||| S:33316 E:33323 ||| VBN
at  ||| S:33323 E:33326 ||| IN
25°C ||| S:33326 E:33330 ||| NNP
,  ||| S:33330 E:33332 ||| ,
even  ||| S:33332 E:33337 ||| RB
in  ||| S:33337 E:33340 ||| IN
EGTA ||| S:33340 E:33344 ||| NNP
.  ||| S:33344 E:33346 ||| .
To  ||| S:33346 E:33349 ||| TO
which  ||| S:33349 E:33365 ||| WDT
IQ  ||| S:33365 E:33368 ||| NNP
domain  ||| S:33368 E:33375 ||| NN
does  ||| S:33375 E:33380 ||| VBZ
this  ||| S:33380 E:33385 ||| DT
weakly  ||| S:33385 E:33392 ||| NN
bound  ||| S:33392 E:33398 ||| VBN
light  ||| S:33398 E:33404 ||| JJ
chain  ||| S:33404 E:33410 ||| NN
bind ||| S:33410 E:33414 ||| NN
?  ||| S:33414 E:33426 ||| .
Although  ||| S:33426 E:33435 ||| IN
calmodulin  ||| S:33435 E:33446 ||| JJ
binds  ||| S:33446 E:33452 ||| NN
to  ||| S:33452 E:33455 ||| TO
IQs  ||| S:33455 E:33459 ||| JJ
1-3  ||| S:33459 E:33463 ||| NN
with  ||| S:33463 E:33468 ||| IN
approximately  ||| S:33468 E:33492 ||| RB
the  ||| S:33492 E:33496 ||| DT
same  ||| S:33496 E:33501 ||| JJ
strength  ||| S:33501 E:33510 ||| NN
in  ||| S:33510 E:33513 ||| IN
the  ||| S:33513 E:33517 ||| DT
presence  ||| S:33517 E:33526 ||| NN
of  ||| S:33526 E:33529 ||| IN
EGTA ||| S:33529 E:33533 ||| NNP
,  ||| S:33533 E:33535 ||| ,
we  ||| S:33535 E:33538 ||| PRP
suggest  ||| S:33538 E:33556 ||| VBP
that  ||| S:33556 E:33561 ||| IN
the  ||| S:33561 E:33565 ||| DT
readily  ||| S:33565 E:33573 ||| RB
released  ||| S:33573 E:33582 ||| VBN
calmodulin  ||| S:33582 E:33593 ||| NN
is  ||| S:33593 E:33596 ||| VBZ
likely  ||| S:33596 E:33603 ||| JJ
to  ||| S:33603 E:33606 ||| TO
be  ||| S:33606 E:33609 ||| VB
that  ||| S:33609 E:33624 ||| DT
bound  ||| S:33624 E:33630 ||| VBN
to  ||| S:33630 E:33633 ||| TO
IQ2 ||| S:33633 E:33636 ||| CD
.  ||| S:33636 E:33638 ||| .
To  ||| S:33638 E:33641 ||| TO
bind  ||| S:33641 E:33646 ||| CD
three  ||| S:33646 E:33652 ||| CD
calmodulins ||| S:33652 E:33663 ||| NN
,  ||| S:33663 E:33665 ||| ,
IQs  ||| S:33665 E:33669 ||| NNP
1-3 ||| S:33669 E:33672 ||| NNP
,  ||| S:33672 E:33674 ||| ,
each  ||| S:33674 E:33679 ||| DT
of  ||| S:33679 E:33692 ||| IN
which  ||| S:33692 E:33698 ||| WDT
are  ||| S:33698 E:33702 ||| VBP
only  ||| S:33702 E:33707 ||| RB
23  ||| S:33707 E:33710 ||| CD
amino  ||| S:33710 E:33716 ||| NNS
acids  ||| S:33716 E:33722 ||| VBP
long ||| S:33722 E:33726 ||| RB
,  ||| S:33726 E:33728 ||| ,
must  ||| S:33728 E:33733 ||| MD
be  ||| S:33733 E:33736 ||| VB
arranged  ||| S:33736 E:33755 ||| VBN
without  ||| S:33755 E:33763 ||| IN
kinks  ||| S:33763 E:33769 ||| NNS
[  ||| S:33769 E:33771 ||| -LRB-
32  ||| S:33771 E:33774 ||| CD
]  ||| S:33774 E:33776 ||| -RRB-
;  ||| S:33776 E:33778 ||| :
this  ||| S:33778 E:33783 ||| DT
arrangement  ||| S:33783 E:33795 ||| NN
may  ||| S:33795 E:33799 ||| MD
produce  ||| S:33799 E:33817 ||| VB
unfavorable  ||| S:33817 E:33829 ||| JJ
strain  ||| S:33829 E:33836 ||| NN
on  ||| S:33836 E:33839 ||| IN
each  ||| S:33839 E:33844 ||| DT
of  ||| S:33844 E:33847 ||| IN
the  ||| S:33847 E:33851 ||| DT
calmodulin  ||| S:33851 E:33862 ||| JJ
molecules ||| S:33862 E:33871 ||| NNS
.  ||| S:33871 E:33883 ||| .
Release  ||| S:33883 E:33891 ||| NN
of  ||| S:33891 E:33894 ||| IN
calmodulin  ||| S:33894 E:33905 ||| NN
from  ||| S:33905 E:33910 ||| IN
IQ2  ||| S:33910 E:33914 ||| NNP
would  ||| S:33914 E:33920 ||| MD
relieve  ||| S:33920 E:33928 ||| VB
all  ||| S:33928 E:33932 ||| DT
of  ||| S:33932 E:33935 ||| IN
that  ||| S:33935 E:33950 ||| DT
strain ||| S:33950 E:33956 ||| NN
;  ||| S:33956 E:33958 ||| :
release  ||| S:33958 E:33966 ||| NN
from  ||| S:33966 E:33971 ||| IN
IQs  ||| S:33971 E:33975 ||| JJ
1  ||| S:33975 E:33977 ||| CD
or  ||| S:33977 E:33980 ||| CC
3  ||| S:33980 E:33982 ||| CD
would  ||| S:33982 E:33988 ||| MD
not ||| S:33988 E:33991 ||| RB
.  ||| S:33991 E:33993 ||| .
Strain  ||| S:33993 E:34000 ||| NN
relief  ||| S:34000 E:34017 ||| NN
also  ||| S:34017 E:34022 ||| RB
may  ||| S:34022 E:34026 ||| MD
accelerate  ||| S:34026 E:34037 ||| VB
calmodulin  ||| S:34037 E:34048 ||| JJ
release  ||| S:34048 E:34056 ||| NN
in  ||| S:34056 E:34059 ||| IN
the  ||| S:34059 E:34063 ||| DT
presence  ||| S:34063 E:34072 ||| NN
of  ||| S:34072 E:34085 ||| IN
Ca  ||| S:34085 E:34088 ||| NNP
2+ ||| S:34088 E:34090 ||| NNP
;  ||| S:34090 E:34092 ||| :
because  ||| S:34092 E:34100 ||| IN
Ca  ||| S:34100 E:34103 ||| NNP
2+apparently  ||| S:34103 E:34116 ||| NNP
rearranges  ||| S:34116 E:34127 ||| VBZ
the  ||| S:34127 E:34141 ||| DT
three-dimensional  ||| S:34141 E:34159 ||| JJ
interaction  ||| S:34159 E:34171 ||| NN
of  ||| S:34171 E:34174 ||| IN
calmodulin  ||| S:34174 E:34185 ||| NN
with  ||| S:34185 E:34190 ||| IN
IQ3 ||| S:34190 E:34193 ||| NNP
,  ||| S:34193 E:34205 ||| ,
binding  ||| S:34205 E:34213 ||| VBG
of  ||| S:34213 E:34216 ||| IN
an  ||| S:34216 E:34219 ||| DT
adjacent  ||| S:34219 E:34228 ||| JJ
calmodulin  ||| S:34228 E:34239 ||| NN
-  ||| S:34239 E:34241 ||| :
on  ||| S:34241 E:34244 ||| IN
IQ2  ||| S:34244 E:34248 ||| CD
-  ||| S:34248 E:34250 ||| :
might  ||| S:34250 E:34256 ||| MD
be  ||| S:34256 E:34269 ||| VB
destabilized  ||| S:34269 E:34282 ||| VBN
even  ||| S:34282 E:34287 ||| RB
more  ||| S:34287 E:34292 ||| RBR
[  ||| S:34292 E:34294 ||| -LRB-
32  ||| S:34294 E:34297 ||| CD
]  ||| S:34297 E:34299 ||| -RRB-
.  ||| S:34299 E:34311 ||| .
Despite  ||| S:34311 E:34319 ||| IN
the  ||| S:34319 E:34323 ||| DT
loss  ||| S:34323 E:34328 ||| NN
of  ||| S:34328 E:34331 ||| IN
calmodulin  ||| S:34331 E:34342 ||| NN
from  ||| S:34342 E:34347 ||| IN
T701-Myo1c  ||| S:34347 E:34358 ||| CD
induced  ||| S:34358 E:34376 ||| NN
by  ||| S:34376 E:34379 ||| IN
elevation  ||| S:34379 E:34389 ||| NN
of  ||| S:34389 E:34392 ||| IN
the  ||| S:34392 E:34396 ||| DT
temperature  ||| S:34396 E:34408 ||| NN
from  ||| S:34408 E:34413 ||| IN
4°C  ||| S:34413 E:34417 ||| CD
to  ||| S:34417 E:34420 ||| TO
25°C ||| S:34420 E:34424 ||| CD
,  ||| S:34424 E:34426 ||| ,
the  ||| S:34426 E:34440 ||| DT
frictional  ||| S:34440 E:34451 ||| JJ
ratio  ||| S:34451 E:34457 ||| NN
( ||| S:34457 E:34458 ||| -LRB-
a  ||| S:34458 E:34460 ||| DT
measure  ||| S:34460 E:34468 ||| NN
of  ||| S:34468 E:34471 ||| IN
the  ||| S:34471 E:34475 ||| DT
protein ||| S:34475 E:34482 ||| NN
's  ||| S:34482 E:34485 ||| POS
asymmetry ||| S:34485 E:34494 ||| NN
)  ||| S:34494 E:34506 ||| -RRB-
increased  ||| S:34506 E:34516 ||| VBD
( ||| S:34516 E:34517 ||| -LRB-
Table  ||| S:34517 E:34523 ||| NNP
4 ||| S:34523 E:34524 ||| CD
) ||| S:34524 E:34525 ||| -RRB-
.  ||| S:34525 E:34527 ||| .
The  ||| S:34527 E:34531 ||| DT
neck-tail  ||| S:34531 E:34541 ||| JJ
region  ||| S:34541 E:34548 ||| NN
of  ||| S:34548 E:34551 ||| IN
Myo1c  ||| S:34551 E:34557 ||| NNP
thus  ||| S:34557 E:34572 ||| RB
appears  ||| S:34572 E:34580 ||| VBZ
to  ||| S:34580 E:34583 ||| TO
adopt  ||| S:34583 E:34589 ||| VB
a  ||| S:34589 E:34591 ||| DT
compact  ||| S:34591 E:34599 ||| JJ
structure  ||| S:34599 E:34609 ||| NN
at  ||| S:34609 E:34612 ||| IN
4°C ||| S:34612 E:34615 ||| NNP
,  ||| S:34615 E:34617 ||| ,
becoming  ||| S:34617 E:34636 ||| VBG
more  ||| S:34636 E:34641 ||| RBR
extended  ||| S:34641 E:34650 ||| VBN
at  ||| S:34650 E:34653 ||| IN
25°C ||| S:34653 E:34657 ||| CD
.  ||| S:34657 E:34659 ||| .
Less  ||| S:34659 E:34664 ||| JJR
calmodulin  ||| S:34664 E:34675 ||| NNS
may  ||| S:34675 E:34679 ||| MD
be  ||| S:34679 E:34682 ||| VB
released  ||| S:34682 E:34691 ||| VBN
at  ||| S:34691 E:34704 ||| IN
lower  ||| S:34704 E:34710 ||| JJR
temperatures  ||| S:34710 E:34723 ||| NNS
because  ||| S:34723 E:34731 ||| IN
the  ||| S:34731 E:34735 ||| DT
Myo1c  ||| S:34735 E:34741 ||| JJ
tail  ||| S:34741 E:34746 ||| NN
may  ||| S:34746 E:34750 ||| MD
bind  ||| S:34750 E:34755 ||| VB
to  ||| S:34755 E:34758 ||| TO
and  ||| S:34758 E:34772 ||| CC
stabilize  ||| S:34772 E:34782 ||| VB
calmodulin ||| S:34782 E:34792 ||| NN
's  ||| S:34792 E:34795 ||| POS
interaction  ||| S:34795 E:34807 ||| NN
with  ||| S:34807 E:34812 ||| IN
the  ||| S:34812 E:34816 ||| DT
Myo1c  ||| S:34816 E:34832 ||| JJ
neck ||| S:34832 E:34836 ||| NN
.  ||| S:34836 E:34866 ||| .
Implications  ||| S:34866 E:34879 ||| NNS
for  ||| S:34879 E:34883 ||| IN
Myo1c  ||| S:34883 E:34889 ||| CD
activity  ||| S:34889 E:34908 ||| NN
The  ||| S:34908 E:34912 ||| DT
Ca  ||| S:34912 E:34915 ||| NNP
2+-dependent  ||| S:34915 E:34928 ||| NNP
change  ||| S:34928 E:34935 ||| NN
in  ||| S:34935 E:34938 ||| IN
interaction  ||| S:34938 E:34950 ||| NN
of  ||| S:34950 E:34963 ||| IN
calmodulin  ||| S:34963 E:34974 ||| NN
with  ||| S:34974 E:34979 ||| IN
IQ1 ||| S:34979 E:34982 ||| NNP
,  ||| S:34982 E:34984 ||| ,
the  ||| S:34984 E:34988 ||| DT
IQ  ||| S:34988 E:34991 ||| NNP
domain  ||| S:34991 E:34998 ||| NN
closest  ||| S:34998 E:35006 ||| NN
to  ||| S:35006 E:35009 ||| TO
the  ||| S:35009 E:35013 ||| DT
motor  ||| S:35013 E:35029 ||| NN
domain ||| S:35029 E:35035 ||| NN
,  ||| S:35035 E:35037 ||| ,
has  ||| S:35037 E:35041 ||| VBZ
important  ||| S:35041 E:35051 ||| JJ
implications  ||| S:35051 E:35064 ||| NNS
for  ||| S:35064 E:35068 ||| IN
Myo1c  ||| S:35068 E:35084 ||| CD
mechanochemical  ||| S:35084 E:35100 ||| JJ
function ||| S:35100 E:35108 ||| NN
.  ||| S:35108 E:35110 ||| .
Although  ||| S:35110 E:35119 ||| IN
Ca  ||| S:35119 E:35122 ||| NNP
2+increases  ||| S:35122 E:35134 ||| NNP
Myo1c  ||| S:35134 E:35150 ||| NNP
ATPase  ||| S:35150 E:35157 ||| JJ
activity ||| S:35157 E:35165 ||| NN
,  ||| S:35165 E:35167 ||| ,
the  ||| S:35167 E:35171 ||| DT
ion  ||| S:35171 E:35175 ||| JJ
completely  ||| S:35175 E:35186 ||| JJ
halts  ||| S:35186 E:35203 ||| NNS
in  ||| S:35203 E:35206 ||| IN
vitro  ||| S:35206 E:35212 ||| JJ
motility  ||| S:35212 E:35221 ||| NNS
[  ||| S:35221 E:35223 ||| -LRB-
19  ||| S:35223 E:35226 ||| CD
]  ||| S:35226 E:35228 ||| -RRB-
.  ||| S:35228 E:35230 ||| .
Ca  ||| S:35230 E:35243 ||| NNP
2+-dependent  ||| S:35243 E:35256 ||| NNP
changes  ||| S:35256 E:35264 ||| NNS
in  ||| S:35264 E:35267 ||| IN
conformation  ||| S:35267 E:35280 ||| NNS
may  ||| S:35280 E:35284 ||| MD
prevent  ||| S:35284 E:35302 ||| VB
amplification  ||| S:35302 E:35316 ||| VBN
of  ||| S:35316 E:35319 ||| IN
a  ||| S:35319 E:35321 ||| DT
small  ||| S:35321 E:35327 ||| JJ
converter-domain  ||| S:35327 E:35344 ||| JJ
movement  ||| S:35344 E:35353 ||| NN
into  ||| S:35353 E:35358 ||| IN
a  ||| S:35358 E:35370 ||| DT
large  ||| S:35370 E:35376 ||| JJ
motor  ||| S:35376 E:35382 ||| NN
step ||| S:35382 E:35386 ||| NN
.  ||| S:35386 E:35388 ||| .
In  ||| S:35388 E:35391 ||| IN
the  ||| S:35391 E:35395 ||| DT
presence  ||| S:35395 E:35404 ||| NN
of  ||| S:35404 E:35407 ||| IN
an  ||| S:35407 E:35410 ||| DT
external  ||| S:35410 E:35419 ||| JJ
force ||| S:35419 E:35424 ||| NN
,  ||| S:35424 E:35436 ||| ,
as  ||| S:35436 E:35439 ||| RB
is  ||| S:35439 E:35442 ||| VBZ
seen  ||| S:35442 E:35447 ||| VBN
by  ||| S:35447 E:35450 ||| IN
Myo1c  ||| S:35450 E:35456 ||| CD
during  ||| S:35456 E:35463 ||| IN
an  ||| S:35463 E:35466 ||| DT
excitatory  ||| S:35466 E:35477 ||| JJ
mechanical  ||| S:35477 E:35498 ||| JJ
stimulus  ||| S:35498 E:35507 ||| NN
in  ||| S:35507 E:35510 ||| IN
a  ||| S:35510 E:35512 ||| DT
hair  ||| S:35512 E:35517 ||| NN
cell  ||| S:35517 E:35522 ||| NN
[  ||| S:35522 E:35524 ||| -LRB-
39  ||| S:35524 E:35527 ||| CD
]  ||| S:35527 E:35529 ||| -RRB-
,  ||| S:35529 E:35531 ||| ,
Ca  ||| S:35531 E:35534 ||| NNP
2+ ||| S:35534 E:35536 ||| NNP
( ||| S:35536 E:35537 ||| -LRB-
which  ||| S:35537 E:35543 ||| WDT
enters  ||| S:35543 E:35550 ||| VBZ
the  ||| S:35550 E:35564 ||| DT
cell  ||| S:35564 E:35569 ||| NN
through  ||| S:35569 E:35577 ||| IN
open  ||| S:35577 E:35582 ||| JJ
transduction  ||| S:35582 E:35595 ||| JJ
channels ||| S:35595 E:35603 ||| NNS
) ||| S:35603 E:35604 ||| -RRB-
,  ||| S:35604 E:35606 ||| ,
should  ||| S:35606 E:35613 ||| MD
permit  ||| S:35613 E:35630 ||| VB
Myo1c  ||| S:35630 E:35636 ||| CD
to  ||| S:35636 E:35639 ||| TO
go  ||| S:35639 E:35642 ||| VB
through  ||| S:35642 E:35650 ||| IN
its  ||| S:35650 E:35654 ||| PRP$
ATPase  ||| S:35654 E:35661 ||| JJ
cycle ||| S:35661 E:35666 ||| NN
,  ||| S:35666 E:35668 ||| ,
binding  ||| S:35668 E:35676 ||| VBG
and  ||| S:35676 E:35690 ||| CC
unbinding  ||| S:35690 E:35700 ||| NN
from  ||| S:35700 E:35705 ||| IN
actin ||| S:35705 E:35710 ||| NN
,  ||| S:35710 E:35712 ||| ,
but  ||| S:35712 E:35716 ||| CC
the  ||| S:35716 E:35720 ||| DT
altered  ||| S:35720 E:35728 ||| JJ
interaction  ||| S:35728 E:35740 ||| NN
of  ||| S:35740 E:35753 ||| IN
calmodulin  ||| S:35753 E:35764 ||| NN
and  ||| S:35764 E:35768 ||| CC
IQ1  ||| S:35768 E:35772 ||| NNP
may  ||| S:35772 E:35776 ||| MD
prevent  ||| S:35776 E:35784 ||| VB
force  ||| S:35784 E:35790 ||| NN
production  ||| S:35790 E:35801 ||| NN
by  ||| S:35801 E:35804 ||| IN
the  ||| S:35804 E:35818 ||| DT
motor ||| S:35818 E:35823 ||| NN
.  ||| S:35823 E:35825 ||| .
We  ||| S:35825 E:35828 ||| PRP
predict  ||| S:35828 E:35836 ||| VBP
that  ||| S:35836 E:35841 ||| WDT
Ca  ||| S:35841 E:35844 ||| MD
2+will  ||| S:35844 E:35851 ||| RB
decrease  ||| S:35851 E:35860 ||| VB
the  ||| S:35860 E:35864 ||| DT
stiffness  ||| S:35864 E:35884 ||| NN
of  ||| S:35884 E:35887 ||| IN
a  ||| S:35887 E:35889 ||| DT
Myo1c-actin  ||| S:35889 E:35901 ||| JJ
interaction ||| S:35901 E:35912 ||| NN
,  ||| S:35912 E:35914 ||| ,
preventing  ||| S:35914 E:35925 ||| VBG
coupling  ||| S:35925 E:35934 ||| NN
of  ||| S:35934 E:35937 ||| IN
the  ||| S:35937 E:35951 ||| DT
energy  ||| S:35951 E:35958 ||| NN
released  ||| S:35958 E:35967 ||| VBN
by  ||| S:35967 E:35970 ||| IN
ATP  ||| S:35970 E:35974 ||| NNP
hydrolysis  ||| S:35974 E:35985 ||| VBD
to  ||| S:35985 E:35988 ||| TO
the  ||| S:35988 E:35992 ||| DT
swing  ||| S:35992 E:35998 ||| NN
of  ||| S:35998 E:36001 ||| IN
the  ||| S:36001 E:36015 ||| DT
neck  ||| S:36015 E:36020 ||| NN
[  ||| S:36020 E:36022 ||| -LRB-
40  ||| S:36022 E:36025 ||| CD
]  ||| S:36025 E:36027 ||| -RRB-
.  ||| S:36027 E:36029 ||| .
This  ||| S:36029 E:36034 ||| DT
behavior  ||| S:36034 E:36043 ||| NN
will  ||| S:36043 E:36048 ||| MD
assist  ||| S:36048 E:36055 ||| VB
Myo1c  ||| S:36055 E:36061 ||| CD
in  ||| S:36061 E:36064 ||| IN
its  ||| S:36064 E:36068 ||| PRP$
role  ||| S:36068 E:36083 ||| NN
of  ||| S:36083 E:36086 ||| IN
adaptation  ||| S:36086 E:36097 ||| NN
in  ||| S:36097 E:36100 ||| IN
hair  ||| S:36100 E:36105 ||| NN
cells ||| S:36105 E:36110 ||| NNS
,  ||| S:36110 E:36112 ||| ,
where  ||| S:36112 E:36118 ||| WRB
the  ||| S:36118 E:36122 ||| DT
motor  ||| S:36122 E:36128 ||| NN
reduces  ||| S:36128 E:36146 ||| VBZ
force  ||| S:36146 E:36152 ||| VB
applied  ||| S:36152 E:36160 ||| VBN
to  ||| S:36160 E:36163 ||| TO
the  ||| S:36163 E:36167 ||| DT
hair  ||| S:36167 E:36172 ||| NN
cell ||| S:36172 E:36176 ||| NN
's  ||| S:36176 E:36179 ||| POS
transduction  ||| S:36179 E:36202 ||| JJ
channel ||| S:36202 E:36209 ||| NN
.  ||| S:36209 E:36221 ||| .
A  ||| S:36221 E:36223 ||| DT
limitation  ||| S:36223 E:36234 ||| NN
of  ||| S:36234 E:36237 ||| IN
our  ||| S:36237 E:36241 ||| PRP$
experiments  ||| S:36241 E:36253 ||| NNS
is  ||| S:36253 E:36256 ||| VBZ
the  ||| S:36256 E:36260 ||| DT
restriction  ||| S:36260 E:36272 ||| NN
of  ||| S:36272 E:36285 ||| IN
Myo1c  ||| S:36285 E:36291 ||| CD
binding  ||| S:36291 E:36299 ||| NN
to  ||| S:36299 E:36302 ||| TO
a  ||| S:36302 E:36304 ||| DT
single  ||| S:36304 E:36311 ||| JJ
type  ||| S:36311 E:36316 ||| NN
of  ||| S:36316 E:36319 ||| IN
light  ||| S:36319 E:36325 ||| JJ
chain ||| S:36325 E:36330 ||| NN
,  ||| S:36330 E:36342 ||| ,
calmodulin ||| S:36342 E:36352 ||| NN
.  ||| S:36352 E:36354 ||| .
Other  ||| S:36354 E:36360 ||| JJ
light  ||| S:36360 E:36366 ||| JJ
chains  ||| S:36366 E:36373 ||| NNS
can  ||| S:36373 E:36377 ||| MD
interact  ||| S:36377 E:36386 ||| VB
with  ||| S:36386 E:36391 ||| IN
IQ  ||| S:36391 E:36404 ||| NNP
domains ||| S:36404 E:36411 ||| NN
,  ||| S:36411 E:36413 ||| ,
including  ||| S:36413 E:36423 ||| VBG
essential  ||| S:36423 E:36433 ||| JJ
light  ||| S:36433 E:36439 ||| JJ
chain  ||| S:36439 E:36445 ||| NN
isoforms  ||| S:36445 E:36454 ||| NNS
[  ||| S:36454 E:36456 ||| -LRB-
41  ||| S:36456 E:36459 ||| CD
]  ||| S:36459 E:36471 ||| -RRB-
and  ||| S:36471 E:36475 ||| CC
calmodulin-like  ||| S:36475 E:36491 ||| JJ
protein  ||| S:36491 E:36499 ||| NN
[  ||| S:36499 E:36501 ||| -LRB-
42  ||| S:36501 E:36504 ||| CD
]  ||| S:36504 E:36506 ||| -RRB-
.  ||| S:36506 E:36508 ||| .
Although  ||| S:36508 E:36517 ||| IN
purified  ||| S:36517 E:36536 ||| FW
bovine  ||| S:36536 E:36543 ||| FW
adrenal  ||| S:36543 E:36551 ||| FW
Myo1c  ||| S:36551 E:36557 ||| FW
does  ||| S:36557 E:36562 ||| VBZ
not  ||| S:36562 E:36566 ||| RB
appear  ||| S:36566 E:36573 ||| VB
to  ||| S:36573 E:36576 ||| TO
have  ||| S:36576 E:36581 ||| VB
alternative  ||| S:36581 E:36603 ||| NN
associated  ||| S:36603 E:36614 ||| VBN
light  ||| S:36614 E:36620 ||| JJ
chains  ||| S:36620 E:36627 ||| NNS
[  ||| S:36627 E:36629 ||| -LRB-
12  ||| S:36629 E:36632 ||| CD
]  ||| S:36632 E:36634 ||| -RRB-
,  ||| S:36634 E:36636 ||| ,
we  ||| S:36636 E:36639 ||| PRP
can  ||| S:36639 E:36643 ||| MD
not  ||| S:36643 E:36647 ||| RB
rule  ||| S:36647 E:36652 ||| VB
out  ||| S:36652 E:36656 ||| RP
the  ||| S:36656 E:36670 ||| DT
possibility  ||| S:36670 E:36682 ||| NN
that  ||| S:36682 E:36687 ||| IN
other  ||| S:36687 E:36693 ||| JJ
light  ||| S:36693 E:36699 ||| JJ
chains  ||| S:36699 E:36706 ||| NNS
bind  ||| S:36706 E:36711 ||| NN
in  ||| S:36711 E:36714 ||| IN
a  ||| S:36714 E:36716 ||| DT
cellular  ||| S:36716 E:36735 ||| JJ
context ||| S:36735 E:36742 ||| NN
.  ||| S:36742 E:36744 ||| .
Nevertheless ||| S:36744 E:36756 ||| RB
,  ||| S:36756 E:36758 ||| ,
purified  ||| S:36758 E:36767 ||| JJ
recombinant  ||| S:36767 E:36779 ||| JJ
full-length  ||| S:36779 E:36801 ||| JJ
Myo1c  ||| S:36801 E:36807 ||| NN
associated  ||| S:36807 E:36818 ||| VBN
with  ||| S:36818 E:36823 ||| IN
calmodulin  ||| S:36823 E:36834 ||| JJ
light  ||| S:36834 E:36840 ||| JJ
chains  ||| S:36840 E:36847 ||| NNS
exhibited  ||| S:36847 E:36867 ||| VBP
actin-activated  ||| S:36867 E:36883 ||| JJ
ATPase  ||| S:36883 E:36890 ||| JJ
activity  ||| S:36890 E:36899 ||| NN
and  ||| S:36899 E:36903 ||| CC
motility  ||| S:36903 E:36923 ||| NN
in  ||| S:36923 E:36926 ||| IN
vitro  ||| S:36926 E:36932 ||| NNS
[  ||| S:36932 E:36934 ||| -LRB-
43  ||| S:36934 E:36937 ||| CD
]  ||| S:36937 E:36939 ||| -RRB-
,  ||| S:36939 E:36941 ||| ,
indicating  ||| S:36941 E:36952 ||| VBG
that  ||| S:36952 E:36967 ||| DT
calmodulin  ||| S:36967 E:36978 ||| NN
can  ||| S:36978 E:36982 ||| MD
function  ||| S:36982 E:36991 ||| VB
as  ||| S:36991 E:36994 ||| IN
a  ||| S:36994 E:36996 ||| DT
Myo1c  ||| S:36996 E:37002 ||| JJ
light  ||| S:37002 E:37008 ||| JJ
chain ||| S:37008 E:37013 ||| NN
.  ||| S:37013 E:37025 ||| .
That  ||| S:37025 E:37030 ||| IN
Myo1c  ||| S:37030 E:37036 ||| NNP
does  ||| S:37036 E:37041 ||| VBZ
not  ||| S:37041 E:37045 ||| RB
bind  ||| S:37045 E:37050 ||| JJ
calmodulin  ||| S:37050 E:37061 ||| NNS
tightly  ||| S:37061 E:37069 ||| RB
is ||| S:37069 E:37071 ||| VBZ
,  ||| S:37071 E:37073 ||| ,
at  ||| S:37073 E:37086 ||| IN
first  ||| S:37086 E:37092 ||| JJ
glance ||| S:37092 E:37098 ||| NN
,  ||| S:37098 E:37100 ||| ,
surprising ||| S:37100 E:37110 ||| JJ
.  ||| S:37110 E:37112 ||| .
Weak  ||| S:37112 E:37117 ||| JJ
calmodulin  ||| S:37117 E:37128 ||| JJ
binding  ||| S:37128 E:37136 ||| NN
may ||| S:37136 E:37139 ||| MD
,  ||| S:37139 E:37151 ||| ,
however ||| S:37151 E:37158 ||| RB
,  ||| S:37158 E:37160 ||| ,
permit  ||| S:37160 E:37167 ||| JJ
access  ||| S:37167 E:37174 ||| NN
of  ||| S:37174 E:37177 ||| IN
IQ  ||| S:37177 E:37180 ||| NNP
domains  ||| S:37180 E:37188 ||| VBD
to  ||| S:37188 E:37191 ||| TO
intracellular  ||| S:37191 E:37215 ||| CD
Myo1c  ||| S:37215 E:37221 ||| CD
receptors ||| S:37221 E:37230 ||| NNS
.  ||| S:37230 E:37232 ||| .
Accordingly ||| S:37232 E:37243 ||| RB
,  ||| S:37243 E:37245 ||| ,
we  ||| S:37245 E:37248 ||| PRP
have  ||| S:37248 E:37253 ||| VBP
found  ||| S:37253 E:37259 ||| VBN
that  ||| S:37259 E:37264 ||| IN
a  ||| S:37264 E:37266 ||| DT
Myo1c  ||| S:37266 E:37282 ||| JJ
fragment  ||| S:37282 E:37291 ||| NN
containing  ||| S:37291 E:37302 ||| VBG
only  ||| S:37302 E:37307 ||| RB
IQs  ||| S:37307 E:37311 ||| JJ
1-3 ||| S:37311 E:37314 ||| NN
,  ||| S:37314 E:37316 ||| ,
partially  ||| S:37316 E:37326 ||| RB
complexed  ||| S:37326 E:37346 ||| VBN
with  ||| S:37346 E:37351 ||| IN
calmodulin ||| S:37351 E:37361 ||| NN
,  ||| S:37361 E:37363 ||| ,
binds  ||| S:37363 E:37369 ||| JJ
avidly  ||| S:37369 E:37376 ||| NN
to  ||| S:37376 E:37379 ||| TO
hair-cell  ||| S:37379 E:37389 ||| JJ
receptors ||| S:37389 E:37398 ||| NNS
;  ||| S:37398 E:37410 ||| :
excess  ||| S:37410 E:37417 ||| JJ
calmodulin  ||| S:37417 E:37428 ||| JJ
blocks  ||| S:37428 E:37435 ||| NNS
this  ||| S:37435 E:37440 ||| DT
interaction ||| S:37440 E:37451 ||| NN
,  ||| S:37451 E:37453 ||| ,
probably  ||| S:37453 E:37462 ||| RB
by  ||| S:37462 E:37475 ||| IN
binding  ||| S:37475 E:37483 ||| VBG
to  ||| S:37483 E:37486 ||| TO
an  ||| S:37486 E:37489 ||| DT
unoccupied  ||| S:37489 E:37500 ||| JJ
IQ  ||| S:37500 E:37503 ||| NNP
site  ||| S:37503 E:37508 ||| NN
on  ||| S:37508 E:37511 ||| IN
the  ||| S:37511 E:37515 ||| DT
Myo1c  ||| S:37515 E:37521 ||| JJ
fragment  ||| S:37521 E:37530 ||| NN
[  ||| S:37530 E:37542 ||| -LRB-
13  ||| S:37542 E:37545 ||| CD
]  ||| S:37545 E:37547 ||| -RRB-
.  ||| S:37547 E:37549 ||| .
IQ2  ||| S:37549 E:37553 ||| NNP
is  ||| S:37553 E:37556 ||| VBZ
highly  ||| S:37556 E:37563 ||| RB
conserved  ||| S:37563 E:37573 ||| VBN
between  ||| S:37573 E:37581 ||| IN
species ||| S:37581 E:37588 ||| NNS
,  ||| S:37588 E:37590 ||| ,
leading  ||| S:37590 E:37608 ||| VBG
us  ||| S:37608 E:37611 ||| PRP
to  ||| S:37611 E:37614 ||| TO
propose  ||| S:37614 E:37622 ||| VB
that  ||| S:37622 E:37627 ||| DT
hair-cell  ||| S:37627 E:37637 ||| JJ
receptors  ||| S:37637 E:37647 ||| JJ
interact  ||| S:37647 E:37656 ||| NN
through  ||| S:37656 E:37674 ||| IN
this  ||| S:37674 E:37679 ||| DT
region  ||| S:37679 E:37686 ||| NN
[  ||| S:37686 E:37688 ||| -LRB-
13  ||| S:37688 E:37691 ||| CD
]  ||| S:37691 E:37693 ||| -RRB-
.  ||| S:37693 E:37695 ||| .
Because  ||| S:37695 E:37703 ||| IN
Myo1c-interacting  ||| S:37703 E:37721 ||| CD
proteins  ||| S:37721 E:37740 ||| NNS
in  ||| S:37740 E:37743 ||| IN
hair  ||| S:37743 E:37748 ||| NN
cells  ||| S:37748 E:37754 ||| NNS
and  ||| S:37754 E:37758 ||| CC
elsewhere  ||| S:37758 E:37768 ||| RB
may  ||| S:37768 E:37772 ||| MD
interact  ||| S:37772 E:37781 ||| VB
through  ||| S:37781 E:37789 ||| IN
IQ  ||| S:37789 E:37802 ||| NNP
domains ||| S:37802 E:37809 ||| NN
,  ||| S:37809 E:37811 ||| ,
regulation  ||| S:37811 E:37822 ||| NN
of  ||| S:37822 E:37825 ||| IN
calmodulin  ||| S:37825 E:37836 ||| JJ
binding  ||| S:37836 E:37844 ||| NN
to  ||| S:37844 E:37847 ||| TO
Myo1c  ||| S:37847 E:37853 ||| CD
-  ||| S:37853 E:37855 ||| :
for  ||| S:37855 E:37869 ||| IN
example ||| S:37869 E:37876 ||| NN
,  ||| S:37876 E:37878 ||| ,
by  ||| S:37878 E:37881 ||| IN
Ca  ||| S:37881 E:37884 ||| NNP
2+-  ||| S:37884 E:37888 ||| NNP
likely  ||| S:37888 E:37895 ||| RB
affects  ||| S:37895 E:37903 ||| VBZ
coupling  ||| S:37903 E:37912 ||| VBN
of  ||| S:37912 E:37915 ||| IN
the  ||| S:37915 E:37919 ||| DT
motor  ||| S:37919 E:37935 ||| NN
protein  ||| S:37935 E:37943 ||| NN
to  ||| S:37943 E:37946 ||| TO
its  ||| S:37946 E:37950 ||| PRP$
cargo ||| S:37950 E:37955 ||| NN
.  ||| S:37955 E:37988 ||| .
Conclusions  ||| S:37988 E:38008 ||| NNS
Under  ||| S:38008 E:38014 ||| IN
low  ||| S:38014 E:38018 ||| JJ
Ca  ||| S:38018 E:38021 ||| NNP
2+conditions  ||| S:38021 E:38034 ||| NNP
and  ||| S:38034 E:38038 ||| CC
normal  ||| S:38038 E:38045 ||| JJ
ionic  ||| S:38045 E:38051 ||| JJ
strength ||| S:38051 E:38059 ||| NN
,  ||| S:38059 E:38069 ||| ,
calmodulin  ||| S:38069 E:38080 ||| JJ
binds  ||| S:38080 E:38086 ||| NNS
moderately  ||| S:38086 E:38097 ||| RB
tightly  ||| S:38097 E:38105 ||| RB
to  ||| S:38105 E:38108 ||| TO
three  ||| S:38108 E:38114 ||| CD
Myo1c  ||| S:38114 E:38120 ||| CD
IQ  ||| S:38120 E:38131 ||| NNP
domains ||| S:38131 E:38138 ||| NN
,  ||| S:38138 E:38140 ||| ,
IQ1 ||| S:38140 E:38143 ||| NNP
,  ||| S:38143 E:38145 ||| ,
IQ2 ||| S:38145 E:38148 ||| NNP
,  ||| S:38148 E:38150 ||| ,
and  ||| S:38150 E:38154 ||| CC
IQ3 ||| S:38154 E:38157 ||| NNP
.  ||| S:38157 E:38159 ||| .
IQ4  ||| S:38159 E:38163 ||| NNP
will  ||| S:38163 E:38168 ||| MD
only  ||| S:38168 E:38173 ||| RB
be  ||| S:38173 E:38176 ||| VB
occupied  ||| S:38176 E:38185 ||| VBN
when  ||| S:38185 E:38198 ||| WRB
the  ||| S:38198 E:38202 ||| DT
calmodulin  ||| S:38202 E:38213 ||| JJ
concentration  ||| S:38213 E:38227 ||| NN
is  ||| S:38227 E:38230 ||| VBZ
very  ||| S:38230 E:38235 ||| RB
high ||| S:38235 E:38239 ||| JJ
.  ||| S:38239 E:38241 ||| .
When  ||| S:38241 E:38246 ||| WRB
linearly  ||| S:38246 E:38263 ||| NNS
arranged  ||| S:38263 E:38272 ||| VBN
in  ||| S:38272 E:38275 ||| IN
the  ||| S:38275 E:38279 ||| DT
Myo1c  ||| S:38279 E:38285 ||| JJ
molecule ||| S:38285 E:38293 ||| NN
,  ||| S:38293 E:38295 ||| ,
at  ||| S:38295 E:38298 ||| IN
least  ||| S:38298 E:38304 ||| JJS
one  ||| S:38304 E:38308 ||| CD
calmodulin  ||| S:38308 E:38327 ||| NNS
( ||| S:38327 E:38328 ||| -LRB-
most  ||| S:38328 E:38333 ||| RBS
likely  ||| S:38333 E:38340 ||| JJ
that  ||| S:38340 E:38345 ||| IN
bound  ||| S:38345 E:38351 ||| VBN
to  ||| S:38351 E:38354 ||| TO
IQ2 ||| S:38354 E:38357 ||| CD
)  ||| S:38357 E:38359 ||| -RRB-
is  ||| S:38359 E:38362 ||| VBZ
bound  ||| S:38362 E:38368 ||| VBN
less  ||| S:38368 E:38373 ||| RBR
tightly ||| S:38373 E:38380 ||| RB
,  ||| S:38380 E:38390 ||| ,
probably  ||| S:38390 E:38399 ||| RB
due  ||| S:38399 E:38403 ||| JJ
to  ||| S:38403 E:38406 ||| TO
steric  ||| S:38406 E:38413 ||| VB
constraints ||| S:38413 E:38424 ||| NNS
.  ||| S:38424 E:38426 ||| .
Upon  ||| S:38426 E:38431 ||| IN
binding  ||| S:38431 E:38439 ||| JJ
Ca  ||| S:38439 E:38442 ||| NNP
2+ ||| S:38442 E:38444 ||| NNP
,  ||| S:38444 E:38454 ||| ,
calmodulin  ||| S:38454 E:38465 ||| VBD
bound  ||| S:38465 E:38471 ||| VBN
to  ||| S:38471 E:38474 ||| TO
IQ2  ||| S:38474 E:38478 ||| CD
dissociates ||| S:38478 E:38489 ||| NNS
;  ||| S:38489 E:38491 ||| :
that  ||| S:38491 E:38496 ||| IN
bound  ||| S:38496 E:38502 ||| VBN
to  ||| S:38502 E:38505 ||| TO
IQ1  ||| S:38505 E:38517 ||| CD
either  ||| S:38517 E:38524 ||| DT
dissociates  ||| S:38524 E:38536 ||| NN
or  ||| S:38536 E:38539 ||| CC
changes  ||| S:38539 E:38547 ||| VBZ
its  ||| S:38547 E:38551 ||| PRP$
conformation  ||| S:38551 E:38564 ||| JJ
sufficiently  ||| S:38564 E:38585 ||| NN
that  ||| S:38585 E:38590 ||| IN
chemomechanical  ||| S:38590 E:38606 ||| FW
coupling  ||| S:38606 E:38615 ||| FW
cannot  ||| S:38615 E:38622 ||| FW
ensue ||| S:38622 E:38627 ||| FW
.  ||| S:38627 E:38651 ||| .
Methods  ||| S:38651 E:38678 ||| NNP
Peptide  ||| S:38678 E:38686 ||| NNP
-  ||| S:38686 E:38688 ||| :
calmodulin  ||| S:38688 E:38699 ||| JJ
interaction  ||| S:38699 E:38711 ||| NN
on  ||| S:38711 E:38714 ||| IN
plates  ||| S:38714 E:38731 ||| JJ
Bullfrog  ||| S:38731 E:38740 ||| NNP
Myo1c  ||| S:38740 E:38746 ||| NNP
IQ  ||| S:38746 E:38749 ||| NNP
peptides  ||| S:38749 E:38758 ||| NN
were  ||| S:38758 E:38763 ||| VBD
synthesized  ||| S:38763 E:38775 ||| NNS
( ||| S:38775 E:38776 ||| -LRB-
Genemed  ||| S:38776 E:38794 ||| NNP
Synthesis ||| S:38794 E:38803 ||| NNP
,  ||| S:38803 E:38805 ||| ,
South  ||| S:38805 E:38811 ||| NNP
San  ||| S:38811 E:38815 ||| NNP
Francisco ||| S:38815 E:38824 ||| NNP
,  ||| S:38824 E:38826 ||| ,
CA ||| S:38826 E:38828 ||| NNP
)  ||| S:38828 E:38830 ||| -RRB-
with  ||| S:38830 E:38835 ||| IN
N-terminal  ||| S:38835 E:38856 ||| JJ
cysteine  ||| S:38856 E:38865 ||| JJ
residues ||| S:38865 E:38873 ||| NNS
:  ||| S:38873 E:38875 ||| :
IQ1  ||| S:38875 E:38879 ||| CD
( ||| S:38879 E:38880 ||| -LRB-
residues  ||| S:38880 E:38889 ||| FW
698-720 ||| S:38889 E:38896 ||| FW
) ||| S:38896 E:38897 ||| -RRB-
,  ||| S:38897 E:38909 ||| ,
CRKHSIATFLQARWRGYHQRQKFL ||| S:38909 E:38933 ||| NNP
;  ||| S:38933 E:38935 ||| :
IQ2  ||| S:38935 E:38939 ||| CD
( ||| S:38939 E:38940 ||| -LRB-
721-743 ||| S:38940 E:38947 ||| NNP
) ||| S:38947 E:38948 ||| -RRB-
,  ||| S:38948 E:38960 ||| ,
CHMKHSAVEIQSWWRGTIGRRKAA ||| S:38960 E:38984 ||| NNP
;  ||| S:38984 E:38986 ||| :
IQ3  ||| S:38986 E:38990 ||| CD
( ||| S:38990 E:38991 ||| -LRB-
744-766 ||| S:38991 E:38998 ||| NNP
) ||| S:38998 E:38999 ||| -RRB-
,  ||| S:38999 E:39011 ||| ,
CKRKWAVDVVRRFIKGFIYRNQPR ||| S:39011 E:39035 ||| NNP
;  ||| S:39035 E:39037 ||| :
and  ||| S:39037 E:39041 ||| CC
IQ4  ||| S:39041 E:39045 ||| NNP
( ||| S:39045 E:39046 ||| -LRB-
767-791 ||| S:39046 E:39053 ||| NNP
;  ||| S:39053 E:39055 ||| :
native  ||| S:39055 E:39072 ||| JJ
cysteine  ||| S:39072 E:39081 ||| NN
at  ||| S:39081 E:39084 ||| IN
residue  ||| S:39084 E:39092 ||| CD
767 ||| S:39092 E:39095 ||| CD
) ||| S:39095 E:39096 ||| -RRB-
,  ||| S:39096 E:39098 ||| ,
CTENEYFLDYIRYSFLMTLYRNQPK ||| S:39098 E:39123 ||| NNP
.  ||| S:39123 E:39135 ||| .
Peptide  ||| S:39135 E:39143 ||| JJ
concentrations  ||| S:39143 E:39158 ||| NNS
were  ||| S:39158 E:39163 ||| VBD
measured  ||| S:39163 E:39172 ||| VBN
by  ||| S:39172 E:39175 ||| IN
determining  ||| S:39175 E:39197 ||| VBG
optical  ||| S:39197 E:39205 ||| JJ
density  ||| S:39205 E:39213 ||| NN
at  ||| S:39213 E:39216 ||| IN
280  ||| S:39216 E:39220 ||| CD
nm ||| S:39220 E:39222 ||| NN
,  ||| S:39222 E:39224 ||| ,
using  ||| S:39224 E:39230 ||| VBG
calculated  ||| S:39230 E:39241 ||| VBN
molar  ||| S:39241 E:39257 ||| JJ
extinction  ||| S:39257 E:39268 ||| NN
coefficients  ||| S:39268 E:39281 ||| NN
of  ||| S:39281 E:39284 ||| IN
7090  ||| S:39284 E:39289 ||| CD
( ||| S:39289 E:39290 ||| -LRB-
IQ1 ||| S:39290 E:39293 ||| NNP
) ||| S:39293 E:39294 ||| -RRB-
,  ||| S:39294 E:39296 ||| ,
11500  ||| S:39296 E:39302 ||| CD
( ||| S:39302 E:39303 ||| -LRB-
IQ2 ||| S:39303 E:39306 ||| NNP
) ||| S:39306 E:39307 ||| -RRB-
,  ||| S:39307 E:39309 ||| ,
7090  ||| S:39309 E:39324 ||| CD
( ||| S:39324 E:39325 ||| -LRB-
IQ3 ||| S:39325 E:39328 ||| NNP
) ||| S:39328 E:39329 ||| -RRB-
,  ||| S:39329 E:39331 ||| ,
and  ||| S:39331 E:39335 ||| CC
5240  ||| S:39335 E:39340 ||| CD
M  ||| S:39340 E:39342 ||| NNP
-1cm  ||| S:39342 E:39347 ||| NNP
-1 ||| S:39347 E:39349 ||| NNP
( ||| S:39349 E:39350 ||| -LRB-
IQ4 ||| S:39350 E:39353 ||| NNP
) ||| S:39353 E:39354 ||| -RRB-
.  ||| S:39354 E:39356 ||| .
We  ||| S:39356 E:39359 ||| PRP
also  ||| S:39359 E:39364 ||| RB
synthesized  ||| S:39364 E:39376 ||| VB
a  ||| S:39376 E:39388 ||| DT
negative-control  ||| S:39388 E:39405 ||| JJ
peptide  ||| S:39405 E:39413 ||| NNS
( ||| S:39413 E:39414 ||| -LRB-
"PVP ||| S:39414 E:39418 ||| NNP
" ||| S:39418 E:39419 ||| ''
)  ||| S:39419 E:39421 ||| -RRB-
corresponding  ||| S:39421 E:39435 ||| JJ
to  ||| S:39435 E:39438 ||| TO
amino  ||| S:39438 E:39454 ||| VB
acids  ||| S:39454 E:39460 ||| JJ
792-816  ||| S:39460 E:39468 ||| NN
of  ||| S:39468 E:39471 ||| IN
frog  ||| S:39471 E:39476 ||| CD
Myo1c  ||| S:39476 E:39482 ||| CD
( ||| S:39482 E:39483 ||| -LRB-
SVLDKSWPVPPPSLREASELLREMC ||| S:39483 E:39508 ||| NNP
;  ||| S:39508 E:39520 ||| :
native  ||| S:39520 E:39527 ||| CD
C816 ||| S:39527 E:39531 ||| CD
)  ||| S:39531 E:39533 ||| -RRB-
and  ||| S:39533 E:39537 ||| CC
a  ||| S:39537 E:39539 ||| DT
positive  ||| S:39539 E:39548 ||| JJ
control  ||| S:39548 E:39556 ||| NN
IQ-peptide  ||| S:39556 E:39567 ||| NNS
( ||| S:39567 E:39568 ||| -LRB-
"NM ||| S:39568 E:39571 ||| NNP
" ||| S:39571 E:39572 ||| ''
)  ||| S:39572 E:39584 ||| -RRB-
corresponding  ||| S:39584 E:39598 ||| JJ
to  ||| S:39598 E:39601 ||| TO
amino  ||| S:39601 E:39607 ||| VB
acids  ||| S:39607 E:39613 ||| JJ
29-52  ||| S:39613 E:39619 ||| NN
of  ||| S:39619 E:39622 ||| IN
bovine  ||| S:39622 E:39629 ||| JJ
neuromodulin  ||| S:39629 E:39652 ||| NN
with  ||| S:39652 E:39657 ||| IN
an  ||| S:39657 E:39660 ||| DT
added  ||| S:39660 E:39666 ||| JJ
C-terminal  ||| S:39666 E:39677 ||| JJ
cysteine  ||| S:39677 E:39696 ||| NNS
( ||| S:39696 E:39697 ||| -LRB-
KAHKAATKIQASFRGHITRKKLKC ||| S:39697 E:39721 ||| NNP
)  ||| S:39721 E:39723 ||| -RRB-
[  ||| S:39723 E:39725 ||| -LRB-
24  ||| S:39725 E:39728 ||| CD
]  ||| S:39728 E:39730 ||| -RRB-
.  ||| S:39730 E:39742 ||| .
For  ||| S:39742 E:39746 ||| IN
measuring  ||| S:39746 E:39756 ||| VBG
interaction  ||| S:39756 E:39768 ||| NN
of  ||| S:39768 E:39771 ||| IN
calmodulin  ||| S:39771 E:39782 ||| NN
with  ||| S:39782 E:39787 ||| IN
peptides  ||| S:39787 E:39806 ||| JJ
conjugated  ||| S:39806 E:39817 ||| NN
to  ||| S:39817 E:39820 ||| TO
plastic  ||| S:39820 E:39828 ||| JJ
plates ||| S:39828 E:39834 ||| NN
,  ||| S:39834 E:39836 ||| ,
we  ||| S:39836 E:39839 ||| PRP
incubated  ||| S:39839 E:39849 ||| VBD
10  ||| S:39849 E:39852 ||| CD
μM  ||| S:39852 E:39855 ||| JJ
peptide  ||| S:39855 E:39873 ||| NN
in  ||| S:39873 E:39876 ||| IN
phosphate-buffered  ||| S:39876 E:39895 ||| JJ
saline  ||| S:39895 E:39902 ||| NNS
( ||| S:39902 E:39903 ||| -LRB-
PBS ||| S:39903 E:39906 ||| NNP
;  ||| S:39906 E:39908 ||| :
137  ||| S:39908 E:39912 ||| CD
mM  ||| S:39912 E:39915 ||| JJ
NaCl ||| S:39915 E:39919 ||| NN
,  ||| S:39919 E:39921 ||| ,
2.7  ||| S:39921 E:39925 ||| CD
mM  ||| S:39925 E:39938 ||| JJ
KCl ||| S:39938 E:39941 ||| NN
,  ||| S:39941 E:39943 ||| ,
4.3  ||| S:39943 E:39947 ||| CD
mM  ||| S:39947 E:39950 ||| JJ
Na  ||| S:39950 E:39964 ||| NNP
2  ||| S:39964 E:39966 ||| CD
HPO  ||| S:39966 E:39981 ||| CD
4  ||| S:39981 E:39983 ||| CD
,  ||| S:39983 E:39985 ||| ,
1.4  ||| S:39985 E:39989 ||| CD
mM  ||| S:39989 E:39992 ||| JJ
KH  ||| S:39992 E:40006 ||| NNP
2  ||| S:40006 E:40008 ||| CD
PO  ||| S:40008 E:40022 ||| CD
4  ||| S:40022 E:40024 ||| CD
,  ||| S:40024 E:40026 ||| ,
pH  ||| S:40026 E:40029 ||| JJ
7.4 ||| S:40029 E:40032 ||| CD
)  ||| S:40032 E:40034 ||| -RRB-
overnight  ||| S:40034 E:40044 ||| JJ
at  ||| S:40044 E:40047 ||| IN
room  ||| S:40047 E:40062 ||| NN
temperature  ||| S:40062 E:40074 ||| NN
in  ||| S:40074 E:40077 ||| IN
a  ||| S:40077 E:40079 ||| DT
maleimide-derivatized  ||| S:40079 E:40101 ||| JJ
96-well  ||| S:40101 E:40109 ||| CD
plate  ||| S:40109 E:40125 ||| NN
( ||| S:40125 E:40126 ||| -LRB-
Pierce ||| S:40126 E:40132 ||| NNP
,  ||| S:40132 E:40134 ||| ,
Rockford ||| S:40134 E:40142 ||| NNP
,  ||| S:40142 E:40144 ||| ,
IL ||| S:40144 E:40146 ||| NNP
) ||| S:40146 E:40147 ||| -RRB-
.  ||| S:40147 E:40149 ||| .
Peptide  ||| S:40149 E:40157 ||| NNP
was  ||| S:40157 E:40161 ||| VBD
present  ||| S:40161 E:40169 ||| JJ
in  ||| S:40169 E:40172 ||| IN
large  ||| S:40172 E:40188 ||| JJ
excess  ||| S:40188 E:40195 ||| NN
over  ||| S:40195 E:40200 ||| IN
free  ||| S:40200 E:40205 ||| JJ
binding  ||| S:40205 E:40213 ||| JJ
sites  ||| S:40213 E:40219 ||| NNS
( ||| S:40219 E:40220 ||| -LRB-
25-50  ||| S:40220 E:40226 ||| FW
pmol ||| S:40226 E:40230 ||| FW
)  ||| S:40230 E:40232 ||| -RRB-
on  ||| S:40232 E:40235 ||| IN
the  ||| S:40235 E:40249 ||| DT
plates ||| S:40249 E:40255 ||| NN
.  ||| S:40255 E:40257 ||| .
To  ||| S:40257 E:40260 ||| TO
remove  ||| S:40260 E:40267 ||| VB
unconjugated  ||| S:40267 E:40280 ||| JJ
peptides ||| S:40280 E:40288 ||| NN
,  ||| S:40288 E:40290 ||| ,
plates  ||| S:40290 E:40297 ||| NN
were  ||| S:40297 E:40312 ||| VBD
washed  ||| S:40312 E:40319 ||| VBN
with  ||| S:40319 E:40324 ||| IN
PBS ||| S:40324 E:40327 ||| NNP
;  ||| S:40327 E:40329 ||| :
unreacted  ||| S:40329 E:40339 ||| JJ
sites  ||| S:40339 E:40345 ||| NNS
were  ||| S:40345 E:40350 ||| VBD
saturated  ||| S:40350 E:40360 ||| VBN
by  ||| S:40360 E:40373 ||| IN
incubating  ||| S:40373 E:40384 ||| NN
with  ||| S:40384 E:40389 ||| IN
10  ||| S:40389 E:40392 ||| CD
μg ||| S:40392 E:40394 ||| CD
/ ||| S:40394 E:40395 ||| CD
ml  ||| S:40395 E:40398 ||| JJ
cysteine  ||| S:40398 E:40407 ||| NN
for  ||| S:40407 E:40411 ||| IN
1  ||| S:40411 E:40413 ||| CD
hour ||| S:40413 E:40417 ||| NN
.  ||| S:40417 E:40419 ||| .
We  ||| S:40419 E:40422 ||| PRP
then  ||| S:40422 E:40437 ||| RB
incubated  ||| S:40437 E:40447 ||| VB
the  ||| S:40447 E:40451 ||| DT
peptide-conjugated  ||| S:40451 E:40470 ||| JJ
plates  ||| S:40470 E:40477 ||| NN
with  ||| S:40477 E:40482 ||| IN
50  ||| S:40482 E:40485 ||| CD
nM  ||| S:40485 E:40488 ||| JJ
Alexa  ||| S:40488 E:40504 ||| NNP
Fluor  ||| S:40504 E:40510 ||| NNP
488  ||| S:40510 E:40514 ||| CD
calmodulin  ||| S:40514 E:40525 ||| NNS
( ||| S:40525 E:40526 ||| -LRB-
Alexa-calmodulin ||| S:40526 E:40542 ||| NNP
;  ||| S:40542 E:40544 ||| :
Molecular  ||| S:40544 E:40554 ||| NNP
Probes ||| S:40554 E:40560 ||| NNP
,  ||| S:40560 E:40572 ||| ,
Eugene ||| S:40572 E:40578 ||| NNP
,  ||| S:40578 E:40580 ||| ,
OR ||| S:40580 E:40582 ||| NNP
)  ||| S:40582 E:40584 ||| -RRB-
in  ||| S:40584 E:40587 ||| IN
100  ||| S:40587 E:40591 ||| CD
μl  ||| S:40591 E:40594 ||| NN
of  ||| S:40594 E:40597 ||| IN
a  ||| S:40597 E:40599 ||| DT
solution  ||| S:40599 E:40608 ||| NN
that  ||| S:40608 E:40613 ||| WDT
contained  ||| S:40613 E:40623 ||| VBD
150  ||| S:40623 E:40627 ||| CD
or  ||| S:40627 E:40640 ||| CC
400  ||| S:40640 E:40644 ||| CD
mM  ||| S:40644 E:40647 ||| JJ
KCl ||| S:40647 E:40650 ||| NN
,  ||| S:40650 E:40652 ||| ,
1  ||| S:40652 E:40654 ||| CD
mM  ||| S:40654 E:40657 ||| JJ
MgCl  ||| S:40657 E:40673 ||| JJ
2  ||| S:40673 E:40675 ||| CD
,  ||| S:40675 E:40677 ||| ,
100  ||| S:40677 E:40681 ||| CD
μM  ||| S:40681 E:40684 ||| JJ
ethylene  ||| S:40684 E:40703 ||| NN
glycol-bis ||| S:40703 E:40713 ||| NNS
( ||| S:40713 E:40714 ||| -LRB-
β-aminoethylether ||| S:40714 E:40731 ||| NNP
) ||| S:40731 E:40732 ||| -RRB-
-N ||| S:40732 E:40734 ||| NNP
, ||| S:40734 E:40735 ||| ,
N ||| S:40735 E:40736 ||| NNP
, ||| S:40736 E:40737 ||| ,
N ||| S:40737 E:40738 ||| NNP
' ||| S:40738 E:40739 ||| POS
, ||| S:40739 E:40740 ||| ,
N ||| S:40740 E:40741 ||| NNP
' ||| S:40741 E:40742 ||| POS
-tetraacetic  ||| S:40742 E:40755 ||| JJ
acid  ||| S:40755 E:40770 ||| NN
( ||| S:40770 E:40771 ||| -LRB-
EGTA ||| S:40771 E:40775 ||| NNP
)  ||| S:40775 E:40777 ||| -RRB-
or  ||| S:40777 E:40780 ||| CC
25  ||| S:40780 E:40783 ||| CD
μM  ||| S:40783 E:40786 ||| JJ
CaCl  ||| S:40786 E:40802 ||| JJ
2  ||| S:40802 E:40804 ||| CD
,  ||| S:40804 E:40806 ||| ,
and  ||| S:40806 E:40810 ||| CC
15  ||| S:40810 E:40813 ||| CD
mM  ||| S:40813 E:40826 ||| JJ
2- ||| S:40826 E:40828 ||| NNP
[ ||| S:40828 E:40829 ||| -LRB-
4- ||| S:40829 E:40831 ||| NNP
( ||| S:40831 E:40832 ||| -LRB-
2-hydroxyethyl ||| S:40832 E:40846 ||| NNP
) ||| S:40846 E:40847 ||| -RRB-
-1-piperazinyl ||| S:40847 E:40861 ||| CD
]  ||| S:40861 E:40863 ||| -RRB-
ethanesulfonic  ||| S:40863 E:40878 ||| JJ
acid  ||| S:40878 E:40893 ||| NN
( ||| S:40893 E:40894 ||| -LRB-
HEPES ||| S:40894 E:40899 ||| NNP
)  ||| S:40899 E:40901 ||| -RRB-
at  ||| S:40901 E:40904 ||| IN
pH  ||| S:40904 E:40907 ||| JJ
7.5 ||| S:40907 E:40910 ||| CD
.  ||| S:40910 E:40912 ||| .
According  ||| S:40912 E:40922 ||| VBG
to  ||| S:40922 E:40925 ||| TO
the  ||| S:40925 E:40929 ||| DT
manufacturer ||| S:40929 E:40941 ||| NN
,  ||| S:40941 E:40953 ||| ,
Alexa-calmodulin  ||| S:40953 E:40970 ||| NNP
had  ||| S:40970 E:40974 ||| VBD
two  ||| S:40974 E:40978 ||| CD
dye  ||| S:40978 E:40982 ||| FW
moieties  ||| S:40982 E:40991 ||| FW
per  ||| S:40991 E:40995 ||| FW
calmodulin  ||| S:40995 E:41016 ||| FW
molecule ||| S:41016 E:41024 ||| FW
;  ||| S:41024 E:41026 ||| :
the  ||| S:41026 E:41030 ||| DT
modified  ||| S:41030 E:41039 ||| JJ
residues  ||| S:41039 E:41048 ||| NNS
were  ||| S:41048 E:41053 ||| VBD
likely  ||| S:41053 E:41060 ||| JJ
Lys-75  ||| S:41060 E:41067 ||| NN
and  ||| S:41067 E:41081 ||| CC
Lys-94 ||| S:41081 E:41087 ||| NNP
,  ||| S:41087 E:41089 ||| ,
the  ||| S:41089 E:41093 ||| DT
most  ||| S:41093 E:41098 ||| RBS
reactive  ||| S:41098 E:41107 ||| JJ
of  ||| S:41107 E:41110 ||| IN
calmodulin ||| S:41110 E:41120 ||| NN
's  ||| S:41120 E:41123 ||| POS
lysine  ||| S:41123 E:41130 ||| JJ
residues  ||| S:41130 E:41149 ||| NNS
[  ||| S:41149 E:41151 ||| -LRB-
44  ||| S:41151 E:41154 ||| CD
]  ||| S:41154 E:41156 ||| -RRB-
.  ||| S:41156 E:41158 ||| .
After  ||| S:41158 E:41164 ||| IN
incubation  ||| S:41164 E:41175 ||| NN
for  ||| S:41175 E:41179 ||| IN
2  ||| S:41179 E:41181 ||| CD
hours  ||| S:41181 E:41187 ||| NNS
at  ||| S:41187 E:41190 ||| IN
room  ||| S:41190 E:41205 ||| NN
temperature ||| S:41205 E:41216 ||| NN
,  ||| S:41216 E:41218 ||| ,
we  ||| S:41218 E:41221 ||| PRP
transferred  ||| S:41221 E:41233 ||| VBD
50  ||| S:41233 E:41236 ||| CD
μl  ||| S:41236 E:41239 ||| NN
of  ||| S:41239 E:41242 ||| IN
the  ||| S:41242 E:41246 ||| DT
solution  ||| S:41246 E:41255 ||| NN
to  ||| S:41255 E:41268 ||| TO
another  ||| S:41268 E:41276 ||| DT
96-well  ||| S:41276 E:41284 ||| JJ
plate  ||| S:41284 E:41290 ||| NN
and  ||| S:41290 E:41294 ||| CC
measured  ||| S:41294 E:41303 ||| VBN
fluorescence  ||| S:41303 E:41326 ||| NNS
( ||| S:41326 E:41327 ||| -LRB-
excitation  ||| S:41327 E:41338 ||| CD
485  ||| S:41338 E:41342 ||| CD
nm ||| S:41342 E:41344 ||| NNS
;  ||| S:41344 E:41346 ||| :
emission ||| S:41346 E:41354 ||| NN
,  ||| S:41354 E:41356 ||| ,
520  ||| S:41356 E:41360 ||| CD
nm ||| S:41360 E:41362 ||| CD
)  ||| S:41362 E:41364 ||| -RRB-
using  ||| S:41364 E:41370 ||| VBG
a  ||| S:41370 E:41372 ||| DT
BMG  ||| S:41372 E:41386 ||| NNP
Labtechnologies  ||| S:41386 E:41402 ||| NNP
Fluorostar  ||| S:41402 E:41413 ||| NNP
403  ||| S:41413 E:41417 ||| CD
microplate  ||| S:41417 E:41428 ||| CD
fluorometer  ||| S:41428 E:41450 ||| NNS
( ||| S:41450 E:41451 ||| -LRB-
Durham ||| S:41451 E:41457 ||| NNP
,  ||| S:41457 E:41459 ||| ,
NC ||| S:41459 E:41461 ||| NNP
) ||| S:41461 E:41462 ||| -RRB-
.  ||| S:41462 E:41464 ||| .
Under  ||| S:41464 E:41470 ||| IN
the  ||| S:41470 E:41474 ||| DT
assay  ||| S:41474 E:41480 ||| JJ
conditions ||| S:41480 E:41490 ||| NNS
,  ||| S:41490 E:41492 ||| ,
the  ||| S:41492 E:41506 ||| DT
inner-filter  ||| S:41506 E:41519 ||| JJ
effect  ||| S:41519 E:41526 ||| NN
( ||| S:41526 E:41527 ||| -LRB-
absorption  ||| S:41527 E:41538 ||| NN
of  ||| S:41538 E:41541 ||| IN
excitation  ||| S:41541 E:41552 ||| NN
or  ||| S:41552 E:41555 ||| CC
emission  ||| S:41555 E:41574 ||| JJ
photons  ||| S:41574 E:41582 ||| NN
by  ||| S:41582 E:41585 ||| IN
the  ||| S:41585 E:41589 ||| DT
sample ||| S:41589 E:41595 ||| NN
)  ||| S:41595 E:41597 ||| -RRB-
was  ||| S:41597 E:41601 ||| VBD
negligible ||| S:41601 E:41611 ||| JJ
.  ||| S:41611 E:41613 ||| .
From  ||| S:41613 E:41618 ||| IN
this  ||| S:41618 E:41633 ||| DT
measurement ||| S:41633 E:41644 ||| NN
,  ||| S:41644 E:41646 ||| ,
we  ||| S:41646 E:41649 ||| PRP
calculated  ||| S:41649 E:41660 ||| VBD
the  ||| S:41660 E:41664 ||| DT
amount  ||| S:41664 E:41671 ||| NN
of  ||| S:41671 E:41674 ||| IN
calmodulin  ||| S:41674 E:41685 ||| VBG
bound  ||| S:41685 E:41701 ||| VBN
to  ||| S:41701 E:41704 ||| TO
the  ||| S:41704 E:41708 ||| DT
conjugated  ||| S:41708 E:41719 ||| JJ
peptides ||| S:41719 E:41727 ||| NN
.  ||| S:41727 E:41729 ||| .
In  ||| S:41729 E:41732 ||| IN
some  ||| S:41732 E:41737 ||| DT
experiments ||| S:41737 E:41748 ||| NNS
,  ||| S:41748 E:41750 ||| ,
we  ||| S:41750 E:41753 ||| PRP
also  ||| S:41753 E:41768 ||| RB
included  ||| S:41768 E:41777 ||| VBD
0.1-100  ||| S:41777 E:41785 ||| CD
μM  ||| S:41785 E:41788 ||| JJ
unconjugated  ||| S:41788 E:41801 ||| JJ
IQ  ||| S:41801 E:41804 ||| NNP
peptide ||| S:41804 E:41811 ||| NN
;  ||| S:41811 E:41813 ||| :
in  ||| S:41813 E:41816 ||| IN
that  ||| S:41816 E:41831 ||| DT
case ||| S:41831 E:41835 ||| NN
,  ||| S:41835 E:41837 ||| ,
we  ||| S:41837 E:41840 ||| PRP
carried  ||| S:41840 E:41848 ||| VBD
out  ||| S:41848 E:41852 ||| RP
duplicate  ||| S:41852 E:41862 ||| JJ
control  ||| S:41862 E:41870 ||| NN
reactions  ||| S:41870 E:41880 ||| NNS
in  ||| S:41880 E:41893 ||| IN
underivatized  ||| S:41893 E:41907 ||| CD
96-well  ||| S:41907 E:41915 ||| CD
plates  ||| S:41915 E:41922 ||| NN
to  ||| S:41922 E:41925 ||| TO
correct  ||| S:41925 E:41933 ||| VB
for  ||| S:41933 E:41937 ||| IN
fluorescence  ||| S:41937 E:41960 ||| NNS
quenching  ||| S:41960 E:41970 ||| VBP
exerted  ||| S:41970 E:41978 ||| VBN
by  ||| S:41978 E:41981 ||| IN
IQ  ||| S:41981 E:41984 ||| NNP
peptides ||| S:41984 E:41992 ||| NN
.  ||| S:41992 E:42022 ||| .
Peptide  ||| S:42022 E:42030 ||| NNP
-  ||| S:42030 E:42032 ||| :
calmodulin  ||| S:42032 E:42043 ||| JJ
interaction  ||| S:42043 E:42055 ||| NN
by  ||| S:42055 E:42058 ||| IN
fluorescence  ||| S:42058 E:42081 ||| JJ
quench  ||| S:42081 E:42098 ||| NN
We  ||| S:42098 E:42101 ||| PRP
used  ||| S:42101 E:42106 ||| VBD
empirically  ||| S:42106 E:42118 ||| JJ
observed  ||| S:42118 E:42127 ||| JJ
changes  ||| S:42127 E:42135 ||| NNS
in  ||| S:42135 E:42138 ||| IN
the  ||| S:42138 E:42152 ||| DT
fluorescence  ||| S:42152 E:42165 ||| JJ
intensity  ||| S:42165 E:42175 ||| NN
of  ||| S:42175 E:42178 ||| IN
Alexa-calmodulin ||| S:42178 E:42194 ||| NNP
,  ||| S:42194 E:42196 ||| ,
large  ||| S:42196 E:42202 ||| JJ
in  ||| S:42202 E:42215 ||| IN
magnitude ||| S:42215 E:42224 ||| NN
,  ||| S:42224 E:42226 ||| ,
to  ||| S:42226 E:42229 ||| TO
measure  ||| S:42229 E:42237 ||| VB
binding  ||| S:42237 E:42245 ||| VBN
of  ||| S:42245 E:42248 ||| IN
IQ  ||| S:42248 E:42251 ||| NNP
peptides  ||| S:42251 E:42260 ||| VBD
to  ||| S:42260 E:42273 ||| TO
calmodulin ||| S:42273 E:42283 ||| VB
.  ||| S:42283 E:42285 ||| .
Peptides  ||| S:42285 E:42294 ||| NNP
and  ||| S:42294 E:42298 ||| CC
50-500  ||| S:42298 E:42305 ||| NNP
nM  ||| S:42305 E:42308 ||| NNP
Alexa-calmodulin  ||| S:42308 E:42325 ||| NNP
were  ||| S:42325 E:42340 ||| VBD
mixed  ||| S:42340 E:42346 ||| VBN
in  ||| S:42346 E:42349 ||| IN
96-  ||| S:42349 E:42353 ||| NNP
or  ||| S:42353 E:42356 ||| CC
384-well  ||| S:42356 E:42365 ||| CD
microtiter  ||| S:42365 E:42376 ||| JJ
plates  ||| S:42376 E:42383 ||| NN
with  ||| S:42383 E:42388 ||| IN
150  ||| S:42388 E:42392 ||| CD
mM  ||| S:42392 E:42405 ||| JJ
KCl ||| S:42405 E:42408 ||| NN
,  ||| S:42408 E:42410 ||| ,
1  ||| S:42410 E:42412 ||| CD
mM  ||| S:42412 E:42415 ||| JJ
MgCl  ||| S:42415 E:42431 ||| JJ
2  ||| S:42431 E:42433 ||| CD
,  ||| S:42433 E:42435 ||| ,
100  ||| S:42435 E:42439 ||| CD
μM  ||| S:42439 E:42442 ||| JJ
EGTA  ||| S:42442 E:42447 ||| NNP
or  ||| S:42447 E:42450 ||| CC
25  ||| S:42450 E:42453 ||| CD
μM  ||| S:42453 E:42456 ||| JJ
CaCl  ||| S:42456 E:42472 ||| JJ
2  ||| S:42472 E:42474 ||| CD
,  ||| S:42474 E:42476 ||| ,
0.5  ||| S:42476 E:42480 ||| FW
mg ||| S:42480 E:42482 ||| FW
/ ||| S:42482 E:42483 ||| FW
ml  ||| S:42483 E:42486 ||| FW
bovine  ||| S:42486 E:42493 ||| FW
serum  ||| S:42493 E:42499 ||| FW
albumin ||| S:42499 E:42506 ||| FW
,  ||| S:42506 E:42518 ||| ,
and  ||| S:42518 E:42522 ||| CC
15  ||| S:42522 E:42525 ||| CD
mM  ||| S:42525 E:42528 ||| JJ
HEPES  ||| S:42528 E:42534 ||| NN
at  ||| S:42534 E:42537 ||| IN
pH  ||| S:42537 E:42540 ||| JJ
7.5 ||| S:42540 E:42543 ||| CD
;  ||| S:42543 E:42545 ||| :
in  ||| S:42545 E:42548 ||| IN
some  ||| S:42548 E:42553 ||| DT
experiments  ||| S:42553 E:42565 ||| NNS
we  ||| S:42565 E:42568 ||| PRP
added  ||| S:42568 E:42584 ||| VBD
50-75  ||| S:42584 E:42590 ||| CD
μM  ||| S:42590 E:42593 ||| JJ
bovine-brain  ||| S:42593 E:42606 ||| JJ
calmodulin ||| S:42606 E:42616 ||| NN
.  ||| S:42616 E:42618 ||| .
Total  ||| S:42618 E:42624 ||| JJ
volume  ||| S:42624 E:42631 ||| NN
varied  ||| S:42631 E:42648 ||| VBN
from  ||| S:42648 E:42653 ||| IN
10  ||| S:42653 E:42656 ||| CD
μl  ||| S:42656 E:42659 ||| NNS
( ||| S:42659 E:42660 ||| -LRB-
384-well  ||| S:42660 E:42669 ||| FW
plates ||| S:42669 E:42675 ||| FW
)  ||| S:42675 E:42677 ||| -RRB-
to  ||| S:42677 E:42680 ||| TO
100  ||| S:42680 E:42684 ||| CD
μl  ||| S:42684 E:42687 ||| NNS
( ||| S:42687 E:42688 ||| -LRB-
96-well  ||| S:42688 E:42696 ||| FW
plates ||| S:42696 E:42702 ||| FW
) ||| S:42702 E:42703 ||| -RRB-
.  ||| S:42703 E:42715 ||| .
After  ||| S:42715 E:42721 ||| IN
1-2  ||| S:42721 E:42725 ||| CD
hours  ||| S:42725 E:42731 ||| NNS
at  ||| S:42731 E:42734 ||| IN
room  ||| S:42734 E:42739 ||| NN
temperature ||| S:42739 E:42750 ||| NN
,  ||| S:42750 E:42752 ||| ,
fluorescence  ||| S:42752 E:42765 ||| NN
was  ||| S:42765 E:42779 ||| VBD
read  ||| S:42779 E:42784 ||| VBN
directly ||| S:42784 E:42792 ||| RB
.  ||| S:42792 E:42804 ||| .
When  ||| S:42804 E:42809 ||| WRB
IQ  ||| S:42809 E:42812 ||| NNP
peptides  ||| S:42812 E:42821 ||| VBD
bound  ||| S:42821 E:42827 ||| VBN
to  ||| S:42827 E:42830 ||| TO
Alexa-calmodulin ||| S:42830 E:42846 ||| JJ
,  ||| S:42846 E:42848 ||| ,
the  ||| S:42848 E:42862 ||| DT
fluorescence  ||| S:42862 E:42875 ||| JJ
intensity  ||| S:42875 E:42885 ||| NN
was  ||| S:42885 E:42889 ||| VBD
reduced  ||| S:42889 E:42897 ||| VBN
as  ||| S:42897 E:42900 ||| IN
the  ||| S:42900 E:42904 ||| DT
quantum  ||| S:42904 E:42912 ||| JJ
yield  ||| S:42912 E:42928 ||| NN
decreased  ||| S:42928 E:42938 ||| VBD
( ||| S:42938 E:42939 ||| -LRB-
fluorescence  ||| S:42939 E:42952 ||| FW
quenching ||| S:42952 E:42961 ||| FW
) ||| S:42961 E:42962 ||| -RRB-
.  ||| S:42962 E:42964 ||| .
We  ||| S:42964 E:42967 ||| PRP
assumed  ||| S:42967 E:42975 ||| VBD
that  ||| S:42975 E:42980 ||| IN
two  ||| S:42980 E:42994 ||| CD
fluorescent  ||| S:42994 E:43006 ||| CD
species  ||| S:43006 E:43014 ||| NNS
were  ||| S:43014 E:43019 ||| VBD
present ||| S:43019 E:43026 ||| JJ
,  ||| S:43026 E:43028 ||| ,
Alexa-calmodulin  ||| S:43028 E:43045 ||| JJ
and  ||| S:43045 E:43049 ||| CC
IQ  ||| S:43049 E:43062 ||| NNP
peptide-bound  ||| S:43062 E:43076 ||| NNP
Alexa-calmodulin ||| S:43076 E:43092 ||| NNP
,  ||| S:43092 E:43094 ||| ,
and  ||| S:43094 E:43098 ||| CC
that  ||| S:43098 E:43103 ||| IN
the  ||| S:43103 E:43107 ||| DT
fluorescence  ||| S:43107 E:43130 ||| JJ
intensity  ||| S:43130 E:43140 ||| NN
(  ||| S:43140 E:43153 ||| -LRB-
I  ||| S:43153 E:43155 ||| PRP
)  ||| S:43155 E:43157 ||| -RRB-
was  ||| S:43157 E:43161 ||| VBD
a  ||| S:43161 E:43163 ||| DT
linear  ||| S:43163 E:43170 ||| JJ
combination  ||| S:43170 E:43182 ||| NN
of  ||| S:43182 E:43185 ||| IN
the  ||| S:43185 E:43199 ||| DT
fluorescence  ||| S:43199 E:43212 ||| NN
of  ||| S:43212 E:43215 ||| IN
the  ||| S:43215 E:43219 ||| DT
two  ||| S:43219 E:43223 ||| CD
species ||| S:43223 E:43230 ||| NNS
:  ||| S:43230 E:43253 ||| :
I  ||| S:43253 E:43255 ||| PRP
=  ||| S:43255 E:43268 ||| SYM
f  ||| S:43268 E:43281 ||| SYM
CaM  ||| S:43281 E:43296 ||| :
I  ||| S:43296 E:43309 ||| PRP
CaM  ||| S:43309 E:43313 ||| JJ
+  ||| S:43313 E:43326 ||| CD
f  ||| S:43326 E:43339 ||| SYM
CaM-IQ  ||| S:43339 E:43357 ||| :
I  ||| S:43357 E:43370 ||| PRP
CaM-IQ  ||| S:43370 E:43377 ||| JJ
( ||| S:43377 E:43378 ||| -LRB-
1 ||| S:43378 E:43379 ||| LS
)  ||| S:43379 E:43391 ||| -RRB-
where  ||| S:43391 E:43408 ||| WRB
f  ||| S:43408 E:43421 ||| JJ
CaM  ||| S:43421 E:43425 ||| JJ
and  ||| S:43425 E:43440 ||| CC
f  ||| S:43440 E:43453 ||| JJ
CaM-IQ  ||| S:43453 E:43460 ||| NNS
are  ||| S:43460 E:43464 ||| VBP
the  ||| S:43464 E:43468 ||| DT
mole  ||| S:43468 E:43473 ||| JJ
fractions  ||| S:43473 E:43483 ||| NNS
of  ||| S:43483 E:43486 ||| IN
the  ||| S:43486 E:43500 ||| DT
two  ||| S:43500 E:43504 ||| CD
components  ||| S:43504 E:43515 ||| NNS
and  ||| S:43515 E:43530 ||| CC
I  ||| S:43530 E:43543 ||| PRP
CaM  ||| S:43543 E:43547 ||| JJ
and  ||| S:43547 E:43562 ||| CC
I  ||| S:43562 E:43575 ||| PRP
CaM-IQ  ||| S:43575 E:43582 ||| JJ
are  ||| S:43582 E:43586 ||| VBP
their  ||| S:43586 E:43592 ||| PRP$
fluorescence  ||| S:43592 E:43615 ||| JJ
intensities ||| S:43615 E:43626 ||| NN
.  ||| S:43626 E:43628 ||| .
Because  ||| S:43628 E:43636 ||| IN
the  ||| S:43636 E:43640 ||| DT
quantum  ||| S:43640 E:43648 ||| JJ
yield  ||| S:43648 E:43654 ||| NN
of  ||| S:43654 E:43667 ||| IN
Alexa-calmodulin  ||| S:43667 E:43684 ||| NNP
is  ||| S:43684 E:43687 ||| VBZ
reduced  ||| S:43687 E:43695 ||| VBN
when  ||| S:43695 E:43700 ||| WRB
IQ  ||| S:43700 E:43703 ||| NNP
peptides  ||| S:43703 E:43712 ||| JJ
bind ||| S:43712 E:43716 ||| NN
,  ||| S:43716 E:43729 ||| ,
I  ||| S:43729 E:43742 ||| PRP
CaM-IQ  ||| S:43742 E:43749 ||| JJ
< ||| S:43749 E:43751 ||| SYM
I  ||| S:43762 E:43775 ||| NN
CaM  ||| S:43775 E:43779 ||| NN
.  ||| S:43779 E:43781 ||| .
The  ||| S:43781 E:43785 ||| DT
fraction  ||| S:43785 E:43794 ||| NN
of  ||| S:43794 E:43797 ||| IN
peptide  ||| S:43797 E:43805 ||| JJ
bound  ||| S:43805 E:43821 ||| NN
is ||| S:43821 E:43823 ||| VBZ
:  ||| S:43823 E:43846 ||| :
To  ||| S:43846 E:43849 ||| TO
calculate  ||| S:43849 E:43859 ||| VB
K  ||| S:43859 E:43872 ||| NNP
d  ||| S:43872 E:43874 ||| NN
,  ||| S:43874 E:43876 ||| ,
we  ||| S:43876 E:43879 ||| PRP
fit  ||| S:43879 E:43883 ||| VBP
the  ||| S:43883 E:43887 ||| DT
data  ||| S:43887 E:43892 ||| NNS
with  ||| S:43892 E:43897 ||| IN
a  ||| S:43897 E:43909 ||| DT
bimolecular-binding  ||| S:43909 E:43929 ||| JJ
isotherm ||| S:43929 E:43937 ||| NN
:  ||| S:43937 E:43960 ||| :
where  ||| S:43960 E:43966 ||| WRB
[ ||| S:43966 E:43967 ||| -LRB-
IQ ||| S:43967 E:43969 ||| NNP
]  ||| S:43969 E:43971 ||| -RRB-
was  ||| S:43971 E:43975 ||| VBD
the  ||| S:43975 E:43979 ||| DT
free  ||| S:43979 E:43984 ||| JJ
IQ-peptide  ||| S:43984 E:43995 ||| JJ
concentration  ||| S:43995 E:44019 ||| NN
added ||| S:44019 E:44024 ||| VBD
.  ||| S:44024 E:44026 ||| .
Because  ||| S:44026 E:44034 ||| IN
we  ||| S:44034 E:44037 ||| PRP
used  ||| S:44037 E:44042 ||| VBD
concentrations  ||| S:44042 E:44057 ||| NNS
of  ||| S:44057 E:44060 ||| IN
Alexa-calmodulin  ||| S:44060 E:44087 ||| JJ
in  ||| S:44087 E:44090 ||| IN
our  ||| S:44090 E:44094 ||| PRP$
experiments  ||| S:44094 E:44106 ||| NNS
that  ||| S:44106 E:44111 ||| WDT
were  ||| S:44111 E:44116 ||| VBD
much  ||| S:44116 E:44121 ||| RB
less  ||| S:44121 E:44126 ||| JJR
than  ||| S:44126 E:44131 ||| IN
the  ||| S:44131 E:44135 ||| DT
K  ||| S:44135 E:44148 ||| NNP
d  ||| S:44148 E:44150 ||| NN
,  ||| S:44150 E:44152 ||| ,
we  ||| S:44152 E:44155 ||| PRP
approximated  ||| S:44155 E:44168 ||| VBP
[ ||| S:44168 E:44169 ||| -LRB-
IQ ||| S:44169 E:44171 ||| NNP
]  ||| S:44171 E:44173 ||| -RRB-
using  ||| S:44173 E:44179 ||| VBG
the  ||| S:44179 E:44193 ||| DT
total  ||| S:44193 E:44199 ||| JJ
IQ  ||| S:44199 E:44202 ||| NNP
peptide  ||| S:44202 E:44210 ||| JJ
concentration ||| S:44210 E:44223 ||| NN
.  ||| S:44223 E:44235 ||| .
In  ||| S:44235 E:44238 ||| IN
other  ||| S:44238 E:44244 ||| JJ
cases ||| S:44244 E:44249 ||| NNS
,  ||| S:44249 E:44251 ||| ,
however ||| S:44251 E:44258 ||| RB
,  ||| S:44258 E:44260 ||| ,
the  ||| S:44260 E:44264 ||| DT
binding  ||| S:44264 E:44272 ||| JJ
data  ||| S:44272 E:44277 ||| NNS
were  ||| S:44277 E:44282 ||| VBD
fit  ||| S:44282 E:44296 ||| VBN
better  ||| S:44296 E:44303 ||| JJR
with  ||| S:44303 E:44308 ||| IN
a  ||| S:44308 E:44310 ||| DT
modified  ||| S:44310 E:44319 ||| JJ
Hill  ||| S:44319 E:44324 ||| NNP
equation ||| S:44324 E:44332 ||| NN
:  ||| S:44332 E:44355 ||| :
where  ||| S:44355 E:44372 ||| WRB
h  ||| S:44372 E:44374 ||| NN
is  ||| S:44374 E:44377 ||| VBZ
the  ||| S:44377 E:44381 ||| DT
Hill  ||| S:44381 E:44386 ||| NNP
coefficient ||| S:44386 E:44397 ||| NN
.  ||| S:44397 E:44399 ||| .
A  ||| S:44399 E:44401 ||| DT
value  ||| S:44401 E:44417 ||| NN
for  ||| S:44417 E:44432 ||| IN
h  ||| S:44432 E:44434 ||| VBG
greater  ||| S:44434 E:44442 ||| JJR
than  ||| S:44442 E:44447 ||| IN
one  ||| S:44447 E:44451 ||| PRP
suggests  ||| S:44451 E:44460 ||| VBZ
the  ||| S:44460 E:44474 ||| DT
fluorescence  ||| S:44474 E:44487 ||| JJ
change  ||| S:44487 E:44494 ||| NN
arose  ||| S:44494 E:44500 ||| VBD
from  ||| S:44500 E:44505 ||| IN
a  ||| S:44505 E:44507 ||| DT
more  ||| S:44507 E:44512 ||| RBR
complex  ||| S:44512 E:44520 ||| JJ
equilibrium  ||| S:44520 E:44542 ||| NN
than  ||| S:44542 E:44547 ||| IN
just  ||| S:44547 E:44552 ||| RB
one  ||| S:44552 E:44556 ||| CD
peptide  ||| S:44556 E:44564 ||| FW
binding  ||| S:44564 E:44572 ||| FW
per  ||| S:44572 E:44576 ||| FW
calmodulin ||| S:44576 E:44586 ||| FW
.  ||| S:44586 E:44598 ||| .
To  ||| S:44598 E:44601 ||| TO
carry  ||| S:44601 E:44607 ||| VB
out  ||| S:44607 E:44611 ||| RP
stoichiometric-titration  ||| S:44611 E:44636 ||| JJ
experiments  ||| S:44636 E:44658 ||| NNS
( ||| S:44658 E:44659 ||| -LRB-
calmodulin  ||| S:44659 E:44670 ||| JJ
concentration  ||| S:44670 E:44684 ||| NN
greater  ||| S:44684 E:44692 ||| JJR
than  ||| S:44692 E:44697 ||| IN
the  ||| S:44697 E:44701 ||| DT
K  ||| S:44701 E:44714 ||| NN
d  ||| S:44714 E:44716 ||| LS
) ||| S:44716 E:44717 ||| -RRB-
,  ||| S:44717 E:44719 ||| ,
we  ||| S:44719 E:44722 ||| PRP
used  ||| S:44722 E:44727 ||| VBD
a  ||| S:44727 E:44729 ||| DT
low  ||| S:44729 E:44733 ||| JJ
concentration  ||| S:44733 E:44747 ||| NN
of  ||| S:44747 E:44760 ||| IN
Alexa-calmodulin  ||| S:44760 E:44777 ||| JJ
as  ||| S:44777 E:44780 ||| IN
a  ||| S:44780 E:44782 ||| DT
reporter  ||| S:44782 E:44791 ||| NN
and  ||| S:44791 E:44795 ||| CC
added  ||| S:44795 E:44801 ||| VBD
an  ||| S:44801 E:44804 ||| DT
excess  ||| S:44804 E:44811 ||| NN
of  ||| S:44811 E:44824 ||| IN
unlabeled  ||| S:44824 E:44834 ||| JJ
calmodulin ||| S:44834 E:44844 ||| NN
.  ||| S:44844 E:44846 ||| .
For  ||| S:44846 E:44850 ||| IN
simplicity  ||| S:44850 E:44861 ||| NN
in  ||| S:44861 E:44864 ||| IN
analysis ||| S:44864 E:44872 ||| NN
,  ||| S:44872 E:44874 ||| ,
we  ||| S:44874 E:44887 ||| PRP
assumed  ||| S:44887 E:44895 ||| VBD
that  ||| S:44895 E:44900 ||| IN
Alexa-calmodulin  ||| S:44900 E:44917 ||| NNP
behaved  ||| S:44917 E:44925 ||| VBD
identically  ||| S:44925 E:44937 ||| VBN
to  ||| S:44937 E:44950 ||| TO
calmodulin ||| S:44950 E:44960 ||| VB
,  ||| S:44960 E:44962 ||| ,
and  ||| S:44962 E:44966 ||| CC
thus  ||| S:44966 E:44971 ||| RB
this  ||| S:44971 E:44976 ||| DT
calmodulin  ||| S:44976 E:44987 ||| JJ
mixture  ||| S:44987 E:44995 ||| NN
was  ||| S:44995 E:45009 ||| VBD
equivalent  ||| S:45009 E:45020 ||| JJ
to  ||| S:45020 E:45023 ||| TO
a  ||| S:45023 E:45025 ||| DT
decrease  ||| S:45025 E:45034 ||| NN
in  ||| S:45034 E:45037 ||| IN
specific  ||| S:45037 E:45046 ||| JJ
activity  ||| S:45046 E:45065 ||| NN
( ||| S:45065 E:45066 ||| -LRB-
fluorescence  ||| S:45066 E:45079 ||| FW
quench ||| S:45079 E:45085 ||| FW
)  ||| S:45085 E:45087 ||| -RRB-
of  ||| S:45087 E:45090 ||| IN
calmodulin ||| S:45090 E:45100 ||| NN
.  ||| S:45100 E:45102 ||| .
We  ||| S:45102 E:45105 ||| PRP
then  ||| S:45105 E:45110 ||| RB
solved  ||| S:45110 E:45117 ||| VBN
the  ||| S:45117 E:45131 ||| DT
bimolecular-binding  ||| S:45131 E:45151 ||| JJ
isotherm  ||| S:45151 E:45160 ||| NN
to  ||| S:45160 E:45163 ||| TO
enable  ||| S:45163 E:45170 ||| VB
us  ||| S:45170 E:45173 ||| PRP
to  ||| S:45173 E:45176 ||| TO
plot  ||| S:45176 E:45181 ||| VB
the  ||| S:45181 E:45195 ||| DT
total  ||| S:45195 E:45201 ||| JJ
ligand  ||| S:45201 E:45208 ||| JJ
concentration  ||| S:45208 E:45222 ||| NN
(  ||| S:45222 E:45235 ||| -LRB-
T  ||| S:45235 E:45237 ||| NN
)  ||| S:45237 E:45239 ||| -RRB-
added  ||| S:45239 E:45245 ||| VBD
versus  ||| S:45245 E:45252 ||| FW
fluorescence  ||| S:45252 E:45275 ||| FW
intensity  ||| S:45275 E:45285 ||| FW
(  ||| S:45285 E:45298 ||| -LRB-
I  ||| S:45298 E:45300 ||| PRP
) ||| S:45300 E:45301 ||| -RRB-
.  ||| S:45301 E:45303 ||| .
The  ||| S:45303 E:45307 ||| DT
concentration  ||| S:45307 E:45321 ||| NN
of  ||| S:45321 E:45324 ||| IN
peptide  ||| S:45324 E:45342 ||| JJ
bound  ||| S:45342 E:45348 ||| NNS
(  ||| S:45348 E:45361 ||| -LRB-
B  ||| S:45361 E:45363 ||| NNP
)  ||| S:45363 E:45365 ||| -RRB-
was ||| S:45365 E:45368 ||| VBD
:  ||| S:45368 E:45391 ||| :
B  ||| S:45391 E:45393 ||| NNP
=  ||| S:45393 E:45406 ||| SYM
m  ||| S:45406 E:45408 ||| FW
[ ||| S:45408 E:45409 ||| -LRB-
CaM ||| S:45409 E:45412 ||| NNP
]  ||| S:45412 E:45425 ||| -RRB-
f  ||| S:45425 E:45438 ||| SYM
CaM-IQ  ||| S:45438 E:45445 ||| FW
( ||| S:45445 E:45446 ||| -LRB-
5 ||| S:45446 E:45447 ||| LS
)  ||| S:45447 E:45459 ||| -RRB-
where  ||| S:45459 E:45476 ||| WRB
m  ||| S:45476 E:45478 ||| NN
is  ||| S:45478 E:45481 ||| VBZ
the  ||| S:45481 E:45485 ||| DT
number  ||| S:45485 E:45492 ||| NN
of  ||| S:45492 E:45495 ||| IN
binding  ||| S:45495 E:45503 ||| JJ
sites  ||| S:45503 E:45519 ||| NNS
per  ||| S:45519 E:45523 ||| IN
calmodulin  ||| S:45523 E:45534 ||| NN
and  ||| S:45534 E:45538 ||| CC
[ ||| S:45538 E:45539 ||| -LRB-
CaM ||| S:45539 E:45542 ||| NNP
]  ||| S:45542 E:45544 ||| -RRB-
is  ||| S:45544 E:45547 ||| VBZ
the  ||| S:45547 E:45551 ||| DT
fixed  ||| S:45551 E:45557 ||| JJ
concentration  ||| S:45557 E:45571 ||| NN
of  ||| S:45571 E:45584 ||| IN
calmodulin ||| S:45584 E:45594 ||| NN
.  ||| S:45594 E:45596 ||| .
The  ||| S:45596 E:45600 ||| DT
free  ||| S:45600 E:45605 ||| JJ
concentration  ||| S:45605 E:45619 ||| NN
of  ||| S:45619 E:45622 ||| IN
IQ  ||| S:45622 E:45625 ||| NNP
peptide  ||| S:45625 E:45633 ||| NNS
(  ||| S:45633 E:45646 ||| -LRB-
F  ||| S:45646 E:45648 ||| NNP
)  ||| S:45648 E:45650 ||| -RRB-
was  ||| S:45650 E:45665 ||| VBD
T  ||| S:45665 E:45667 ||| NN
-  ||| S:45667 E:45680 ||| :
B  ||| S:45680 E:45682 ||| NNP
.  ||| S:45682 E:45684 ||| .
We  ||| S:45684 E:45687 ||| PRP
substituted  ||| S:45687 E:45699 ||| VBD
the  ||| S:45699 E:45703 ||| DT
expression  ||| S:45703 E:45724 ||| NN
for  ||| S:45724 E:45739 ||| IN
B  ||| S:45739 E:45741 ||| NNP
in  ||| S:45741 E:45744 ||| IN
equations  ||| S:45744 E:45754 ||| NNS
( ||| S:45754 E:45755 ||| -LRB-
2 ||| S:45755 E:45756 ||| LS
)  ||| S:45756 E:45758 ||| -RRB-
and  ||| S:45758 E:45762 ||| CC
( ||| S:45762 E:45763 ||| -LRB-
5 ||| S:45763 E:45764 ||| LS
)  ||| S:45764 E:45776 ||| -RRB-
into ||| S:45776 E:45780 ||| IN
:  ||| S:45780 E:45803 ||| :
Note  ||| S:45803 E:45808 ||| VB
that  ||| S:45808 E:45824 ||| DT
n  ||| S:45824 E:45826 ||| NN
[ ||| S:45826 E:45827 ||| -LRB-
CaM ||| S:45827 E:45830 ||| NNP
]  ||| S:45830 E:45832 ||| -RRB-
is  ||| S:45832 E:45835 ||| VBZ
the  ||| S:45835 E:45839 ||| DT
maximum  ||| S:45839 E:45847 ||| JJ
amount  ||| S:45847 E:45854 ||| NN
of  ||| S:45854 E:45857 ||| IN
IQ  ||| S:45857 E:45870 ||| NNP
peptide  ||| S:45870 E:45878 ||| NN
that  ||| S:45878 E:45883 ||| WDT
can  ||| S:45883 E:45887 ||| MD
bind  ||| S:45887 E:45892 ||| VB
( ||| S:45892 E:45893 ||| -LRB-
B  ||| S:45893 E:45906 ||| NNP
max  ||| S:45906 E:45910 ||| CD
) ||| S:45910 E:45911 ||| -RRB-
.  ||| S:45911 E:45913 ||| .
We  ||| S:45913 E:45916 ||| PRP
then  ||| S:45916 E:45921 ||| RB
solved  ||| S:45921 E:45928 ||| VBN
equation  ||| S:45928 E:45937 ||| NN
( ||| S:45937 E:45938 ||| -LRB-
6 ||| S:45938 E:45939 ||| CD
)  ||| S:45939 E:45941 ||| -RRB-
for  ||| S:45941 E:45955 ||| IN
fluorescence  ||| S:45955 E:45968 ||| JJ
intensity  ||| S:45968 E:45978 ||| NN
using  ||| S:45978 E:45984 ||| VBG
Mathematica  ||| S:45984 E:45996 ||| NNP
4.0  ||| S:45996 E:46000 ||| NNP
( ||| S:46000 E:46001 ||| -LRB-
Wolfram  ||| S:46001 E:46019 ||| NNP
Research ||| S:46019 E:46027 ||| NNP
,  ||| S:46027 E:46029 ||| ,
Champaign ||| S:46029 E:46038 ||| NNP
,  ||| S:46038 E:46040 ||| ,
IL ||| S:46040 E:46042 ||| NNP
) ||| S:46042 E:46043 ||| -RRB-
:  ||| S:46043 E:46066 ||| :
For  ||| S:46066 E:46081 ||| IN
m  ||| S:46081 E:46083 ||| CD
=  ||| S:46083 E:46085 ||| SYM
1 ||| S:46085 E:46086 ||| CD
,  ||| S:46086 E:46088 ||| ,
the  ||| S:46088 E:46092 ||| DT
only  ||| S:46092 E:46097 ||| JJ
free  ||| S:46097 E:46102 ||| JJ
parameters  ||| S:46102 E:46123 ||| NNS
were  ||| S:46123 E:46128 ||| VBD
K  ||| S:46128 E:46141 ||| NNP
d  ||| S:46141 E:46143 ||| NN
and  ||| S:46143 E:46158 ||| CC
I  ||| S:46158 E:46171 ||| PRP
CaM-IQ  ||| S:46171 E:46178 ||| JJ
.  ||| S:46178 E:46180 ||| .
We  ||| S:46180 E:46183 ||| PRP
were  ||| S:46183 E:46188 ||| VBD
forced  ||| S:46188 E:46195 ||| VBN
to  ||| S:46195 E:46198 ||| TO
include  ||| S:46198 E:46217 ||| VB
I  ||| S:46217 E:46230 ||| PRP
CaM-IQ  ||| S:46230 E:46237 ||| JJ
as  ||| S:46237 E:46240 ||| IN
one  ||| S:46240 E:46244 ||| CD
of  ||| S:46244 E:46247 ||| IN
the  ||| S:46247 E:46251 ||| DT
fit  ||| S:46251 E:46255 ||| NN
parameters ||| S:46255 E:46265 ||| NNS
;  ||| S:46265 E:46277 ||| :
the  ||| S:46277 E:46281 ||| DT
limited  ||| S:46281 E:46289 ||| JJ
solubility  ||| S:46289 E:46300 ||| NN
of  ||| S:46300 E:46303 ||| IN
IQ  ||| S:46303 E:46306 ||| NNP
peptides  ||| S:46306 E:46315 ||| NN
in  ||| S:46315 E:46318 ||| IN
the  ||| S:46318 E:46322 ||| DT
assay  ||| S:46322 E:46338 ||| JJ
solution  ||| S:46338 E:46347 ||| NN
prevented  ||| S:46347 E:46357 ||| VBD
us  ||| S:46357 E:46360 ||| PRP
from  ||| S:46360 E:46365 ||| IN
using  ||| S:46365 E:46371 ||| VBG
very  ||| S:46371 E:46376 ||| RB
high  ||| S:46376 E:46381 ||| JJ
peptide  ||| S:46381 E:46399 ||| JJ
concentrations  ||| S:46399 E:46414 ||| NNS
that  ||| S:46414 E:46419 ||| WDT
would  ||| S:46419 E:46425 ||| MD
independently  ||| S:46425 E:46439 ||| RB
establish  ||| S:46439 E:46449 ||| VB
its  ||| S:46449 E:46463 ||| PRP$
value  ||| S:46463 E:46469 ||| NN
by  ||| S:46469 E:46472 ||| IN
producing  ||| S:46472 E:46482 ||| VBG
a  ||| S:46482 E:46484 ||| DT
plateau  ||| S:46484 E:46492 ||| NN
in  ||| S:46492 E:46495 ||| IN
the  ||| S:46495 E:46510 ||| DT
T  ||| S:46510 E:46512 ||| NN
vs.  ||| S:46512 E:46527 ||| IN
I  ||| S:46527 E:46529 ||| PRP
plot ||| S:46529 E:46533 ||| VBD
.  ||| S:46533 E:46535 ||| .
We  ||| S:46535 E:46538 ||| PRP
then  ||| S:46538 E:46543 ||| RB
used  ||| S:46543 E:46548 ||| VBN
the  ||| S:46548 E:46552 ||| DT
value  ||| S:46552 E:46558 ||| NN
of  ||| S:46558 E:46572 ||| IN
I  ||| S:46572 E:46585 ||| PRP
CaM-IQ  ||| S:46585 E:46592 ||| VBP
determined  ||| S:46592 E:46603 ||| VBN
from  ||| S:46603 E:46608 ||| IN
the  ||| S:46608 E:46623 ||| DT
m  ||| S:46623 E:46625 ||| NN
=  ||| S:46625 E:46627 ||| SYM
1  ||| S:46627 E:46629 ||| CD
fit  ||| S:46629 E:46633 ||| NN
and  ||| S:46633 E:46637 ||| CC
refit  ||| S:46637 E:46643 ||| VBG
the  ||| S:46643 E:46647 ||| DT
data  ||| S:46647 E:46652 ||| NNS
for  ||| S:46652 E:46667 ||| IN
m  ||| S:46667 E:46669 ||| CD
=  ||| S:46669 E:46671 ||| SYM
2 ||| S:46671 E:46672 ||| CD
,  ||| S:46672 E:46674 ||| ,
using  ||| S:46674 E:46680 ||| VBG
K  ||| S:46680 E:46693 ||| NNP
d  ||| S:46693 E:46695 ||| NN
as  ||| S:46695 E:46698 ||| IN
the  ||| S:46698 E:46702 ||| DT
only  ||| S:46702 E:46707 ||| JJ
free  ||| S:46707 E:46712 ||| JJ
parameter ||| S:46712 E:46721 ||| NN
.  ||| S:46721 E:46723 ||| .
To  ||| S:46723 E:46726 ||| TO
judge  ||| S:46726 E:46742 ||| VB
the  ||| S:46742 E:46746 ||| DT
stoichiometry ||| S:46746 E:46759 ||| NN
,  ||| S:46759 E:46761 ||| ,
we  ||| S:46761 E:46764 ||| PRP
compared  ||| S:46764 E:46773 ||| VBN
by  ||| S:46773 E:46776 ||| IN
eye  ||| S:46776 E:46780 ||| NN
the  ||| S:46780 E:46784 ||| DT
effectiveness  ||| S:46784 E:46808 ||| NN
of  ||| S:46808 E:46811 ||| IN
the  ||| S:46811 E:46815 ||| DT
fit  ||| S:46815 E:46819 ||| NN
under  ||| S:46819 E:46825 ||| IN
the  ||| S:46825 E:46829 ||| DT
two  ||| S:46829 E:46833 ||| CD
conditions ||| S:46833 E:46843 ||| NNS
.  ||| S:46843 E:46873 ||| .
Baculovirus  ||| S:46873 E:46885 ||| NNP
constructs  ||| S:46885 E:46906 ||| VBZ
Using  ||| S:46906 E:46912 ||| VBG
methods  ||| S:46912 E:46920 ||| NNS
described  ||| S:46920 E:46930 ||| VBD
previously  ||| S:46930 E:46941 ||| RB
for  ||| S:46941 E:46945 ||| IN
rat  ||| S:46945 E:46949 ||| CD
Myo1c  ||| S:46949 E:46955 ||| CD
[  ||| S:46955 E:46957 ||| -LRB-
43  ||| S:46957 E:46970 ||| CD
]  ||| S:46970 E:46972 ||| -RRB-
,  ||| S:46972 E:46974 ||| ,
we  ||| S:46974 E:46977 ||| PRP
cloned  ||| S:46977 E:46984 ||| VBP
full-length  ||| S:46984 E:46996 ||| JJ
bullfrog  ||| S:46996 E:47005 ||| JJ
Myo1c  ||| S:47005 E:47011 ||| NN
into  ||| S:47011 E:47016 ||| IN
the  ||| S:47016 E:47030 ||| DT
baculovirus  ||| S:47030 E:47042 ||| FW
transfer  ||| S:47042 E:47051 ||| FW
vector  ||| S:47051 E:47058 ||| FW
pBlueBacHis2B  ||| S:47058 E:47072 ||| FW
( ||| S:47072 E:47073 ||| -LRB-
Invitrogen ||| S:47073 E:47083 ||| NNP
,  ||| S:47083 E:47095 ||| ,
Carlsbad ||| S:47095 E:47103 ||| NNP
,  ||| S:47103 E:47105 ||| ,
CA ||| S:47105 E:47107 ||| NNP
) ||| S:47107 E:47108 ||| -RRB-
,  ||| S:47108 E:47110 ||| ,
introducing  ||| S:47110 E:47122 ||| VBG
an  ||| S:47122 E:47125 ||| DT
N-terminal  ||| S:47125 E:47136 ||| JJ
hexahistidine  ||| S:47136 E:47160 ||| JJ
tag  ||| S:47160 E:47164 ||| NN
for  ||| S:47164 E:47168 ||| IN
purification  ||| S:47168 E:47181 ||| NN
and  ||| S:47181 E:47185 ||| CC
a  ||| S:47185 E:47187 ||| DT
DLYDDDDK  ||| S:47187 E:47196 ||| NNP
epitope  ||| S:47196 E:47204 ||| JJ
tag  ||| S:47204 E:47208 ||| NN
for  ||| S:47208 E:47222 ||| IN
antibody  ||| S:47222 E:47231 ||| NN
detection ||| S:47231 E:47240 ||| NN
.  ||| S:47240 E:47242 ||| .
Baculoviruses  ||| S:47242 E:47256 ||| NNP
were  ||| S:47256 E:47261 ||| VBD
generated ||| S:47261 E:47270 ||| VBN
,  ||| S:47270 E:47282 ||| ,
purified ||| S:47282 E:47290 ||| NN
,  ||| S:47290 E:47292 ||| ,
and  ||| S:47292 E:47296 ||| CC
characterized  ||| S:47296 E:47310 ||| VBD
using  ||| S:47310 E:47316 ||| VBG
standard  ||| S:47316 E:47325 ||| JJ
techniques  ||| S:47325 E:47336 ||| NNS
[  ||| S:47336 E:47348 ||| -LRB-
43  ||| S:47348 E:47351 ||| CD
45  ||| S:47351 E:47354 ||| CD
]  ||| S:47354 E:47356 ||| -RRB-
.  ||| S:47356 E:47386 ||| .
Protein  ||| S:47386 E:47394 ||| NN
expression  ||| S:47394 E:47405 ||| NN
and  ||| S:47405 E:47409 ||| CC
purification  ||| S:47409 E:47432 ||| JJ
Bullfrog  ||| S:47432 E:47441 ||| NNP
Myo1c  ||| S:47441 E:47447 ||| NNP
or  ||| S:47447 E:47450 ||| CC
its  ||| S:47450 E:47454 ||| PRP$
neck-tail  ||| S:47454 E:47464 ||| JJ
fragment  ||| S:47464 E:47473 ||| NN
( ||| S:47473 E:47474 ||| -LRB-
Fig.  ||| S:47474 E:47479 ||| NNP
1A ||| S:47479 E:47481 ||| NNP
, ||| S:47481 E:47482 ||| ,
1B ||| S:47482 E:47484 ||| CD
)  ||| S:47484 E:47496 ||| -RRB-
were  ||| S:47496 E:47501 ||| VBD
co-expressed  ||| S:47501 E:47514 ||| JJ
with  ||| S:47514 E:47530 ||| IN
Xenopus  ||| S:47530 E:47538 ||| NNP
calmodulin  ||| S:47538 E:47549 ||| NN
in  ||| S:47549 E:47552 ||| IN
Sf9  ||| S:47552 E:47556 ||| CD
cells  ||| S:47556 E:47572 ||| NNS
using  ||| S:47572 E:47578 ||| VBG
methods  ||| S:47578 E:47586 ||| NNS
described  ||| S:47586 E:47596 ||| VBD
previously  ||| S:47596 E:47607 ||| RB
[  ||| S:47607 E:47609 ||| -LRB-
43  ||| S:47609 E:47612 ||| CD
]  ||| S:47612 E:47614 ||| -RRB-
.  ||| S:47614 E:47627 ||| .
Xenopus  ||| S:47627 E:47635 ||| JJ
calmodulin  ||| S:47635 E:47646 ||| NN
is  ||| S:47646 E:47649 ||| VBZ
identical  ||| S:47649 E:47659 ||| JJ
to  ||| S:47659 E:47672 ||| TO
all  ||| S:47672 E:47676 ||| DT
other  ||| S:47676 E:47682 ||| JJ
sequenced  ||| S:47682 E:47692 ||| JJ
vertebrate  ||| S:47692 E:47703 ||| JJ
calmodulins ||| S:47703 E:47714 ||| NN
,  ||| S:47714 E:47716 ||| ,
including  ||| S:47716 E:47736 ||| VBG
bovine  ||| S:47736 E:47743 ||| JJ
calmodulin  ||| S:47743 E:47754 ||| NNS
[  ||| S:47754 E:47756 ||| -LRB-
46  ||| S:47756 E:47759 ||| CD
]  ||| S:47759 E:47761 ||| -RRB-
;  ||| S:47761 E:47763 ||| :
we  ||| S:47763 E:47766 ||| PRP
presume  ||| S:47766 E:47774 ||| VBD
that  ||| S:47774 E:47779 ||| DT
bullfrog  ||| S:47779 E:47798 ||| JJ
calmodulin  ||| S:47798 E:47809 ||| NN
is  ||| S:47809 E:47812 ||| VBZ
also  ||| S:47812 E:47817 ||| RB
identical ||| S:47817 E:47826 ||| JJ
.  ||| S:47826 E:47828 ||| .
Recombinant  ||| S:47828 E:47840 ||| JJ
proteins  ||| S:47840 E:47849 ||| NNS
were  ||| S:47849 E:47864 ||| VBD
partially  ||| S:47864 E:47874 ||| RB
purified  ||| S:47874 E:47883 ||| VBN
by  ||| S:47883 E:47886 ||| IN
centrifugation  ||| S:47886 E:47901 ||| NN
of  ||| S:47901 E:47904 ||| IN
an  ||| S:47904 E:47907 ||| DT
Sf9-cell  ||| S:47907 E:47926 ||| JJ
extract  ||| S:47926 E:47934 ||| NN
and  ||| S:47934 E:47938 ||| CC
Ni  ||| S:47938 E:47941 ||| NNP
2+-nitrilotriacetic  ||| S:47941 E:47961 ||| FW
acid  ||| S:47961 E:47966 ||| FW
chromatography  ||| S:47966 E:47981 ||| FW
[  ||| S:47981 E:47993 ||| -LRB-
43  ||| S:47993 E:47996 ||| CD
]  ||| S:47996 E:47998 ||| -RRB-
;  ||| S:47998 E:48000 ||| :
further  ||| S:48000 E:48008 ||| JJ
purification  ||| S:48008 E:48021 ||| NN
was  ||| S:48021 E:48025 ||| VBD
achieved  ||| S:48025 E:48034 ||| VBN
using  ||| S:48034 E:48040 ||| VBG
gel  ||| S:48040 E:48054 ||| JJ
filtration  ||| S:48054 E:48065 ||| NN
at  ||| S:48065 E:48068 ||| IN
4°C  ||| S:48068 E:48072 ||| CD
on  ||| S:48072 E:48075 ||| IN
a  ||| S:48075 E:48077 ||| DT
25-ml  ||| S:48077 E:48083 ||| NNP
Superdex  ||| S:48083 E:48092 ||| NNP
200  ||| S:48092 E:48096 ||| CD
HR  ||| S:48096 E:48099 ||| CD
10 ||| S:48099 E:48101 ||| CD
/ ||| S:48101 E:48102 ||| CD
30  ||| S:48102 E:48105 ||| CD
column  ||| S:48105 E:48122 ||| NN
run  ||| S:48122 E:48126 ||| VBN
at  ||| S:48126 E:48129 ||| IN
0.5  ||| S:48129 E:48133 ||| CD
ml ||| S:48133 E:48135 ||| CD
/ ||| S:48135 E:48136 ||| CD
min  ||| S:48136 E:48140 ||| NN
in  ||| S:48140 E:48143 ||| IN
400  ||| S:48143 E:48147 ||| CD
mM  ||| S:48147 E:48150 ||| JJ
KCl ||| S:48150 E:48153 ||| NN
,  ||| S:48153 E:48155 ||| ,
1  ||| S:48155 E:48157 ||| CD
mM  ||| S:48157 E:48160 ||| JJ
MgCl  ||| S:48160 E:48176 ||| JJ
2  ||| S:48176 E:48178 ||| CD
,  ||| S:48178 E:48180 ||| ,
100  ||| S:48180 E:48184 ||| CD
μM  ||| S:48184 E:48187 ||| JJ
EGTA ||| S:48187 E:48191 ||| NNP
,  ||| S:48191 E:48193 ||| ,
15  ||| S:48193 E:48196 ||| CD
mM  ||| S:48196 E:48199 ||| JJ
HEPES  ||| S:48199 E:48205 ||| NNP
pH  ||| S:48205 E:48208 ||| NNP
7.5  ||| S:48208 E:48222 ||| CD
with  ||| S:48222 E:48227 ||| IN
an  ||| S:48227 E:48230 ||| DT
AKTA-FPLC  ||| S:48230 E:48240 ||| JJ
system  ||| S:48240 E:48247 ||| NN
( ||| S:48247 E:48248 ||| -LRB-
Amersham  ||| S:48248 E:48257 ||| NNP
Pharmacia  ||| S:48257 E:48267 ||| NNP
Biotech ||| S:48267 E:48274 ||| NNP
,  ||| S:48274 E:48286 ||| ,
Piscataway ||| S:48286 E:48296 ||| NNP
,  ||| S:48296 E:48298 ||| ,
NJ ||| S:48298 E:48300 ||| NNP
) ||| S:48300 E:48301 ||| -RRB-
.  ||| S:48301 E:48303 ||| .
The  ||| S:48303 E:48307 ||| DT
concentration  ||| S:48307 E:48321 ||| NN
of  ||| S:48321 E:48324 ||| IN
each  ||| S:48324 E:48329 ||| DT
purified  ||| S:48329 E:48348 ||| JJ
recombinant  ||| S:48348 E:48360 ||| JJ
protein  ||| S:48360 E:48368 ||| NN
was  ||| S:48368 E:48372 ||| VBD
calculated  ||| S:48372 E:48383 ||| VBN
by  ||| S:48383 E:48386 ||| IN
measuring  ||| S:48386 E:48406 ||| VBG
absorption  ||| S:48406 E:48417 ||| NN
at  ||| S:48417 E:48420 ||| IN
280  ||| S:48420 E:48424 ||| CD
nm  ||| S:48424 E:48427 ||| NNS
and  ||| S:48427 E:48431 ||| CC
using  ||| S:48431 E:48437 ||| VBG
extinction  ||| S:48437 E:48448 ||| NN
coefficients  ||| S:48448 E:48471 ||| VBZ
calculated  ||| S:48471 E:48482 ||| VBN
from  ||| S:48482 E:48487 ||| IN
the  ||| S:48487 E:48491 ||| DT
appropriate  ||| S:48491 E:48503 ||| JJ
aminoacid  ||| S:48503 E:48513 ||| NNS
sequence  ||| S:48513 E:48522 ||| VBP
using  ||| S:48522 E:48538 ||| VBG
the  ||| S:48538 E:48542 ||| DT
ExPASy  ||| S:48542 E:48549 ||| JJ
ProtParam  ||| S:48549 E:48559 ||| JJ
tool  ||| S:48559 E:48574 ||| NN
http://www.expasy.ch/tools/protparam.html ||| S:48574 E:48615 ||| NN
,  ||| S:48615 E:48617 ||| ,
assuming  ||| S:48617 E:48626 ||| VBG
2.5  ||| S:48626 E:48640 ||| CD
calmodulins  ||| S:48640 E:48652 ||| NN
per  ||| S:48652 E:48656 ||| IN
full-length  ||| S:48656 E:48668 ||| JJ
Myo1c  ||| S:48668 E:48674 ||| NNP
( ||| S:48674 E:48675 ||| -LRB-
53,619  ||| S:48675 E:48682 ||| NNP
M  ||| S:48682 E:48684 ||| NNP
-1cm  ||| S:48684 E:48689 ||| NNP
-1 ||| S:48689 E:48691 ||| NNP
)  ||| S:48691 E:48693 ||| -RRB-
or  ||| S:48693 E:48706 ||| CC
T701  ||| S:48706 E:48711 ||| CD
fragment  ||| S:48711 E:48720 ||| NNS
( ||| S:48720 E:48721 ||| -LRB-
65,565  ||| S:48721 E:48728 ||| NNP
M  ||| S:48728 E:48730 ||| NNP
-1cm  ||| S:48730 E:48735 ||| NNP
-1 ||| S:48735 E:48737 ||| NNP
) ||| S:48737 E:48738 ||| -RRB-
.  ||| S:48738 E:48740 ||| .
We  ||| S:48740 E:48743 ||| PRP
typically  ||| S:48743 E:48753 ||| RB
obtained  ||| S:48753 E:48772 ||| VBD
100-300  ||| S:48772 E:48780 ||| CD
μg  ||| S:48780 E:48783 ||| NN
of  ||| S:48783 E:48786 ||| IN
recombinant  ||| S:48786 E:48798 ||| JJ
protein  ||| S:48798 E:48806 ||| NN
from  ||| S:48806 E:48811 ||| IN
~10  ||| S:48811 E:48815 ||| CD
9Sf9  ||| S:48815 E:48820 ||| CD
cells ||| S:48820 E:48825 ||| NNS
.  ||| S:48825 E:48837 ||| .
Full-length  ||| S:48837 E:48849 ||| JJ
Myo1c  ||| S:48849 E:48855 ||| NN
had  ||| S:48855 E:48859 ||| VBD
NH  ||| S:48859 E:48873 ||| NNP
4  ||| S:48873 E:48875 ||| CD
Cl-activated  ||| S:48875 E:48888 ||| JJ
ATPase  ||| S:48888 E:48895 ||| JJ
activity  ||| S:48895 E:48904 ||| NN
[  ||| S:48904 E:48906 ||| -LRB-
12  ||| S:48906 E:48909 ||| CD
]  ||| S:48909 E:48921 ||| -RRB-
of  ||| S:48921 E:48924 ||| IN
1.8  ||| S:48924 E:48928 ||| CD
±  ||| S:48928 E:48930 ||| CD
0.7  ||| S:48930 E:48934 ||| CD
s  ||| S:48934 E:48936 ||| CD
-1 ||| S:48936 E:48938 ||| CD
,  ||| S:48938 E:48940 ||| ,
with  ||| S:48940 E:48945 ||| IN
a  ||| S:48945 E:48947 ||| DT
K  ||| S:48947 E:48960 ||| NNP
m  ||| S:48960 E:48962 ||| NN
for  ||| S:48962 E:48966 ||| IN
ATP  ||| S:48966 E:48970 ||| NNP
of  ||| S:48970 E:48973 ||| IN
0.3  ||| S:48973 E:48977 ||| CD
±  ||| S:48977 E:48979 ||| CD
0.1  ||| S:48979 E:48983 ||| CD
mM ||| S:48983 E:48985 ||| NN
.  ||| S:48985 E:48987 ||| .
Actin  ||| S:48987 E:49003 ||| FW
activated  ||| S:49003 E:49013 ||| FW
basal  ||| S:49013 E:49019 ||| FW
Mg  ||| S:49019 E:49022 ||| FW
2+-ATPase  ||| S:49022 E:49032 ||| FW
activity  ||| S:49032 E:49041 ||| FW
~15-fold ||| S:49041 E:49049 ||| FW
.  ||| S:49049 E:49061 ||| .
Calmodulin  ||| S:49061 E:49072 ||| NNP
was  ||| S:49072 E:49076 ||| VBD
purified  ||| S:49076 E:49085 ||| VBN
from  ||| S:49085 E:49090 ||| IN
bovine  ||| S:49090 E:49097 ||| JJ
brain  ||| S:49097 E:49103 ||| NN
( ||| S:49103 E:49104 ||| -LRB-
Pel-Freez ||| S:49104 E:49113 ||| NNP
,  ||| S:49113 E:49125 ||| ,
Rogers ||| S:49125 E:49131 ||| NNP
,  ||| S:49131 E:49133 ||| ,
AR ||| S:49133 E:49135 ||| NNP
)  ||| S:49135 E:49137 ||| -RRB-
by  ||| S:49137 E:49140 ||| IN
isoelectric  ||| S:49140 E:49152 ||| JJ
precipitation  ||| S:49152 E:49166 ||| NN
and  ||| S:49166 E:49180 ||| CC
phenyl-agarose  ||| S:49180 E:49195 ||| NNP
( ||| S:49195 E:49196 ||| -LRB-
Sigma ||| S:49196 E:49201 ||| NNP
,  ||| S:49201 E:49203 ||| ,
St.  ||| S:49203 E:49207 ||| NNP
Louis ||| S:49207 E:49212 ||| NNP
,  ||| S:49212 E:49214 ||| ,
MO ||| S:49214 E:49216 ||| NNP
)  ||| S:49216 E:49218 ||| -RRB-
chromatography  ||| S:49218 E:49233 ||| NNS
[  ||| S:49233 E:49235 ||| -LRB-
47  ||| S:49235 E:49248 ||| CD
]  ||| S:49248 E:49250 ||| -RRB-
;  ||| S:49250 E:49252 ||| :
its  ||| S:49252 E:49256 ||| PRP$
concentration  ||| S:49256 E:49270 ||| NN
was  ||| S:49270 E:49274 ||| VBD
measured  ||| S:49274 E:49283 ||| VBN
assuming  ||| S:49283 E:49292 ||| VBG
a  ||| S:49292 E:49294 ||| DT
molar  ||| S:49294 E:49310 ||| JJ
extinction  ||| S:49310 E:49321 ||| NN
coefficient  ||| S:49321 E:49333 ||| NN
of  ||| S:49333 E:49336 ||| IN
3030  ||| S:49336 E:49341 ||| CD
M  ||| S:49341 E:49343 ||| NNP
-1cm  ||| S:49343 E:49348 ||| CD
-1at  ||| S:49348 E:49353 ||| CD
276  ||| S:49353 E:49357 ||| CD
nm  ||| S:49357 E:49360 ||| NNS
[  ||| S:49360 E:49362 ||| -LRB-
48  ||| S:49362 E:49365 ||| CD
]  ||| S:49365 E:49377 ||| -RRB-
.  ||| S:49377 E:49407 ||| .
Gel  ||| S:49407 E:49411 ||| FW
filtration  ||| S:49411 E:49432 ||| FW
Stokes  ||| S:49432 E:49439 ||| FW
radii  ||| S:49439 E:49445 ||| FW
of  ||| S:49445 E:49448 ||| IN
Myo1c  ||| S:49448 E:49454 ||| NNP
and  ||| S:49454 E:49458 ||| CC
T701-Myo1c  ||| S:49458 E:49469 ||| NNP
were  ||| S:49469 E:49474 ||| VBD
measured  ||| S:49474 E:49493 ||| VBN
using  ||| S:49493 E:49499 ||| VBG
gel  ||| S:49499 E:49503 ||| JJ
filtration  ||| S:49503 E:49514 ||| NN
on  ||| S:49514 E:49517 ||| IN
a  ||| S:49517 E:49519 ||| DT
25-ml  ||| S:49519 E:49525 ||| NNP
Superdex  ||| S:49525 E:49534 ||| NNP
200  ||| S:49534 E:49538 ||| CD
HR  ||| S:49538 E:49541 ||| CD
10 ||| S:49541 E:49543 ||| CD
/ ||| S:49543 E:49544 ||| CD
30  ||| S:49544 E:49557 ||| CD
column  ||| S:49557 E:49564 ||| NN
at  ||| S:49564 E:49567 ||| IN
either  ||| S:49567 E:49574 ||| DT
4°C  ||| S:49574 E:49578 ||| NNP
or  ||| S:49578 E:49581 ||| CC
room  ||| S:49581 E:49586 ||| NN
temperature  ||| S:49586 E:49598 ||| NN
( ||| S:49598 E:49599 ||| -LRB-
23-25°C ||| S:49599 E:49606 ||| NNP
) ||| S:49606 E:49607 ||| -RRB-
.  ||| S:49607 E:49619 ||| .
Columns  ||| S:49619 E:49627 ||| NNS
were  ||| S:49627 E:49632 ||| VBD
run  ||| S:49632 E:49636 ||| VBN
at  ||| S:49636 E:49639 ||| IN
0.5  ||| S:49639 E:49643 ||| CD
ml ||| S:49643 E:49645 ||| CD
/ ||| S:49645 E:49646 ||| CD
min  ||| S:49646 E:49650 ||| NN
in  ||| S:49650 E:49653 ||| IN
400  ||| S:49653 E:49657 ||| CD
mM  ||| S:49657 E:49660 ||| JJ
KCl ||| S:49660 E:49663 ||| NN
,  ||| S:49663 E:49665 ||| ,
1  ||| S:49665 E:49667 ||| CD
mM  ||| S:49667 E:49670 ||| JJ
MgCl  ||| S:49670 E:49686 ||| JJ
2  ||| S:49686 E:49688 ||| CD
,  ||| S:49688 E:49690 ||| ,
15  ||| S:49690 E:49693 ||| CD
mM  ||| S:49693 E:49696 ||| JJ
HEPES  ||| S:49696 E:49702 ||| NNP
pH  ||| S:49702 E:49705 ||| NNP
7.5 ||| S:49705 E:49708 ||| CD
,  ||| S:49708 E:49710 ||| ,
and  ||| S:49710 E:49714 ||| CC
either  ||| S:49714 E:49721 ||| RB
100  ||| S:49721 E:49735 ||| CD
μM  ||| S:49735 E:49738 ||| JJ
EGTA  ||| S:49738 E:49743 ||| NNP
or  ||| S:49743 E:49746 ||| CC
25  ||| S:49746 E:49749 ||| CD
μM  ||| S:49749 E:49752 ||| JJ
CaCl  ||| S:49752 E:49768 ||| JJ
2  ||| S:49768 E:49770 ||| CD
;  ||| S:49770 E:49772 ||| :
5-20  ||| S:49772 E:49777 ||| CD
μg  ||| S:49777 E:49780 ||| NN
of  ||| S:49780 E:49783 ||| IN
recombinant  ||| S:49783 E:49795 ||| JJ
protein  ||| S:49795 E:49803 ||| NN
was  ||| S:49803 E:49817 ||| VBD
applied  ||| S:49817 E:49825 ||| VBN
to  ||| S:49825 E:49828 ||| TO
the  ||| S:49828 E:49832 ||| DT
column ||| S:49832 E:49838 ||| NN
.  ||| S:49838 E:49840 ||| .
Columns  ||| S:49840 E:49848 ||| NNS
were  ||| S:49848 E:49853 ||| VBD
calibrated  ||| S:49853 E:49864 ||| VBN
using  ||| S:49864 E:49880 ||| VBG
20-200  ||| S:49880 E:49887 ||| NNP
μg  ||| S:49887 E:49890 ||| VBD
each  ||| S:49890 E:49895 ||| DT
of  ||| S:49895 E:49898 ||| IN
globular  ||| S:49898 E:49907 ||| JJ
proteins  ||| S:49907 E:49916 ||| NNS
of  ||| S:49916 E:49919 ||| IN
known  ||| S:49919 E:49925 ||| VBN
Stokes  ||| S:49925 E:49932 ||| JJ
radii  ||| S:49932 E:49948 ||| NNS
( ||| S:49948 E:49949 ||| -LRB-
thyroglobulin ||| S:49949 E:49962 ||| UH
,  ||| S:49962 E:49964 ||| ,
8.50  ||| S:49964 E:49969 ||| CD
nm ||| S:49969 E:49971 ||| NNS
;  ||| S:49971 E:49973 ||| :
ferritin ||| S:49973 E:49981 ||| CD
,  ||| S:49981 E:49983 ||| ,
6.10  ||| S:49983 E:49988 ||| CD
nm ||| S:49988 E:49990 ||| NNS
;  ||| S:49990 E:49992 ||| :
catalase ||| S:49992 E:50000 ||| CD
,  ||| S:50000 E:50012 ||| ,
5.22  ||| S:50012 E:50017 ||| CD
nm ||| S:50017 E:50019 ||| NNS
;  ||| S:50019 E:50021 ||| :
aldolase ||| S:50021 E:50029 ||| CD
,  ||| S:50029 E:50031 ||| ,
4.81  ||| S:50031 E:50036 ||| CD
nm ||| S:50036 E:50038 ||| NNS
;  ||| S:50038 E:50040 ||| :
bovine  ||| S:50040 E:50047 ||| FW
serum  ||| S:50047 E:50053 ||| FW
albumin ||| S:50053 E:50060 ||| FW
,  ||| S:50060 E:50062 ||| ,
3.55  ||| S:50062 E:50077 ||| CD
nm ||| S:50077 E:50079 ||| NNS
;  ||| S:50079 E:50081 ||| :
ovalbumin ||| S:50081 E:50090 ||| CD
,  ||| S:50090 E:50092 ||| ,
3.05  ||| S:50092 E:50097 ||| CD
nm ||| S:50097 E:50099 ||| NNS
;  ||| S:50099 E:50101 ||| :
chymotrypsinogen ||| S:50101 E:50117 ||| CD
,  ||| S:50117 E:50119 ||| ,
2.09  ||| S:50119 E:50124 ||| CD
nm ||| S:50124 E:50126 ||| NNS
;  ||| S:50126 E:50128 ||| :
and  ||| S:50128 E:50142 ||| CC
RNase  ||| S:50142 E:50148 ||| NNP
A ||| S:50148 E:50149 ||| NNP
,  ||| S:50149 E:50151 ||| ,
1.64  ||| S:50151 E:50156 ||| CD
nm ||| S:50156 E:50158 ||| NNS
;  ||| S:50158 E:50160 ||| :
all  ||| S:50160 E:50164 ||| DT
obtained  ||| S:50164 E:50173 ||| VBN
from  ||| S:50173 E:50178 ||| IN
Amersham  ||| S:50178 E:50187 ||| NNP
Pharmacia  ||| S:50187 E:50207 ||| NNP
Biotech ||| S:50207 E:50214 ||| NNP
) ||| S:50214 E:50215 ||| -RRB-
.  ||| S:50215 E:50217 ||| .
Proteins  ||| S:50217 E:50226 ||| NNS
were  ||| S:50226 E:50231 ||| VBD
detected  ||| S:50231 E:50240 ||| VBN
by  ||| S:50240 E:50243 ||| IN
absorption  ||| S:50243 E:50254 ||| NN
at  ||| S:50254 E:50257 ||| IN
280  ||| S:50257 E:50271 ||| CD
nm ||| S:50271 E:50273 ||| NNS
.  ||| S:50273 E:50303 ||| .
Velocity  ||| S:50303 E:50312 ||| JJ
sedimentation  ||| S:50312 E:50326 ||| NN
on  ||| S:50326 E:50329 ||| IN
sucrose  ||| S:50329 E:50337 ||| FW
gradients  ||| S:50337 E:50357 ||| FW
Sedimentation  ||| S:50357 E:50371 ||| FW
coefficients  ||| S:50371 E:50384 ||| FW
of  ||| S:50384 E:50387 ||| IN
full-length  ||| S:50387 E:50399 ||| JJ
and  ||| S:50399 E:50413 ||| CC
T701-Myo1c  ||| S:50413 E:50424 ||| NNP
were  ||| S:50424 E:50429 ||| VBD
measured  ||| S:50429 E:50438 ||| VBN
using  ||| S:50438 E:50444 ||| VBG
linear  ||| S:50444 E:50451 ||| JJ
5-20 ||| S:50451 E:50455 ||| CD
%  ||| S:50455 E:50457 ||| NN
sucrose  ||| S:50457 E:50475 ||| NN
gradients  ||| S:50475 E:50485 ||| NN
in  ||| S:50485 E:50488 ||| IN
11.5  ||| S:50488 E:50493 ||| CD
ml  ||| S:50493 E:50496 ||| NN
of  ||| S:50496 E:50499 ||| IN
400  ||| S:50499 E:50503 ||| CD
mM  ||| S:50503 E:50506 ||| JJ
KCl ||| S:50506 E:50509 ||| NN
,  ||| S:50509 E:50511 ||| ,
1  ||| S:50511 E:50513 ||| CD
mM  ||| S:50513 E:50516 ||| JJ
MgCl  ||| S:50516 E:50532 ||| JJ
2  ||| S:50532 E:50534 ||| CD
,  ||| S:50534 E:50536 ||| ,
15  ||| S:50536 E:50539 ||| CD
mM  ||| S:50539 E:50542 ||| JJ
HEPES  ||| S:50542 E:50548 ||| NNP
pH  ||| S:50548 E:50551 ||| NNP
7.5 ||| S:50551 E:50554 ||| CD
,  ||| S:50554 E:50556 ||| ,
0.2  ||| S:50556 E:50560 ||| CD
mM  ||| S:50560 E:50573 ||| JJ
phenylmethylsulfonyl  ||| S:50573 E:50594 ||| JJ
fluoride ||| S:50594 E:50602 ||| NN
,  ||| S:50602 E:50604 ||| ,
10  ||| S:50604 E:50607 ||| CD
μM  ||| S:50607 E:50610 ||| JJ
leupeptin ||| S:50610 E:50619 ||| NN
,  ||| S:50619 E:50621 ||| ,
10  ||| S:50621 E:50624 ||| CD
μM  ||| S:50624 E:50637 ||| JJ
pepstatin ||| S:50637 E:50646 ||| NN
,  ||| S:50646 E:50648 ||| ,
and  ||| S:50648 E:50652 ||| CC
either  ||| S:50652 E:50659 ||| RB
100  ||| S:50659 E:50663 ||| CD
μM  ||| S:50663 E:50666 ||| JJ
EGTA  ||| S:50666 E:50671 ||| NNP
or  ||| S:50671 E:50674 ||| CC
25  ||| S:50674 E:50677 ||| CD
μM  ||| S:50677 E:50680 ||| JJ
CaCl  ||| S:50680 E:50696 ||| JJ
2  ||| S:50696 E:50698 ||| CD
.  ||| S:50698 E:50700 ||| .
Gradients  ||| S:50700 E:50710 ||| NNP
were  ||| S:50710 E:50715 ||| VBD
calibrated  ||| S:50715 E:50726 ||| VBN
with  ||| S:50726 E:50741 ||| IN
2-20  ||| S:50741 E:50746 ||| CD
μg  ||| S:50746 E:50749 ||| CD
internal  ||| S:50749 E:50758 ||| JJ
standards  ||| S:50758 E:50768 ||| NNS
of  ||| S:50768 E:50771 ||| IN
known  ||| S:50771 E:50777 ||| VBN
sedimentation  ||| S:50777 E:50801 ||| JJ
coefficients  ||| S:50801 E:50814 ||| NNS
( ||| S:50814 E:50815 ||| -LRB-
catalase ||| S:50815 E:50823 ||| UH
,  ||| S:50823 E:50825 ||| ,
11.3  ||| S:50825 E:50830 ||| NNP
S ||| S:50830 E:50831 ||| NNP
;  ||| S:50831 E:50833 ||| :
bovine  ||| S:50833 E:50840 ||| FW
serum  ||| S:50840 E:50846 ||| FW
albumin ||| S:50846 E:50853 ||| FW
,  ||| S:50853 E:50865 ||| ,
4.31  ||| S:50865 E:50870 ||| NNP
S ||| S:50870 E:50871 ||| NNP
;  ||| S:50871 E:50873 ||| :
lysozyme ||| S:50873 E:50881 ||| CD
,  ||| S:50881 E:50883 ||| ,
1.91  ||| S:50883 E:50888 ||| NNP
S ||| S:50888 E:50889 ||| NNP
;  ||| S:50889 E:50891 ||| :
all  ||| S:50891 E:50895 ||| DT
obtained  ||| S:50895 E:50904 ||| VBN
from  ||| S:50904 E:50919 ||| IN
Sigma-Aldrich ||| S:50919 E:50932 ||| NNP
) ||| S:50932 E:50933 ||| -RRB-
.  ||| S:50933 E:50935 ||| .
After  ||| S:50935 E:50941 ||| IN
centrifugation  ||| S:50941 E:50956 ||| NN
at  ||| S:50956 E:50959 ||| IN
33,000-40,000  ||| S:50959 E:50973 ||| CD
rpm  ||| S:50973 E:50987 ||| NN
in  ||| S:50987 E:50990 ||| IN
an  ||| S:50990 E:50993 ||| DT
SW  ||| S:50993 E:50996 ||| NNP
41  ||| S:50996 E:50999 ||| CD
rotor  ||| S:50999 E:51005 ||| NN
for  ||| S:51005 E:51009 ||| IN
15-18  ||| S:51009 E:51015 ||| CD
hours  ||| S:51015 E:51021 ||| NNS
at  ||| S:51021 E:51024 ||| IN
4°C  ||| S:51024 E:51028 ||| NNP
or  ||| S:51028 E:51031 ||| CC
25°C ||| S:51031 E:51035 ||| NNP
,  ||| S:51035 E:51047 ||| ,
gradients  ||| S:51047 E:51057 ||| NN
were  ||| S:51057 E:51062 ||| VBD
fractionated  ||| S:51062 E:51075 ||| VBN
from  ||| S:51075 E:51080 ||| IN
the  ||| S:51080 E:51084 ||| DT
bottom  ||| S:51084 E:51091 ||| NN
into  ||| S:51091 E:51096 ||| IN
~30  ||| S:51096 E:51110 ||| CD
fractions ||| S:51110 E:51119 ||| NNS
.  ||| S:51119 E:51121 ||| .
Calibration  ||| S:51121 E:51133 ||| JJ
proteins  ||| S:51133 E:51142 ||| NNS
were  ||| S:51142 E:51147 ||| VBD
located  ||| S:51147 E:51155 ||| VBN
using  ||| S:51155 E:51161 ||| VBG
a  ||| S:51161 E:51173 ||| DT
Bradford  ||| S:51173 E:51182 ||| NNP
protein  ||| S:51182 E:51190 ||| NN
assay  ||| S:51190 E:51196 ||| NNS
[  ||| S:51196 E:51198 ||| -LRB-
49  ||| S:51198 E:51201 ||| CD
]  ||| S:51201 E:51203 ||| -RRB-
;  ||| S:51203 E:51205 ||| :
Myo1c-containing  ||| S:51205 E:51232 ||| CD
fractions  ||| S:51232 E:51242 ||| NNS
were  ||| S:51242 E:51247 ||| VBD
located  ||| S:51247 E:51255 ||| VBN
by  ||| S:51255 E:51258 ||| IN
ELISA  ||| S:51258 E:51264 ||| NNP
[  ||| S:51264 E:51266 ||| -LRB-
43  ||| S:51266 E:51269 ||| CD
]  ||| S:51269 E:51271 ||| -RRB-
using  ||| S:51271 E:51277 ||| VBG
an  ||| S:51277 E:51280 ||| DT
antibody  ||| S:51280 E:51299 ||| NN
against  ||| S:51299 E:51307 ||| IN
the  ||| S:51307 E:51311 ||| DT
Myo1c  ||| S:51311 E:51317 ||| JJ
tail  ||| S:51317 E:51322 ||| NN
( ||| S:51322 E:51323 ||| -LRB-
mT2 ||| S:51323 E:51326 ||| CD
/ ||| S:51326 E:51327 ||| CD
M2 ||| S:51327 E:51329 ||| CD
;  ||| S:51329 E:51331 ||| :
ref.  ||| S:51331 E:51336 ||| CD
[  ||| S:51336 E:51338 ||| -LRB-
50  ||| S:51338 E:51341 ||| CD
]  ||| S:51341 E:51343 ||| CD
)  ||| S:51343 E:51345 ||| -RRB-
or  ||| S:51345 E:51348 ||| CC
against  ||| S:51348 E:51366 ||| IN
the  ||| S:51366 E:51370 ||| DT
DLYDDDDK  ||| S:51370 E:51379 ||| FW
epitope  ||| S:51379 E:51387 ||| FW
tag  ||| S:51387 E:51391 ||| FW
( ||| S:51391 E:51392 ||| -LRB-
anti-Xpress ||| S:51392 E:51403 ||| NNP
;  ||| S:51403 E:51405 ||| :
Invitrogen ||| S:51405 E:51415 ||| LS
) ||| S:51415 E:51416 ||| -RRB-
.  ||| S:51416 E:51418 ||| .
To  ||| S:51418 E:51431 ||| TO
determine  ||| S:51431 E:51441 ||| VB
the  ||| S:51441 E:51445 ||| DT
location  ||| S:51445 E:51454 ||| NN
of  ||| S:51454 E:51457 ||| IN
protein  ||| S:51457 E:51465 ||| NN
peaks ||| S:51465 E:51470 ||| NNS
,  ||| S:51470 E:51472 ||| ,
plots  ||| S:51472 E:51478 ||| NNS
of  ||| S:51478 E:51491 ||| IN
fraction  ||| S:51491 E:51500 ||| NN
number  ||| S:51500 E:51507 ||| NN
versus  ||| S:51507 E:51514 ||| IN
the  ||| S:51514 E:51518 ||| DT
levels  ||| S:51518 E:51525 ||| NNS
of  ||| S:51525 E:51528 ||| IN
Myo1c  ||| S:51528 E:51534 ||| NNP
or  ||| S:51534 E:51537 ||| CC
calibration  ||| S:51537 E:51559 ||| JJ
proteins  ||| S:51559 E:51568 ||| NNS
were  ||| S:51568 E:51573 ||| VBD
fit  ||| S:51573 E:51577 ||| VBN
with  ||| S:51577 E:51582 ||| IN
either  ||| S:51582 E:51589 ||| DT
one ||| S:51589 E:51592 ||| CD
,  ||| S:51592 E:51594 ||| ,
two ||| S:51594 E:51597 ||| CD
,  ||| S:51597 E:51599 ||| ,
or  ||| S:51599 E:51602 ||| CC
three  ||| S:51602 E:51608 ||| CD
Gaussian  ||| S:51608 E:51627 ||| JJ
curves ||| S:51627 E:51633 ||| NN
.  ||| S:51633 E:51645 ||| .
For  ||| S:51645 E:51649 ||| IN
calmodulin  ||| S:51649 E:51660 ||| JJ
preloading  ||| S:51660 E:51671 ||| NN
of  ||| S:51671 E:51674 ||| IN
T701-Myo1c ||| S:51674 E:51684 ||| NNP
,  ||| S:51684 E:51686 ||| ,
10  ||| S:51686 E:51689 ||| CD
μM  ||| S:51689 E:51702 ||| JJ
purified  ||| S:51702 E:51711 ||| JJ
calmodulin  ||| S:51711 E:51722 ||| NN
was  ||| S:51722 E:51726 ||| VBD
incubated  ||| S:51726 E:51736 ||| VBN
with  ||| S:51736 E:51741 ||| IN
1  ||| S:51741 E:51743 ||| CD
μM  ||| S:51743 E:51746 ||| JJ
Myo1c  ||| S:51746 E:51752 ||| NN
in  ||| S:51752 E:51755 ||| IN
a  ||| S:51755 E:51767 ||| DT
solution  ||| S:51767 E:51776 ||| NN
containing  ||| S:51776 E:51787 ||| VBG
either  ||| S:51787 E:51794 ||| DT
100  ||| S:51794 E:51798 ||| CD
μM  ||| S:51798 E:51801 ||| JJ
EGTA  ||| S:51801 E:51806 ||| NNP
or  ||| S:51806 E:51809 ||| CC
25  ||| S:51809 E:51812 ||| CD
μM  ||| S:51812 E:51815 ||| JJ
CaCl  ||| S:51815 E:51831 ||| JJ
2  ||| S:51831 E:51833 ||| CD
for  ||| S:51833 E:51837 ||| IN
60  ||| S:51837 E:51840 ||| CD
min  ||| S:51840 E:51844 ||| NN
at  ||| S:51844 E:51847 ||| IN
room  ||| S:51847 E:51852 ||| NN
temperature  ||| S:51852 E:51864 ||| NN
prior  ||| S:51864 E:51880 ||| RB
to  ||| S:51880 E:51883 ||| TO
centrifugation ||| S:51883 E:51897 ||| VB
.  ||| S:51897 E:51927 ||| .
Determination  ||| S:51927 E:51941 ||| NN
of  ||| S:51941 E:51944 ||| IN
molecular  ||| S:51944 E:51954 ||| JJ
mass  ||| S:51954 E:51969 ||| NN
We  ||| S:51969 E:51972 ||| PRP
used  ||| S:51972 E:51977 ||| VBD
the  ||| S:51977 E:51981 ||| DT
modified  ||| S:51981 E:51990 ||| JJ
Svedberg  ||| S:51990 E:51999 ||| JJ
equation  ||| S:51999 E:52008 ||| NN
for  ||| S:52008 E:52022 ||| IN
molecular-mass  ||| S:52022 E:52037 ||| JJ
determination ||| S:52037 E:52050 ||| NN
:  ||| S:52050 E:52073 ||| :
where  ||| S:52073 E:52090 ||| WRB
M  ||| S:52090 E:52092 ||| NNP
=  ||| S:52092 E:52094 ||| SYM
molecular  ||| S:52094 E:52104 ||| JJ
mass ||| S:52104 E:52108 ||| NN
,  ||| S:52108 E:52110 ||| ,
η  ||| S:52110 E:52112 ||| VBG
=  ||| S:52112 E:52114 ||| SYM
viscosity  ||| S:52114 E:52134 ||| NN
of  ||| S:52134 E:52137 ||| IN
the  ||| S:52137 E:52141 ||| DT
medium ||| S:52141 E:52147 ||| NN
,  ||| S:52147 E:52160 ||| ,
N  ||| S:52160 E:52162 ||| NNP
=  ||| S:52162 E:52164 ||| NNP
Avogadro ||| S:52164 E:52172 ||| NNP
's  ||| S:52172 E:52175 ||| POS
number ||| S:52175 E:52181 ||| NN
,  ||| S:52181 E:52194 ||| ,
a  ||| S:52194 E:52196 ||| DT
=  ||| S:52196 E:52198 ||| NNP
Stokes  ||| S:52198 E:52205 ||| NNP
radius ||| S:52205 E:52211 ||| NN
,  ||| S:52211 E:52224 ||| ,
s  ||| S:52224 E:52226 ||| VBG
=  ||| S:52226 E:52228 ||| SYM
sedimentation  ||| S:52228 E:52242 ||| FW
coefficient ||| S:52242 E:52253 ||| FW
,  ||| S:52253 E:52255 ||| ,
=  ||| S:52255 E:52267 ||| CD
partial  ||| S:52267 E:52275 ||| JJ
specific  ||| S:52275 E:52284 ||| JJ
volume ||| S:52284 E:52290 ||| NN
,  ||| S:52290 E:52292 ||| ,
and  ||| S:52292 E:52296 ||| CC
ρ  ||| S:52296 E:52298 ||| NN
=  ||| S:52298 E:52300 ||| SYM
density  ||| S:52300 E:52308 ||| NN
of  ||| S:52308 E:52311 ||| IN
the  ||| S:52311 E:52315 ||| DT
medium ||| S:52315 E:52321 ||| NN
.  ||| S:52321 E:52333 ||| .
Partial  ||| S:52333 E:52341 ||| JJ
specific  ||| S:52341 E:52350 ||| JJ
volume  ||| S:52350 E:52357 ||| NN
was  ||| S:52357 E:52361 ||| VBD
calculated  ||| S:52361 E:52372 ||| VBN
from  ||| S:52372 E:52377 ||| IN
the  ||| S:52377 E:52391 ||| DT
composition  ||| S:52391 E:52403 ||| NN
of  ||| S:52403 E:52406 ||| IN
Myo1c  ||| S:52406 E:52412 ||| NNP
or  ||| S:52412 E:52415 ||| CC
T701-Myo1c ||| S:52415 E:52425 ||| NNP
,  ||| S:52425 E:52427 ||| ,
along  ||| S:52427 E:52433 ||| RB
with  ||| S:52433 E:52438 ||| IN
the  ||| S:52438 E:52452 ||| DT
appropriate  ||| S:52452 E:52464 ||| JJ
number  ||| S:52464 E:52471 ||| NN
of  ||| S:52471 E:52474 ||| IN
calmodulins ||| S:52474 E:52485 ||| NN
,  ||| S:52485 E:52487 ||| ,
by  ||| S:52487 E:52490 ||| IN
summing  ||| S:52490 E:52498 ||| VBG
the  ||| S:52498 E:52502 ||| DT
partial  ||| S:52502 E:52520 ||| JJ
specific  ||| S:52520 E:52529 ||| JJ
volumes  ||| S:52529 E:52537 ||| NNS
of  ||| S:52537 E:52540 ||| IN
each  ||| S:52540 E:52545 ||| DT
amino  ||| S:52545 E:52551 ||| JJ
acid  ||| S:52551 E:52556 ||| NN
[  ||| S:52556 E:52558 ||| -LRB-
30  ||| S:52558 E:52561 ||| CD
]  ||| S:52561 E:52563 ||| -RRB-
.  ||| S:52563 E:52565 ||| .
We  ||| S:52565 E:52568 ||| PRP
used  ||| S:52568 E:52573 ||| VBD
η  ||| S:52573 E:52575 ||| CD
=  ||| S:52575 E:52587 ||| SYM
1.002  ||| S:52587 E:52593 ||| CD
×  ||| S:52593 E:52595 ||| CD
10  ||| S:52595 E:52598 ||| CD
-2g  ||| S:52598 E:52602 ||| CD
cm  ||| S:52602 E:52605 ||| CD
-1s  ||| S:52605 E:52609 ||| CD
-1and  ||| S:52609 E:52615 ||| CD
ρ  ||| S:52615 E:52617 ||| CD
=  ||| S:52617 E:52619 ||| SYM
0.998  ||| S:52619 E:52625 ||| FW
g  ||| S:52625 E:52627 ||| FW
cm  ||| S:52627 E:52630 ||| FW
-3 ||| S:52630 E:52632 ||| FW
.  ||| S:52632 E:52644 ||| .
Errors  ||| S:52644 E:52651 ||| NNS
in  ||| S:52651 E:52654 ||| IN
molecular  ||| S:52654 E:52664 ||| JJ
mass  ||| S:52664 E:52669 ||| NN
were  ||| S:52669 E:52674 ||| VBD
propagated  ||| S:52674 E:52685 ||| VBN
from  ||| S:52685 E:52690 ||| IN
standard  ||| S:52690 E:52709 ||| JJ
deviations  ||| S:52709 E:52720 ||| NNS
for  ||| S:52720 E:52724 ||| IN
Stokes  ||| S:52724 E:52731 ||| NNP
radius  ||| S:52731 E:52738 ||| NN
and  ||| S:52738 E:52742 ||| CC
sedimentation  ||| S:52742 E:52766 ||| JJ
coefficient  ||| S:52766 E:52778 ||| JJ
measurements ||| S:52778 E:52790 ||| NNS
.  ||| S:52790 E:52792 ||| .
To  ||| S:52792 E:52795 ||| TO
calculate  ||| S:52795 E:52805 ||| VB
error  ||| S:52805 E:52811 ||| NN
in  ||| S:52811 E:52824 ||| IN
calmodulin  ||| S:52824 E:52835 ||| JJ
stoichiometry ||| S:52835 E:52848 ||| NN
,  ||| S:52848 E:52850 ||| ,
we  ||| S:52850 E:52853 ||| PRP
used  ||| S:52853 E:52858 ||| VBD
the  ||| S:52858 E:52862 ||| DT
conservative  ||| S:52862 E:52885 ||| JJ
assumption  ||| S:52885 E:52896 ||| NN
that  ||| S:52896 E:52901 ||| IN
all  ||| S:52901 E:52905 ||| DT
error  ||| S:52905 E:52911 ||| NN
in  ||| S:52911 E:52914 ||| IN
the  ||| S:52914 E:52918 ||| DT
molecular-mass  ||| S:52918 E:52943 ||| JJ
measurement  ||| S:52943 E:52955 ||| NN
was  ||| S:52955 E:52959 ||| VBD
due  ||| S:52959 E:52963 ||| JJ
to  ||| S:52963 E:52966 ||| TO
variability  ||| S:52966 E:52978 ||| VB
in  ||| S:52978 E:52981 ||| IN
the  ||| S:52981 E:52985 ||| DT
number  ||| S:52985 E:52992 ||| NN
of  ||| S:52992 E:53005 ||| IN
calmodulins ||| S:53005 E:53016 ||| NN
.  ||| S:53016 E:53028 ||| .
The  ||| S:53028 E:53032 ||| DT
frictional  ||| S:53032 E:53043 ||| JJ
ratio  ||| S:53043 E:53049 ||| NN
was  ||| S:53049 E:53053 ||| VBD
determined  ||| S:53053 E:53064 ||| VBN
from ||| S:53064 E:53068 ||| IN
:  ||| S:53068 E:53091 ||| :
where  ||| S:53091 E:53108 ||| WRB
f  ||| S:53108 E:53110 ||| NN
is  ||| S:53110 E:53113 ||| VBZ
the  ||| S:53113 E:53117 ||| DT
frictional  ||| S:53117 E:53128 ||| JJ
coefficient  ||| S:53128 E:53140 ||| NN
of  ||| S:53140 E:53153 ||| IN
the  ||| S:53153 E:53157 ||| DT
Myo1c-calmodulin  ||| S:53157 E:53174 ||| JJ
complex  ||| S:53174 E:53182 ||| NN
and  ||| S:53182 E:53197 ||| CC
f  ||| S:53197 E:53210 ||| CD
0  ||| S:53210 E:53212 ||| CD
is  ||| S:53212 E:53215 ||| VBZ
the  ||| S:53215 E:53219 ||| DT
frictional  ||| S:53219 E:53230 ||| JJ
coefficient  ||| S:53230 E:53242 ||| NN
of  ||| S:53242 E:53245 ||| IN
a  ||| S:53245 E:53257 ||| DT
sphere  ||| S:53257 E:53264 ||| NN
of  ||| S:53264 E:53267 ||| IN
equal  ||| S:53267 E:53273 ||| JJ
volume ||| S:53273 E:53279 ||| NN
.  ||| S:53279 E:53281 ||| .
Accordingly ||| S:53281 E:53292 ||| RB
,  ||| S:53292 E:53294 ||| ,
the  ||| S:53294 E:53298 ||| DT
frictional  ||| S:53298 E:53309 ||| JJ
ratio  ||| S:53309 E:53325 ||| NN
of  ||| S:53325 E:53328 ||| IN
a  ||| S:53328 E:53330 ||| DT
globular  ||| S:53330 E:53339 ||| JJ
protein  ||| S:53339 E:53347 ||| NN
will  ||| S:53347 E:53352 ||| MD
be  ||| S:53352 E:53355 ||| VB
1 ||| S:53355 E:53356 ||| CD
;  ||| S:53356 E:53358 ||| :
that  ||| S:53358 E:53363 ||| IN
of  ||| S:53363 E:53366 ||| IN
an  ||| S:53366 E:53369 ||| DT
elongated  ||| S:53369 E:53389 ||| JJ
protein  ||| S:53389 E:53397 ||| NN
will  ||| S:53397 E:53402 ||| MD
be  ||| S:53402 E:53405 ||| VB
> ||| S:53405 E:53406 ||| CD
1 ||| S:53406 E:53407 ||| CD
.  ||| S:53407 E:53437 ||| .
Stoichiometry  ||| S:53437 E:53451 ||| JJ
determination  ||| S:53451 E:53465 ||| NN
by  ||| S:53465 E:53468 ||| IN
gel  ||| S:53468 E:53472 ||| JJ
scanning  ||| S:53472 E:53491 ||| JJ
T701-Myo1c  ||| S:53491 E:53502 ||| NN
and  ||| S:53502 E:53506 ||| CC
bovine-brain  ||| S:53506 E:53519 ||| JJ
calmodulin  ||| S:53519 E:53530 ||| NN
were  ||| S:53530 E:53535 ||| VBD
separated  ||| S:53535 E:53555 ||| VBN
by  ||| S:53555 E:53558 ||| IN
sodium  ||| S:53558 E:53565 ||| FW
dodecyl  ||| S:53565 E:53573 ||| FW
sulfate  ||| S:53573 E:53581 ||| FW
gel  ||| S:53581 E:53585 ||| FW
electrophoresis  ||| S:53585 E:53601 ||| FW
( ||| S:53601 E:53602 ||| -LRB-
SDS-PAGE ||| S:53602 E:53610 ||| NNP
)  ||| S:53610 E:53622 ||| -RRB-
and  ||| S:53622 E:53626 ||| CC
stained  ||| S:53626 E:53634 ||| NN
with  ||| S:53634 E:53639 ||| IN
Coomassie  ||| S:53639 E:53649 ||| NNP
blue  ||| S:53649 E:53654 ||| JJ
R250 ||| S:53654 E:53658 ||| NN
.  ||| S:53658 E:53660 ||| .
Gels  ||| S:53660 E:53665 ||| NNP
were  ||| S:53665 E:53670 ||| VBD
scanned  ||| S:53670 E:53688 ||| VBN
with  ||| S:53688 E:53693 ||| IN
a  ||| S:53693 E:53695 ||| DT
flatbed  ||| S:53695 E:53703 ||| JJ
scanner ||| S:53703 E:53710 ||| NN
;  ||| S:53710 E:53712 ||| :
calmodulin  ||| S:53712 E:53723 ||| NNS
was  ||| S:53723 E:53727 ||| VBD
quantified  ||| S:53727 E:53738 ||| VBN
using  ||| S:53738 E:53754 ||| VBG
analysis  ||| S:53754 E:53763 ||| NN
of  ||| S:53763 E:53766 ||| IN
the  ||| S:53766 E:53770 ||| DT
resulting  ||| S:53770 E:53780 ||| VBG
images  ||| S:53780 E:53787 ||| NNS
with  ||| S:53787 E:53792 ||| IN
NIH  ||| S:53792 E:53796 ||| NNP
Image  ||| S:53796 E:53802 ||| NNP
version  ||| S:53802 E:53820 ||| NN
1.62 ||| S:53820 E:53824 ||| CD
.  ||| S:53824 E:53826 ||| .
The  ||| S:53826 E:53830 ||| DT
concentration  ||| S:53830 E:53844 ||| NN
of  ||| S:53844 E:53847 ||| IN
the  ||| S:53847 E:53851 ||| DT
T701-Myo1c  ||| S:53851 E:53862 ||| JJ
heavy  ||| S:53862 E:53868 ||| JJ
chain  ||| S:53868 E:53874 ||| NN
was  ||| S:53874 E:53888 ||| VBD
determined  ||| S:53888 E:53899 ||| VBN
by  ||| S:53899 E:53902 ||| IN
measuring  ||| S:53902 E:53912 ||| VBG
absorbance  ||| S:53912 E:53923 ||| NN
at  ||| S:53923 E:53926 ||| IN
280  ||| S:53926 E:53930 ||| CD
nm ||| S:53930 E:53932 ||| NN
,  ||| S:53932 E:53934 ||| ,
although  ||| S:53934 E:53953 ||| IN
the  ||| S:53953 E:53957 ||| DT
analysis  ||| S:53957 E:53966 ||| NN
was  ||| S:53966 E:53970 ||| VBD
complicated  ||| S:53970 E:53982 ||| VBN
by  ||| S:53982 E:53985 ||| IN
the  ||| S:53985 E:53989 ||| DT
uncertain  ||| S:53989 E:53999 ||| JJ
calmodulin  ||| S:53999 E:54020 ||| JJ
stoichiometry  ||| S:54020 E:54034 ||| NNS
(  ||| S:54034 E:54047 ||| -LRB-
p  ||| S:54047 E:54049 ||| LS
) ||| S:54049 E:54050 ||| -RRB-
.  ||| S:54050 E:54052 ||| .
To  ||| S:54052 E:54055 ||| TO
circumvent  ||| S:54055 E:54066 ||| VB
this  ||| S:54066 E:54071 ||| DT
problem ||| S:54071 E:54078 ||| NN
,  ||| S:54078 E:54080 ||| ,
we  ||| S:54080 E:54093 ||| PRP
solved  ||| S:54093 E:54100 ||| VBD
several  ||| S:54100 E:54108 ||| JJ
simultaneous  ||| S:54108 E:54121 ||| JJ
equations  ||| S:54121 E:54131 ||| NN
for  ||| S:54131 E:54146 ||| IN
p  ||| S:54146 E:54148 ||| NN
.  ||| S:54148 E:54150 ||| .
The  ||| S:54150 E:54154 ||| DT
molar  ||| S:54154 E:54160 ||| JJ
extinction  ||| S:54160 E:54181 ||| NN
coefficient  ||| S:54181 E:54193 ||| NN
of  ||| S:54193 E:54196 ||| IN
the  ||| S:54196 E:54200 ||| DT
T701-Myo1c ||| S:54200 E:54210 ||| FW
/ ||| S:54210 E:54211 ||| FW
calmodulin  ||| S:54211 E:54222 ||| FW
complex  ||| S:54222 E:54230 ||| FW
( ||| S:54230 E:54231 ||| -LRB-
ε  ||| S:54231 E:54244 ||| FW
T701-CaM  ||| S:54244 E:54253 ||| FW
)  ||| S:54253 E:54255 ||| -RRB-
is  ||| S:54255 E:54258 ||| VBZ
given  ||| S:54258 E:54264 ||| VBN
by ||| S:54264 E:54266 ||| IN
:  ||| S:54266 E:54278 ||| :
ε  ||| S:54278 E:54291 ||| CD
T701-CaM  ||| S:54291 E:54300 ||| CD
=  ||| S:54300 E:54302 ||| SYM
ε  ||| S:54302 E:54315 ||| FW
T701  ||| S:54315 E:54320 ||| FW
+  ||| S:54320 E:54333 ||| FW
p  ||| S:54333 E:54335 ||| FW
·ε  ||| S:54335 E:54349 ||| FW
CaM  ||| S:54349 E:54353 ||| FW
( ||| S:54353 E:54354 ||| -LRB-
10 ||| S:54354 E:54356 ||| CD
)  ||| S:54356 E:54368 ||| -RRB-
where  ||| S:54368 E:54374 ||| WRB
ε  ||| S:54374 E:54387 ||| JJ
T701  ||| S:54387 E:54392 ||| NN
is  ||| S:54392 E:54395 ||| VBZ
the  ||| S:54395 E:54399 ||| DT
extinction  ||| S:54399 E:54410 ||| NN
coefficient  ||| S:54410 E:54422 ||| NN
of  ||| S:54422 E:54435 ||| IN
the  ||| S:54435 E:54439 ||| DT
T701-Myo1c  ||| S:54439 E:54450 ||| JJ
heavy  ||| S:54450 E:54456 ||| JJ
chain  ||| S:54456 E:54462 ||| NN
alone  ||| S:54462 E:54468 ||| RB
( ||| S:54468 E:54469 ||| -LRB-
57,990  ||| S:54469 E:54476 ||| NNP
M  ||| S:54476 E:54478 ||| NNP
-1cm  ||| S:54478 E:54483 ||| NNP
-1 ||| S:54483 E:54485 ||| NNP
) ||| S:54485 E:54486 ||| -RRB-
,  ||| S:54486 E:54488 ||| ,
ε  ||| S:54488 E:54501 ||| JJ
CaM  ||| S:54501 E:54505 ||| NN
is  ||| S:54505 E:54508 ||| VBZ
the  ||| S:54508 E:54512 ||| DT
extinction  ||| S:54512 E:54523 ||| NN
coefficient  ||| S:54523 E:54535 ||| NN
of  ||| S:54535 E:54548 ||| IN
calmodulin  ||| S:54548 E:54559 ||| NNS
( ||| S:54559 E:54560 ||| -LRB-
2560  ||| S:54560 E:54565 ||| CD
M  ||| S:54565 E:54567 ||| NNP
-1cm  ||| S:54567 E:54572 ||| NNP
-1 ||| S:54572 E:54574 ||| NNP
) ||| S:54574 E:54575 ||| -RRB-
,  ||| S:54575 E:54577 ||| ,
and  ||| S:54577 E:54592 ||| CC
p  ||| S:54592 E:54594 ||| NN
is  ||| S:54594 E:54597 ||| VBZ
the  ||| S:54597 E:54601 ||| DT
calmodulin ||| S:54601 E:54611 ||| NN
: ||| S:54611 E:54612 ||| :
T701  ||| S:54612 E:54627 ||| CD
stoichiometry ||| S:54627 E:54640 ||| NNS
.  ||| S:54640 E:54642 ||| .
The  ||| S:54642 E:54646 ||| DT
concentration  ||| S:54646 E:54660 ||| NN
of  ||| S:54660 E:54663 ||| IN
T701-Myo1c  ||| S:54663 E:54674 ||| CD
heavy  ||| S:54674 E:54690 ||| JJ
chain  ||| S:54690 E:54696 ||| NN
is  ||| S:54696 E:54699 ||| VBZ
given  ||| S:54699 E:54705 ||| VBN
by ||| S:54705 E:54707 ||| IN
:  ||| S:54707 E:54730 ||| :
where  ||| S:54730 E:54736 ||| WRB
A280  ||| S:54736 E:54741 ||| NNP
is  ||| S:54741 E:54744 ||| VBZ
the  ||| S:54744 E:54748 ||| DT
absorbance  ||| S:54748 E:54759 ||| NN
of  ||| S:54759 E:54762 ||| IN
the  ||| S:54762 E:54766 ||| DT
complex  ||| S:54766 E:54774 ||| NN
at  ||| S:54774 E:54777 ||| IN
280  ||| S:54777 E:54781 ||| CD
nm  ||| S:54781 E:54794 ||| NN
for  ||| S:54794 E:54798 ||| IN
a  ||| S:54798 E:54800 ||| DT
1  ||| S:54800 E:54802 ||| CD
cm  ||| S:54802 E:54805 ||| CD
pathlength ||| S:54805 E:54815 ||| NNS
.  ||| S:54815 E:54817 ||| .
Finally ||| S:54817 E:54824 ||| RB
,  ||| S:54824 E:54847 ||| ,
p  ||| S:54847 E:54849 ||| FW
· ||| S:54849 E:54850 ||| FW
[ ||| S:54850 E:54851 ||| -LRB-
T701  ||| S:54851 E:54867 ||| NNP
HC  ||| S:54867 E:54870 ||| NNP
]  ||| S:54870 E:54872 ||| -RRB-
=  ||| S:54872 E:54874 ||| SYM
[ ||| S:54874 E:54875 ||| -LRB-
CaM ||| S:54875 E:54878 ||| NNP
]  ||| S:54878 E:54880 ||| -RRB-
( ||| S:54880 E:54881 ||| -LRB-
12 ||| S:54881 E:54883 ||| CD
)  ||| S:54883 E:54895 ||| -RRB-
where  ||| S:54895 E:54901 ||| WRB
[ ||| S:54901 E:54902 ||| -LRB-
CaM ||| S:54902 E:54905 ||| NNP
]  ||| S:54905 E:54907 ||| -RRB-
is  ||| S:54907 E:54910 ||| VBZ
the  ||| S:54910 E:54914 ||| DT
calmodulin  ||| S:54914 E:54925 ||| JJ
concentration  ||| S:54925 E:54939 ||| NN
determined  ||| S:54939 E:54960 ||| VBN
by  ||| S:54960 E:54963 ||| IN
gel  ||| S:54963 E:54967 ||| JJ
scanning ||| S:54967 E:54975 ||| NN
.  ||| S:54975 E:54977 ||| .
Solving  ||| S:54977 E:54985 ||| VBG
for  ||| S:54985 E:55000 ||| IN
p  ||| S:55000 E:55002 ||| NNS
:  ||| S:55002 E:55043 ||| :
Other  ||| S:55043 E:55049 ||| JJ
methods  ||| S:55049 E:55067 ||| NNS
We  ||| S:55067 E:55070 ||| PRP
measured  ||| S:55070 E:55079 ||| VBD
the  ||| S:55079 E:55083 ||| DT
free  ||| S:55083 E:55088 ||| JJ
Ca  ||| S:55088 E:55091 ||| JJ
2+concentrations  ||| S:55091 E:55108 ||| NN
in  ||| S:55108 E:55111 ||| IN
our  ||| S:55111 E:55125 ||| PRP$
solutions  ||| S:55125 E:55135 ||| NNS
using  ||| S:55135 E:55141 ||| VBG
spectrofluorometry  ||| S:55141 E:55160 ||| NN
with  ||| S:55160 E:55165 ||| IN
Calcium  ||| S:55165 E:55173 ||| NNP
Green-2  ||| S:55173 E:55191 ||| NNP
( ||| S:55191 E:55192 ||| -LRB-
Molecular  ||| S:55192 E:55202 ||| NNP
Probes ||| S:55202 E:55208 ||| NNP
) ||| S:55208 E:55209 ||| -RRB-
.  ||| S:55209 E:55211 ||| .
SDS-PAGE  ||| S:55211 E:55220 ||| NNP
was  ||| S:55220 E:55224 ||| VBD
carried  ||| S:55224 E:55232 ||| VBN
out  ||| S:55232 E:55236 ||| RP
with  ||| S:55236 E:55241 ||| IN
18 ||| S:55241 E:55243 ||| CD
%  ||| S:55243 E:55255 ||| NN
acrylamide  ||| S:55255 E:55266 ||| FW
Criterion  ||| S:55266 E:55276 ||| FW
gels  ||| S:55276 E:55281 ||| FW
( ||| S:55281 E:55282 ||| -LRB-
Bio-Rad  ||| S:55282 E:55290 ||| NNP
Laboratories ||| S:55290 E:55302 ||| NNPS
;  ||| S:55302 E:55314 ||| :
Hercules ||| S:55314 E:55322 ||| NNP
,  ||| S:55322 E:55324 ||| ,
CA ||| S:55324 E:55326 ||| NNP
) ||| S:55326 E:55327 ||| -RRB-
;  ||| S:55327 E:55329 ||| :
gels  ||| S:55329 E:55334 ||| NNS
were  ||| S:55334 E:55339 ||| VBD
stained  ||| S:55339 E:55347 ||| VBN
with  ||| S:55347 E:55352 ||| IN
Coomassie  ||| S:55352 E:55362 ||| NNP
blue  ||| S:55362 E:55377 ||| JJ
R250 ||| S:55377 E:55381 ||| NN
.  ||| S:55381 E:55414 ||| .
Authors ||| S:55414 E:55421 ||| NNP
'  ||| S:55421 E:55423 ||| POS
contributions  ||| S:55423 E:55445 ||| NNS
Author  ||| S:55445 E:55452 ||| NN
1  ||| S:55452 E:55454 ||| CD
( ||| S:55454 E:55455 ||| -LRB-
PGG ||| S:55455 E:55458 ||| NNP
)  ||| S:55458 E:55460 ||| -RRB-
conceived  ||| S:55460 E:55470 ||| VBD
of  ||| S:55470 E:55473 ||| IN
the  ||| S:55473 E:55477 ||| DT
experimental  ||| S:55477 E:55490 ||| JJ
approach ||| S:55490 E:55498 ||| NN
,  ||| S:55498 E:55508 ||| ,
carried  ||| S:55508 E:55516 ||| VBD
out  ||| S:55516 E:55520 ||| RP
many  ||| S:55520 E:55525 ||| JJ
of  ||| S:55525 E:55528 ||| IN
the  ||| S:55528 E:55532 ||| DT
experiments ||| S:55532 E:55543 ||| NNS
,  ||| S:55543 E:55545 ||| ,
supervised  ||| S:55545 E:55556 ||| VBD
the  ||| S:55556 E:55568 ||| DT
technician  ||| S:55568 E:55579 ||| NN
who  ||| S:55579 E:55583 ||| WP
performed  ||| S:55583 E:55593 ||| VBD
the  ||| S:55593 E:55597 ||| DT
remainder ||| S:55597 E:55606 ||| NN
,  ||| S:55606 E:55608 ||| ,
developed  ||| S:55608 E:55618 ||| VBD
the  ||| S:55618 E:55630 ||| DT
methods  ||| S:55630 E:55638 ||| NNS
for  ||| S:55638 E:55642 ||| IN
analysis ||| S:55642 E:55650 ||| NN
,  ||| S:55650 E:55652 ||| ,
analyzed  ||| S:55652 E:55661 ||| VBD
and  ||| S:55661 E:55665 ||| CC
interpreted  ||| S:55665 E:55677 ||| VBD
the  ||| S:55677 E:55681 ||| DT
data ||| S:55681 E:55685 ||| NNS
,  ||| S:55685 E:55695 ||| ,
and  ||| S:55695 E:55699 ||| CC
wrote  ||| S:55699 E:55705 ||| VBD
the  ||| S:55705 E:55709 ||| DT
manuscript ||| S:55709 E:55719 ||| NN
.  ||| S:55719 E:55721 ||| .
Author  ||| S:55721 E:55728 ||| NN
2  ||| S:55728 E:55730 ||| CD
( ||| S:55730 E:55731 ||| -LRB-
JLC ||| S:55731 E:55734 ||| NNP
)  ||| S:55734 E:55736 ||| -RRB-
contributed  ||| S:55736 E:55748 ||| VBD
to  ||| S:55748 E:55751 ||| TO
the  ||| S:55751 E:55763 ||| DT
development  ||| S:55763 E:55775 ||| NN
of  ||| S:55775 E:55778 ||| IN
the  ||| S:55778 E:55782 ||| DT
experimental  ||| S:55782 E:55795 ||| JJ
approach ||| S:55795 E:55803 ||| NN
,  ||| S:55803 E:55805 ||| ,
helped  ||| S:55805 E:55812 ||| VBD
analyze  ||| S:55812 E:55828 ||| JJ
and  ||| S:55828 E:55832 ||| CC
interpret  ||| S:55832 E:55842 ||| VB
the  ||| S:55842 E:55846 ||| DT
data ||| S:55846 E:55850 ||| NNS
,  ||| S:55850 E:55852 ||| ,
and  ||| S:55852 E:55856 ||| CC
edited  ||| S:55856 E:55863 ||| VBG
the  ||| S:55863 E:55867 ||| DT
manuscript ||| S:55867 E:55877 ||| NN
.  ||| S:55877 E:55894 ||| .
